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Abstract
The impact upon cognitive function as a result of major depressive disorder (MDD) has
been consistently documented, with depressed individuals demonstrating extensive and
varied cognitive deficits. The pattern of deficits seen in MDD could be partially explained
by a dysfunction of working memory. However, attempts to determine whether or not
depressed individuals are in fact impaired on tasks reliant on working memory have
produced results that are inconsistent. Yet, both resting state and activation studies of
patients with MDD have identified functional impairments in regions of cortex commonly
associated with normal working memory function in healthy adults. The main aims of this
series of investigations were to determine (1) whether individuals with a diagnosis ofmajor
depression where significantly impaired on a parametric working memory task (i.e. the n-
back task), compared to matched controls, and (2) whether any significant difference
between the experimental groups was associated with a significant group difference in
cortical activation during performance of the task (i.e. using BOLD fMRl). It was
determined that the consumption of anti-depressant medication in the patient group was a
potential confounder of any observations in the first two experiments. Thus, additional
aims of this study were to determine (3) whether the administration of anti-depressant
medication had any significant behavioural effect upon performance on the n-back task, and
(4) whether the consumption of anti-depressant medication had any significant effect upon
the pattern ofactivation observed during performance of the task. In order to address these
aims three experimental studies were conducted. (1) Experiment One: Working Memory
in Depression: The performance of twenty individuals with MDD and twenty matched,
healthy controls was assessed on the n-back task (i.e. accuracy (percentage correct) and
reaction time (msec)). Analysis of the data revealed a significant main effect ofparticipant
group with regards to both accuracy and reaction time (i.e. Fa. 3av=5.93, p = 0.02 and
Fn.38f=25.16, p < 0.001, respectively), with patients showing lower mean accuracy scores,
and higher mean reaction times. (2) Experiment Two: Working Memory in Depression: a
functional MRI study: Ten individuals with MDD and ten matched, healthy controls
undertook the n-back task while undergoing fMRI scanning. Analysis of the behavioural
data revealed a significant main effect of participant group on mean accuracy scores (i.e.
Fa.i«= 4.727, p = 0.043), with patients exhibiting lower average scores across all task levels.
However, there was no significant main effect ofparticipant group on mean reaction time.
Analysis of the functional imaging data, using SPM99, revealed a significant difference
between patients and controls in the level of activation in the medial orbital prefrontal
cortex/ subgenual anterior cingulate with increased task difficulty, i.e. level ofactivation in
patients was greater in this region compared to controls (i.e. Ke=128, p(comcted>=0.025). (3)
Experiment Three: The effect of escitalopram on working memory in normal, healthy
adults: A functional MRI study: Ten healthy volunteers were given escitalopram for 7
consecutive days, i.e. lOmg/day. Participants were scanned while medication free and on
the final day of their prescription. The consumption of escitalopram did increase
participants' subjective assessment of state anxiety (i.e. t m = -2.172, p = 0.029), but there
was no effect ofmedication status on either aspect ofbehavioural performance on the n-back
task. Random effects analysis of the functional imaging data revealed no significant
differences between conditions with regards to the level of activation in any area of cortex.
Overall, the results of this study were indicative of a significant dysfunction of working
memory in individuals with major depression. Furthermore, it would appear that this
observed dysfunction was associated with a quantitative difference in the level offunctional
activation in the medial orbital prefrontal cortex/subgenual anterior cingulate in depressed
patients. Moreover, the results of the final experiment in this series allow us to speculate
that the differences, both behavioural and functional, noted between patients and controls
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Chapter 1: Literature Review
1.1 Major Depression
1.1.1 Epidemiology of major depression
Major depressive disorder (MDD) is a psychiatric illness that is not only common in the
general population but is of significant personal and social concern. Individuals suffering
from depression commonly experience reduced productivity and quality of life, in
conjunction with a significant increase in mortality (Doris, Ebmeier & Shajahan, 1999).
Moreover, the World Health Organisation's Global Burden of Disease project rated
depressive illness as the second major cause of disease burden in developed countries, and
has predicted this burden to increase (Patten, 2003).
Understanding the impact of major depression is reliant on access to accurate
epidemiological data. However, as a result of varied methodological approaches accurate
epidemiological data is difficult to obtain. These methodological differences extend not only
to the operational definitions of depression employed in individual studies but also to
sampling methods and methods of data acquisition. While some studies have examined the
incidence and prevalence of major depression via community studies (e.g. Kessler et al.,
2003), other epidemiological investigations have relied on the clinical records of individuals
receiving treatment for affective disorders in a given region. However, despite the
differences in methodology between studies it is possible to obtain a reasonable impression
of the general epidemiology of major depression by considering the comparative evidence
from studies that have employed different methodological approaches.
One indication of the incidence of depression in the general population is the number of
individuals currently receiving either in- or outpatient hospital care for affective disorders.
In 2001-2002 there were 52,569 hospital admissions for affective disorders in England and
Wales (source: Department of Health, United Kingdom, http://www.doh.gov.uk. accessed
28/10/03). In this same period it was estimated that worldwide cases of unipolar depression
amounted to 150,762,000 out of an estimated total population of 6,122,210,000 (i.e.
approximately 2.5%; source: World Health Organisation, Global Burden of Disease Study,
http://www3.who.int. accessed 28/10/03).
1
However, community based surveys have estimated that the true incidence may be greater
than consideration of hospital admissions may indicate. The advantage of this type of
approach is that it allows for the inclusion of individuals who may be experiencing
symptoms of depression but who do not seek treatment to be in incidence estimates. A
recent community based survey of a sample of 9090 American adults predicted the lifetime
rate ofMDD to be around 16%, with a 12-month rate of 6.6%.
Epidemiological studies of the rate of depression also indicate an increase in the incidence of
unipolar affective disorders, in conjunction a successive decrease in the average age of
depressed cohorts across time. Although it may be argued that these changes are the result
of social or environmental influences on the rate of depression, it is imperative to consider
alternative explanations for the apparent alterations in the characteristics of depressed
individuals. Indeed, there are a variety of potential explanations for these changes in the
demographics of the MDD population. For example, the increased incidence of unipolar
depression may reflect changes in diagnostic criteria or increased likelihood of presentation,
as opposed to a genuine change in the prevalence of major depression. Similarly, the
successive decrease in the mean age of depressed populations may be attributed to a greater
awareness of the likelihood of affective disorders in adolescent populations that may
influence the probability of diagnosing major depression in younger individuals, rather than
the presence of affective disorders in younger cohorts being a novel phenomenon.
1.1.2 Defining major depression
'Depression' commonly denotes a general lowering of mood, or feeling of sadness. Yet, the
experience of the clinically depressed individual could reasonably be defined as being more
severe than this commonly accepted definition infers. It is, therefore, imperative to establish
the boundary between the normal experience of sadness and the pathological state that
constitutes depressive illness. However, in order to make this distinction it is essential to
appreciate the complexity of the range of symptoms that characterise major depression.
Indeed, clinically depressed individuals will not only experience a lowering in their mood,
but may also endure a loss of interest in or ability to experience pleasure and feelings of
worthlessness and guilt. Moreover, individuals with major depression will also commonly
exhibit changes in thought, activity, social behaviour, and vegetative functions (Beaumont,
Kenealy & Rogers, 1999).
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The diagnostic criterion for a major depressive episode (MDE) in DSM-IV (American
Psychiatric Association, 1994) reflects the intricacy in depressive symptomology. The DSM
model of MDE is inclusive of alterations of mood, pleasure, and body weight, disorders of
sleep, psychomotor retardation or agitation, feelings worthlessness or guilt, diminished
ability to think or concentrate, and recurrent thoughts of death or suicidal ideation. Within
this framework major depressive disorder (MDD) is defined as the occurrence of one or
more major depressive episodes.
Despite certain commonalities in the experience of major depression, the pattern of
symptoms observed in depressed patients can vary quite dramatically between individuals.
This also needs to be accounted for in any reasonable attempt at classification. Therefore,
rather than adopting a monothetic approach to defining depression - i.e. where all
properties are both necessary and sufficient for classification - diagnostic tools such as DSM-
IV assume a polythetic approach. Within this approach an individual may be diagnosed as
suffering from depression if they exhibit a selection of the properties that have been defined
as characteristic of this particular class of illness. Moreover, this approach recognises that a
significant proportion of patients may experience a specific symptom (or symptoms) but that
no single symptom is necessary or sufficient for diagnosis.
The complexity of depression is evident in approaches to classifying depressive illness is
also reflected in measures of severity of depressive illness. There are numerous indices
available for determining the intensity of an individual's depression, for example measures
such as the Beck Depression Inventory (BDI) (Beck et al., 1961) and the Hamilton Rating
Scale for Primary Depressive Illness (HRSD) (Hamilton, 1967). Both of these measures
consider the potential spectrum of depressive symptoms in their assessment of severity of
depression.
Therefore, in empirical investigations of major depression it may be more productive to
consider an operational definition of major depression that relies on clinical diagnosis in
conjunction with an appropriate measure of symptom severity. The outcome of this
approach is an operational definition of unipolar, major depressive illness that allows us to
appreciate the complexity of the experience of depressive illness. Moreover, this approach
to the classification of depressed participants in experimental studies can enable the
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determination of the relative impact of different aspects of depression and its severity on
other experimental measures.
1.1.3 Profile of cognitive function in major depression
Major depression is not only defined by the presence of certain abnormalities in affect, but is
also characterised by dysfunction in aspects of cognitive function. While unipolar
depression is commonly associated with the disorder of psychological constructs such as
attitudes or attributions, individuals with depression also exhibit a tendency to experience
dysfunction in the more general processing, storage, and retrieval of information. It is this
latter dysfunction of cognition that is the focus of this section.
Neisser, (1967) defined cognition as "all the processes by which the sensory input is
transformed, reduced, elaborated, stored, recovered, and used" (p.4). Thus, within this
framework the term 'cognition' may be defined as those functions pertaining to sensation,
perception, imagery, attention, recall, memory, problem solving, and thinking.
Consequently, cognitive dysfunction may be defined as a disorder of any or all of these
processes.
In order to ascertain the cognitive profile in unipolar depression there are a number of
factors that it is necessary to consider. Firstly, cognitive dysfunction has traditionally been
considered a transitory aspect of depressive illness and may only last as long as the
depressive episode (Bazin et al., 1994; Moffoot et al., 1994; Elliott, 1998). However, recent
evidence has been indicative of persistent deficits in cognition in chronic and treatment
resistant cases of depressive illness (Kessing, 1998). The persistence of cognitive deficits may
be associated with depressive subtype (Austin et al., 1999) or treatment, e.g.
electroconvulsive therapy (ECT). In addition, as with the expression of other symptoms,
cognitive dysfunction observed during a MDE can vary between individuals in both nature
and severity.
Therefore, in order to determine a model of cognitive dysfunction in major depression it is
imperative to consider: (1) whether there is reasonable evidence of cognitive dysfunction in
major depression; (2) the profile of cognitive deficits commonly observed in major
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depression; (3) the factors that underlie such dysfunctions; and (4) whether such deficits are
trait or state aspects of depressive illness.
1.1.3.1 Summary of cognitive deficits in major depression
A considerable volume of research literature has been concerned with cognitive function
associated with depressive illness. However, there have been notable differences in the
outcomes of such investigations. While some studies have noted a significant deficit in
depressed patients in a number of different cognitive processes (e.g. Austin et al., 1992;
Brown et al., 1994; Moffoot et al., 1994; Beats, Sahakian & Levy, 1996; Elliott et al., 1996;
Austin et al., 1999; Landro, Stiles & Sletvold, 2001; Ravnkilde et al., 2002), others have found
no or little evidence of impairment in measures of cognitive function (e.g. Miller et al., 1991).
This variability in empirical observations between studies makes it difficult to ascertain
whether there are reasonable grounds for presuming a pattern of specific cognitive
impairment in major depression, or whether depressed individuals experience a global
impairment of cognitive function.
One possible explanation is that the inconsistencies in experimental findings between
different studies have arisen from the substantial diversity in approaches to studying
cognitive function in major depression. While some studies have been relatively
conservative in their choice and definition of depressed samples, examining deficits in
clearly defined sub-samples of depressed individuals, others have considered cognitive
function in more diverse samples of patients, e.g. including individuals with unipolar and
bipolar depression (BD), and with various between subjects differences in history and
symptom presentation. Similarly, studies have also been relatively diverse in the cognitive
processes that they studied and the assessments employed, e.g. while some studies have
examined a variety of aspects of cognition using well known neuropsychological batteries,
others have chosen to examine single cognitive functions with less well known or specially
designed tasks.
The methodological variation between studies makes it a potentially complex task to
ascertain a reliable model of the cognitive function in individuals with MDD. A potential
solution to this issue is to determine those cognitive functions that are consistently noted as
being impaired in depressed patients across studies and that appear to show a deficit
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associated with the affective facets of depressive illness. This may be achieved by
ascertaining commonalities in the approaches of different investigators, and by identifying
similar observations between studies, irrespective of the similarities or differences in
experimental methodologies.
Bearing this in mind, the aim of this section is to review the literature pertinent to cognitive
function in depression in order to ascertain the potential profile of cognitive deficit in major
depression. Although important relationships do exist between a number of the cognitive
functions explored here, some processes which are intrinsically linked (e.g. information
processing and attention) have been dealt with separately.
(Note: A summary of the original articles and review papers examining cognitive and
neuropsychological deficits in depression which were considered in this review are
presented in Appendices 1A and IB).
Psychomotor function
Disturbance of psychomotor function is a common aspect of unipolar depression.
Psychomotor dysfunction is so commonplace in patients suffering from MDD that it is
included as a diagnostic criterion in classification systems such as DSM-IV and ICD-10. One
potential reason for its inclusion may be the high predictive value of psychomotor
dysfunction for the presence of depressive illness. Indeed, in an examination of the
predictive value of each individual diagnostic criteria on DSM-III one study found that
psychomotor change was one of the best predictors of MDD (i.e. Buchwald & Rudickdavis,
1993).
The profile of psychomotor function observed in depressed patients includes both
psychomotor retardation and agitation. Moreover, impairment has been noted in varied
aspects of psychomotor function such as gross motor activity, body movement, speech, and
motor response time (Sobin & Sackeim, 1997). Despite the importance of all of these factors
in accounting for psychomotor disturbance in major depression, in this instance our concern
is with those aspects pertaining to cognitive function.
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A number of investigations have observed psychomotor dysfunction associated with the
performance of tests of cognition (e.g. Beats et al., 1996; Austin et al., 1999, Moffoot et al.,
1994; Ilsley, Moffoot & O'Carroll, 1995; Moritz et al., 2002; Ravnkilde et al., 2002). These
studies have all noted evidence of psychomotor slowing in individuals with major
depressive illness compared to matched, healthy controls, on a number of different cognitive
measures. The assessments used in these investigations have included both simple and
choice reaction time (RT) tasks (i.e. Beats et al., 1996; Austin et al., 1999), measures of verbal
fluency (i.e. Beats et al., 1996; Austin et al., 1999), the digit symbol substitution (DSST) of the
Wechsler Adult Intelligence Scale - Revised (WAIS-R: Wechsler, 1981; i.e. Moffoot et al.,
1994; Ilsley et al., 1995; Ravnkilde et al., 2002), the reaction time measure of the Cambridge
Automated Neuropsychological Test Battery (CANTAB: Robbins et al., 1994; i.e. Moffoot et
al., 1994), and the Trails A and B tasks (Reitan, 1992; i.e. Moritz et al., 2002; Ravnkilde et al.,
2003).
However, not all studies that have considered psychomotor function in MDD have found
evidence of significant deficits. In a study of one hundred and twenty three depressed
outpatients, Grant and colleagues found no evidence of psychomotor dysfunction in
depressed patients compared to controls on the Trails A task (Grant, Thase & Sweeney,
2001). Likewise, the failure to observe any significant deficit in psychomotor function has
also been noted in other investigations, on a range of neuropsychological measures (e.g.
Miller et al., 1991; Sweeney, Kmiec & Kupfer, 2000).
Despite the contradictory indications of these latter findings there does appear to be greater
support for the notion of psychomotor slowing in major depression. For example, in a
review of cognitive function in MDD, which considered papers over a period of twenty-two
years, Veiel concluded that there was evidence of psychomotor slowing across studies
(Veiel, 1997). A number of studies that met the inclusion criteria for the review found that
on choice reaction time measures patients with MDD performed worse than controls.
Moreover, one of the studies included in this review had considered both
electrophysiological and behavioural measures of psychomotor performance. The authors
proposed that the deficit seen in choice reaction time in depression was not due to the
slowing of perceptual processes, but rather could be attributed to slowing of the response
processing stages (i.e. Knott & Lapierre, 1987).
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Consequently, it is reasonable to conclude that there is evidence of psychomotor slowing
associated with performance of cognitive tasks in patients with major depression. However,
while these studies provide rather consistent evidence of psychomotor impairment in major
depression, there are number of important factors regarding these studies that should be
noted. Firstly, Austin and colleagues noted that while there was clear evidence of
psychomotor retardation in a sub-group of melancholic patients compared to healthy
controls, non-melancholic patients were largely unimpaired (Austin et al., 1999). In
addition, Moffoot found that in depressed patients with a diagnosis of melancholia and clear
diurnal variation in mood, the degree of psychomotor deficit seen in patients was more
severe and extensive in the morning (Moffoot et al., 1994).
It is also important to note that this particular deficit does not appear to be task specific. The
generalised nature of psychomotor dysfunction in depressed patients has been suggested as
evidence for the notion that psychomotor retardation may be a causal factor in the range of
cognitive dysfunctions observed in MDD. Nonetheless, studies that have observed
psychomotor dysfunction in samples of depressed individuals have observed that when
psychomotor performance is included as a co-variate in analysing cognitive performance
that it cannot account for the difference seen between patients and controls on all measures
of cognitive performance (i.e. Ravnkilde et al., 2002). Moreover, studies that have failed to
find differences between MDD patients and healthy controls on measures of psychomotor
function have still observed depression associated deficits on other measures of cognitive
function, such as performance on the Wisconsin Card Sorting Test (WCST; Heaton, 1981) (i.e.
Grant et al., 2001), attention (i.e. Miller et al., 1991), and episodic memory (i.e. Sweeney et al.,
2000).
Information processing
■ Effortful vs. automatic processing
It has long been a popular notion that the resources available to an individual for cognitive
processing are limited. Moreover, it has been suggested that the amount of processing
required varies between different tasks (Kahneman, 1973). This further implies that
different tasks place unequal demands upon the information processing system, resulting in
different classes of information processing tasks.
8
Broadly speaking one can separate the types of information processing that individuals
require to perform cognitive tasks into 'effortful' and 'automatic' processes (Hasher & Zacks,
1979). 'Effortful' tasks are defined as those cognitive tasks that an individual must initiate
intentionally, which are amenable to the effects of practice, and which place a high level of
demand upon the attentional resources of the information processing system. In addition,
effortful tasks also show a tendency to interfere with the ability of an individual to
effectively process other tasks that also require attentional resources. 'Automatic' tasks, on
the other hand, occur without conscious awareness and intention, do not benefit from
practice, and place minimal demand upon attentional resources. Moreover, a task that is
automatic in nature should not interfere with the processing of cognitively demanding tasks
(Posner & Snyder, 1975).
Although the distinction between effortful and automatic information processing is one that
is useful both theoretically and in research settings, cognitive theorists have suggested that it
is not sufficient to describe all cognitive processes in terms of just these two categories, and
that instead information may be better described in terms of a continuum of automaticity.
Major depression is commonly associated with increased levels of state stress, which may be
contributory to the profile of information processing function observed in MDD. Hasher and
Zacks (1979) argued that conditions of stress place demands upon attentional resources, and
as a result would be expected to interfere with the effective processing of effortful cognitive
tasks, but not automatics ones. Consequently, it has been postulated that MDD will be
associated with an impairment of tasks that place high demands on attentional resources, i.e.
effortful tasks, and a relative sparing of low demand, i.e. automatic, tasks, as a result of
stress-mediated demands on processing resources (e.g. Hartlage et al., 1993). This notion has
been supported by evidence from a number of investigations which have noted a significant
difference between depressed patients and healthy controls on measures of effortful
processing (e.g. Golinkoff & Sweeney, 1989; Roy-Byrne et al., 1986; Beats et al., 1996;
Thomas, Goudemand & Rousseaux, 1999).
One of the most extensive reviews of automatic and effortful processing was conducted by
Hartlage and colleagues (i.e. Hartlage et al., 1993). This review considered a wide range of
mnemonic and non-mnemonic cognitive tasks, including: intellectual functioning; problem
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solving; general learning; encoding; reading; psychomotor retardation; and automatic
processing (e.g. frequency encoding, spatial location, and activation of self-relevant content).
The authors concluded that depression was associated with an impairment of effortful
processing, across a range of tasks. Conversely, it was observed that depressed individuals
experienced only a minimal amount of interference in automatic processing. They further
noted that the level of impairment was related to the degree of effortfulness of the task,
severity of depression, and the valence of the stimulus material used.
Despite the obvious discrepancies in the performance of effortful and automatic tasks noted
in depressed individuals there remains the issue of whether this difference is due to the
degree of automaticity or effortfulness required by the task or whether it can be attributed to
some other factor of performance. It has been suggested that the difference between the two
types of task may simply be the result of differences in the degree of difficulty of tasks. By
their nature effortful tasks do tend to be more complex and difficult to perform, while
automatic tasks are often more simple and easier to perform. Thus, it is essential that this
difference be taken into account when considering the evidence of impairment in
information processing associated with major depression.
Irrespective of how the available data is interpreted, there is considerable evidence of
impairment in effortful information processing associated with depression. However, at
least one paper concerned with relative performance of patients and controls on measures of
automatic and effortful tasks noted that the difference in performance between tasks could
not be solely explained by the level of automaticity (i.e. Thomas et al., 1999). In this study
individuals with major depression were compared to healthy controls on levels of a task that
differed in the degree of effortfulness. Participants were asked to attempt simple and choice
reaction time variations of two types of attentional task: (1) the combination of two
concurrent tasks, and (2) tasks involving decision-making. The authors observed that while
control participants performed worse on the dual task conditions, compared to the single
task condition, the opposite was true of depressed patients. Moreover, depressed patients
were significantly impaired, with regards to both accuracy and timing, on those tasks that
involved decision-making processes. It was concluded that the pattern of results indicated a
more specific pattern of impairment on effortful tasks and that individuals suffering from
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depression may be able to successfully undertake tasks that are effortful in their nature as
long as they do not include a decision-making component.
" Speed of information processing
In addition to the proposed deficit in effortful information processing, it has been suggested
the depressed patients also experience impairments in the speed of information processing.
Evidence of this type of cognitive dysfunction has come from studies that have examined
speed of processing during the investigation of depressed patients on a battery of
neuropsychological assessments. For example, Austin noted an impairment of information
processing speed in a group of melancholic patients using simple and choice reaction time
measures, compared to matched controls (Austin et al., 1999). Similarly, Beats and
colleagues also observed impaired speed of processing in a sample of elderly depressed
patients on a choice reaction time task (Beats et al., 1996).
Information processing speed has also been examined in studies which made no other
assessment of cognitive function in depressed patients (e.g. Tsourtos, Thompson & Stough,
2002). Tsourtos and colleagues assessed information processing in patients with MDD and
matched controls using an 'inspection time' task. The advantage of the inspection time
paradigm is that it provides a measure of speed of processing without the need for a
speeded motor response. As with those studies that considered processing speed in
conjunction with other cognitive measures, this investigation concluded that patients were
indeed impaired on this measure of processing speed. In addition to the use of this simple
performance measure, a further advantage of this study was its use of young, unmedicated,
unipolar depressed patients. It has previously been suggested that cognitive slowing is only
associated with depressive illness in middle aged and elderly individuals (Purcell et al.,
1997). However, this latter study provides evidence that impairments traditionally
associated only with older depressed patients may in fact be characteristic of major
depression irrespective of age.
Mnemonic function
Impairments in mnemonic function have been one of the most frequently investigated and
reported deficits in studies of cognitive function in depression (e.g. Austin et al., 1992;
Austin et al., 1999; Bazin et al., 1994; Beats et al., 1996; Brand, Jolles & Gispen-de Wied, 1992;
Brown et al., 1994; Elliott & Greene, 1992; Elliott et al., 1996; Ilsley et al., 1995; Landro et al.,
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2001; Moffoot et al., 1994; Beats et alv 1996; Ravnkilde et al., 2003). Studies have examined
performance on a variety of measures of memory function in depressed patients, including
verbal and visuospatial measures of both short- and long-term memory. Given the scope of
research that has considered mnemonic function in depression, the various subsystems of
human memory, and the variety of tasks employed it is advisable to consider the evidence
pertaining to each subsystem separately.
(Note: As a result of its close association with others functions that come under the collective
title of 'executive function', working memory (WM) function in depression will be discussed
in the following sub-section).
■ Short-term memory (STM)
'Short-term memory' refers to a passive, limited, and temporary information store (see
section 1.2). According to traditional models of human memory, the short-term store
facilitates the encoding of information from sensory memory, it's temporary storage, and
potential transferral to a long-term memory store (Atkinson & Shiffrin, 1968). Depressed
patients commonly report a subjective feeling of dysfunction in their short-term memory.
However, the empirical data suggests that there may not be an obvious impairment of the
short-term store in MDD.
Despite the subjective ratings of patients samples, there are studies which are indicative of
sparing of the short-term memory systems in adults with MDD (e.g. Cohen et al., 1999
Moffoot et al., 1994; Beats et al., 1996; Purcell et al., 1997; Sweeney et al., 2000; Grant et al.,
2001). In one study, which compared the profile of cognitive deficit in schizophrenic and
depressed patients, individuals with a diagnosis of MDD were found to be unimpaired on
two measures of short-term function compared to normal controls, i.e. digit span and word
span recall tasks (Cohen et al., 1999). Grant and colleagues observed a similar pattern of
results in a larger scale investigation. This study examined STM function on a variety of
cognitive tasks, in a sample of more than one hundred depressed outpatients. The authors
concluded that there was no evidence of a significant difference between patients and
matched controls on measures of both visual and verbal short-term memory (Grant et al.,
2001).
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Miller also failed to find any significant dysfunction in either verbal or visuospatial STM in a
sample of depressed patients, on short-term memory measures of the Luria-Nebraska
Neuropsychological Battery (LNNB: Golden et al., 1985; Miller et al., 1991). However, while
these findings are in concordance with the studies outlined above, it should be noted that
the LNNB was originally designed for use with neurologically impaired patients, and thus
may not be sensitive enough to detect cognitive differences between depressed patients and
healthy controls. Moreover, as opposed to more traditional neuropsychological batteries,
which adopt a qualitative, psychometric approach to assessment, the LNNB is based on a
theory of higher cortical functioning. Although the converse may be true, it is possible that
adopting such an approach to paradigm may affect the reliability of this measure when used
with other clinical populations.
In contrast to these investigations, there are studies which are indicative of a dysfunction of
short-term memory associated with major depression (e.g. Wolfe et al., 1987; Miller et al.,
1991; Austin et al., 1992; Brand et al., 1992; Brown et al., 1994; Beats et al., 1996; Elliott et al.,
1996; Kessing, 1998; Austin et al., 1999; Shah et al., 1999; Moritz et al., 2002; Ravnkilde et al.,
2002; Porter et al., 2003). On one hand, there are a number of investigations that have found
evidence of a deficit in verbal STM in MDD patients, compared to control participants on a
variety of assessments of verbal learning such as the Rey Auditory Verbal Learning Test
(RAVLT; Rey, 1964) (e.g. Wolfe et al., 1987; Miller et al., 1991; Austin et al., 1992; Brown et al.,
1994; Austin et al., 1999), the California Verbal Learning Test (CVLT; Delis et al., 1987) (e.g.
Elderkin-Thompson et al., 2003), and the Luria Verbal Learning Test (Christensen, 1975) (e.g.
Ravnkilde et al., 2002). Thus, suggesting a reliable impairment of verbal STM in MDD.
There are also studies that have noted impairment in the visuospatial short-term store in
MDD. In a sample of elderly depressed patients, Beats found evidence of a significant
depression related impairment using a battery of tests of visuospatial memory, i.e. pattern
and spatial recognition, delayed match-to-sample (DMTS) and paired-associated learning
subtests of the CANTAB (Robbins et al., 1994; in Beats et al., 1996). Similarly, Elliott and
colleagues also noted deficits on pattern and spatial recognition and DMTS tasks in a group
of middle aged, chronically depressed patients, compared to healthy controls (Elliott et al.,
1996).
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These observations have also been replicated in more specific sub-groups of depressed
patients. Indeed, Porter observed a significant difference between medication free patients
(i.e. for a minimum period of 6 weeks prior to testing) and a group of matched controls on
all of these CANTAB assessments (Porter et al., 2003). Thus, suggesting that impaired short-
term visuospatial ability associated with MDD is a manifestation of depressive illness rather
than an effect of anti-depressant medication.
The observed disparity in findings between studies regarding short-term memory in MDD
may be the result of methodological differences between studies. Therefore, in order to
determine whether MDD is associated with an attenuation of STM function it may be more
appropriate to examine the findings of meta-analytical or review papers of cognitive
function in major depression.
There are a number of articles which have reviewed mnemonic function in MDD (e.g.
Cassens, Wolfe & Zola, 1990; Roediger & McDermott, 1992; Burt, Zembar & Neiderehe, 1993;
Christensen et al., 1997; Zakzanis, Leach & Kaplan, 1998; Austin, Mitchell & Goodwin, 2001;
Porter et al., 2003; Tavares, Drevets & Sahakian, 2003). However, the majority of reviews
have either concerned themselves with the various subdivisions in long-term memory or do
not make clear distinctions between short- and long-term memory processes in their analysis
of relevant studies. Despite this, there are a handful of reviews that have findings pertinent
to STM function in major depression.
Cassens reviewed available literature, over a fifteen year period, which had considered
cognitive function in depression (Cassens et al., 1990). This review observed that there was
evidence of 'significant and reproducible deficits' in learning verbal material and in
narrative recall (pp 206). Furthermore, the authors also noted that there was evidence of
dysfunction in numerous tests of nonverbal learning, in conjunction with a relative sparing
of 'facial recall' (i.e. memory for faces), associated with MDD. However, while evidence was
included from studies utilising STM tasks to assess these types of function, the authors did
not clearly distinguish between the relative long-term and short-term processes in each of
these functions in drawing their conclusions. Therefore, it is difficult to ascertain whether
this review is indicative of a significant dysfunction of STM or just of the general processes
involved in human memory, such as encoding.
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Given the large body of supporting evidence, it seems reasonable to conclude that there is, to
some degree, an impairment of both verbal and visual STM associated with MDD.
However, given that there is inconsistency in the findings between different studies, it is
important that the potential differences between investigations in specific pertinent factors
that may contribute to the differences in experimental observations are considered. This
issue shall be broached in subsequent sections of this chapter.
■ Long-term memory (LTM)
'Long-term memory' traditionally refers to the more permanent storage of information (see
section 1.2). While there is considerable debate in cognitive psychology as to the duration
and capacity of a LTM store, it is commonly accepted that the memories retained in this store
can be characterised as either 'implicit' or 'explicit' memory. Within this model, implicit
tasks are defined as those on which performance is not reliant on conscious recollection of a
learning event. Explicit tasks, on the other hand, require individuals to consciously recall or
remember information that they have previously learned. Research into LTM in major
depression has largely focussed on the relative performance of patients on these two sub¬
types of long-term memory performance.
As opposed to the research literature concerned with short-term memory, the evidence
regarding the integrity of long-term memory in MDD is relatively consistent. A number of
studies have directly compared the performance of patients with major depression and
healthy controls on measures of both implicit and explicit memory and noted an impairment
of the latter, but not the former (e.g. Denny & Hunt, 1992; Bazin et al., 1994; Ilsley et al., 1995;
Cassens et al., 1990; MacQueen et al., 2002). Moreover, dysfunction in explicit memory in
depressed patients has been observed using a variety of different cognitive tasks, including
cued and free recall (i.e. Cassens et al., 1990; Denny & Hunt, 1992; Bazin et al., 1994), word-
stem completion (i.e. Cassens et al., 1990; Bazin et al., 1994; Ilsley et al., 1995), the Rivermead
Behavioural Memory Test (RMBT; Wilson, Cockburn & Baddeley, 1985), and verbal learning
assessments, such as the RAVLT (e.g. Wolfe et al., 1987).
The dysfunction in explicit memory has been further demonstrated in a number of review
studies, including meta-analytical investigations. Zakzanis and colleagues conducted a
meta-analysis of data from 726 depressed patients and 795 matched controls, across a variety
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of cognitive tasks (Zakzanis et al., 1998). The experimenters concluded that across tasks the
largest effect of MDD on LTM was on measures of encoding and retrieval from episodic
memory. Moreover, the effect of MDD on episodic memory function was evident in an
array of tasks, including the RAVLT, the Wechsler Memory Scale - Revised (WMS-R;
Wechsler, 1987), the Mattis Dementia Rating Scale (MDRS; Mattis, 1988), and the Rey-
Osterrieth Complex Figure (ROCF; Lezak, 1995).
While the majority of studies that have explored explicit memory in depression have used
tasks that assess an individual's 'episodic' memory (i.e. the recollection of personally
experienced events), there is also alternative form of explicit LTM, i.e. 'semantic memory',
that should be considered in assessing the integrity of LTM. Semantic memory, which can
be defined as an individual's conceptual knowledge (i.e. knowledge of concepts, rules, and
facts), has been considered in a number of studies of MDD (e.g. Wolfe et al., 1987; Austin et
al., 1992; Ilsley et al., 1995). However, these studies have all noted that depressed patients
were unimpaired on measures of semantic memory, such as oral verbal fluency tasks,
compared to matched normal controls.
In contrast to the previous observations, there are investigations that have noted a significant
impairment of implicit memory in depressed patients. For example, Elliott and Greene
(1992) assessed both explicit and implicit long term memory using four different types of
task, i.e. cued and free recall (i.e. explicit memory) and word-stem completion and
homophone spelling tasks (i.e. implicit memory). They found that depressed patients were
significantly impaired on all of these tasks compared to a sample of healthy normal controls.
The authors suggested that these observations might be indicative of a more global pattern
of cognitive impairment in major depression than previously thought, or that depression
may interfere with 'data-driven' encoding processes. However, it should be noted that this
study employed relatively small numbers of participants in each sample (i.e. ten in each) and
did not report effect sizes. Therefore, it is possible that the observations in this study may be
due anomalies in the data, such as outliers, leading to distortion of the data set as a result of
employing small numbers of participants.
In addition to those studies that have investigated the relative effect of depression on
implicit and explicit memory, there are a number of studies that have considered the
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comparative effect ofMDD on visual and verbal long-term memory. Landro and colleagues
compared depressed patients and healthy controls on measures of verbal and non-verbal
LTM (i.e. Randt Memory Test; Randt, Brown & Osbourne, 1980; the recurring recognition
figures test; Kimura, 1963). The authors found that while depressed individuals were
comparatively impaired in their verbal LTM, non-verbal LTM was unimpaired in the
depressed sample relative to controls (Landro et al., 2001).
There are also those studies that have failed to find any evidence of any significant deficit in
long-term memory associated with major depression (e.g. Grossman et al., 1993; Fossati et
al., 1999). Indeed, one study found that, while there was evidence of a significant executive
deficit associated with depression, depressed participants were not impaired on any
measure of mnemonic function compared to normal controls, including a measure of
episodic memory (Grossman et al., 1993).
Therefore, it is reasonable to conclude that there is a significant impairment of LTM
associated with major depression, which appears to be limited to episodic explicit memory.
However, the contradictions that exist in the literature should be considered in the
construction of a model of cognitive function in MDD.
Executive function
'Executive function' is a term that is used to describe a set of functions involved in the ability
to initiate and carry out goal-directed behaviour, and includes processes such as attention,
concentration, decision-making, planning and working memory (Fuster, 1989). In addition
to the considerable quantity of evidence regarding mnemonic function in MDD, a variety of
studies have examined the integrity of various processes involved in executive function in
individuals suffering from depression (e.g. Channon, Baker & Robertson, 1993; Grossman et
al., 1993; Palmer et al., 1996; Channon & Green, 1999; Cohen et al., 1999; Grant et al., 2001;
Ravnkilde et al., 2002; Watkins & Brown, 2002; Elderkin-Thompson et al., 2003; Porter et al.,
2003).
In order to ascertain an appropriate model of executive processes in depressed individuals it
is important to consider their performance on measures of each of the cognitive processes
that contributes to executive function.
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■ Attention
Attention is proposed to be involved in the transfer of information from sensory to short-
term memory, and, therefore, is a critical resource for the successful completion of any
conscious process (Ashcraft, 1994). Depressed patients will often complain of experiencing
impaired attention. Indeed, this type of cognitive dysfunction is so commonplace that
impaired concentration has been included as a diagnostic criteria for MDD in DSM-IV
(American Psychiatric Association, 1994).
As previously noted, depressed patients appear to be impaired on effortful tasks, i.e. those
tasks requiring conscious processing of information. Given the critical association between
mechanisms of attention and conscious processing, it is reasonable to suggest that
individuals with unipolar depression will be impaired measures of attention. Indeed, there
are many investigations that have noted a significant impairment on measures of attention
in MDD patients compared to healthy controls (e.g. Miller et al., 1991; Grossman et al., 1993;
Trichard et al., 1995; Purcell et al., 1997; Moritz et al., 2002; Ravnkilde et al., 2002; Porter et
al., 2003). Investigations of attention in MDD have studied different types of attentional
process, including global attentional processes, selective attention, and attentional set-
shifting. However, as with most other areas of cognition, the available evidence relating to
each of these attentional subtypes is rather contradictory.
A review of investigations of attention in major depression noted that global impairment of
attention was associated with MDD, and was most consistently replicated in those
investigations using measures of prolonged simple and choice RT, the Continuous
Performance Test (CPT: Mirsky et al., 1960) and the Digit Symbol Substitution Test (DSST:
Wechsler, 1981; i.e. Mialet, Pope & Yurgelun-Todd, 1996). The authors of this review
suggested that impairment on these measures in MDD was indicative of a level of cognitive
retardation associated with depressive illness. They also indicated that this type of
impairment was often confounded by the psychomotor retardation associated with MDD,
and that this confounding effect was evident on those tasks of attention which also have a
psychomotor component, e.g. Trail Making Test A and B (Reitan & Wolfson, 1993).
In addition to a global impairment of attention, deficits in selective attention have also been
noted in studies of MDD. In their study of elderly depressed patients, Beats and colleagues
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employed a visual search task to assess selective attention. They found that depressed
patients were significantly impaired on this particular measure, compared to a group of
matched healthy controls (Beats et al., 1996). Although it could be argued that the deficit
noted in this study may be specific to depression in elderly samples, other studies involving
samples of younger adults have also noted deficits in selective attention (e.g. Trichard et al.,
1995; Beats et al., 1996; Landro et al., 2001; Moritz et al., 2002). Moreover, in an investigation
of cognitive function in unmedicated depressed patients, Porter also found that a depression
was associated with a significant deficit in selective attention (Porter et al., 2003).
Studies of attention in MDD have also examined the performance of depressed patients on
tests of attentional set-shifting, which are essentially measures of cognitive flexibility. In
addition to deficits in global attention function and selective attention, there is evidence to
suggest that attentional set-shifting is also significantly impaired in MDD (e.g. Purcell et al.,
1997; Merriam et al., 1999; Grant et al., 2001; Moritz et al., 2002). In one investigation of
executive function, Channon examined set-shifting ability in dysphoric individuals (i.e.
mean score on the BDI = 17.8) using the Wisconsin Card Sorting Test (WCST; Heaton, 1981).
It was observed that, compared to normal controls, dysphoric participants made
significantly more perseverative and non-perseverative errors on this task (Channon, 1996).
Although this study examined dysphoric individuals, rather than a clinical sample, review
evidence suggests that the pattern of deficits seen in dysphoric groups is similar, but less
severe, than impairment in MDD patients (Hartlage et al., 1993). Moreover, a number of
studies of clinically depressed samples have also noted dysfunction in attentional set-
shifting. For example, Fossati et al., (1999) used a modified version of the WCST to examine
the relative performance of depressed and schizophrenic patients and healthy controls.
They found that depressed patients made more perseverative errors on this measure
compared to controls, although the difference between the three experimental groups failed
to reach significance.
Despite the lack of a significant effect in the latter studies, there are investigations of clinical
depressed patients that have observed a significant deficit on this measure in MDD. In a
study of cognitive function in MDD, Grant and colleagues found evidence of a significant
impairment on the WCST associated with depressive illness in a sample of 123 depressed
patients. The authors noted that depressed individuals performed significantly worse than
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normal controls on the WCST on a number of performance parameters, including the
number of categories completed, perservative responses, perseverative errors, and failure to
maintain set. Interestingly, this was the only significant difference the researchers found on
a range of measures of cognitive performance between depressed patients and healthy
controls (Grant et al., 2001).
Significant differences between depressed individuals and healthy controls on measures of
set-shifting have also been noted on assessments other than the WCST. Purcell and
colleagues found a relative detriment in the performance of depressed patients on the
intradimensional /extradimensional (ID/ED) set-shifting subtest of the CANTAB. In this
study only 50% of depressed participants managed to complete all stages of the task
successfully, compared to 85% of healthy controls. Moreover, depressed patients required
more trials than controls to reach the criterion at the ID shift and ED shift stages of the task.
In addition to the comparison of mean percentage of stages completed, the authors also
compared the relative performance of depressed and controls participants at each individual
stage of the task, including only those participants who met the criterion for the given stage
in the analyses. The results of these analyses indicated that depressed and control
participants differed only in their performance on the ED shift stage of the task (Purcell et
al., 1997). Thus, indicating that set-shifting dysfunction in patients with major depression
may be specific to ED shifts only.
Despite the relative consistency of evidence relating to set-shifting in MDD, there are studies
which have failed to observe a deficit in this function associated with depression. In another
study that employed the ID/ED set shift task, Elliott and colleagues found no significant
differences between a sample of patients with major depression and healthy controls on any
of the measures of set-shifting (Elliott et al., 1996). Similarly, Sweeney found no significant
deficit on the WCST in depressed adults, as compared to normal control participants
(Sweeney et al., 2000).
Overall, it appears that MDD is associated with a significant dysfunction in a variety of
subtypes of attention, such as selective attention and attentional set-shifting. Moreover,
there is evidence to suggest that such deficits are apparent in a range of depressive sub¬
groups, and across a variety of cognitive assessments. However, impairment of attention
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might not be specific to MDD. Indeed a similar pattern of results has been observed in a
range of other psychiatric disorders (Mialet et al., 1996). Therefore, attentional dysfunction
in major depression may be the result of underlying factors that are common to a range of
psychiatric illnesses.
■ Decision-making
Decision-making is another component of executive function that is relevant to clinical
descriptions of and diagnostic criteria for depressive disorders. Despite the importance of
decision-making in models of executive function and depression, there are relatively few
studies of cognition in depression that have included specific measures of this function.
Murphy and colleagues considered the relative performance of both MDD and BD patients
and a sample of matched controls on a computerised decision-making task (after Rogers et
al., 1999a), that was based on a gambling paradigm. On this task participants were required
to make probability-based choices and to qualify their choices with an associated 'bet'.
Depressed participants (i.e. both MDD and BD) were found to be impaired on the task on a
number of parameters, compared to controls. In addition to slower deliberation times,
patients failed to accumulate as many points on the task and were more likely to use
suboptimal betting strategies (Murphy et al., 2001). Thus, indicating that the deficit in
decision-making in major depression is another clinical descriptor that can be empirically
measured, and used in the distinction of depressed and normal healthy individuals.
However, there is the need for the replication of these findings in order to support this
assumption.
■ Planning
In studies of cognitive function in MDD one of the most commonly used assessments of
planning has been the Tower of London (TOL; Shallice, 1982). As with the other measures of
cognitive function that have already been considered, the experimental evidence regarding
planning performance in major depression is not entirely consistent.
Deficits in the TOL have been noted in diverse samples of MDD patients, including elderly
(Beats et al., 1996) and medication free depressed patients (Porter et al., 2003). Yet, there are a
handful of investigations that have failed to find significant deficits associated with MDD
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using the TOL task (e.g. Sweeney et al.; 2000; Grant et al., 2001). However, it has been
suggested that performance on the TOL may be attenuated by the psychomotor component
of the task, and both these latter studies both studied samples of depressed patients who did
not exhibit psychomotor slowing.
In order to determine the contribution of psychomotor function to the performance of
depressed patients on measures of planning ability, Elliott compared the performance of
MDD patients and healthy controls on two versions of the TOL, i.e. the original TOL and the
new TOL task (NTOL; Owen et al., 1995a). The NTOL task retained the essential features of
the TOL but reduced motor demands. In this study it was found that depressed patients
were not only impaired on the TOL, i.e. patients exhibited a global deficit in performance
accuracy and were slower overall in their planning times, but also showed a deficit in
performance on the NTOL, i.e. the mean percentage correct, across all levels of the task, was
significantly lower for depressed participants (Elliott et al., 1996). The results of this study
confirm the notion that planning on the TOL is to some extent mediated by psychomotor
function. More importantly, however, it is also indicative of a planning deficit associated
with MDD, which cannot be attributed to depression related psychomotor retardation alone.
■ Working memory (WM)
The human working memory system is an active short-term store, which comprised of three
components, i.e. the central executive, the phonological loop, and the visuospatial sketchpad
(Baddeley & Hitch, 1974; see section 1.2 for a more in-depth account of this model of
working memory, and its functional distinctions). Working memory has an integral role in
the allocation of processing resources in short-term tasks, and the integration of information
from both the long- and short-term stores required for specific task performance. Thus, the
processes involved in WM form an essential component of the executive system of human
cognition.
It has been suggested that the varied pattern of cognitive impairment observed in major
depression may be the result of a faulty allocation of resources, such as would be typical of a
dysfunction of the central executive component of working memory (Channon et al., 1993).
However, there have been relatively few studies that have specifically considered working
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memory in MDD compared to other cognitive processes. Moreover, those studies that have
considered working memory in depression have been inconsistent in their observations.
Working memory function can be categorised into two basic forms - i.e. spatial and verbal
WM. The most reliable data regarding working memory in MDD appears to come from
those studies that have examined verbal WM in depressed individuals. The digit span
forwards (DGF) and digit span backwards (DGB) subtests of the WMS-R are two of the more
popular assessments that have been used to measure verbal WM in studies of depression.
Using both of these measures, one study found that although there was a WM deficit
associated with MDD it was only borderline for separating depressed patients and healthy
controls (Elderkin-Thompson et al., 2003). Yet, other studies have found significant
differences between MDD patients and controls in verbal working memory using both the
DGF and DGB (e.g. Fossati et al., 1999, Moffoot et al., 1994, and Moritz et al., 2002).
Examination of verbal WM in MDD has not been limited to studies of DGF and DGB.
Landro and colleagues studied verbal WM using the Paced Auditory Serial Addition Test
(PASAT; Gronwall &Wrightson, 1975). Participants were assessed using two versions of the
PASAT, i.e. a two second interval between the presentation of stimulus items and a four
second interval. Depressed participants were found to have significantly lower scores on this
measure of verbal WM compared to matched controls (Landro et al., 2001). Thus,
supporting the proposal of impairedWM function in major depression.
While the findings relevant to test of verbal working memory appear to be relatively
consistent, observations of spatial working memory in MDD are somewhat less reliable. On
one hand, those studies that failed in general to find significant differences between
depressed patients and healthy normal controls were also unsuccessful in observing any
disparity between experimental groups on measures of spatial WM (i.e. Lancaster et al.,
1997; Purcell et al., 1997; Sweeney et al., 2000; Grant et al., 2001). Yet, the authors of a number
of other studies have noted a discrepancy between the performance of patients and controls
on tests of spatial WM. For example, in their study of elderly depressed patients, Beats
research group noted that depression was associated with a detriment in performance on
measures of spatial working memory taken from the CANTAB neuropsychological test
battery (Beats et al., 1996). Correspondingly, Elliott also found impairment on the same
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CANTAB measures of spatial WM in a sample of younger adults with major depression
(Elliott et al., 1996).
Other researchers have suggested an impairment in spatial working memory associated with
MDD which is evident in performance on other spatial measures of executive function, such
as the WCST and the TOL (i.e. Elliott et al., 1996; Fossati et al., 1999; Murphy et al., 2003). As
previously noted, the use of both of these measures has produced contradictory findings,
and performance on each may be confounded by the presence/absence of other dysfunctions
of cognition. Therefore, the discrepancy in findings of studies that have considered spatial
WM may be linked to the association between this type of working memory and these
particular measures of executive function.
Studies that have considered the working memory system by examining either phonological
loop or the visuospatial sketchpad function have tended to contemplate its integrity in MDD
as a complete system. However, in order to determine whether there is a disruption in the
central executive, with relative sparing of the other sub-systems, it is imperative to consider
not only the available evidence regarding the working memory system as a whole, but also
the findings relating to the integrity of the executive processes of the system. One potential
approach to this issue is the examination of the performance of depressed patients on
measures that manipulate the central executive.
Although there are not many studies that have considered the executive components of
working memory in MDD, Channon and colleagues conducted an exploratory study
examining the performance of depressed patients on measures of each element of the
working memory system. The experimenters employed three measures of phonological
loop function, i.e. phonological similarity and word length effect tasks, and DGF, and a
single measure of the integrity of the visuospatial sketchpad, i.e. forward block sequence
span (after Milner, 1971). Central executive function, on the other hand, was measured
using the backward digit span and block sequence span tasks, the PASAT, the Trail Making
tasks, and a letter cancellation test. Although the authors found no significant differences in
the performance of depressed and normal individuals on measures of phonological loop or
the visuospatial sketchpad function, differences were noted between the experimental
groups on measures of central executive function. Patient span was significantly smaller
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than controls on the DGB, and there was a trend towards a significant difference between
patients and controls on the PASAT (Channon et al., 1993).
Given the lack of pertinent literature, it is difficult to draw reasonable conclusions regarding
the integrity of the visuospatial sketchpad and the phonological loop in MDD. Yet, if we are
to assume that both the DGB and the PASAT are valid measures of central executive
function, the available evidence appears to suggest that there is a reliable impairment of the
central executive in patients with MDD. However, although both of these assessments are
reliant on working memory, requiring manipulation and recall of information in the short
term, it may be the case that the type of working memory being investigated does not adhere
to the popular Baddeley and Hitch (1974) model of WM. Indeed, it has been suggested that
in the case of the PASAT the function being assessed is closer in nature to the description of
WM in the Honig model of working memory (Honig, 1978; in Landro et al., 2001). This
model describes WM as a system where the content of a temporary store is continually
refreshed and information is discarded once it is no longer of use.
Although the Honig model of working memory has been influential, the Baddeley model
has proven to be extremely popular in the study of working memory, in both normal and
clinical populations. This popularity may be attributed to evidence from neuroimaging and
genetics studies which support the functional distinction between the various components
proposed by this model. Consequently, it order to facilitate reasonable conclusions about the
integrity of the central executive component of working memory in MDD it may be
advantageous to examine WM function using tasks which adequately assess the
subcomponents of the Baddeley and Hitch model. This latter point shall be discussed later
in this chapter (see section 1.2).
1.1.3.2 Factors affecting the severity of cognitive impairment
Significant differences exist between the methodologies of the various investigations of
cognitive function in major depression. Key factors of interest include participant
characteristics, the nature of the assessment(s) used, and the function(s) of interest. The
functions that have been investigated, and their operational definitions, have been relatively
stable between different studies. In addition, the majority of studies considered in this
review either used cognitive assessments with established reliability and validity, or
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variations based on such tasks. Nevertheless, there are factors of paradigm design that have
been shown to be influential in the performance of depressed patients on measures of
cognitive function, e.g. the use of feedback and the affective valence of stimulus material. In
addition, it would appear that an important source of variance in the observations of
different studies is the result of differences in patient characteristics. Common factors of
interest to investigators have included participant age, the severity of depressive illness, and
medication status.
There are a number of studies that have considered how specific characteristics of
experimental design and individual participants are related to participant performance. By
considering how these factors have impacted upon the performance of individuals on
different measures of cognition it is possible to determine those elements that might be
consequential in the differences observed between different studies of cognition in MDD
(see Appendix 1A for full list of specified factors of interest in those studies considered for
this review).
Motivation
Motivation is a central aspect of depressive illness and as such has previously been
considered a key factor in the performance of depressed patients in experimental studies of
cognitive function. Indeed, it has been suggested that low motivation is a causal factor in
the performance of depressed participants on measures of cognition (Schmand et al., 1994).
Evidence from empirical studies of the neuropsychological profile in MDD appears to
support this notion (Channon et al., 1993; Beats et al., 1996; Elliott et al., 1997).
However, it is important to note that if motivation were the fundamental factor in impaired
cognition in major depression then it would be reasonable to expect a consistent impairment
in depressed patients across all tasks. Yet, there is quite clearly evidence of discrepancies in
the performance of MDD patients on both the same and different cognitive measures, and a
relative sparing of some cognitive functions. Therefore, although motivation is an important
factor it cannot singularly account for the profile of cognitive impairment seen in MDD
(Elliott, 1998). Resultantly, we need to consider alternative patient characteristics that may
aid in the understanding of the types of deficits noted in major depression.
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Severity of depression
The level of depressive illness at the time of assessment has been one of the most
consistently examined factors. Yet, the currently available data regarding the impact of this
characteristic constitute some of the most disjointed findings in the depression literature.
One of the most commonly used measures of severity of depressive illness in experiments is
the HRSD. A variety of investigations have observed significant correlations between
severity of depression, as determined using the HRSD, and the performance of depressed
patients on a range of measures of cognition (e.g. Cohen et al., 1982; Austin et al., 1992;
Channon et al., 1993; Austin et al., 1999; Merriam et al., 1999; Sweeney et al., 2000; Grant et
al., 2001; Ravnkilde et al., 2002; Elderkin-Thompson et al., 2003). Moreover, other studies
have noted that not only does severity of depression correlate with cognitive performance,
but it can also account for a significant proportion of the variance in the scores of depressed
participants. For example, one study found that the severity of depression, as measured
using the Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962) accounted for
approximately 28% of the variance in scores of depressed patients on a range of measures.
On the other hand, a number of studies that have failed to find evidence of the association
between severity of depression and cognitive performance (e.g. Golinkoff & Sweeney, 1989;
Miller et al., 1991; Channon et al., 1993; Channon & Green, 1999; Murphy et al., 1999;
Murphy et al., 2001; MacQueen et al., 2002; Moritz et al., 2002). Thus, suggesting that
depressive severity may not be associated with cognitive performance, and that cognitive
dysfunction in MDD may instead be mediated by other factors that are pertinent to
depression.
It is important to note that these contradictory findings cannot simply be explained by
differences in the choice of affective assessment, i.e. all the studies listed here used the
HRSD. Similarly, the discrepancy does not appear to be related to the presence or absence of
cognitive impairment. Indeed a number of studies that have found no association between
severity of depression and performance on measures of cognition have found significant
differences between depressed patients and controls on the cognitive assessments they
employed.
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It could be argued that the choice of HRSD may be a key component in the disparity in
findings between different studies. The HRSD is an objective measure of depression, which
is reliant on the rating of the clinician conducting the interview. Therefore, it is possible that
differences between different studies may reflect differences in the assessments of raters in
different investigations. However, this is unlikely given the highly structured nature of the
HRSD and it's strict scoring guide. Moreover, the same discrepancy in findings has been
noted using more subjective measures of affect, such as the BDI. While some studies found a
significant correlation between BDI score and cognitive performance (e.g. Cohen et al., 1982;
Channon et al., 1993; Grant et al., 2001; MacQueen et al., 2002), others failed to replicate this
association (e.g. Channon et al., 1993; Channon & Green, 1999). Given that the examination
of the observations of single investigations does not appear to aid in the resolution of this
issue, it may be advantageous to consider the conclusions from review and meta-analytical
studies.
In a review of cognition in depression, Austin and co-authors argued that there were many
studies that demonstrated that cognitive function was independent of severity of depression
(Austin et al., 2001). However, in a meta-analysis of studies examining mnemonic function
Burt and colleagues found the converse to be true, with both recall and recognition being
impacted by the degree of depression (Burt et al., 1993). Moreover, in their meta-analysis of
cognitive function in depression, Christensen and colleagues also concluded that severity of
depression was correlated with performance (Christensen et al., 1997). In addition, a
number of review articles also support the notion of an association between severity of
depression and cognitive performance (i.e. Hartlage et al., 1993; Crews & Harrison, 1995;
Christensen et al., 1997; Sobin & Sackeim, 1997; Elliott, 1998).
Therefore, it seems reasonable to conclude that performance on a variety of measures of
cognitive function in MDD is associated with the severity of depression. This may partially
explain some of the inconsistencies in presence or absence of significant cognitive
dysfunction between studies. However, it should be noted that the severity of depression
appears to only be associated with the severity of cognitive impairment seen in depressed
patients, rather than the type of deficit.
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Depressive subtype
It has been proposed that there is a differential pattern of cognitive function between
individuals with different depressive subtypes. In one investigation, Austin considered the
profile of cognitive function in melancholic and non-melancholic depressed patients.
Although, melancholic individuals exhibited dysfunction on a range of mnemonic and
executive tasks, compared to controls, non-melancholic patients were largely unimpaired on
the same measures (Austin et al., 1999). However, a later review by Austin and colleagues
concluded that there was little evidence of an association between cognitive performance
and subtype ofMDD (Austin et al., 2001).
In addition, investigations into the impact of depressive subtype on cognition have also
considered the relative performance of 'endogenous' and 'reactive' depressed patients.
However, both meta-analytical and review evidence suggested that there are no significant
difference between these two types of depressive illness on measures of cognition (i.e.
Austin et al., 1992; Crews & Harrison, 1995; Christensen et al., 1997).
Therefore, while some individual investigations of cognition in MDD have noted differences
in the cognitive profile of patients with different diagnostic subtypes of depression, across
the range of studies considered for this review there is little evidence for this type of
distinction. Indeed, it seems likely that the similarities in cognitive profile between different
sub-types of depressed patients are more numerous than the differences.
Age
There are two aspects of participant age that are of interest in the performance of depressed
patients on cognitive measures, i.e. age at the time of assessment and age at the time of onset
of first depressive episode. Although, not all studies have considered the contribution of
participant age to the cognitive profile in MDD, there are a handful of studies which suggest
that the current age of participants is unimportant in the performance of depressed patients
(Austin et al., 1992; Purcell et al., 1997; Austin et al., 1999). However, the conclusions of a
number of reviews of cognition in depression are counter-indicative, and seem to support
the notion of a significant relationship between the age of participants and cognitive
performance. Indeed, a number of review papers have concluded that there is a greater
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degree of impairment in older, compared to younger, adult depressed patients (e.g. Austin
et al., 1992; Burt et al., 1993; Sobin & Sackeim, 1997; Elliott, 1998).
It has been proposed that the relationship between participant age and level of impairment
in depression is not defined by a straight interaction effect. Indeed, Elliott noted that while
depressed patients under the age of 40 were more likely to exhibit executive dysfunction,
impairment in patients over 50 extended to mnemonic function, with those patients over 70
also exhibiting an additional impairment of cognitive slowing (Elliott, 1998).
Therefore, it can be presumed that the mean age of a given sample of depressed patients will
impact upon the observed performance on measures of cognition. Which implies that age is
a potentially important factor in explaining the differences in the observations of different
empirical investigations of cognition in MDD.
The available data also suggests that the age of the individual at the time of the onset of their
first depressive episode does impact upon specific aspects cognitive performance. The
association between measures of psychomotor function and onset age appears to be
characterised by a significant inverse correlation between these factors. This relationship has
been observed in both elderly and younger depressed adults (i.e. Beats et al., 1996; Grant et
al., 2001). Moreover, Grant also found a significant correlation between age of onset and
performance on measures of executive function (Grant et al., 2001).
These findings may reflect the presence of some factor relating to the age of onset of first
depressive episode that is also significant to the presence of specific forms of cognitive
dysfunction. Alternatively, it may simply reflect the impact of the total duration of
depressive illness. In order to clarify this issue it would be desirable to determine the impact
of onset age on measures of cognition in patients who have been matched for total illness
duration and number of depressive episodes.
Medication status
(Note: The issue of impact of antidepressant medication on cognition shall be discussed in
greater depth in section 1.3 of this chapter)
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It is common for depressed patients who participate in experimental investigations to be
receiving psychotropic medication at the time of assessment. As a result of the potential
confounding effect of medication on patient performance, it is desirable to attempt to ensure
that depressed patients are medication free at the time of participation. However, it is not
always practically or ethically possible to guarantee this. Therefore, it is important to
consider the potential relationship between patient medication status and cognition. Indeed,
there is evidence to suggest that some types of medication used to treat MDD may have an
impact upon performance on cognitive function - i.e. in both normal and clinical samples
(see section 1.3).
There are many investigations that have examined whether there is a significant impairment
of cognition in the performance of those patients receiving anti-depressant medication,
compared to those who are medication free at the time of testing. One review suggested that
the consumption of anti-depressants might have been a confounding factor in the
performance of measures of psychomotor function in MDD patients (i.e. Sobin & Sackeim,
1997). However, this conclusion appears to be contradictory to the observations of the
majority of individual investigations considered here.
Elliott suggested that, although some more traditional tricyclic medications can disrupt
some aspects of cognition, modern anti-depressants have a less noticeable effect (Elliott,
1998). This proposal was supported by evidence from two separate studies by Austin and
colleagues (i.e. Austin et al., 1992; Austin et al., 1999). These studies both found a lack of a
significant effect of the consumption of anti-depressant medication on cognitive function in
depressed patients. Similarly, other investigators have also failed to note a significant
impact of anti-depressant medication on cognitive performance in depression, on a range of
measures (e.g. Golinkoff & Sweeney, 1989; Purcell et al., 1997; Channon & Green, 1999;
Sweeney et al., 2000; MacQueen et al., 2002; Ravnkilde et al., 2002; Murphy et al., 2003).
Based on the currently available evidence it would appear that modern anti-depressant
medications have little impact upon the ability of depressed patients to perform cognitive
tasks. Moreover, given the proposed relationship between the affective presentation of
depressed patients and the degree of cognitive impairment they experience, it can be
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speculated that the effect of antidepressant medication on cognitive function in treatment
responsive patients may be facilitatory.
Diurnal variation
Diurnal variation in affect is a common aspect of the experience of MDD. This normally
takes the form of a lowering of affect in the morning, and an improved mood level in the
evening. Given the proposed link between severity of depression and cognition, it has been
suggested by some investigators that such variation may have an impact upon the observed
pattern of cognitive function in depressed patients.
In order to determine whether this assertion was accurate, Moffoot and colleagues studied
the cognitive performance of a group of melancholic depressed patients who had a clear
diurnal variation in mood. Participants in this study were assessed in both the morning and
the evening on a range of executive and mnemonic tasks. It was found that depressed
patients were significantly impaired on a number of assessments, compared to controls, at
both assessment times. However, the pattern of impairment seen in patients in the morning
was more diverse and severe than the evening pattern (Moffoot et al., 1994). Thus,
suggesting that as the mood of depressed patients improved so did their ability to
successfully undertake the cognitive tasks.
This study is not the only one to note an effect of diurnal variation on measures of cognition.
Porterfield and colleagues also conducted an investigation of the effect of diurnal variation
on the performance of a group of patients with a diagnosis of MDD and clear diurnal
variation in mood on a range of neuropsychological measures. These authors found that
measures of executive function and verbal fluency were sensitive to diurnal changes in
mood (Porterfield et al., 1997).
The observation of the effect of diurnal variation has also been observed in more elementary
measures of cognitive function. Indeed, in a review of psychomotor function in MDD, Sobin
and Sackheim concluded that diurnal variation was significantly associated with the
psychomotor performance of depressed patients (Sobin & Sackeim, 1997).
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Although the concept of diurnal variation in MDD is intrinsically linked to the notion of
severity of depression, the consistency of findings relating to the effect of this factor on
observed cognitive performance suggest that its impact may be mediated by factors other
than severity alone. For example, Moffoot also noted that the level of impairment in
depressed participants was significantly correlated with Cortisol levels. Therefore, it may be
postulated that Cortisol may be an important mediating factor in the observed association
between diurnal variation in mood in depressed patients and cognitive function.
Feedback
The use of feedback in cognitive paradigms and its effect upon the performance of depressed
patients is linked to the issue of motivation. It has been noted that the nature of feedback
given to patients with MDD can have a differential effect on response, compared to normal
controls. Depressed patients not only respond less well to positive reinforcement or reward
than controls, but also exhibit a tendency to evaluate their performance more negatively. It
has been predicted that while control participants will respond to negative feedback with
increased motivation, depressed patients are more likely to experience a detriment in
motivation or a 'catastrophic reaction' to testing when challenged by negative feedback.
This theory of abnormal response to negative feedback in major depression has been
supported by evidence from Elliott and colleagues (e.g. Elliott et al., 1997).
However, Elliott's findings have not been replicated in all investigations of the effect of
feedback on cognition in depressed patients. Although Shah and colleagues did find
evidence of impaired performance on the Delayed and Simultaneous Match to Sample
(DMTS and SMTS) subtests of the CANTAB in both depressed and schizophrenic patients,
they found no evidence of a motivational effect of negative feedback in controls.
Furthermore, there was no indication of an abnormal response to this type of feedback in
patient samples (Shah et al., 1999).
Nonetheless, given the critical role of motivation in the performance of depressed
participants and the likelihood of this effect of feedback, it is essential to acknowledge the
potential effect of the use of paradigms with an intrinsic feedback mechanism in the
assessment of cognitive function in MDD.
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Affective valence
Another important aspect of paradigm design in investigations of cognition in depression is
the hedonic tone of the stimuli that are used. Major depression appears to be associated
with a specific deficit in information processing, which is characterised by abnormalities in
the processing of mood-congruent material. The empirical evidence is suggestive of a
facilitation of the processing of emotionally negative stimuli in major depression, compared
to neutral or positive stimuli. However, this type of deficit has been found to be rather
specific. Indeed, two separate investigations both found that although the affective valence
of stimuli affected the processing of explicit material, implicit tasks were largely unaffected
(i.e. Denny & Hunt, 1992; Watkins et al., 1992). In addition, in their review of effortful and
automatic processing in depression, Hartlage and colleagues also noted that the degree of
impairment on effortful tasks was related to the valence of the stimulus material used in the
given task. They concluded that depressed patients exhibited better performance levels on
effortful tasks that had used negatively valenced stimuli, compared to positive or neutral
stimuli (Hartlage et al., 1993).
Although not all studies have found evidence of this sort of bias in information processing in
MDD (e.g. Ilsley et al., 1995), there is considerable support for the notion of the impact of the
affective valence of stimuli when assessing depressed patients. Therefore, that the choice of
stimuli might impact upon the likelihood of observing significant differences between MDD
patients and matched controls on measures of cognition should be noted when considering
the evidence of cognitive dysfunction in MDD.
1.1.4 Aetiology of cognitive dysfunction in major depression
Despite a significant degree of inconsistency in the literature which has examined the
various aspects of human cognition in those experiencing major depressive illness, there is
still considerable evidence to suggest that MDD is associated with a substantial impairment
in cognitive function. In addition, is appears that the cognitive profile of depressed patients
is mediated by a number of contributory factors. While some of these factors are applicable
to a range of psychiatric conditions others appear to be more specific, applying only to those
patients with major depression. Although it is imperative to be able to predict the extent of
cognitive deficit associated with unipolar depression and the relative importance of those
34
key factors in patient performance, it is equally important that the aetiology of the profile of
cognition in MDD is understood.
One potential approach to the understanding of cognitive dysfunction in major depression is
to determine the underlying psychological factors. There are many different psychological
theories of depression, which have been developed to aid the understanding of the
symptomatic experience of depressed individuals. Although not all psychological accounts
of MDD are useful in comprehending the pattern of cognitive impairment seen in depressed
patients, some psychological theories do aid in the clarification of cognitive dysfunction in
major depression, such as Beck's cognitive theory of depression and Seligman's theory of
learned helplessness.
Those psychological theories that are relevant to our comprehension of cognitive
dysfunction in major depression do not lend themselves to all aspects of cognitive
impairment in MDD, yet are useful in aiding our understanding of some specific deficits. A
good example of this is the application of Beck's cognitive theory of depression to the
comprehension of biases in information processing associated with major depression. Beck
proposed that individuals who became depressed had experienced a predisposition to
depressive thinking, and were actively engaged in the maintenance of such thinking.
Moreover, he suggested that this predisposition was essential to the formation of depressive
'schemas', and that the activation of these schemas was a causal factor in developing
depression (Beck, 1967; Beck, 1976).
The notion of a causal association between a predisposition to negative thinking and
depressive illness is also congruent with Bower's network theory (Bower, 1981). Bower
proposed that emotions are stored in a semantic network, with each emotion being
represented by a single node with numerous connections to other nodes. Within this model,
these additional nodes do not just correspond to emotions but instead may represent
memories, events, ideas, concepts etc. It was proposed that within this network activation in
a single node - via external or internal events - would spread to those nodes with reciprocal
connections. Within such a network system the activation of a particular node could,
therefore, prime activation in related nodes. In other words, the activation of nodes
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corresponding to emotionally negative stimuli may be primed by the experience of
depressed mood, given the reciprocal relationship between these two factors.
In addition, to its predictive value in determining the onset of depressive illness and
accounting for biases in information processing, Beck's cognitive theory may also be useful
in explaining the abnormal response of depressed patients to negative feedback. Beck's
theory suggests that individuals with MDD will actively distort external information in a
negative fashion, using a variety of processes, e.g. overgeneralization, selective abstraction,
catastrophising, and dichotomous thinking. Beck suggested that the negative processing of
information was a key factor in the depressed individuals development of negative views of
the self, the world, and the future. An essential component of this process is the ability to
screen out affirmative information, and to enhance the processing of negative information
(Beck, 1967; Beck, 1976).
Psychological theories of major depression are also useful in the explanation of other
cognitive dysfunctions that have been observed in unipolar depressed patients, such as
deficits in motivation. The importance of motivation in the performance of depressed
patients in experimental investigations has already been noted in this review. Indeed,
motivation appears to be an essential factor in cognitive performance in MDD.
Motivational deficits may be partially explained by Seligman's theory of learned
helplessness (Seligman, 1975). Seligman proposed that depressed individuals anticipate the
occurrence of negative events but not positive ones, and believe such events to be inevitable,
and, therefore, feel incapable of preventing such events from happening. Seligman also
suggested that those who suffer from depression would attribute blame for adverse events
to internal, fixed causes, rather than external, changeable ones. Within this framework
motivational deficit in depression may be determined by the feeling of inability to alter ones
circumstances that is experienced by depressed individuals. Furthermore, as the level of
importance of an uncontrollable event increases the level of control perceived by the
individual will decrease, thus leading to a greater depressive reaction - i.e. reduced
motivation.
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Although psychological approaches are useful in assisting in our understanding of causal
factors in aspects of cognitive abnormality in MDD, there are still many gaps in our
understanding of the processes underlying such behavioural deficits. Moreover, such
theories do not account for full scope of cognitive dysfunction noted in depressed patients.
Therefore, it may be advantageous to consider alternative models of depressive
symptomology that can more appropriately account for the complexity of the experimental
evidence in this field, such as the neuropsychological approach.
1.1.5 Neuropsychological profile in major depression
Neuropsychological approaches to the understanding of depressive symptomology provide
an alternative, but complementary, approach to the psychological theories of major
depression. These approaches are concerned with the association between observable
behaviour and underlying biological causes, and purport that the cognitive dysfunctions in
MDD can largely be attributed to the manifestations of abnormalities in the structure and
functioning of regions of cortex postulated to be involved in specific aspects of cognitive
function.
Evidence for impaired regions of activation in depression comes from a number of sources.
Firstly, there is the evidence of the cortical activation associated with performance of
cognitive tasks that depressed individuals have been noted to be impaired on in normal
healthy adults. Additional evidence also arises from comparison between cognitive deficits
seen in clinical groups with known structural abnormalities and similar performance
profiles in depressed patients. However, a more direct approach to the understanding of
neuropsychological function in depressed patients is the examination of evidence from
neuroimaging studies of depression.
1.1.5.1 Neuroimaging and major depression
There is considerable range of neuroimaging investigations that have been concerned with
major depression, ranging from the examination of brain structure in MDD at a cellular level
to studies of gross brain function. It is proposed that in order to ascertain an accurate
neuropsychological model of brain function one must contemplate the available data
relating to both structural and functional brain imaging in depression.
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1.1.5.1.1 Structural deficits in depression
The first structural imaging study of mood disordered patients was a computerised
tomography (CT) study, which was conducted by Jacoby and Levi (i.e. Jacoby & Levi, 1981).
Rangel-Guerra and colleagues conducted the first magnetic resonance imaging (MRI) study
of depression a couple of years later (i.e. Rangel-Guerra et al., 1983). The introduction of
MRI brought about significant changes in structural imaging, including the ability to
produce high-resolution images with more accurate structural localisations. Moreover, it
allowed for an improvement in the qualitative volumetric analysis of both cortical and
subcortical gray matter (Soares & Mann, 1997).
In a review of structural neuroimaging studies of mood disorders (i.e. both MDD and BD)
Soares and Mann suggested that the prefrontal cortex (PFC) played an integral role in
cognitive dysfunction and the modulation of mood in depression, as a result of its extensive
connections to both cortical and subcortical regions. More specifically, they proposed that a
network involving a limbic-thalamic-cortical circuit, consisting of the medial and
ventrolateral PFC, the amygdala, and the mediodorsal nucleus of the thalamus, and a limbic-
striatal-pallidal-thalamic circuit, involving the striatum and the ventral pallidum underlay
the pathophysiology of mood disorders (Soares & Mann, 1997; see Figure 1.1).
Soares and Mann considered structural neuroimaging evidence of both generalised and
regional brain abnormalities in patients with affective disorders in order to determine
whether their proposed model of PFC involvement in the symptom presentation in
depression was accurate. In the case of unipolar depressed patients the most consistent
observations were of reduced cortical volume in frontal lobe (FL), cerebellum, caudate, and
putamen. Although their findings did support the proposed neuroanatomic model of mood
regulation, they suggested that further examination of the clinical and biological correlates
of these structural changes was required in order to develop a more inclusive model.
Support for the Soares and Mann model of structural deficits associated with depressive
illness came from a later review of 3D MRI studies of neuroanatomic changes in unipolar
depression by Sheline (i.e. Sheline, 2000). This review noted that changes in cortical
structure associated with early onset depression in the hippocampus, amygdala, caudate
nucleus, putamen, and frontal cortex. Thus, supporting the notion of a fronto-striatal deficit
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in MDD predicted by the Soares and Mann model. It was proposed that this pattern of
tissue loss could have resulted from a number of mechanisms, including: neuronal cell loss
through repeated exposure to episodes of hypercortisolemia; increased vulnerability to
glutamate neurotoxicity, as a result of glial cell loss; and reduction in neurotrophic factors
and in cortical neurogenesis resulting from increased level of stress. This review also
considered the persistence of these types of structural deficit and found that the only deficit
to persist beyond resolution of depressive symptoms was volume loss in the hippocampus.
Figure 1.1: Soares and Mann (1997) neuroanatomical model of mood regulation
However, the pattern of structural impairment implied by both of these review articles may
not be consistent across sub-groups of depressed patients. Indeed, recent evidence suggests
that the integrity of cortical structures may be associated with patient outcome. Shah and
colleagues examined structural MRI scans of twenty patients suffering from chronic,
treatment-resistantmajor depression. Using voxel-based analysis, the structural scans of this
group were compared to those of recovered patients and healthy controls. In addition to
subtle changes in the left hippocampus, right fronto-striatal atrophy was observed in the
treatment-resistant patients, but not in other groups. Furthermore, the degree of atrophy
noted in patients was correlated with the cumulative number of electroconvulsive therapy
(ECT) treatment received. Thus, suggesting that this type of structural deficit was not
necessarily a causal factor in depressive illness, but instead may have been acquired and
related to the severity of depression (Shah et al., 2002).
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These findings were an extension of an earlier study by Shah and colleagues, which also
highlighted the importance of structural deficits in major depression (i.e. Shah et al., 1998).
In this earlier study MRI structural images of chronic treatment resistant depressed patients
- who were characterised by a period of MDD lasting two years or more - and healthy
controls were compared for evidence of depression associated structural deficits. The results
of a voxel-by-voxel analysis of participants' brain images revealed reduced gray matter
density in the left temporal cortex, in a region that included the hippocampus in depressed
patients. In addition, there was also a depression associated trend towards reduced density
in the right hippocampus. Moreover, the authors also noted a significant correlation
between the density of the left hippocampus and the performance of depressed patients on a
measure of verbal memory (Shah et al., 1998). Thus, suggesting that structural deficits may
be of functional and behavioural significance in MDD.
There is also evidence to suggest that the relationship between structural deficit and
depressive symptoms is not only apparent in adults with MDD. Steingard used volumetric
analysis to compare the MRI scans of depressed children and adolescents to those of non-
depressed psychiatric controls. The investigators examined the frontal lobe, lateral
ventricular, and total cerebral volumes (FLV, VV, and CV) and, as a result of individual
differences in head and body size, compared experimental groups for differences in the
ratios of FLV/CV and VV/CV. Depressed participants were found to have significantly
smaller FLV/CV and significantly larger VV/CV ratios. The pattern of decreased frontal lobe
volume in the depressed children was similar to that seen in depressed adults. These
findings indicate that this region might play a role in the pathogenesis of early onset
depression (Steingard et al., 1996).
Although there is relatively consistent evidence regarding the nature of structural deficits
associated with MDD, this latter study raises the question of whether the structural changes
seen in depressed individuals are causal factors in depressive illness? Certainly, both of the
review articles of structural imaging in affective disorders considered here suggest that, with
the exception of hippocampal volume, those cortical changes seen in depressed patients
disappear upon recovery. Moreover, the studies conducted by Shah are indicative of
persistent deficits only in those patients who experience chronic, treatment-resistant
depression, i.e. no persistent differences were noted between recovered patients and healthy
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controls. Based on these observations one could suggest that if such structural deficits only
persist during the course of an individual's depression then they may be a result of MDD,
rather than a causal factor. However, determining the nature of the relationship between
major depression and specific structural abnormalities is complex, and is reliant on the
provision of evidence of structural deficits preceding the onset of depression.
It has been noted that lesions in particular cortical regions as a result of stroke, for example,
can precipitate the onset of affective disorders. Indeed, epidemiological data from across the
world indicates that prevalence rates for MDD post-stroke are 19.3% among in-patients and
23.3% for outpatients (Robinson, 2003). Although some studies have failed to find a
significant association between lesion location and affective disorder, a recent meta-analysis
which examined the lesion location and time since the incidence of stroke found that in the 2
months following an acute stroke left frontal and left basal ganglia lesions were significantly
more frequent in those patients presenting with major depression ((i.e. Robinson, in press;
cited in Robinson, 2003). Similarly, another meta-analysis by Narushima and colleagues
found a significant correlation between the severity of depression in poststroke patients and
the proximity of the lesion to the frontal pole in patients with left hemisphere stroke
(Narushima, Rosier & Robinson, 2003). As with the previously presented findings, both of
these studies are indicative of structural deficits in frontal and striatal regions of cortex in
depressed individuals, which may be associated with the presentation of depressive
symptoms.
As there is a potential causal link between the regions of structural abnormality and
cognitive deficits in MDD, the presence of structural deficits in patients with major
depression is not only of concern in the affective presentation of depressed patients, but is
also of interest in understanding the model of cognitive dysfunction in MDD. However, it is
not sufficient to infer this sort of association in the absence of evidence to suggest that the
regions that show structural dysfunction in MDD and are indeed associated with cognitive
function in normal healthy adults are functionally abnormal in unipolar depression.
1.1.5.1.2 Functional deficits in depression
In addition to structural imaging studies, functional neuroimaging has also been used to
explore the pathophysiology of unipolar depression. Generally speaking there are two
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approaches to the non-invasive imaging of brain function: electrophysiological methods and
metabolic/vascular methods. Recent research into neural function in major depression has
focussed largely on the latter approach, using a range of metabolic imaging techniques such
as functional MRI (fMRI), positron emission tomography (PET), and single photon emission
computerised tomography (SPECT). Using these imaging methods, investigators have
conducted two general types of examination of brain function, i.e. 'resting state' and
'activation' studies. Resting state investigations are those studies that examine regions of
cortical activation while patients are inactive, or 'at rest'. Activation studies, on the other
hand, consider the pattern of activation during performance of a specific cognitive task. By
considering evidence from both approaches it is possible to determine an accurate model of
cortical function inmajor depression.
(Note: A summary of the observations from resting state and activation studies of brain
function associated with MDD considered for this review can be seen in Appendices 1C and
ID).
Resting state studies
Using either PET or SPECT in conjunction with a variety of different paradigm approaches,
resting state investigations of brain function have identified a number of regions of
abnormal cortical activation in studies of depressed patients. While some studies have
simply compared resting state activations in depressed patients and healthy controls, other
studies have considered the differences in function between individuals during depressed
episodes and periods of remission. There are also those investigations that have considered
the association between the performance of depressed patients on a given cognitive task and
resting state activation.
While there are studies of resting state blood flow that have implied a reduction in global
flow in depressed patients (e.g. Sackeim et al., 1990), there is evidence to suggest that the
profile of cognitive dysfunction in MDD is the result of more localised abnormalities.
Indeed, across investigations there appears to be evidence of a dysfunction in frontal
subcortical circuitry (Elliott, 1998). This assertion can be qualified by examining the
available evidence from the various research groups who have been involved in resting state
imaging studies ofMDD.
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Bench and colleagues, for example, employed PET to consider resting regional cerebral
blood flow (rCBF) in a sample of forty individuals with a diagnosis ofmajor depression, and
compared the acquired images to those of a group of matched healthy controls (i.e. Bench et
al., 1992; Bench et al., 1993). It was observed that in contrast to controls, depressed patients
exhibited a relative decrease in rCBF in the left anterior cingulate (AC) and left dorsolateral
prefrontal cortex (DLPFC). Patients also showed tendency towards decreased blood flow in
the left angular gyrus and increased blood flow in the left posterior cingulate cortex.
In addition to investigating the mean blood flow differences between patients and controls,
Bench also considered the relationship between the functional abnormalities associated with
MDD and symptom presentation. In order to do this the authors identified three factors of
interest, which had loadings for anxiety, psychomotor dysfunction, and cognitive
performance. It was found that anxiety was positively correlated with blood flow in the
posterior cingulate and the inferior parietal lobule bilaterally, whereas psychomotor
retardation correlated negatively with rCBF in the left hemisphere in DLPFC and the
angular gyrus. Furthermore, cognitive performance was correlated positively with the level
of blood flow in the left medial prefrontal cortex (Bench et al., 1992; Bench et al., 1993).
Therefore, these studies not only implied that there was an abnormal pattern of cortical
activation associated with MDD, but that specific abnormalities in regional blood flow may
be linked to specific aspects of depressive symptomology.
This pattern of cortical dysfunction has also been noted in other series of PET studies. The
Danish PET/depression project have also examined the association between
neuropsychological function and cerebral blood flow in major depression in a series of
investigations (e.g. Soares & Mann, 1997; Videbech et al., 2001; Videbech et al., 2002;
Ravnkilde et al., 2003). A series of studies by this research group have found a significant
increase in blood flow in the right hippocampus and the left cerebellum in depressed
patients, compared to controls, in conjunction with a trend towards increased in rCBF in the
left lateral occipito-temporal gyrus (Videbech et al., 2001). Moreover, further analysis of
resting state blood flow also revealed an increase in the AC gyrus and the basal ganglia in
patients with MDD (Videbech et al., 2002).
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The Danish PET/depression project also extended their analyses in order to examine the
relationship between abnormalities in blood flow and cognitive function in depression (i.e.
Ravnkilde et al., 2003). In these studies, participants were asked to complete a battery of
neuropsychological assessments, which the experimenters then used to extract a set of
principal components: i.e. general ability; attention; verbal memory; visual memory;
language; and executive function. Multiple linear regression analyses were then used to
determine whether there was a correlation between these components and blood flow in
selected regions of interest. The only significant correlations between cognitive components
and blood flow for patients were for general ability (i.e. positive correlation with bilateral
hippocampal function) and executive function (i.e. positive correlation in right temporal
cortex and right AC). However, significant differences in correlations with blood flow
between patients and controls were noted for general ability (i.e. right orbitofrontal cortex
and bilateral hippocampus), attention (i.e. anterior cingulate), visual memory (i.e. left
posterior cingulate), and language (right prefrontal cortex). The authors concluded that the
cognitive deficits they had noted in the depressed sample were not associated with the rCBF
of the anatomical structures that were affected in this group, and therefore that cognitive
dysfunction in depression was not related to specific locations in the brain as with normal
cognition.
Other resting state studies have also found evidence of an association between measures of
cognition and resting blood flow. In two separate studies, Dolan and colleagues observed a
reduced rCBF in the DLPFC, bilaterally and the left AC in patients with depressive disorders
(i.e. Dolan et al., 1992; Dolan et al., 1993). Moreover, in the first of these investigations it was
found that cognitive impairment in depression was associated with decreased blood flow in
the left anterior medial PFC, in conjunction with increased blood flow in the cerebellar
vermis. This data appears to suggest that there is a pattern of functional abnormality that is
specific to the type of cognitive impairment observed in major depression. However, as
with the pattern of cognitive dysfunction in MDD it is possible that blood flow abnormalities
may not be specific to depression, but instead may reflect dysfunctions that are common to
other psychiatric disorders.
In an attempt to answer whether the rCBF abnormalities that had been documented in
studies of MDD were specific to depression or the type of cognitive dysfunction, Dolan
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compared the regional cerebral blood flow of depressed and schizophrenic individuals with
a deficit in psychomotor function, i.e. poverty of speech. It was found that psychomotor
retardation was associated with significantly lower rCBF in DLPFC, independent of
diagnosis (Dolan et al., 1993). Thus, implying that blood flow abnormalities may be
associated with the nature of cognitive dysfunction rather than depression per se.
Abnormalities in blood flow in major depression have not only been noted in frontal cortex,
there is also evidence to suggest striatal dysfunction in major depression. As already noted,
the Danish PET/depression project found evidence of increased blood flow in the basal
ganglia in depressed patients (Videbech et al., 2002). In addition to the findings of this
research group, an early study of frontal cortex and basal ganglia metabolism in affective
disorders found that unipolar depression was associated with a decreased metabolic rate in
the basal ganglia (Buchsbaum et al., 1986). Although, this observation should be treated
cautiously given the relatively small number of unipolar depressed patients who
participated in the study (i.e. N = 4). Nonetheless, there is additional evidence to suggest
striatal dysfunction in MDD. In a comparison of the relative blood flow in MDD and
obsessive-compulsive disorder (OCD), Saxena and colleagues found that a combined
diagnosis of MDD and OCD was associated with significantly lower metabolism in the
caudate than in OCD alone (Saxena et al., 2001). However, it is possible that in this
particular study dysfunction in cerebral blood flow may have been the result of a factor
resulting from the dual diagnosis, rather than a contributory factor ofMDD.
While there is considerable evidence of abnormalities in resting state blood flow in MDD, a
key factor in our understanding of the pathophysiology of depression is whether such
deficits are state or trait factors. In order to address this issue, some studies have
investigated resting rCBF in individuals who have recovered from depression. In a follow
up to their original investigations, Bench and colleagues identified and re-scanned twenty
five of the original sample of depressed patients who participated in the study and had
experienced clinical remission (Bench, Frackowiak & Dolan, 1995). The authors compared
recovered patients to samples of both depressed and healthy control participants. They
found that remission was associated with a significant increase in rCBF in the left DLPFC
and medial prefrontal cortex (PFC), including AC. Although there was a relative increase in
the blood flow in the angular gyrus the effect disappeared when depressed and recovered
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patients were matched for medication status. Therefore, this series of investigations implies
a level of frontal dysfunction in blood flow in the frontal cortex in MDD, which is associated
with symptom severity and appears to be state (rather than trait) related.
Tutus and colleagues also examined the effect of remission from major depression on
regional cerebral blood flow. Using SPECT, these authors examined the profile of blood
flow in unipolar (i.e. N = 10) and bipolar (i.e. N = 7) patients, who met the DSM-IV criteria
for a MDE, during depressed and remitted episodes. During depressed episodes unipolar
depressed patients showed a relative increase in rCBF in the left frontal cortex compared to
both bipolar and healthy controls subjects. However, these differences in cortical metabolism
disappeared upon remission. Thus, supporting the notion that resting state blood flow
abnormalities in MDD are a state, rather than trait, aspect of depressive illness (Tutus et al.,
1998). Yet, the differences between observed blood flow in unipolar and bipolar patients
suggests that these state abnormalities may be specific to episodes of major depression in
MDD only.
In summary, resting state studies of rCBF in MDD appear to consistently implicate a
significant dysfunction in blood flow in a number of frontal and striatal regions during
episodes of major depression. Thus, supporting the notion of impaired fronto-striatal
circuitry in major depression. Moreover, frontal dysfunction appears to most reliably noted
in areas which constitute the medial prefrontal cortex. This region has a number of primary
projections to other cortical regions, including striatal areas, which are involved in a number
of both affective and cognitive processes in normal healthy adults (Elliott, 1998: see Figure
1.2). Therefore, abnormal blood flow in the frontal lobes in depressed patients may be a
causal factor in dysfunction in fronto-striatal circuitry, and in the affective and cognitive
symptoms in MDD.
Although these abnormalities have been shown to correlate with cognitive dysfunction in
depression, there is evidence to suggest localised blood flow dysfunctions in MDD may not
be directly associated with specific aspects of cognition. Moreover, deficits in cerebral blood
flow may not be attributable to MDD but instead may reflect the presence of certain
symptoms of depression, which are common to other psychiatric illnesses. Finally, resting
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state studies support the theory that blood flow dysfunctions in MDD are a state aspect of
the disorder.
Figure 1.2: Elliott's (1998) model of the role of medial prefrontal cortex in the presentation of
symptoms in major depression.
■ Factors affecting resting state blood flow in major depression
Similar to the profile of cognitive dysfunction seen in MDD, there are a number of
potentially confounding factors that have been proposed to impact upon cerebral metabolic
rate in depressed patients. Common factors of interest in resting state studies of MDD have
included severity of depression (e.g. Mathew et al., 1980; Sackeim et al., 1990; Austin et al.,
1992; Tutus et al., 1998; Saxena et al., 2001; Videbech et al., 2001; Skaf et al., 2002; Videbech et
al., 2002) and medication status (e.g. Sackeim et al., 1990; Bench et al., 1992; Dolan et al., 1992;
Bench et al., 1993; Saxena et al., 2001; Videbech et al., 2001). Although there is reasonable
reliability in the regions of abnormal blood flow associated with depression identified across
studies, the confounding effect of such factors is not consistently evident.
In two separate investigations using 133Xenon inhalation it was found that brain metabolism
was associated with severity of depression, as measured using the HRSD (i.e. Mathew et al.,
1980; Sackeim et al., 1990). The first of these investigations noted a significant inverse
correlation between HRSD score and rCBF values in a sample of depressed patients.
Furthermore, the latter study found that the extent of topographic abnormality in depressed
participants was significantly associated with severity of depression.
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A similar pattern of results has been noted in other studies of resting state blood flow in
depression. For example, in a PET investigation of brain metabolism in MDD, Saxena found
that HRSD score was negatively correlated with rCBF in the hippocampus and amygdala
(Saxena et al., 2001). Whereas, Skaf and colleagues noted that severity of depression was
associated with metabolic rate in the right dorsal AC (Skaf et al., 2002).
However, not all studies have found evidence of an association between the severity of
depression and measures of cerebral metabolism. There are both SPECT and PET
examinations of blood flow in depression which have failed to find any significant
relationship between severity of depression and metabolic rate (e.g. Tutus et al., 1998;
Videbech et al., 2001).
A number of resting state studies that have considered medication status appear to support
the notion that medication is unimportant in resting blood flow in depressed patients.
Bench concluded that there were no significant differences between medicated and
unmedicated patients in global blood flow or in blood flow in those regions that had been
identified as being significantly associated with major depression (Bench et al., 1992; Bench
et al., 1993). However, they did note a trend towards a relative decrease in flow in the
medicated group in the right inferior frontal lobe. Similarly, irrespective of presence of
cognitive impairment, Dolan also noted that medication status had no effect on resting blood
flow in depressed patients (Dolan et al., 1992).
Activation studies
Resting state studies have been, and still are, important in the provision of information
relevant to the understanding of the pathogenesis of cognitive dysfunction in depression.
Nonetheless, the inference of a causal link between cognitive and metabolic abnormalities in
such studies may be flawed as a result of the fact that measures of cognition and blood flow
are not made simultaneously. While these factors may be correlated it is possible that the
changes in blood flow reflect some changes in another, possibly unknown or unrelated,
factor. Functional activation approaches to neuroimaging partially resolve this issue.
Although there is still the possibility of the confounding effect of some unknown factor, the
fact that measures of cognitive performance and brain metabolism are made at the same
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time allows for more accurate temporal and spatial localisation of regions of activation
associated with specific cognitive profiles.
Functional activation studies of depression have mainly used either PET or blood
oxygenation level dependent (BOLD) functional MRI to examine cortical activation during
the performance of cognitive measures. Despite the variety of cognitive dysfunctions that
have been noted in patients with major depression, the majority of studies appear to have
focussed on tasks that are likely to be reliant on those areas of cortex thought to be
functionally abnormal inMDD, such as measures of executive function and verbal fluency.
* Functional neuroimaging of verbal fluency
There have been two recent neuroimaging investigations of verbal fluency in MDD. The
first of these two studies (i.e. Okada et al., 2003) employed BOLD fMRI to assess cortical
activation during performance of a standard measure of verbal fluency. Depressed
individuals were found to be significantly impaired upon the verbal fluency task, compared
to healthy controls, in terms of the number of words generated. The effect of participant
group was also apparent in the level of cortical activation seen in participants, i.e. activation
in the left PFC was severely attenuated in the depressed patients compared to controls.
The second of these investigations (i.e. Videbech et al., 2003) also found an impairment of
verbal fluency associated with major depression. However, the researchers involved in this
study failed to find any significant differences in regions of cortical activation between
patients and normal controls. Both groups activated a network of regions encompassing the
left AC, left DLPFC, left medial PFC, and right cerebellum during performance of the task,
yet there was no significant difference in the level of activation of these regions between
experimental groups.
This latter investigation contrasts significantly with the observations of resting state studies,
which have shown significant abnormalities in these regions in samples of depressed
patients compared to normal controls. Assuming that the evidence from resting-state
studies is reliable, then there are a number of explanations for the lack of a significant
difference in this study. For example, there may be differences between the pattern and
magnitude of cortical activation in patients and controls but they may be too small to detect,
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or they may be masked by the contribution of individual differences in either experimental
group. Alternatively, it may be the case that under situations of sufficient difficulty patients
are able to increase the level of activation of regions of cortex necessary to perform the task
at hand.
■ Functional neuroimaging of executive function
There are a variety of neuroimaging studies of MDD that have examined brain metabolism
associated with the performance of a range of measures of executive function, including
planning, set-shifting, response inhibition, and working memory (i.e. both verbal and
spatial).
Elliott and colleagues investigated cortical metabolism associated with a test of planning (i.e.
the TOL task) using PET, in two separate investigations (i.e. Elliott et al., 1997; Elliott et al.,
1998). In the first of these investigations depressed patients were found to be significantly
impaired on the TOL task in terms of accuracy, but not reaction time, compared to a group
of matched healthy controls. In addition, the increase in difficulty experienced by patients
was disproportionate to task difficulty. The differences in behavioural performance in this
study were reflected in significant differences between depressed patients and control
participants in rCBF. During task performance controls engaged a network of PFC, AC,
posterior cortical areas and subcortical structures (including the striatum). Patients, on the
other hand, failed to show significant activation in both the cingulate and the striatum.
Additionally, activation in other prefrontal and posterior regions was severely attenuated in
patients, relative to controls. Moreover, patients did not exhibit the augmentation of
activation in the caudate nucleus, and right PFC that was associated with increased task
difficulty in control participants.
In the second of these two investigations the authors again examined TOL performance
during PET scanning. However, this time the experimental procedure was altered to include
a 'guessing' task. Both tasks were administered under three different experimental feedback
conditions, i.e. positive, negative, and neutral. Patients' overall accuracy was significantly
lower than controls, and both groups performed worse in the negative feedback condition
than in the positive condition. However, under neutral feedback conditions the performance
of controls was most similar to the positive condition, whereas the patients performance
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profiles was more akin to performance in the negative condition. In addition to these
behavioural differences, these experimental manipulations resulted in significant differences
in rCBF between patients and controls in the medial caudate and the ventromedial
orbitofrontal cortex. Moreover, activity in depressed patients was lower overall, and they
failed to show the differential response to the different feedback conditions that was noted in
the control group. Therefore, the results of both investigations by Elliott and colleagues
support the notion of impaired frontal and striatal function in MDD, and are indicative of an
association between fronto-striatal dysfunction and impairments on measures of planning
ability.
It was previously noted in this review that some researchers have observed differences in
the performance of depressed patients and normal controls on measures of attentional set-
shifting, such as the WCST. However, not all studies have found dysfunction on this
measure in MDD. Moreover, in those studies that have failed to find a depression associated
deficit on the WCST there also appears to be a lack of metabolic differences between
depressed patients and healthy controls. In an investigation of proposed 'hypofrontality' in
schizophrenia and depression, Berman examined the relative performance of depressed and
schizophrenic patients, and healthy controls on the WCST, during functional neuroimaging
(i.e. 133Xenon inhalation). In this investigation the performance of patients did not differ
significantly from controls on any parameter of the task. Accordingly, there were no
significant differences in either global or regional flow between patients and controls
(Berman et al., 1993). Although this observation is in contradiction to both cognitive and
neuroimaging studies of MDD, it is possible that the relatively small number of depressed
patients (i.e. N = 10) had an effect on the statistical power of this study, and, therefore, may
have impacted upon the findings.
Another example of executive function that has been studied in functional neuroimaging
investigations of MDD is 'response inhibition'. Kaiser and colleagues investigated this
particular cognitive function using an auditory 'Go'/'No-go' task. In contrast to the other
studies mentioned in this review, this particular investigation involved electrophysiological
neuroimaging method, i.e. high-resolution electroencephalography (EEG). The authors
found that while there was no difference between depressed patients and controls on the
'Go' task conditions, patients were impaired on the 'No-go' conditions. Thus, the
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behavioural findings were indicative of impairment in response inhibition in MDD. This
impairment was accompanied by a reduction in the early fronto-temporal positivity in the
N2 time window, which was associated with performance of the 'No-go' task in controls.
Therefore, the results of this study are suggestive of a dysfunctional activation of the
network that normally subserves executive control (Kaiser et al., 2003).
Data relating to the functional neuroimaging of working memory in MDD is of particular
relevance to the current series of investigations. There are two studies that have specifically
considered WM function in major depression. Firstly, a study by Barch and colleagues
examined the performance of depressed, schizophrenic, and healthy controls on a 2-back
working memory task, during acquisition of BOLD fMRI sequences (Barch et al., 2003).
Whereas, Pelsoi compared the performance of individuals with MDD and healthy controls
on the Sternberg working memory task (Sternberg, 1966) during EEG (Pelosi et al., 2000).
In the latter of these two studies, Pelsoi found that depressed patients made significantly
more mistakes as the memory load of the task was increased from one item to five items,
compared to controls. In addition, there were significant differences in the response patterns
of event-related potentials (ERP's) of patients and controls. The abnormalities that were
noted by the authors were suggestive of abnormal sensory/perceptual processing in MDD,
which the authors inferred was the result of deficits in selective attention mechanisms.
Moreover, the nature of ERP dysfunction seen in depressed patients was indicative of
compensatory mechanisms or a dysfunction of inhibitory systems. Given that the types of
abnormalities seen in patients were sensitive to memory load, the researchers suggested that
theymight reflect alterations ofmemory related processes.
Barch and colleagues, on the other hand, investigated both verbal and visual working
memory function by using both words and faces as stimulus items on a 2-back variation of
the n-back paradigm. The authors found that depressed patients were unimpaired on both
verbal and visual versions of thisWM task, compared to controls. However, despite the lack
of behavioural differences on these measures, controls demonstrated significantly higher
activation than depressed patients in bilateral thalamus, right precentral gyrus, and right
parietal cortex in response to both experimental conditions. While controls showed task
related activation for words, but not faces, in the right middle-temporal gyrus and right
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superior frontal gyrus, patients exhibited the opposite pattern of activation. Therefore,
although the results of this study are indicative of sparing of both verbal and visual working
memory in MDD, there is evidence of depression related dysfunction in regions of cortex
associated withWM function in normal healthy adults (see section 1.2).
Executive dysfunctions in depressed patients have also been observed on measures of
sustained attention. Kimbrell recently studied brain activation associated with sustained
attention in MDD using fluorine-18-deoxy-glucose (18FDG) PET, in a sample of depressed
patients whose diagnoses ranged from euthymic to severely depressed. Depressed patients
and healthy controls both completed an auditory continuous performance test. Although
patient's performance was similar to controls on measures of accuracy, depression was
associated with slower reaction times. It was observed that severely depressed patients
showed a decrease in regional cerebral glucose metabolism (rCRMglu) in the right
hemisphere in PFC and paralimbic/amygdala regions, and bilaterally in the insula and
temporoparietal cortex (i.e. rCRMglu right hemisphere > left). Furthermore, they also
exhibited increased metabolic activity bilaterally in the cerebellum, lingula/cuneus, and
brain stem. However, given the lack of significant group differences in accuracy measures, it
is possible that the differences in glucose metabolism are simply a reflection of differences in
psychomotor function (Kimbrell et al., 2002). Alternatively, the lack of significant
behavioural differences between patients and control may be the result of the inclusion of
patients with lower levels of depression in the analysis. Regional metabolic differences
associated with performance on this measure may be attributable to a dysfunction of
sustained attention that is related to the severity of depression.
In summary, functional neuroimaging studies of major depression for the most part appear
to support the notion of a profile of cognitive dysfunction similar to that seen in the studies
of cognition only. There is also considerable evidence to suggest that to some extent
individuals with major depression are significantly impaired on a range of cognitive tasks,
which may be the manifestation of a dysfunction in the central executive component of
working memory. Furthermore, evidence from both structural and functional neuroimaging
studies of MDD is indicative of abnormalities in the fronto-striatal system. Certainly, there
is a striking pattern of prefrontal dysfunction associated with MDD, even in those studies
that failed to find significant behavioural differences between depressed patients and
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matched healthy controls. Indeed, such dysfunctions may underlie deficits in the allocation
of processing resources. However, in order to qualify this assertion we need to examine
current thinking regarding models of working memory and the pattern of cortical function




1.2.1 The structure of human memory
The basic requirements of the system human memory are the encoding, storage, and
retrieval of information. It has been proposed that in order to perform these functions
effectively the human memory system must consist of a sensory register, a short-term store,
and a long-term store (see Figure 1.3).
Figure 1.3: Schematic representation of the model of human memory as proposed by
Atkinson and Shiffrin (1968; adapted from Baddeley, 1995).
The standard theory of human information processing (i.e. Atkinson & Shiffrin, 1968) states
that information from the sensory modalities is received and temporarily stored in the
sensory register. Information that is attended to is then transferred to the short-term store,
where it is temporarily maintained prior to appropriate response, information loss, or
transfer to the more permanent long-term store. Information is encoded into long-term
memory by means of rehearsal, such as maintenance or elaborative rehearsal. Output from
this system is mediated by the short-term store. Therefore, there must be a reciprocal
transfer of information between short-term and long-term memory. Although this model of
memory has proven extremely popular, certain shortcomings regarding the description of
short-term memory in such a system have been suggested.
There have been numerous models of short-term memory that are consistent with the
Atkinson and Shiffrin model of memory, and which inevitably share certain characteristics.
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Such models of STM propose a system of limited storage and processing capacity, in which
verbal memory span is heavily reliant on the capacity of STM. Moreover, traditional
explanations of short-term memory imply a relatively passive form of information storage.
However, it is apparent that this type of STS would not be capable of performing the variety
of cognitive tasks that are evident in the observation of everyday information processing in
humans. Indeed, it has been noted that the degree of interference experienced during dual
task performance paradigms, compared to the performance of individual tasks, is not as
acute as would be predicted by the original model of STM (Baddeley, 1999). Therefore,
Baddeley proposed that the demands placed upon a short-term storage system required a
more dynamic type of processing, such that a number of separate pieces of information
could be held online at any one time and could be interrelated with information from both
the STS and the LTS (Baddeley & Hitch, 1974). He described this type of short-term memory
as 'working memory'.
1.2.2 Baddeley & Hitch model of working memory
As opposed to the passive 'buffer' storage system characterised by models of 'short-term
memory', accounts of working memory attempt to characterise the more active nature of the
human information processing (Newell, 1973). 'Working memory' refers to a cognitive
system that provides temporary storage and manipulation of the information necessary to
undertake complex cognitive tasks (Baddeley, 1992). Baddeley and Hitch (1974) proposed a
model of working memory system that is characterised by an attentional control system, i.e.
the 'central executive', which is subserved by two 'slave systems', i.e. the visuospatial
sketchpad and the phonological loop (see Figure 1.4).
Central Executive
Visuospatial sketchpad Phonological loop
Figure 1.4: Schematic representation of the Baddeley & Hitch (1974) model of working
memory.
The central executive is proposed to be a limited-capacity attentional system, which controls
information transfer to and from the visuospatial sketchpad and phonological loop.
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Moreover, it has responsibility for the association of these slave systems with the long-term
memory store. Resultantly, the central executive is the most complicated aspect of the
working memory system, and as such is probably the least understood (Baddeley, 1999).
However, there is evidence to suggest that the capacity of the central executive, as assessed
using measures of working memory span, is significantly correlated with an individual's
comprehension capacity and with traditional measures of general intelligence.
The phonological loop, on the other hand, is involved in the processing of verbal
information and, therefore, is comprised of a temporary store and a process for the rehearsal
of verbal information. There is experimental evidence to support this notion of the role of
the phonological loop. For example, a temporary store for verbal information is evidenced
by the 'acoustic similarity effect' and the disruptive effect of task irrelevant spoken material
on the recall of visually presented stimulus items. The acoustic similarity effect refers to the
tendency for participant's errors to be phonologically similar to the correct stimulus item
and for sequences of acoustically similar stimuli to be more difficult to recall in the same
order than dissimilar items (Baddeley 1966: cited in Baddeley, 1999). Whereas, the latter
effect has been noted in instances of the presentation of spoken material in both native and
non-native language, but not using meaningless noise. Therefore, suggesting that the effect
is related to sound rather than meaning, but is not just the result of distraction (Salame &
Baddeley, 1982).
In addition, support for the presence of a phonological rehearsal process comes from
experimental evidence of the 'word length effect'. It has been noted that in word recall tasks
the greater the length of the words to be remembered the lower the average number of
words recalled by participants (Baddeley, Thomson & Buchanan, 1975). If participants are
prevented from engaging in subvocal rehearsal of the words, e.g. using articulatory
suppression, then this effect disappears. Thus, indicating that this type of rehearsal process
is an essential component of the temporary storage of verbal material.
It has been postulated that the visuospatial sketchpad is involved in the manipulation and
maintenance of visual information. Evidence for these distinctions in the visuospatial
sketchpad has come from studies of 'mental rotation'. In such tasks participants are
presented with two visual stimulus items that have different orientations, and are asked to
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decide whether the image are depictions of the same stimulus item. It has been suggested
that participants complete this task by creating a visual image of the original stimulus item
and mentally rotating this image to the match the orientation of the second item, and then
making a decision regarding stimulus similarity. Indeed, the available evidence suggests
that the time taken to make this decision is positively correlated with the extent of rotation in
real space. Consequently, this sort of information processing must be reliant on the
temporary storage and active manipulation of visual stimulus items, which corresponds to
the account of visuospatial function in the Baddeley and Hitch model ofWM.
Although there is abundant experimental support for the Baddeley and Hitch model of
working memory, it has been noted that the original model could not fully account for the
functions of an appropriate short-term store. Therefore, Baddeley proposed that a forth
component be included in the model, i.e. an episodic buffer (Baddeley, 2000: see Figure 1.5).
He suggested that the episodic buffer was a limited capacity storage system, which was
capable of bringing together information from the other subsidiary systems and the long-
term store, in order to provide a unitary episodic representation in short-term memory.
The Baddeley and Hitch model of working memory function has proven to be very popular,
and the distinctions it makes appear to be supported by the behavioural evidence from
normal adult participants. However, it is also important to determine whether the
distinctions made in this model between the various cognitive components of the working
memory system are reflected in the underlying biological systems. Indeed, studies of
working memory impairments associated with specific hereditary disorders, such as
William's and Down's syndromes, are indicative of a functional separability of the
processing of visual and verbal information in the short-term (e.g. Jarrold, Baddeley &
Hewes, 1999 and Wang & Bellugi, 1994). Both of these studies found evidence of
significantly better verbal processing in William's syndrome patients, compared to Down's
syndrome. Conversely, participant's with Down's syndrome performed significantly better
on visuospatial short-term tasks. It was proposed that William's syndrome was associated
with a specific dysfunction in the visuospatial sketchpad. Whereas, Down's syndrome
individuals had an apparent deficit in the phonological loop, with relative sparing of
visuospatial functions. Thus, these studies both observed pattern of results that support the
idea of separate verbal and visual short-term memory stores.
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Figure 1.5: Schematic representation of the revised model of human working memory
(adapted from Baddeley, 2000).
Although genetic studies do support the propositions of the above model of working
memory, regarding the functional separability of the verbal and spatial short-term memory
they do not elucidate as to the underlying mechanisms of the subcomponents of this system.
However, examination of functional neuroimaging studies of working memory in healthy
populations has not only revealed evidence relating to the separability of mechanisms of
verbal and spatial short-term stores, but has allowed for investigation of the regions of
cortical activation relating to the individual components of the working memory system.
1.2.3 Neuroimaging studies of working memory
There are numerous approaches to paradigm design in functional neuroimaging, including
'subtraction', 'parametric', 'factorial', and 'conjunction' approaches (see Chapter 2 for further
details). However, studies of cortical activation associated with the performance of working
memory tasks have largely utilised subtraction or parametric variations of three main types
of working memory task: delayed response; n-back; and self-ordered tasks. The nature of
working memory can be clarified by considering the contributions of each of these different
approaches to the understanding of working memory function in normal populations.
(Note: A summary of those original articles considered for this section can be seen in
Appendix IE).
1.2.3.1 Subtraction studies of functional activation associated with working memory
Smith & Jonides examined the neural correlates of verbal, spatial, and object memory in a
series of PET studies that used subtraction paradigms (i.e. Jonides et al., 1993; Smith &
Jonides, 1994; Awh et al., 1996). The same basic DMTS paradigm was used in each of these
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experiments to investigate the proposed distinctions in the working memory system. In the
experimental condition of each study participants were asked to recall whether a probe-
recognition item has previously appeared in a set of target items, i.e. either verbal (letters),
spatial (dots) or object. Both global and regional blood flow under these conditions were
compared to the pattern of cortical metabolism under a control condition, in which the target
and probe information were presented simultaneously.
At a global level, the authors noted that all of the significant regions of activation in the
spatial working memory conditions were in the right hemisphere (RH). On the other hand,
performance of the verbal task was associated with activation in the left hemisphere (LH).
Thus, global analysis implied a double dissociation in brain metabolism associated with
performance of verbal and spatial working memory tasks. In order to expand upon these
results, the experimenters examined regional changes in blood flow associated with the
performance of each type of task.
The spatial task was found to be associated with activation in the right posterior parietal and
anterior occipital cortices. Both of these areas have previously been identified as being
involved in spatial processing/memory and the maintenance of visual images, respectively
(Smith & Jonides, 1997). Moreover, spatial WM was also associated with activation in two
frontal regions in the left hemisphere. However, the role of these regions was less clear. The
authors suggested that this activation might have been involved a rehearsal process, similar
to the subvocal rehearsal of information in the phonological loop.
Analysis of the regional changes in blood flow during performance of the verbal task
revealed four LH regions of significant change, i.e. two frontal regions that included Broca's
area, supplementary motor and premotor areas, and two regions in the posterior parietal
cortex. The frontal activations occurred in regions that have previously been shown to be
involved in higher-level speech processes (Fuster 1995; cited in Smith & Jonides, 1997).
Therefore, it was suggested these regions might be involved in the subvocal rehearsal of
verbal information. Posterior parietal cortex, on the other hand, has been suggested to play
a role in the storage of verbal material. Patients with damage to this area have been noted to
experience deficits in memory span for verbal material (Shallice 1988; cited in Smith &
Jonides, 1997). Thus, this region is a possible location for the phonological store.
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Between conditions comparisons were also conducted in order to determine the differences
in activation between object and spatial conditions, and between object and verbal
conditions. There was evidence of a double dissociation between global activation
associated with object task performance and activation for spatial tasks, i.e. global analysis
revealed that the majority of regions (i.e. 3 of 4) during performance of the object task were
in the left hemisphere. The regional analysis demonstrated that the object task had resulted
in activation in the same premotor and posterior parietal regions that were activated by the
verbal task. A unique activation was also seen in the inferotemporal cortex - an area that is
believed to be involved in object recognition. It was proposed that the activation seen in the
left posterior parietal cortex might have been associated with participants creating a verbal
description of the objects for the purpose of item rehearsal. Despite the similarities between
the object and verbal conditions there was still dissociation in the global activation between
these two task types. More specifically, inferotemporal activation was specific to the object
task and some of the frontal activations were unique to verbal conditions.
Based on these observations, Smith and Jonides proposed that there was evidence of
functional separability of the components of human working memory. Taking this into
account, in a review of their neuroimaging studies of working memory they suggested an
amended model of working memory, and included details of the regions they believed were
integral to the normal functioning of this type of short-term memory system (see Figure 1.6;
Smith & Jonides, 1997).
There are also other investigations which support the notion of a spatial dissociation in
regions of significant change in brain metabolism associated with different subtypes of
working memory. D'Esposito and colleagues conducted a review of functional
neuroimaging studies of spatial and nonspatial (i.e. verbal and object) working memory.
The authors considered evidence of significant signal change from twenty different
neuroimaging studies. Examination of locations of lateral prefrontal activation revealed that
the activation associated with the performance of both spatial and nonspatial tasks was
evenly distributed throughout the lateral PFC, i.e. there was no dorsal/ventral dissociation
between different task types. However, there was evidence of hemispheric specialisation
associated with working memory function. Spatial tasks were associated with greater
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activation in the right PFC, whereas nonspatial tasks generated greater left hemisphere
activation in PFC (D'Esposito et al., 1998).
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Figure 1.6: Graphic representation of Smith & Jonides' proposed model of cortical regions
supporting working memory function (adapted from Smith & Jonides, 1999). This schematic
representation of the processes involved in working memory and the regions of cortical
activation resulting from the presentation of stimulus information in the visual modality. Note:
Block arrows indicate region(s) of associated activation tor specific components of the WM
system.
Paulesu, Frith, and Frackowiak (1993) also investigated the spatial dissociation of the
regional activations associated with different working memory processes with respect to
verbal working memory. Participants in this study were asked to undertake two different
tasks: short-term memory for letters and rhyming judgement for letters. It was proposed
that the former task would only engage the short-term store, whereas the latter would be
reliant on the subvocal rehearsal system. Therefore, the authors suggested that by
measuring the relative activity generated by each of these tasks it should be possible to
determine the cortical areas supporting each of these processes. Analysis of PET acquired
imaging data revealed that phonological processing was associated with significant
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activation bilaterally in BA 44, superior temporal gyri (BA 22/42), supramarginal gyri (BA
40) and insulae. The authors suggested that this arrangement of regions comprises the
functional anatomy of the phonological loop. Moreover, an attempt to identify those regions
associated with specific phonological functions implied that the supramarginal gyrus (BA
40) was the primary location for the phonological store, and that Broca's area (LH; BA 44)
was essential for subvocal rehearsal. Significant activations were also noted in the
supplementary motor area (SMA) and cerebellum, and possibly the sensory-motor areas.
However, it is possible that these additional activations were related to the activation of a
network associated with language planning and execution (Paulesu, Frith & Frackowiak,
1993).
In addition to the highlighted frontal and parietal activations, working memory function has
also been linked to activation in the anterior cingulate, occipital cortex, and the cerebellum
(Cabeza & Nyberg, 2000). Indeed, changes in the degree of activation in the anterior
cingulate (BA 32) have regularly been noted in studies of working memory. However, there
is evidence to suggest that such activations may not reflect specific working memory
processes, but instead may reflect the degree of difficulty of the task. Barch and colleagues
studied the performance of neurologically normal participants on the continuous
performance test (CPT; Rosvold et al., 1956). Demand on working memory was varied on
this task by varying the delay time between the cue and the probe on this task, whereas
presenting either degraded or non-degraded stimulus items altered task difficulty. Regions
that showed an effect of delay on activation included the left middle frontal gyrus
(corresponding to DLFPC, the left inferior frontal gyrus (BA 44), and the left posterior
parietal lobule. None of these regions showed an activation response to the changes in task
difficulty. However, a number of regions did show a response in activation as a result of
manipulation of task difficulty, including the anterior cingulate, right inferior frontal cortex,
and a subcortical region. The effect seen in these regions was greatest in the anterior
cingulate (Barch et al., 1997). Thus, supporting the proposed role of AC activation in the
mediation of responses to the manipulation of task difficulty.
Therefore, it appears that there is a hemispheric dissociation in cortical activation during
performance of different types of working memory task: spatial/left hemisphere and
nonspatial/right hemisphere. There is also evidence to suggest that specific regions, or
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assemblies of regions, support specific processes in the working memory system. Moreover,
there appears to be dissociation between those regions of cortex that are associated with the
level of difficulty of certain working memory tasks and those which are associated with the
processes of working memory. However, an additional factor yet to be considered is the
effect of cognitive load on the working memory system.
1.2.3.2 Parametric investigations of functional activation associated with working memory
A number of the studies already mentioned have relied on subtraction paradigms in order to
make inferences about the functional neuroanatomy of human working memory. While
such investigations have inevitably been useful in developing our understanding of working
memory and its underlying processes there are complications that are intrinsic to this type of
approach. The most obvious of which is the problem of 'pure insertion' (see Sternberg,
1969). In such paradigms the determination of the pattern of activation associated with a
specific process is reliant on the assumption that the two chosen tasks (i.e. the experimental
task and the control task) differ only in the inclusion of the process of interest, and that
inclusion of this process does not impact upon other aspect of information processing.
However, it is reasonable to assume that the inclusion of the process of interest may have a
noticeable effect on the execution of other processes necessary for the successful completion
of a given task. Moreover, it may rely on the implication of supplementary processes not
required the control task.
One potential way to address this issue is to instead employ a single behavioural measure
that can be varied around a single parameter, i.e. parametric paradigms. The use of
parametric measures allows the experimenter to keep all other cognitive factors constant
while incrementally increasing (or decreasing) the level of difficulty of the process of
interest. This approach has been of particular use in the functional neuroimaging studies of
working memory as it has enabled investigators to determine not only those regions that
may be associated with the verbal or spatial aspects of WM but to ascertain cortical regions
that correspond to central executive function, i.e. those regions which respond to alterations
in cognitive load.
Many investigators have employed variations on a parametric working memory task known
as the 'n-back' task in order to investigate both verbal (e.g. Cohen et al., 1994; Schumacher et
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al., 1996; Braver et al., 1997; Cohen et al., 1997; Manoach et al., 1997; D'Esposito et al., 1998;
Ye et al., 1998; Isoardi et al., 1999; LaBar et al., 1999; Rypma et al., 1999; Honey, Bullmore &
Sharma, 2000; Nystrom et al., 2000; Glabus et al., 2003) and spatial (e.g. Casey et al., 1998;
D'Esposito et al., 1998; Callicott et al., 1999; Thomas et al., 1999; Jansma et al., 2000; Nystrom
et al., 2000; Postle et al., 2000) working memory systems. This paradigm has been developed
from a task that was originally used in an EEG investigation of the spatiotemporal dynamics
of human working memory (i.e. Gevins & Cutillo, 1993). Normally the task is presented as a
delayed match-to-sample task, in which participants are presented with a series of visual
arrays (either spatial or nonspatial). The level of difficulty of the n-back task is then
manipulated by altering the number of intervening arrays between presentation of the items
to be recalled and the probe for recall of the items. Commonly, difficulty is varied around
four levels of this parameter, i.e. 0-, 1-, 2-, and 3-back. In 0-back conditions participants
simply have to respond to the current stimulus items. However, in 1-back conditions they
are required to respond to the items that appeared in the previous array. Similarly, in 2- and
3-back conditions there are 2 and 3 intervening stimulus arrays between encoding and
response, respectively.
Performance on the n-back task can be measured on two factors, i.e. accuracy and reaction
time. It has been observed that as the level of task difficulty is increased (i.e. from 0-to 3-
back) there is a corresponding decline in participant's accuracy, and an increase in reaction
time (e.g. Braver et al., 1997; Callicott et al., 1999; Jansma et al., 2000). Indeed, reaction time
has been highlighted as a measure that is sensitive to manipulations of memory load
(Baddeley, 1986). Therefore, it can be predicted that the changes in cortical activation that
accompany the increase in n-back, and thus the increase in memory load, will be associated
with a decline in the performance of participants.
The n-back task has proven popular with researchers examining the functional anatomy of
working memory for a number of reasons. Primarily, variations on the task have produced
robust findings regarding the functional underpinnings of WM (e.g. Casey et al., 1998).
Moreover, it is reasonably easy to manipulate the task around a number of factors while still
retaining the essential components that contribute to its reliability. Experimenters have
designed both verbal and spatial variants and the paradigm can be altered to assess either
recognition or recall ability. Moreover, the level of difficulty of the task can be easily altered
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in order to bring about changes in cognitive load. The ease with which this task can be
adapted for the needs of a single study, or series of studies, makes it particularly amenable
to the understanding of the processes of working memory not only in normal participants
but also in clinical populations.
Verbal working memory
Neuroimaging studies that have used variants of the n-back task to investigate working
memory have largely concerned themselves with the neural correlates of the increase in task
difficulty (see Figure 1.7). Braver and colleagues conducted two fMRI investigations of
verbal WM across 0- to 3-back levels of n-back (Braver et al., 1997). The variations of the task
that they employed in the two studies were essentially the same, although the paradigm
used in the second study comprised shorter block durations and included fewer trials of
each level of the task. In their first study they noted a linear change in the degree of
activation in the middle frontal gyrus (MFG; BA 46/9) bilaterally, the left inferior frontal
gyrus (LIFG; BA 44/45), the anterior cingulate (BA 32), and a more anterior inferior site (BA
47/10). However, planned comparisons revealed monotonic changes in activation associated
with increased task difficulty in MFG and LIFG only. In both instances there was a linear
relationship between signal and load. Moreover, they noted similar findings in their
analysis of the relationship between RT and signal change.
The results of the second study by this group for the most part replicated the findings of the
first. However, in this instance load-sensitive activity was additionally observed in the right
homologue of LIFG (BA 44), left frontal operculum, and a number of motor, premotor, and
supplementary motor regions (BA 4 & 6). Additionally, non-frontal activity was noted in
bilateral posterior parietal cortex (BA 40/7) and the left caudate nucleus.
The load-dependent activity of these cortical regions has been observed in other studies that
have also employed verbal variations of the n-back task. For example, in an fMRI
investigation of the effects of both time and load on activation, Cohen and colleagues also
noted a significant effect of memory load in DLPFC (Cohen et al., 1997). Moreover, areas of
posterior parietal cortex (BA 40) and in posterior regions of frontal cortex (including Broca's
area) were also found to be sensitive to the effects of load, but also co-occurred with regions
that were sensitive to the effects of time and load. This study also noted significant effects of
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time, but not load, in visual, motor, and somatosensory cortex. While the pattern of results
in this study is similar to that seen in the Braver study, the effect of load on PFC in this case
appeared as a step function rather than a monotonic linear increase across all levels of the
task, i.e. the primary increase in activation occurred between the 1- and 2-back levels of the
task.
Figure 1.7: Diagram of regions of cortex exhibiting load dependent activity during
performance of parametric working memory tasks - lateral view. The numbers on each
cortical section correspond to Brodmann areas. Note: The choice of colour of each of the
relevant sections is unimportant. A range of colours has been used in order to highlight the
structural distinction between the various regions involved in load-dependent activity.
The relative effects of time and load on the pattern of cortical activation were also noted in a
PET investigation of verbal n-back performance, conducted by Smith and Jonides (i.e.
Jonides et al., 1997). This study observed a pattern of results that indicated that as the level
of difficulty of n-back was increased there was an apparent increase in the number of
activated regions, including DLPFC. However, further analysis revealed that the same
regions were active across all levels of the task (i.e. 0- to 3-back), but that at lower levels of
the task the signal intensity in the activated regions was below threshold. Linear increases
in activation with increasing memory load were noted in the bilateral cerebellum, bilateral
DLPFC (LH: BA 46/10, RH: 9/10/46), Broca's area, right superior parietal cortex (BA 7), right
premotor cortex (BA 6), and a region comprising the left premotor area and the anterior
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cingulate (BA 6/32). As in the Cohen study, activation in the visual, motor and
somatosensory cortex was significant but not associated with memory load per se.
Thus, the available evidence indicates that the regions of cortical activation associated with
verbal working memory processes in subtraction studies also exhibit significant changes in
signal intensity under parametric paradigm conditions. Moreover, regions within the
proposed cortical assembly supporting verbal WM show monotonic, or at least linear,
changes in activations with relative increases in memory load. A similar pattern of results
has also been noted in parametric studies of regional activations associated with spatial
working memory.
Spatial working memory
In an parametric study of spatial working memory, Callicott and colleagues noted load-
sensitive responses in a distributed network of regions that included DLFPC (BA 9-10/44-46),
premotor cortex (BA 6/8), the basal ganglia and thalamus, parietal cortex (BA 7/39-40), and in
a pericingulate regions comprising the medial frontal gyrus (BA 6) and the anterior cingulate
(BA 32). Moreover, there was evidence of significant laterality in the regions of activation
associated with memory load. The number of significant foci of activation in DLPFC was
greater in the right hemisphere, compared to the left, and included both dorsal (BA 9/46) and
ventral (BA 6/8 areas). Interestingly, the authors also observed that the signal change in
DLPFC loci evinced a U-shaped response to the linear increase in task difficulty. It was
suggested that this pattern of activation was evidence of a capacity-constrained response.
This proposal was additionally supported by the observed predictive value of DLPFC
activation and performance within capacity (i.e. 2-back condition), but to a much lesser
degree beyond capacity (i.e. 3-back) (Callicott et al., 1999).
As with activation associated with verbal WM, prefrontal load-dependent activation during
performance of spatial n-back tasks has also been observed in other functional neuroimaging
studies of WM in normal adults (e.g. Casey et al., 1998; Jansma et al., 2000; Postle et al.,
2000). Moreover, there is evidence to suggest that the co-localisation of load-sensitive and
load-insensitive activations is also apparent in spatial WM tasks. Jansma examined spatial
working memory across four levels of n-back, and found evidence of co-localisation of these
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two response types bilaterally in DLPFC and parietal cortex, and in the anterior cingulate
(Jansma et al., 2000).
This model of activation associated with parametric spatial WM performance can also be
extended to populations other than normal healthy adults. Thomas and colleagues found
evidence of activation of similar cortical regions in healthy adults and children (aged 8 -10
years) in an fMRI investigation of spatialWM. In a comparison of adults and children on the
n-back task and a control motor condition revealed that both experimental groups
experienced reliable working memory associated activation in the right hemisphere in the
superior frontal gyrus (BA 8), DLPFC (BA 10/46), superior parietal cortex and bilaterally in
inferior parietal cortex. Thus, indicating that the same regions of cortex subserves working
memory in both children and adults (Thomas et al., 1999).
In addition to the investigation of the regions of activation associated with performance of
working memory tasks have highlighted significant factors the impact upon the observed
cortical function. In a recent fMRI investigation of verbal working memory, using the n-back
task, Glabus highlighted significant differences in the regions of activation associated with
task performance between sub-groups of 'high' and 'low' performers. Although the group
model of activation in this study highlighted regions of significant activation in the
prefrontal and parietal cortices, there were considerable interindividual differences in
activation. It was found that those who performed well on the task (i.e. high performers)
engaged a LH sub-network, which comprised the inferior parietal lobule and Broca's area,
whereas, those participants who were relatively impaired on the paradigm (i.e. low
performers) utilised a RH sub-network including inferior parietal and DLPFC. Therefore,
the authors suggested that better performance on measures of verbal WM is associated with
activation of neural systems associated with verbal information processing. Moreover, it
was proposed that an observed interaction between the parahippocampal gyrus and the
inferior parietal lobule may have been associated with the implementation of different task
strategies (Glabus et al., 2003).
There is also evidence to imply the same kind of performance related activation associated
with measures of spatial working memory. Although they did not directly compare
different sub-groups of participants, Jansma and colleagues did note a significant positive
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correlation between performance (i.e. accuracy) and activation in a large region of load-
sensitive activity in the anterior cingulate and in a smaller region of load-sensitive activity in
the right parietal cortex. However, given the previously outlined response of anterior
cingulate to aspects of task difficulty, this may simply reflect the increased level of task
difficulty rather than a functional dissociation associated with the level of performance of
individual participants.
In summary, it appears that the proposed dissociation between verbal and spatial working
memory functions is reflected in the hemispheric specialisation associated with each
separate form of WM (i.e. spatial WM -> RH, and verbal/nonspatial -> LH). There is also
evidence to suggest that activation in specific cortical regions is associated with the
performance of specific processes within each of the working memory slave systems, such as
storage and rehearsal, with prefrontal regions apparently supporting spatial and verbal
rehearsal and parietal regions functioning in the short-term storage of spatial and nonspatial
material. Moreover, evidence from parametric working memory tasks is indicative of load-
dependent activity in a distributed network of prefrontal and posterior parietal regions
associated with executive, storage, and rehearsal functions of WM. Specifically, it has been
suggested that, as a result of its sensitivity to changes in memory load, the DLPFC may be
the functional site of the central executive component of human working memory.
Although, there is evidence of activation in visual, motor, and sensorimotor areas associated
with the performance of working memory tasks such activation is not load sensitive and
may reflect motor aspects of working memory, such as speech planning and execution.
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1.3 Antidepressant medication and cognition
1.3.1 Pharmacotherapy and depression
1.3.1.1 The monoamine hypothesis of major depression
The monoamine (or biogenic amine) hypothesis of major depression postulates that MDD is
the result of abnormalities in neurotransmitter function in the brain. More specifically, it
proposes that depressed mood is the consequence of deficiencies in monoamine
neurotransmitters, such as noradrenaline (NA) and serotonin (5-HT).
Evidence for this hypothesis was first suggested by the observation that manipulations of
the levels of biogenic amines could either induce or alleviate the symptoms of major
depression. For example, an investigation in the mid-fifties found that consumption of the
antihyperintensive medication resperine precipitated depressed mood (i.e. Muller et al.,
1955; cited in Hirschfeld, 2000). It was found that resperine interfered with the storage of 5-
HT in two ways, i.e. through the depletion of stores of serotonin in the brain and the storage
of the serotonin metabolite 5-hydroxyindolacetic acid (5-HIAA) in urine (Shore, Silver, and
Brodie, 1955; cited in Hirschfeld, 2000). Therefore, it has been proposed that resperine
brings about depletion in the presynaptic level of monoamines, as a result of its disruption
of the vesicular storage of both NA and 5-HT, and that this depletion is critical in the noted
induction of depression associated with resperine administration.
The notion of the role of monoamines in the precipitation of depression is also supported by
the observed reversibility of depressive symptoms upon cessation of resperine. Moreover, a
normalisation of mood can be attained via the administration of monoamine precursors,
such as dihydroxyphenylalanine, which effectively reverses the impact on monoamine levels
caused by medications such as resperine. The result of which is a normalisation of mood.
This effect has been noted in both animal models and human participants.
The role of 5-HT and NA in depression has been further supported by observation that
medications used in treatment of depression appear to remedy the depressive symptoms by
altering the synaptic availability of monoamines. For example, the action of both the
tricyclic and monoamine oxidase inhibitors (MAOIs) in alleviating depressive episodes
appears to be the result of their ability to increase the level of monoamines at the synapse.
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However, the relationship between mood and monoamine levels may not be as simple as
this theory predicts. In studies of normal healthy participants depletion of 5-HT and NA, i.e.
via tryptophan depletion or administration of low doses of a-methyl-p-tyrosine, has not
necessarily led to the onset of depressive symptoms. Moreover, depressed patients who are
treated with either 5-HT selective reuptake inhibitors, but not NA reuptake inhibitors, may
suffer a brief relapse upon depletion of 5-HT. Conversely, those patients who are treated
with NA reuptake inhibitors, but not 5HT-reuptake inhibitors, can experience relapse if
briefly exposed to depletion of NA. However, the experimental evidence suggests that
although their depletion is not sufficient alone to induce depression, monoamines may be
critically involved in the maintenance of antidepressant response (Duman, 1999).
While there is a clear association between monoamine availability and depression, there are
also a number of problems with this hypothesis, such as the delayed action of many
antidepressants. Although many antidepressants will have an impact upon monoamine
levels within hours of the first administration it can sometimes be weeks before an effect
upon mood will be noted in the depressed patient. Thus, suggesting that while the
alteration of the level of monoamines at the synapse is necessary, it may not be sufficient
alone in the reversal of depressive symptoms. Nonetheless, despite such criticisms the
monoamine hypothesis of depression has remained one of the most influential, and has
largely dictated the psychopharmacological approach to the treatment of major depression.
1.3.1.2 Classes of antidepressant medication
It has been proposed that the mechanisms that lead to the transportation of biogenic amines
such as 5-HT, NA, and dopamine (DA) to the presynaptic cortical neuron are essential to the
termination of the physiological actions of these transmitters on their receptor sites.
Consequently, any action that inhibits this re-uptake mechanism should both prolong the
physiological action of the neurotransmitter and bring about relevant behavioural changes
(Leonard, 1992). However, this action alone does not appear to be sufficient to bring about
changes in depressed mood. For example, drugs such as cocaine and amphetamine, which
bring about delay in the re-uptake of biogenic amines, appear to have little effect on
depression. Even so, the pharmacological treatment of major depression has largely
focussed on those treatments that have an effect on the re-uptake of monoamines.
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Despite similarities in their physiological actions, antidepressant medications can bee
categorised into different subtypes. The classification of antidepressants is largely based
upon the known receptor affinities of antidepressant medications. The result of adopting
this approach to the classification of medications used in the treatment of depression is three
general classes of antidepressant (AD) medication, i.e. the previously mentioned tricyclic
antidepressants (TCAs) and MAOIs, as well as the more modern selective serotonin re¬
uptake inhibitors (SSRIs). Although there are similarities in the mechanisms of each of these
classes of AD, there are crucial differences in the antidepressant action of each different
subtype. Therefore, it seems appropriate to examine the nature of each class independently.
Tricyclic antidepressants
Tricyclic antidepressants get their name from the presence of a core structure comprised of
three benzene rings. Included in this class of medications such as imipramine, amitriptyline,
trimipramine, doxepine, desipramine, nortriptyline, and protriptyline. The primary action
of TCA drugs is in the inhibition of the re-uptake of NA, and, to a lesser degree, 5-HT.
In addition to their affinity for biogenic amine receptors, TCAs are also active at multiple
nonmonoamine sites, such as histamine-1, muscarinic acetylcholine, and ai-adrenergic
receptors. Many of the side effects associated with TCA medications can be attributed to the
affinity for these drugs at these nonmonoamine receptor sites, at therapeutic dose levels.
Indeed, this varied affinity has been implicated in a number of the potential side effects
associated with therapeutic usage of TCAs, including dry mouth, blurred vision,
constipation, urinary retention, memory impairment, tachycardia, sedation, weight gain,
hypotension, and potentiation of other CNS depressants (Berman et al., 1999). Due to the
risk and range of side effects associated with tricyclic medications, other classes of
antidepressant medication are more commonly favoured over TCAs in the treatment of
MDD.
Monoamine oxidase inhibitors
Medications within the MAOI class, such as phenelzine, tranylcypromine, and
moclobemide, are categorised by their ability to block the action of the MAO isozymes A
and B. The antidepressant activity of this class of drugs is largely attributed to their ability
to block MAOa, since the inhibition of MAOb has limited effect on the symptoms of major
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depression. The result of this action is a decrease in the metabolism of NA, thus increasing
the synaptic availability of this monoamine.
The side effects of MAOIs have been known to include acute and severe elevations of blood
pressure, headaches, nausea, sweating, pallor, and vomiting. Moreover, patients taking
MAOIs may have to adhere to strict dietary restrictions. Resultantly, MAOI antidepressants
are relatively less popular in the treatment ofMDD than other AD medications.
Selective serotonin reuptake inhibitors
As with the TCA medications, SSRI antidepressant act upon the uptake of both NA and 5-
HT. However, their affinity for the 5-HT transporter is in order of 1-2 times the magnitude
of their affinity for NA (Richelson, 1991; cited in Berman et al., 1999). Given their relative
effectiveness and tolerability, SSRI medications such as fluoxetine, paroxetine, sertraline,
fluvoxamine, and citalopram are in common use for the treatment ofMDD.
Although there is a considerable range of studies that have examined the affinity, efficacy,
and tolerability of the various classes of antidepressant medications, the relevance of AD
medication to this particular series of investigations is their impact upon cognitive
performance and cerebral metabolism. Therefore, the following sections of this review will
consider the available evidence pertaining to each of these factors.
1.3.2 The profile of cognitive function associated with antidepressant medication
It is commonly accepted that the advent of adequate psychopharmacological treatments for
depression has fundamentally changed the evolution and prognosis of MDD (Amado-
Boccara et al., 1995). Moreover, it has been proposed that modern ADs make it possible
individuals with major depression to be treated as outpatients and to retain much of their
normal activity, including work responsibilities. However, for depressed patients to
maintain a level of functioning that is as close as possible to normal it is essential that the
antidepressants which patients are prescribed impactminimally upon cognitive function.
The association between cognitive performance and antidepressant medication is also a key
factor in patient compliance. Indeed, it has been found that patients are less likely to comply
with pharmacological intervention if they experience disturbances of mnemonic or
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psychomotor function (Amado-Boccara et alv 1995). The profile of cognitive function
associated with AD medication is not only of concern in a clinical setting. Indeed, the
consumption of ADs is a potential confounding factor in empirical investigations of major
depression. Therefore, it is essential that researchers and clinicians are able to identify and
quantify possible dysfunctions of cognition that are associated with the administration AD
medication, rather than being symptomatic ofMDD.
A number of studies have investigated whether the consumption of AD medication has a
significant association with cognitive performance, on a number of different cognitive
measures. There has been considerable variation in the methodological approaches of
different studies, including differences in the type of antidepressant investigated, the
experimental groups of interest (i.e. normal healthy adults or depressed patients), the
cognitive processes of interest, and the choice of AD administration (i.e. acute, subacute, or
chronic). The consideration of a selection of original articles and review papers which have
examined these factors should allow us to determine: (1) whether the consumption of
antidepressant medication has a significant impact upon cognitive function, and (2) which
factors in experimental design are pertinent to the observation of cognitive dysfunction in
individuals who have been prescribed an AD.
Psychomotor function
Manipulation of the serotonergic system has been shown to have an impact upon many
aspects of cognitive performance, including psychomotor function (reviewed by Lucki,
1998). Therefore, studies of the effect of antidepressant medication on cognition have tended
to include measures of psychomotor ability. The measures used in the assessment of
psychomotor function have ranged from elementary tests of motor ability, such as the finger
tapping test (FTT), to more complex assessments which mimic real life situations, e.g. tests
that simulate driving. The outcome of the investigation of measures of psychomotor ability
appears to be reliant on the class of medication used and the affinity of the chosen
medication.
A key factor in the effect of antidepressant medication on psychomotor performance appears
to be the receptor affinity of the chosen AD. Acute administration medications that have a
biochemical profile that includes affinities for muscarinic acetylcholine, Hi-histaminic, and
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ai-andrenergic receptors appear to have a deleterious effect upon measures of psychomotor
performance, whereas those medications which are primarily involved in the inhibition of 5-
HT uptake appear to have no such detrimental effect (reviewed by Amado-Boccara et al.,
1995). Thus, there appears to be a proposed distinction between the effect of TCA and SSRI
medications in the performance ofmeasures of psychomotor function.
Indeed, a number of empirical investigations have noted the differential effect of TCA and
SSRI medication on the measures of motor function. For example, Fairweather and
colleagues conducted a comparison on the effect of citalopram (an SSRI) and dothiepin (a
TCA) in a sample of healthy participants (i.e. N = 14; 5 male and 9 female participants).
Participants were prescribed citalopram (i.e. 10, 20 or 40 mg/day for 8 days), dothiepin
(75mg on days 1 & 8, with placebo on intervening days), or a placebo only (once daily for 8
days). Each participant was tested on a battery of neuropsychological assessments at 2-, 4-,
5-, and 8-hour intervals after consumption of medication on days 1 and 8 of the study, i.e.
prior to commencement of medication, and after subacute administration of medication. It
was found that while citalopram had no significant effect on psychomotor performance on
both a choice reaction time and the Leeds Psychomotor Test, irrespective of dosage.
Dothiepin, on the other hand, was found to induce a sedative effect on motor function on all
of the measures which were used (Fairweather et al., 1997). These findings replicated those
of an earlier study by the same research group, which found no effect of fluvoxamine (an
SSRI) on the same measures of psychomotor performance in healthy male volunteers (i.e. N
= 12), but the same sedative effect of dothiepin (Fairweather, Ashford & Hindmarch, 1996).
The comparative effects of TCA and SSRI medications on motor performance have also been
extended to studies of more complex motor function. Hindmarch studied the impact of
fluoxetine (an SSRI) and dothiepin on the performance of a simulated driving task. As with
the previous investigations this study involved normal healthy adults, who acted as their
own controls in a placebo-controlled study. Participants' performance on the driving
simulation task was measured on a number of performance factors, and under two 'alcohol'
conditions, i.e. consumption of medication either with alcohol or an alcohol placebo.
Irrespective of the consumption of alcohol, dothiepin impaired performance on the task.
However, acute dose administration of fluoxetine had no impact upon performance in both
alcohol conditions (Hindmarch, 1988). Thus, indicating that the sedative effects of TCAs
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upon psychomotor performance in normal healthy adults is not just applicable to
elementary measures of motor function, but can indeed be extended to more complex forms
of psychomotor ability.
One potential explanation of the relative differences in the effect of TCA and SSRI
medications on the performance of psychomotor tasks may be attributable to the differences
in the affinity of these two classes of AD medication to NA receptors. In order to determine
the relative effect of 5-HT and NA reuptake inhibition upon cognitive performance, Nathan
and colleagues examined the comparative effect of serotonin and noradrenaline reuptake
inhibitors (i.e. citalopram and venlafaxine, respectively). The effect of both of these
medications upon the performance of a choice reaction time measure in normal healthy
volunteers (i.e. N = 9, all male) was compared to the effect of amitriptyline (a TCA) and a
placebo. It was found that acute administration of citalopram actually had a facilitatory
effect on psychomotor function, which was evident in decreased reaction times on the CRT
task in participants in this condition. Alternatively, venlafaxine was found to have no effect
on any measure of psychomotor speed in this study (Nathan et al., 2000).
The results of the Nathan study appear to support the notion of a lack a sedative effect of
SSRI medication on psychomotor performance. Indeed, the findings of this particular
investigation are indicative of an improvement in psychomotor function in participants who
are given SSRI medication. This beneficial effect of 5-HT reuptake inhibition on
psychomotor performance has also been noted in studies that have administered other SSRI
medications, such as sertraline (Hindmarch & Bhatti, 1988) and paroxetine (Hindmarch &
Harrison, 1988). Thus, it would appear that the effects of SSRI medication on psychomotor
performance are at worst negligible, and may even beneficial.
The failure of venlafaxine to impact upon psychomotor function may be attributed to its low
affinity for 5-HT receptors, compared to SSRI medication. Although venlafaxine does have
some affinity for the re-uptake inhibition of 5-HT the magnitude of its effect on this
mechanism is somewhere in the order of 160 times less than that of citalopram (Nathan et al.,
2000).
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The relative difference in the effect of venlafaxine and citalopram also has important
consequences in the comparative differences between TCA and SSRI medications on motor
function. Venlafaxine is similar to TCA medications in its profile of affinity for NA reuptake
inhibition. Therefore, the sedative effects of tricyclics may possibly be attributable to the
affinity of this class of medication for nonmonoamine receptor sites.
Executive function
Monoamine function in the brain is not only of importance to the integrity of psychomotor
function, but also plays a role in carrying out executive functions. In a review of chemical
modulation of executive functions in the brain, Robbins suggested that catecholamines (i.e.
DA and NA) were involved in the execution of tests of planning or working memory,
whereas serotonin function appears to be involved in set-shifting and decision-making tasks
(Robbins, 2000). This behavioural dissociation is also reflected in the functional dissociation
of the putative regions of PFC that support these types of executive function. It would
appear that the effect of catecholamines on cognitive performance is associated with those
tasks reliant on dorsolateral and rostrolateral PFC. Serotonin, on the other hand, seems to
be involved in the execution of tasks that are mediated by orbitofrontal PFC (Robbins, 2000).
Therefore, given the relative effect of different biogenic amines on cognitive function, it is
reasonable to suggest that medications that have an effect upon the cortical levels of these
neurotransmitters will have an impact upon executive function. As with psychomotor
function, a number of studies have considered the relative effects of such medications on
different aspects of executive function, including planning, working memory, and selective
attention. Moreover, some investigations have also considered the relative influence of
different classes of AD medication on these types of cognitive functions.
One commonly used objective measure of attention and information processing in studies of
antidepressant effects on cognition is the critical flicker fusion frequency threshold (CFFT).
This assessment requires participants to respond at the frequency at which a rapidly
repeated visual stimulus (i.e. light emitting diodes) stops being perceived as separate
stimulus items and instead appears to be a continuous light. This measure has produced
reliable evidence of information processing effects of ADs, and has also been suggested as an
appropriate measure of central nervous system (CNS) function.
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A review of studies that have used the CFFT to measure information processing ability in
normal participants found that all studies meeting the inclusion criteria for the study
observed a significant impairment of CFFT associated with the administration of TCAs
(cited in Hindmarch, 1995). In contrast, SSRIs have been associated with an increase in
CFFT. This latter effect has been noted with a variety of different SSRI medications, such as
sertraline (Hindmarch & Bhatti, 1988), citalopram (Fairweather et al., 1997; Nathan et al.,
2000), and paroxetine (Hindmarch and Kerr, 1994; cited in Hindmarch, 1995). Moreover, the
positive effect of SSRIs on CFFT has been observed to be immediate and dose dependent.
Therefore, the experimental evidence is suggestive of impairment in information processing
and CNS function associated with TCA treatment. However, the administration of SSRIs
seems to be associated with sparing or enhancement of these functions.
Selective attention has also been assessed in studies of the behavioural toxicity of
antidepressants using measures such as the continuous performance test (CPT), the symbol
cancellation test of the WMS-R, the Digit Symbol Substitution Test (DSST), and the Stroop
colour-naming test. In single dose investigations of the effect of ADs on cognition in healthy
adults impairments, on measures of selective attention have been noted with the
administration of a range of TCA medications, such as amitriptyline and imipramine.
However, these impairments have not been observed in studies of long-term repeated
administration of TCAs in both healthy and depressed experimental groups. Indeed there is
evidence to suggest that in the case of amitriptyline performance may return to baseline
levels in chronic AD administration paradigms. This is again in contrast to the effect of
SSRI medications, which appear to have either no sedative effect or a positive effect on
measures of selective attention when administered acutely to healthy volunteers. This
pattern of findings also seems to extend to the long-term administration of these drugs in
both depressed patients and healthy controls (see Amado-Boccara et al., 1995 for review).
The relative effect of TCAs and SSRIs on other measures of executive function, such as
working memory has also been considered. For example, van Laar and colleagues
investigated the relative effects of a weeklong course of amitriptyline, nefazedone (i.e. a 5-
HT2 receptor agonist), or paroxetine on a working memory task, in a sample of healthy
volunteers (i.e. N = 24; 12 male and 12 female). The authors found that amitriptyline
resulted in increased reaction times on the first day of testing (i.e. day 1), whereas paroxetine
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and nefazedone were both associated with a decrease in RT. With the exception of
nefazedone, the deviations from baseline were found to have largely diminished by the final
day of testing (i.e. day 8). Performance on the working memory task in this study was also
measured in terms of the percentage of misses and false alarms. At day 1, amitriptyline
resulted in an increase in the percentage of misses, although the other medications had no
effect at this point on this measure. However, by day 8 both paroxetine and nefazedone had
resulted in a significant increase in the percentage of misses, and there was a trend towards a
significant increase associated with amitriptyline. The only other significant finding in this
study was a significant increase in the percentage of false alarms on day 1 in those
participants taking the TCA (van Laar et al., 2002).
These observations are in concordance with the noted predictions of Robbins, which stated
that the manipulation of the serotonergic system would be expected to have no effect on
measures of working memory, whereas the manipulation of catecholamine systems may
possibly lead to the disruption of working memory ability (i.e. Robbins, 2000).
Thus, the observations of the effect of antidepressant medications on executive function
appear to largely mimic those seen in studies of psychomotor function. Although TCA
drugs appear to have a sedative effect on aspects of executive function, such as information
processing, selective attention, and working memory, SSRI medications appear to have a
neutral or positive effect on the same measures. The discrepancy in these findings may be
attributed to either the increased affinity for serotonin exhibited by SSRIs, or to the
nonmonoamine affinities of the TCAs, or perhaps a combination of the effect of both factors.
Memory and learning
Mnemonic function has also been studies in investigations of the association between
antidepressant medication and cognitive function. As previously noted in this review, there
are various divisions that exist in the human memory system, including a variety of
subdivisions within both the short- and long-term stores. Studies of the behavioural impact
of AD medication have included measures of both short- and long-term memory, and have
extended to include assessment of both semantic and episodic long-term memory.
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In his review of the effect of antidepressants on cognition, Amado-boccara suggests that
acute administration of TCAs to healthy controls largely appears to have no effect on
mnemonic function. This extends to measures of short-term memory, such as the digit span
test, and long-term memory, including learning, recognition, and recall of both verbal and
visual material. Moreover, in this review a number of SSRI drugs were noted to have no
sedative effect on any of the included measures of memory and learning, and none were
found to enhance memory function. This pattern of findings was also applicable to the long-
term administration of these drugs in normal volunteers (Amado-Boccara et al., 1995).
Although the findings across studies included in the above review were relatively
consistent, there is evidence to suggest a potential effect of antidepressants on specific
aspects of memory. For example, a study by Harmer and colleagues found that acute
administration of citalopram had no effect on the immediate recall of auditory verbal
material, but that it induced an enhancement in long-term memory performance in terms of
both delayed recall and recognition (Harmer et al., 2002).
In addition, it has also been suggested that the noradrenergic system may play a critical role
in the consolidation of emotional memory, namely that blocking the adrenergic system in
humans may result in a reduced capacity for the recall of emotionally salient material.
However, the findings regarding this hypothesis are not entirely consistent. While an earlier
study by O'Carroll found that the administration of an agent which stimulated central
noradrenergic activity (i.e. yohimbine) resulted in healthy volunteers recalling more
emotional material than participants given an agent that blocked noradrenergic activity (i.e.
metoprolol; O'Carroll et al., 1999), a later study found no effect of selective stimulation of the
noradrenergic system (i.e. using reboxetine) on long-term memory function (i.e. Papps et al.,
2002).
In summary, those studies that have examined the effect of various antidepressant
medications on a number of different aspects of cognition seem to imply a relatively
consistent profile of cognition associated with different classes of medication. Tricyclic
antidepressants reliably impair the performance of normal healthy adults on measures of
psychomotor and executive function. This effect has been noted in acute, subacute, and
chronic administration of TCAs in normal healthy participants. Selective serotonin reuptake
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inhibitors, on the other hand, result in a relative sparing or enhancement of these same
functions, again in healthy volunteers, and between acute and different multiple dose
administrations. In addition, the administration of either class of medication has not been
noted to have any significant or consistent effect on mnemonic function.
A major issue in the majority of studies of the behavioural effect of antidepressants is the fact
that most studies employ samples of healthy volunteers. On one hand this does have the
advantage of segregating effects on cognition that are due to the medication in question
from deficits that are associated with the profile of cognitive dysfunctions associated with
MDD. However, it should be noted that there is a possible and likely interaction effect
between the symptomatic profile of clinical groups and antidepressant medication. This
interaction should be taken into account when estimating the effect of ADs on any measure
of cognitive function in the clinically depressed population, based on observations in non¬
clinical samples.
Although there is a reasonably reliable profile of cognitive function associated with different
classes of antidepressant medication, also of interest in the series of investigations that have
comprised this study was the potential effect of AD drugs on the neuroimaging data
acquired in functional activation studies of major depression. Therefore, the following
section of this review will aim to determine the potential effect of antidepressant
medications on cerebral metabolism, and their impact on the acquisition of functional
neuroimaging data.
1.3.3 Functional neuroimaging studies of cerebral metabolism associated with
antidepressant medication
The function of the serotonin extends beyond the regulation of affective behaviour and
includes a variety of mechanisms, which extend to a broad range of physiological systems,
such as cardiovascular regulation, respiration and thermoregulation, and behavioural
processes. Resultantly, the physiological impact of any agent that alters 5-HT function is
potentially varied. As already noted, the majority of medications that are currently in use as
treatments for major depression do, to some degree, impact upon the level of 5-HT available
at receptor sites in the brain. Therefore, of concern in studies of depression is not only the
effect that antidepressants may have on the behavioural aspects of the symptom
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presentation of depressed individual, but how ADs may impact upon the physiological
systems of the patient.
The probability of disruptions in cerebral metabolism resulting from properties of the type
of psychotropic medication being taken by patients at the time of testing, rather than being
endemic to the experimental group is of particular concern when conducting functional
neuroimaging studies, such as fMRI or PET, of clinical populations. Yet, despite this
potentially significant confounding factor, there have been relatively few studies of the effect
of antidepressants on regional cerebral blood flow. Moreover, the majority of studies have
only considered the metabolic effects of medications belonging to the SSRI class of ADs.
Nonetheless, consideration of the literature available for different medications within this
class should allow for the determination of a model of the potential effect of antidepressant
medication on measures of cerebral blood flow.
Fluoxetine
Bonne and colleagues conducted one of the few studies to monitor the effect of chronic
administration of AD medication in a sample of normal volunteers. These investigators
employed "mTc-HMPAO SPECT to determine the blood flow consequences of the
consumption of fluoxetine, i.e. 20mg/day for a period of 6 weeks. Using a region of interest
approach, the authors aimed to determine whether there were any significant changes in
global or regional cerebral blood flow associated with chronic administration of fluoxetine.
However, the results of their data analysis revealed no AD associated changes in blood flow,
at both global and regional levels of analysis (Bonne et al., 1999). Therefore, they suggested
that the changes in CBF seen in previous studies were potentially the result of differences
between depressed patients and healthy controls, or between acute and chronic
administration of ADs.
A later study by Mayberg also examined the metabolic effects of fluoxetine. However, in
this study the authors employed a sample of depressed patients. Mayberg and colleagues
were interested in the differential regional metabolic effect of fluoxetine in patients who did
and did not respond to AD treatment, i.e. 'responders' and 'nonresponders', respectively.
The investigators examined time course changes in brain glucose metabolism in a sample of
hospitalised unipolar depressed patients using PET, and noted time specific and response-
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specific effects at two different time points, i.e. 1-week and 6-weeks after the commencement
of AD medication. It was found that although the pattern of cortical function was similar
between responders and nonresponders at 1-week, after 6-weeks there were significant
differences between the groups. Responders were characterised by relatively decreased
activation in the limbic and striatal regions, and increases in brain stem and dorsal cortical
regions (prefrontal and parietal, and anterior and posterior cingulate). Nonresponders, on
the other hand, either showed the same pattern of cortical metabolism as they had at 1-week,
or failed to show changes in subgenual cingulate or PFC (Mayberg et al., 2000).
Venlafaxine
Two studies by Kalin and colleagues have also examined the profile of regional cerebral
metabolism associated with the AD treatment of depressed patients, using venlafaxine (i.e.
Kalin et al., 1997; Davidson et al., 2003). Both studies compared the performance of
depressed patients to normal controls on a measure of affective processing at baseline, and
at a period of two weeks after the commencement of venlafaxine treatment. The second
study also examined the relative changes at 8-weeks following the start of medication.
Although the patterns of cortical activation were similar between patients and controls at
different time points in the first study, in the baseline measurement controls displayed a
decreased activation in response to positive stimulus items which was absent in the patients.
However, after two weeks of treatment with venlafaxine an area of activation appeared in
the right secondary visual cortex of depressed patients in response to positive stimuli (Kalin
et al., 1997). Thus, suggesting that the patients' response to treatment was mediated by
changes in cortical function, which resulted in the pattern of activation in patients
mimicking the activation of controls.
The second investigation by this group also found significant treatment associated changes
in cortical activation. The baseline measures from this study revealed a significant difference
between patients and controls in the left insular cortex and the anterior cingulate. In both
instances the degree of activation in patients was significantly lower than controls.
However, after just two weeks of venlafaxine treatment patients a showed relative increase
in the insular cortex. Moreover, after eight weeks there was an apparent normalisation in
activation in the anterior cingulate (Davidson et al., 2003).
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Therefore, both of these studies support the notion of specific alterations in cerebral
metabolism as a result of the administration of antidepressant medication. Moreover, in
accordance with the Mayberg study, these findings support the notion of an association
between these types of changes in regional cerebral blood flow and the likelihood of
response to AD treatment.
Sertraline
Metabolic functional neuroimaging has also been employed to examine the association
between another SSRI medication, i.e. sertraline, and regional cerebral blood flow. Drevets
and colleagues used PET to determine the nature of this relationship in a sample of
previously unmedicated MDD patients. Following treatment with sertraline, cortical
metabolism significantly decreased in the left amygdala and left subgenual AC of depressed
patients. In addition, there was a trend towards a significant difference in post-treatment
blood flow in the orbital and posterior cingulate cortices. It was found that these changes
were largely limited to those patients who responded to treatment and who remained well
at 6-month follow-up. Indeed, the metabolic reduction in the amygdala was significantly
correlated with HRSD score (Drevets, Bogers & Raichle, 2002).
Paroxetine
A further study to employ this type of experimental method to examine the association
between AD medication and cortical metabolism was a study of the effect of paroxetine on
cortical metabolism, conducted by Kennedy and colleagues. In this study, the experimenters
assessed the effect of six weeks of paroxetine treatment on frontal and limbic activation in a
sample of male depressed patients. Using PET, it was observed that following successful
paroxetine therapy patients exhibited increase glucose metabolism in dorsolateral,
ventrolateral, and medial aspects of the PFC (i.e. more left, than right, lateralised), the
parietal cortex and the dorsal anterior cingulate. Moreover, areas of decreased metabolism
were found in both anterior and posterior insular regions (LH), in conjunction with
decreases in the right hippocampal and parahippocampal regions (Kennedy et al., 2001).
Thus, implying that successful AD treatment was associated with a reversal of the frontal
hypofrontality and limbic hyperactivity that are believed to characterise cerebral metabolism
in MDD.
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In conclusion, the available evidence is indicative of a significant association between
consumption of antidepressant medication and both global and regional cerebral blood flow.
More specifically, this association appears to be conditional, applying only to those
participants with a clinical diagnosis of depression and who also respond to antidepressant
treatment. Based on the available evidence, chronic administration of AD drugs appears to
have no significant effect on metabolism in normal healthy volunteers. However, given the
relative lack of evidence regarding the relationship between blood flow and medication
status in healthy adults, it is difficult to draw any definitive conclusions regarding this issue.
Given the rather consistent nature of the evidence supporting the notion that the relative
effect of AD medications on cerebral metabolism is an important factor in the nature of the
imaging data acquired in studies ofMDD, this is an important issue which needs to be taken
into account in functional neuroimaging investigations of depressed patients who are not
medication naive.
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1.4 Experimental aims and hypotheses
1.4.1 Introduction to experimental aims
There are a number of pertinent points that arise from the consideration of the background
literature relevant to the study of cognitive function in major depression. First of all, there is
the issue of whether there is a consistent pattern of cognitive impairment associated with
major depression, and if so can this pattern be best characterised as a global or specific
impairment of cognitive function? Secondly, which factors associated with major depression
may be critical factors in the types of cognitive dysfunctions commonly associated with
MDD? For example, are cognitive impairments in major depression the manifestation of
underlying abnormalities in cortical function? And finally, which factors are of importance
in attempting to understand the relationship between major depression, cortical function,
and cognitive performance?
The aim of this series of investigations was to attempt to produce experimental evidence that
would be useful in answering these questions. In order to achieve this three empirical
investigations were conducted. The aims and hypotheses of each of these investigations are
outlined in the following sub-sections.
1.4.2 Experiment one: Working memory in depression
Depressed patients may exhibit both qualitative and quantitative changes in how internal
and external information is processed, interpreted, and stored (Weingartner et al., 1981).
Evidence to support this pattern of dysfunction comes from investigations of a variety of
measures of cognitive performance in individuals with a clinical diagnosis of major
depression. Deficits have been noted in tasks ranging from elementary processes, such as
basic psychomotor function, to the higher cognitive processing required by measures of
mnemonic function.
It has previously been suggested that the range of deficits associated with MDD may be the
result of abnormalities in executive function in depressed patients, such as would be
characterised by a deficit in the central executive component of the human working memory
system (Channon et al., 1993). However, there have been relatively few studies of cognition
in MDD that have employed specific measures of working memory and the findings
relevant to the integrity of WM in depressed individuals are inconsistent, with some
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investigations finding little evidence impairment on tests of working memory. Moreover,
those studies that have found evidence of a working memory dysfunction associated with
the central executive have done so using measures such as the DGB and PASAT, both of
which may require the short-term manipulation of information in a manner that is better
characterised by models ofWM other than the Baddeley and Hitch (1974) model.
In addition, there is also the issue of the considerable variation in the approaches of different
studies of the association between MDD and cognitive performance on a number of
potentially confounding factors, such as participant age, severity of depression, and
diagnostic profile.
Therefore, the aims of the first study were to compare the performance of a clearly defined
sample of depressed patients and matched, healthy controls on a measure of working
memory that had been shown to accurately assess the manipulation of the central executive
component of the working memory system in normal healthy adults, i.e. the n-back task.
The experimental hypotheses in this study were as follows:
1. All participants will experience an increase in difficulty in performance of the n-back
task associated with the linear increase in task difficulty; and
2. Depression will be associated with a relative impairment of performance on the n-
back task.
1.4.3 Experiment two: Working memory in depression: a functional MRI study
The review of structural neuroimaging studies of major depression revealed evidence of
abnormalities in both frontal and striatal regions of cortex associated with MDD. It has been
suggested that these structural abnormalities may have a contributory effect to the profile of
affective and cognitive symptoms observed in depressed patients.
In addition, functional neuroimaging studies of MDD have implied that the same regions
that have been shown to be structurally abnormal are also functionally abnormal in
depressed individuals. Moreover, the metabolic dysfunction in specific regions of the
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frontal cortex may be critically related to the profile of cognitive dysfunction related to the
experience of unipolar depression.
Moreover, there is also considerable overlap in the regions of structural and functional
abnormality associated with major depression and those regions that have been noted to
mediate working memory function in normal healthy adults, including regions of both
dorsal and ventral prefrontal cortex. Thus, supporting the notion of impairment of working
memory function in major depression, and allowing for the inference of causal mechanisms
in this type of deficit.
Therefore, the aim of the second experiment in this study was to extend the observations of
the first study to see if there was a depression associated impairment in the performance of
tasks reliant on normal working memory function, and to determine whether any difference
in the performance of depressed patients and healthy controls could be attributed to the
differences in cortical activation during performance of the n-back task (i.e. as assessed using
fMRI).
Based on the observations of previous neuroimaging investigations, the additional
experimental hypothesis that was examined in the second experiment was:
3. Relative differences in the performance of depressed patients and healthy controls
on the n-back task will be associated with relative differences in the level of cortical
activation in those regions putative to normal working memory function.
1.4.4 Experiment three: The effect of escitalopram on working memory in normal healthy
adults: A functional MRI study
A main factor of concern in any study of clinical populations is the impact of psychotropic
medication upon observed symptomology. Of particular significance in studies of
depression is the effect of antidepressant medication on cognition. In the case of unipolar
depression, investigations of antidepressant medications on measures of cognitive function
have produced mixed results. While some classes of antidepressants, such as the TCAs,
appear to have a sedative effect on various aspects of cognition, others types of AD
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medication, e.g. SSRIs, seem to produce either no effect or a facilitatory effect on cognitive
performance.
However, in functional neuroimaging investigations an additional factor of interest is the
effect of any agent consumed by participants on mechanisms that are critical to the
acquisition of imaging data, i.e. regional metabolic blood flow. With regards to depressed
patients there appears to be a reliable effect of antidepressant medications on cerebral blood
flow in treatment responsive patients.
Therefore, it was decided that the consumption of antidepressant medication was an issue
that needed to be addressed in the current series of experiments. There were a number of
potential ways to deal with this factor that were considered, such as attempting to recruit a
control sample of medication-free depressed patients to compare with the original sample of
depressed patients who took part in the second experiment. An alternative proposal was the
use of follow-up scans for the sample of depressed patients in experiment two during a
period of medication-free remission from MDD. However, both of these methodological
approaches were rejected due to practical and ethical considerations.
First of all, one of the first courses of action of any physician faced with depressive
symptomology in a patient is the prescription of an AD medication. Therefore, the
recruitment of individuals who are depressed but not medicated often relies on the use of
prospective sampling methods. Although this approach can identify individuals who are
significantly depressed there is the potential ethical issue of withholding treatment from
individuals who have been identified as being depressed for research purposes. In the case
of the second approach, given the small number of participants being scanned in experiment
two (i.e. N = 10), the limited timeframe of this project and the likely duration of depression,
it was felt that it was unlikely that a reasonable number of previously examined depressed
patients would have been in a position to be re-scanned.
Thus, it was felt that the most reasonable approach to this problem was to control for the
effects of medication on the cognitive performance of the n-back task and the associated
cortical activation in the depressed sample by comparing depressed individuals with a
sample of medicated healthy controls on both of these aspects of performance. Although,
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the Bonne study was indicative of no effect of chronic administration of AD drugs on
cerebral blood flow in normal healthy adults, this represents findings from one investigation
only and there is evidence to suggest that there may be an acute dosing response in healthy
volunteers. Moreover, there is significant amount of evidence that is suggestive of
similarities in the behavioural effects of AD medication in depressed and normal samples
(see Amado-Boccara et al., 1995 for a review).
Taking account of these observations, the third, and final, study in this project involved the
scanning of normal healthy controls following the subacute administration of an SSRI
medication (i.e. escitalopram) and during a medication-free period. As with the previous
study, the pattern of cortical activation associated with the performance associated with
attempting the n-back task was determined using functional MRI.
Based on previous findings relating to the effect of SSRI medication on cognitive function
(i.e. neutral or facilitatory) and cortical activation, the experimental hypotheses that were
addressed in experiment three were:
4. Subacute administration of an SSRI medication (i.e. escitalopram) in normal healthy
adults will be associated with significant alterations in performance on measures of
cognitive function, including working memory.
5. Compared to the medication-free condition, participants in the post-medication
condition will experience a relative alteration in the degree of activation in those
areas of cortex associated with metabolic changes in treatment responsive depressed
patients.
The following chapters outline the methodological approaches used to investigate each of
these experimental hypotheses (i.e. Chapter 2, 4, and 6) and the associated outcomes of each
study (i.e. Chapters 3, 5, and 7).
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Chapter 2: Methodology - Experiment One
2.1 Design
A case control study with a single between subjects factor of participant group (i.e.
depressed patients vs. matched, healthy controls) was employed to test the experimental
hypotheses (see Chapter 1: pp 89). The within subjects factor was the level of difficulty on
the n-back task (i.e. 0-, 1-, 2-, and 3-back). The dependent variable was performance at each
level of difficulty of the n-back task. With respect to n-back performance, both mean
number of correct responses (i.e. expressed as a percentage of total number of potential
responses) and mean reaction time. Both simple group effects and group by task difficulty




Ethical approval from the Lothian NHS board, Psychiatry and Psychology Research Ethics
Committee, and management approval from the Lothian Primary Care NHS Trust, were
obtained for the recruitment of patients of the Royal Edinburgh and associated hospitals to
participate in the study. In order to recruit suitable participants a prospective sampling
method was employed.
Initially consultants of the Royal Edinburgh Hospital were notified of the study, its aims and
proposed method, and the possibility of their patients being approached to participate.
They were asked to notify the researchers if they had any objection in principle to the
potential participation of their patients in the experiment.
Following the general approval of the consultants ward staff in the general adult mental
health wards of the Royal Edinburgh Hospital were contacted regarding the study. An
information sheet was given to staff that outlined the details of the investigation and the
types of patients that were being sought. This was provided to ward staff along with a copy
of the information sheet for patients and contact details for the researchers. The same
information was also sent to staff of the outpatient units associated with the hospital.
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After the initial contact a number of follow up visits and phone calls were made to ward
staff and the day hospitals in order to ascertain whether patients who met the criteria for
participation were being treated and whether they would be able to participate in the study.
Potential patients were approached based on the recommendation of a member of staff
responsible for their care. Once a suitable patient had been identified a meeting or telephone
call with the patient was arranged, in which the nature of the investigation was explained.
They were provided with an information sheet with a full outline of the study, and details of
individuals who could be contacted regarding the study. Each potential participant was
advised to read the information carefully and to discuss participation with those responsible
for his or her psychiatric care, as well as friends and family members. After a period of at
least 24 hours patients were then re-contacted in order to ascertain whether or not they
wished to participate in the study.
2.2.1.2 Control recruitment
Control participants in this study were opportunistically sampled. At the same time as
members of ward staff of the Royal Edinburgh hospital were contacted regarding the need
for suitable patient participants they were also given an information sheet outlining the need
for normal, healthy controls. This form described the need for controls in this type of study,
the type of controls that were being sought, and the expectations of those willing to
participate in the investigation. The researchers asked staff to recommend any individuals,
including themselves, who met the criteria for participation.
Similarly information was circulated in the Division of Psychiatry at the University of
Edinburgh regarding the need for healthy controls. Staff and post-graduate students were e-
mailed the details of the study and asked to recommend individuals who they felt would be
suitable to act as controls.
Through this opportunistic method a number of individuals were identified who met the
criteria for inclusion as normal control participants. From those who volunteered a sample
was selected of those who it was felt provided the most suitable matches for the depressed
individuals who had been recruited to participate. While some of these individuals included
staff of the University of Edinburgh, Division of Psychiatry and the Royal Edinburgh
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Hospital, it was ensured that none of the control participants were involved in a dependent
relationship with either of the investigators. In a similar approach as was adopted with
depressed patients interested in participating in the study, potential participants were
contacted by the researchers and provided with full details of the project and given the
opportunity to ask questions. They were also advised to discuss participation in the study
with friends and family, and were re-contacted after a minimum period of 24 hours
regarding consent to participate.
2.2.2 Participant details
Participants were twenty individuals with a diagnosis of major depressive disorder and
twenty matched normal, healthy controls (see Table 2.1 below). All patients who
participated in the project were either in- or out patients (i.e. six and fourteen respectively)
of the Royal Edinburgh Hospital, and associated hospitals, within the Lothian Primary Care
NHS Trust. These patients were selected on the basis of a diagnosis of major depressive
disorder by those responsible for their medical care. In addition, the average length of time
since initial diagnosis and length of the current episode was 79.3 and 13.9 months,
respectively.
Level of depression at the time of cognitive assessment was determined using the Beck
Depression Inventory (BDI) Beck et al., 1961 and the Hamilton Rating Scale for Primary
Depressive Illness (HRSD) Hamilton, 1967. It was ensured that depressed patients scored at
least 15 on both the BDI and the HRSD, as this was deemed to be indicative of a significant








Patients 34.65 (8.887) 111.25 (9.233) 4:16
Controls 30.80 (8.889) 117.50 (6.629) 4:16
Table 2.1: Summary of participant demographic details: Experiment One
All participants who participated in this study were required to meet the criteria outlined in
Table 2.2. Moreover, control participants were required to have no history of psychiatric
illness, although, it should be noted that this information was obtained via self-report and
was not corroborated with each individual's own doctor or other individuals.
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Inclusion criteria: All participants Inclusion criteria: Patients only
Aged 18 - 50 years old.
No history of serious physical health problems,
including diabetes, liver disease, heart attack,
and stroke.
No history of head injury
No history of alcohol or drug misuse
Not colour blind
Not pregnant
No history of psychotic symptoms
No medication change in the 7 days
preceding participation
No electroconvulsive therapy in the 6
months preceding participation
Table 2.2: Criteria for inclusion - Experiment One
Within the depressed sample eighteen patients were taking anti-depressant medication at
the time of testing (see Table 2.3). Of the two patients who were not currently taking
medication for their illness, one patient had been medication free for two weeks and the
other for three months. Furthermore, five participants were also taking additional
medication at the time of participation. The combinations of medication being consumed by
patients not only included anti-depressant but also other classes of psychotropic medication
(see Table 2.4).
2.2.3 Excluded/Withdrawn participants
An additional eleven patients were recruited for the study but failed to either commence or
complete testing. Four of these depressed patients were withdrawn from the study due to
failure to meet our minimum BDI and HRSD requirements. In the remaining sample of six,
one patient was recruited but discharged from the hospital prior to testing phase, and did
not respond to numerous attempts to contact her. In addition, three patients experienced a
catastrophic reaction during testing, and were unwilling to rearrange alternative testing
sessions. The final patient in this sub-group was omitted from the study due to a change in
diagnosis after recruitment but prior to testing.
Furthermore, one patient and one control participant completed testing but it was later
observed that there had been an error in the data acquisition for the n-back task for both of
these subjects. We were unable to rearrange testing sessions for these two participants, and
thus their other data was excluded from the final analyses.
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It should also be noted that an additional male participant was recruited in the pilot stages
of the study. However, the patient's age exceeded our upper limit (i.e. he was 59 years old)
and although the patient did complete all testing sessions, his data has not been included in
any of the analyses.










Table 2.3: Details of anti-depressant medications being consumed by depressed patients at
the time of participation - Experiment One
(* This participant was also taking venlafaxine)















Table 2.4: Combinations of medication being consumed by those patients who were
prescribed more than one medication at the time of participation - Experiment One
2.3 Materials (see Appendix 2)
2.3.1 Pre-test materials
Participant information sheet
As noted above, prior to participation all participants were provided with a copy of an
information sheet for participants (see Appendix 2). Participants were given the information
sheet a minimum of 24 hours prior to participation, and were advised to consult with friends,
family, and (in the case of patients) those responsible for their medical care before deciding
whether or not to participate in the study. Individuals were also advised that they were at
liberty to discuss any questions or queries that they had with either of the investigators.
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Consent form
Participants were asked to sign a consent form prior to participation, which outlined the
conditions of testing. In addition, it was verbally reiterated to all participants that
participation in the study was on an entirely voluntary basis, and was completely
independent of current or future treatment as a patient of Lothian Primary Care NHS Trust.
Participants were also advised that agreement to participate did not imply commitment to
complete testing, and that they were free to withdraw at any stage during the study, without
giving a reason. For all participants there was a copy of the signed consent form for the
participant and one for the investigators. Patients were asked to sign an additional copy of
the consent form, which was later appended to their medical records.
Once informed consent had been obtained participants were asked to complete the following
pre-test measures, which had been compiled in order to determine the suitability of a
particular candidate for participation.
Medical questionnaire
Initially individuals were asked to complete a medical questionnaire. Two copies of this
questionnaire were prepared, i.e. one for patients and one for controls. Each version of the
questionnaire posed questions relating to each of the relevant inclusion criteria for patients
and controls, e.g. 'Have you ever had a head injury?' Participants were also asked to impart
any additional information that may have excluded them from participation in either this or
future phases of the project, e.g. whether or not they were colour blind, or whether or not
they were currently pregnant.
Patient information sheet
For all patients who participated in the study a member of staff involved in their medical
care was asked to complete a 'Patient Information Sheet' (see Appendix 2). Information
obtained in this form was used to support patient statements with regards to details which
may possibly have excluded them from participation in the study, e.g. a history or drug or
alcohol abuse. For some patients this information was determined from medical notes
provided by staff members.
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2.3.2 Affective indices
Participants were required to complete a number of affective assessments prior to testing.
All participants completed the Beck Depression Inventory Beck et al., 1961, the Stress
Arousal Checklist Mackay et al., 1978, and the Alderley Park State Anxiety Questionnaire
Walker, 1990. In addition, patients were also retied on the Hamilton Rating Scale for
primary depressive illness Hamilton, 1967.
Beck Depression Inventory (BDI; Beck et al., 1961)
A full description of the BDI and the appropriate procedure can be found in Beck et al.,
(1961). Briefly, the BDI consists of 21 items that deal with various aspects of depressive
symptomology, e.g. mood, sense of failure, sleep disturbance etc. Participants are asked to
indicate which of 4 statements allocated to each item most accurately describes their
emotional state at the time of testing and over the preceding 7 days. The statements
associated with each item are allocated a score from 0-3. Each statement is scored in such a
way that the higher scores are indicative of greater severity of the symptom in question. For
example:
Item 1: Mood
1. I do not feel sad (0)
2. I feel sad (1)
3. I am sad all the time and I can't snap out of it (2)
4. I am so sad or unhappy that I can't stand it (3)
The statements for each item can be read aloud to participants, with participants then asked
to indicate to the experimenter which item they feel is the most accurate description of their
mood. Alternatively, the assessment can be self-administered. The latter approach was
employed in this particular investigation. However, a researcher was available during
completion of this task in the event that participants experienced difficulty in understanding
the statements or were unsure of how to respond.
Individuals were advised as to how to complete the assessment by the investigator, i.e. to
read through each of the items, and to select (by circling the relevant statement number) the
statements in each item that they felt best describes how they were feeling 'today' and have
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been feeling for the previous 7 days. Participants were also advised that if they felt unable to
decide between two statements for a particular item then they should circle both statements.
In accordance with the instructions for rating the ESDI, participants are allocated a score
based on the sum of the statement scores for all of the items. In those instances where a
participant selects two statements for the same item the statement with the greater allocated
score is selected for inclusion in the overall rating. The following interpretation guidelines




16-19 Mild - moderate depression
20-29 Moderate - severe depression
30-63 Severe depression
Table 2.5: Interpretation guidelines for the BDI. Adapted from Beck (1987). (From the Beck
Depression Inventory)
Based on the above guidelines, a BDI score of less than 9 was deemed appropriate for control
participants. Whereas, a score of greater than 15 was determined to be the minimum
accepted score for patients.
Hamilton Rating Scale for primary depressive illness (HRSD; Hamilton, 1967)
A full description of the HRSD and its administration can be seen in Hamilton (1967). The
HRSD consists of 21 open ended questions, again relating to various aspects of depressive
symptomatology. Either a trained clinician or researcher carries out the assessment. For
each question there is a guide to the types of response that may be given, and how each
category of response should be scored. For example:
Item 1: Depressed Mood
Researcher prompts: What's your mood been like this week?
Have you been down or depressed?
Sad? Hopeless?
In the last week, how often have you felt (OWN EQUIVALENT)?
Every day?
Have you been crying at all?
How long have you been feeling this way?
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Score: 0 - absent
1 - indicated only on questioning
2 - spontaneously reported verbally
3 - communicated non-verbally, i.e. racial expression, posture voice,
tendency to weep
4 - VIRTUALLY always: this is spontaneous verbal and non-verbal
communication
The absence of a particular symptom is always rated as 0 and the maximum score for each
item can vary from 2-4. As with the BDI, the overall rating for the HRSD is calculated by
summing the score allocated for each of the items.
It has been noted (i.e. Frank et al, 1991) that a score of < 7 on the HRSD should be deemed as
asymptomatic, whereas a score > 15 is indicative of an individual being symptomatic for
major depressive illness.
Stress Arousal Checklist (SAC; Mackay et al., 1978)
The SAC is used as a measure of state stress (see Mackay et al., 1978; Cox & Mackay, 1985).
The checklist is underpinned by a two-dimensional model of mood (i.e. Cox & Mackay,
1985). The first dimension relates to feelings of unpleasantness/pleasantness or hedonic tone
(i.e. stress) and the second to wakefulness/drowsiness or vigour (i.e. arousal).
Respondents are presented with a list of 30 different mood adjectives (e.g. 'tense', 'relaxed'
etc). Fifteen of these adjectives are 'positive' and fifteen are 'negative'. Furthermore, each
adjective is accompanied by four different response choices, i.e. ++, +, ?, and -. Twelve of the
items relate to the arousal dimension of the model, with the remaining 18 items relating to
the stress dimension. Participants are asked to rate whether or not the adjective describes
how they are currently feeling, by circling the appropriate response, i.e. definitely -> ++,
more or less -> +, not sure/can't decide -> ?, definitely not -> -.
The recommended scoring of the checklist is to allocate a score of 1 for each ++ or + response,
and a score of 0 for ? or - responses for negative adjectives. Positive adjectives, on the other
hand, are allocated a score of 1 for a ? or - response, otherwise a score of 0 is allocated. Thus
resulting in a range of scores on the stress scale of 0 - 18, and a range of 0 - 12 on the arousal
scale.
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Alderley Park State Anxiety Questionnaire (APSAQ; Walker, 1990)
This particular questionnaire is administered in order to estimate state anxiety. Participants
are asked to respond to 12 items relating to state anxiety. There are 5 'positive' and 7
'negative' statements (e.g. 'I feel I can cope' and 'I am worried', respectively). Participants
are asked to indicate the extent to which each of the statements corresponds to how they are
currently feeling, i.e. 'not at all', 'slightly', 'moderately',' considerably', or 'extremely'. Thus
the potential score range for each item is 0 - 5. For each type of statement (i.e. positive or
negative) the following scores are allocated for each category of response:
Statement Type Response
Not at all Slightly Moderately Considerably Extremely
Positive 5 4 3 2 1
Negative 1 2 3 4 5
Table 2.6: Response ratings for positive and negative items on the APSAQ
Therefore, the maximum potential score on the APSAQ is 60, with a high score being
indicative of a high level of state anxiety.
2.3.3 Cognitive assessments
National adult reading test (NART; Nelson & Willison, 1991)
The NART was used employed in order to estimate the WAIS-R (Wechsler, 1981) full scale
IQ of control participants and the premorbid IQ of the depressed patients). Full details of
the procedure for the NART, normative data, and WAIS and WAIS-R IQ estimations can be
found in the NART test manual (i.e. Nelson & Willison, 1991).
The NART is composed of 50 'irregular' English words, i.e. words that do not conform to
typical or common rules of grapheme-phoneme representation and pronunciation, e.g.
naive. In order to complete the task participants are simply asked to read aloud the list of
words to the experimenter, and are allocated a score equal to the total number of errors that
they make. The predicted equivalent full scale, verbal, or performance IQ can then be
estimated based on the number of errors committed by the participant - e.g. 20 errors
estimated WAIS-R full scale IQ = 106.
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Test of Everyday Attention (TEA; Robertson et at., 1994)
The TEA is a test battery designed to assess performance of everyday tasks reliant on normal
attention function, e.g. searching a map for certain symbols. Each of the subtests of the TEA
has been designed to assess a specific type of attention, i.e. the map search task is designed
to assess selective attention. It is assumed that in normal, healthy adults accurate
performance of each of the subtests is reliant on frontal lobe function.
In order to allow for re-testing of participants on each of TEA tests, there are three versions
of the test battery available, i.e. versions A, B, and C. Each of these versions of the TEA
consists of 8 separate subtests, two of which were employed in the current study. The two
subtests used in this investigation were the 'Elevator Counting with Distraction' and 'Visual
Elevator' tasks.
• Elevator counting with distraction (ECD)
In this particular test of attention participants are asked to imagine that they are to count the
number of floors that an elevator ascends by counting the number of low tones that they
hear in a series of mixed tones, i.e. both high and low. Therefore, in order to perform the
task accurately the participant needs to ignore the high tones in each series. This task has
been designed to assess auditory selective attention and is understood to load on a factor
auditory-verbal working memory.
• Visual elevator (VE)
As with the ECD task, the VE assessment of attention function is essentially a counting task.
Participants are presented with a series of pictures (i.e. ten). Each picture in the series
consists of a number of pictures of a pair of elevator doors, interspersed with both 'up' and
'down' arrows. Participants are asked to determine which floor the elevator will stop at by
counting the number of pictures of doors. They are asked to start by counting 'up', starting
at the first floor. However, each time they encounter an up or down arrow they need to
determine whether to continue or reverse the direction of the lift. Thus, the VE subtest has
been designed to assess attentional switching and hence cognitive flexibility. In addition, it
has also been shown that the number of correct items on the VE task loads on the same
attentional switching factor as the number of categories in the WCST (Robertson et al., 1994).
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Performance on the VE is defined by both the number of correct items, and the average
reaction time per attentional switch for correct items.
For each of these subtests participants are allocated a score based on the number of items
that they respond correctly two (i.e. maximum possible score = 10, in both cases). The raw
scores for participants are then adjusted to allow for the age of the participant. This is
achieved by allocating the participant a 'scaled score', which is based on their raw score and
their age group (these scaled scores are available in the test manual). For example, a 25-year-
old participant obtaining a raw score of 6 on the ECD would be given a scaled score of 7, etc.
In addition to a score for accuracy, in the VE task participants are also allocated a score
based on the average time taken per attentional switch for each correct item (i.e. in seconds).
This raw timing score is also converted to a scaled score based on the participant's age
group, e.g. a 45-year-old participant averaging 4.4 seconds/switch would be allocated a
scaled score of 8.
Both the VE and ECD subtests of the TEA have been shown to have reasonable test/re-test
reliability. Using a one-week test-retest approach, with both normal controls and stroke





Version A with B
Normal Controls
(N = 39):
Version B with C
Stroke patients
(N = 74):









0.79 0.70 Not calculated
Table 2.7: Pearson correlation coefficient data for participants tested on either version A then
version B of the TEA, or version B then version C, in a one week test-retest approach
(adapted from TEA Test Manual; Robertson et al., 1994).
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The n-back task
■ Paradigm design in imaging studies
Given that this study was conducted as a pilot to the main functional imaging experiment it
was essential that the working memory paradigm employed was suitable for use in both
neuropsychological and neuroimaging studies. There are a number of potential approaches
to paradigm design that can be utilised in functional imaging studies, including subtractive,
factorial, conjunction and parametric designs (see Figure 2.1). Therefore, it was important
to ascertain which type of experimental design would result in a paradigm that was not only
suitable for this initial study but would give us the best chance of obtaining meaningful data
in latter investigations.
(1)
A B AB ABABA
(2)
A1 B A3 B A2BA3BA1
(3)
A nAB A + 8 nAB B nAB A * B nAB A nAB A ♦ B
(4)
AB AC AD /~\ ABC ADC /"\ ADB
►
Time
Figure 2.1: Illustration of the various approaches to paradigm design in functional imaging
studies: (1) Subtraction, (2) Parametric, (3) Factorial, (4) Conjunction. In all images process
'A' is the process of interest.
The prototypical design employed in functional imaging studies is the 'subtraction'
paradigm. In this approach the first step is to design two cognitive tasks (e.g. tasks A and B)
that are identical apart from the fact that one contains the cognitive process of interest. The
cortical activation associated with this process is then determined through examination of
the differences in the activation associated with performance of the two tasks, i.e. the
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assumption being that any significant changes observed in the task containing the process of
interest but not in the 'control' task are those associated specifically with this process.
While subtraction provides a relatively simple approach to the issues of paradigm design
there are potential flaws with adopting this approach. The most commonly cited issue in the
problem of 'pure insertion', i.e. there is an assumption that addition of the process of interest
does not impact upon the nature of the activation seen during performance of the
experimental task. However, it is entirely likely that in the experimental task this change
may bring about more fundamental changes in the other cognitive processes required to
complete the task, and it may indeed be these alternative changes that are the cause of the
differences in activation seen between the two different tasks.
An alternative approach to subtraction is 'parametric' paradigm design. In parametric
paradigms, rather than comparing the absolute differences between two tasks, a single task
is designed which has an initial baseline level followed by additional task levels of increased
difficulty (e.g. Al< A2 < A3) - i.e. there is variation around a single parameter in the task.
Given that the processes involved in each level of the task are essentially the same the issue
of insertion is removed.
'Factorial' paradigms, on the other hand, examine the interaction between two different
cognitive processes of interest (e.g. process A and process B). In such designs tasks are
designed which involve either process A or process B or both processes. The paradigm is
constructed in such a way that participants undertake one of these possible task conditions
interspersed with a condition that involves neither process of interest (i.e. nAB). One of the
main advantages of this approach is that it allows investigators to examine the possibility of
interaction between different cognitive processes (e.g. where A - nAB o (A + B) - B).
The final approach to paradigm design is the 'conjunction' approach. This strategy may be
employed in those instances where investigators are not interested in the possibility of
interaction between distinct cognitive processes. Essentially conjunction paradigms involve
a series of categorical subtraction experiments, where each experiment is aimed at isolating
the same process (e.g. process A). However, unlike regular subtraction paradigms the
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experimental and control conditions do not only differ in the process of interest but in
several other processes as well.
While both conjunction and factorial designs reduce the likelihood of the problems
associated with subtraction they do not completely eliminate the chance. Parametric
paradigms, on the other hand, apparently appear to overcome this issue completely.
Therefore, given that we were concerned with only one cognitive process (i.e. central
executive function) it was decided that the most suitable type of paradigm to employ in this
series of experiments would be a parametric one.
■ Design of the n-back task (details of the background of the n-back task can be viewed in
Chapter 1: section 1.2)
The n-back paradigm was chosen as a measure of working memory function in this series of
studies for a number of reasons. A primary reason for this choice of paradigm was its
previously demonstrated reliability, i.e. both behavioural and functional, in assessing
working memory ability in normal healthy volunteers. Moreover, the parametric nature of
the n-back task was deemed to be appropriate for enabling the more sensitive examination
of working memory function in MDD patients, i.e. by manipulating the level of cognitive
load it should be possible to determine not only if depression is associated with a
dysfunction of WM but to extent of this deficit. Finally, the fact that the n-back paradigm
can be easily manipulated, based on the demand characteristics of the study, but still retain
the factors that contribute to its reliability, also made it a suitable paradigm for the measure
of working memory function in this project.
As we were dealing with a population who were potentially significantly cognitively
impaired at the time of testing, it was felt that a delayed match-to-sample task variation
might prove too taxing for the patient sample. Therefore, a variation of the n-back task was
developed which is reliant on immediate recall ability for a single stimulus item only.
In our version of the n-back task participants were presented with a series of pictures, each
consisting of four numbered boxes with a coloured dot in one of the boxes (see Figure 2.1).
Participants were then asked to either press the button corresponding to the current position
of the dot (i.e. Shadow/O-back), or to press the button corresponding to where the dot was in
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(A) the previous picture (i.e. 1-back), or (B) two pictures previously (i.e. 2-back), or (C) three
pictures previously (i.e. 3-back). In accordance with normal parametric paradigm design, it
was presumed that the shadow task, while relying on the same perceptive and motor
functions as the other levels of the task, did not have the same reliance on normal working
memory function. It was assumed that by increasing the number of intervening items
between presentation and recall we would increase the memory load on the central
executive, thereby increasing task difficulty in a parametric fashion.
N-BACK
0 1 2 3
NR = NO RESPONSE
Figure 2.2: Illustration of the levels of n-back employed in the current series of experiments
The task was developed using E-prime (Beta 4) software (Psychology Software Tools Inc.,
Pittsburgh, PA), and was presented on a workstation running Windows 98 operating
system.
2.4 Procedure
All participants were tested on an individual basis. Although the majority of participants
were tested at the Division of Psychiatry, a number of the patient sample were tested in a
quiet room in a ward at the Royal Edinburgh Hospital, as a result of their conditions of stay
at the hospital.
In order to protect participant anonymity prior to testing each participant was allocated a
participation code, which was largely based on his or her experimental group. All paper
and electronic data for each participant was recorded using this code. Furthermore, any
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electronic data containing personal details of participants was password protected.
Consequently, the data was stored and analysed in such a way as to make it impossible for
other individuals to identify the contribution of specific individuals to the data profile of
their experimental group.
Participants were first of all required to complete each of the relevant pre-test measures (see
above). Based on these assessments participant suitability was judged. Participants meeting
each of the inclusion criteria then proceeded to complete each of the affective and cognitive
assessments outlined above.
2.4.1 Affective assessments
The first assessment that all participants undertook was the BDI, which, as previously noted,
was self-administered. Participants were advised to read each set of statements carefully,
and to circle which of the four statements presented most accurately described how they
were 'currently' feeling (i.e. at the time of testing) and had been feeling for the preceding 7
days. Although each participant was advised to select only one statement in each item, if
participants enquired what they should do if they felt that they could not decide between
two statements they were advised to circle both items.
As noted above, participant's scores were based on the sum of the statement numbers that
they selected for each of the 21 items. Where participants had selected two statements, the
higher value statement was included in this calculation. Any control participant scoring > 7,
and any patient scoring < 15 on the BDI were then excluded from the study.
Following completion of the BDI, participants were then asked to complete the SAC. They
were advised that they should circle the response for each adjective that was the most
accurate description of how they were feeling 'now', i.e. at the time of testing. They were
also advised to try and complete the assessment as accurately as possible, and to try and go
with their first response to each adjective. Participant scores for each of the two scales, i.e.
stress and arousal, were then calculated as outlined above.
The next assessment that participants completed was the APSAQ. As with the BDI and the
SAC this questionnaire was self-administered. In accordance with the normal procedure for
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the APSAQ, participants were asked to indicate, by ticking the relevant response box, how
they were 'currently' feeling. Participant scores were then calculated as outlined above.
After completion of the other three affective indices, the HRSD was then administered to
patients by either a trained clinician or researcher. Each patient was informed that the
assessment took the form of structured interview, and that the interviewer would be asking
him or her questions relating to various aspects of their depressive illness. Patients were
advised to answer the questions based on how they were feeling at the time of testing and
had been feeling for the preceding week. Again, they were advised to answer all questions
as accurately as possible. Following completion of the HRSD, patient scores were calculated
for both 17 and 21 items.
2.4.2 Cognitive assessments
Test of everyday attention
First of all participants undertook the ECD subtest of the TEA (i.e. version A). The auditory
tones for each stimulus set were presented using the standard tape cassette (provided by
Thames Valley Test Company). Participants were instructed to listen carefully to each set of
tones and to count the number of low tones that they heard in each set while ignoring the
high tones.
In order to ensure that the nature of the task was entirely explicit participants were given the
opportunity to practice the task using two example stimuli sets. The first of these was
counted aloud with the researcher. Once it was ensured that the individual in question
properly understood the nature of the task participants then attempted the second practice
item on their own. Each individual was given the opportunity to repeat each of these
practice items until both the participant and the researcher were confident that the
experimental trials should begin. There were ten experimental trials, and each participant
was allocated an ECD score based on the number of correct responses.
Following completion of the ECD, participants also attempted the VE task (i.e. version A).
The nature of the task was explained to the participant, i.e. that they were required to
determine the destination floor of the elevator, by counting the number of floors that the
elevator either ascended or descended. Participants were then shown two examples of the
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test stimuli (see test manual for details). The experimenter ran through the first example
with the participant until it was apparent that the participant fully understood the nature of
the task. The participant was then given the opportunity to attempt the second practice item
by him/herself. As with the ECD task, participants were free to practice both of the example
items until they felt comfortable starting the experimental trials.
Participants were advised to attempt all ten of the experimental trials, and that they should
begin each new trial only when they felt ready. They were also informed that the task
would be timed and that they should complete each experimental trial in as quickly as
possible.
Each participant was allocated a score based on the total number of correct trials and a score
for the average time taken to make each attentional shift for the number of correct items.
The latter score was calculated by summing the total time taken for all correct items and
dividing it by the sum of the number of switches for those same items. Once the raw scores
for both TEA subtests had been obtained for each participant the relevant scaled score was
also noted and both scores were recorded.
The n-back task
Participants were given a verbal description of the n-back task prior to commencing the
experimental task. The n-back program was then started and participants viewed a number
of instruction screens that outlined the nature of the task in greater detail. Moreover, the
instruction screens included visual illustrations of each of the levels of task difficulty, i.e.
Shadow/O-back, 1-back, 2-back, and 3-back. Each individual was then given the opportunity
to practice each of the different task levels. These practice trials consisted of a single block
each of 1-, 2-, and 3-back trials with a block of the shadow task between each subsequent
level of the task.
Following the practice phase, and once it was ensured that the competently understood the
task, participants began the experimental trials. Individuals were required to perform a total
of ten blocks each of 1-, 2-, and 3-back conditions, with each n-back block being separated by








Figure 2.3: Running order for n-back blocks in the n-backtask, i.e. S = shadow, 1 = 1-back,
2 = 2-back, 3 = 3-back
Each experimental block consisted of 10 stimulus items, which were each displayed for 3
seconds (i.e. inter-stimulus interval (ISI) = 3 sec.). Therefore, the duration of each n-back
block was equal to 30 seconds. Consequently, the ideal running time for the completion of
the entire task was just over 30 minutes. However, each of the n-back blocks was preceded
by a prompt screen, which informed participants which version of the task they were to
perform, e.g. "ONE - BACK", and in order to begin each of the experimental blocks (i.e. to
move past the prompt screen) the participant was required to press the space bar.
Therefore, if a participant felt the need to take a short rest between trials then they had this
option. In fact, prior to testing participants were advised that if they felt the need for a rest
between each of the blocks they should feel free to do so. It was felt that this might aid
performance of the entire task for patients given that they may have had an exaggerated
difficulty in maintaining concentration for such extended periods of time. As a result, the
actual time taken for each participant to complete the n-back task varied between subjects.
Nonetheless, it should be noted that in most instances participants chose not to dwell on the
prompt screens for any extended period of time.
2.4.3 Data Analysis
All of the data obtained in this study were analysed using SPSS for Windows (Release 11;
SPSS Inc.). A number of individual analyses were carried out, which will be fully outlined in
the following results section (i.e. Chapter 3). However, the two main analyses were two 2 x
4 mixed ANOVAs, which considered the effect of experimental group (i.e. patient or control)
and level of task difficulty (i.e. 0-, 1-, 2-, or 3-back) on performance on the n-back task, both
in terms of accuracy (i.e. percentage of correct responses) and reaction time.
Ill









HRSD 23.90 (5.79) 11-34 N/A N/A N/A
BDI 33.25 (11.38) 15-51 2.15 (2.11) 0-8 31.10
SAC-
Stress
12.85 (5.89) 0-18 3.50 (4.26) 0-13 9.35
SAC-
Arousal
9.15 (3.48) 1-12 3.70 (2.72) 0-7 5.45
APSAQ 38.00 (9.81) 20-53 19.10 (3.19) 13-25 18.90
Table 3.1: Mean scores on each of the affective assessments: 20 patients vs. 20 controls
(Experiment one).
Independent samples t-tests revealed a significant difference in the scores of patients and
controls for the BDI (i.e. t (20.305) = 12.02, p < 0.001), for both the stress and arousal dimensions
of the SAC (i.e. t (38) = 5.75 and t (38) = 5.52, p < 0.001, respectively), and for the APSAQ (i.e. t
(22.984) = 8.19, p < 0.001), with patients scoring significantly higher than controls on all of these
measures.
However, the distribution of scores, using Shapiro-Wilks (S-W) tests of normality, for each of
the affective measures deviated significantly from a normal distribution (i.e. S-W (40) = 0.85, S-
W (40) = 0.85, S-W (40) = 0.91, & S-W <40) = 0.89, p < 0.001 for BDI, SAC-stress, SAC-arousal, and
APSAQ, respectively). Therefore, in order to assess the reliability of the t-test results, each of
these measures were also subjected to non-parametric analysis, i.e. Mann-Whitney U-test.
The Mann-Whitney U-test also revealed a significant effect of participant group on each of
the affective measures, i.e. BDI U = 0.00, p < 0.001, SAC-stress U = 46.50, p < 0.001, SAC-
arousal U = 50.00, p < 0.001, and APSAQ U = 10.50, p < 0.001.
Therefore, we can conclude that patients did not only exhibit higher levels of depressive
symptoms, as indicated by the significant difference in the BDI scores between participant
groups, but they were also experienced higher levels of state stress, arousal and anxiety at
the time of testing.
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3.2 Test of Everyday Attention
3.2.1 Elevator counting with distraction
Analysis of performance on the elevator counting with distraction subtest of the TEA, i.e.
independent samples t-test, revealed a significant difference between patients and controls
in mean number of correct items. This difference in performance between groups was
apparent in both the raw data and the scaled scores (i.e. t pros) = 2.57, p = 0.015 and t (38) = 2.32,
p = 0.026, respectively).
3.2.2 Visual Elevator
3.2.2.1 Accuracy
As with the elevator counting with distraction task, there was a significant difference
between the experimental groups in mean accuracy (i.e. number of correct items) on the
visual elevator task. Again, a significant difference was evident both in the raw data and in
the scaled scores for each group (i.e. t (25.03) = 3.07, p = 0.005 and t (38) = 2.76, p = 0.009).
Participant Group
Figure 3.1: Average number of correct items (scaled) on each of the TEA subtests -
Experiment 1 (20 controls vs. 20 patients)
3.2.2.2 Timing
In addition to the significant differences between patients and controls in the number of
correct items in each of the TEA subtests, the analysis further revealed a significant
difference between groups in mean reaction time (i.e. time per attentional switch for correct
items) on the visual elevator task. As with the other TEA measures, this significant
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difference was noted in both the mean of the raw reaction time scores and the scaled scores
(i.e. t (22.2i) = -4.92, p <0.001 and t (38) = 5.44, p <0.001).
control dopr»si«d
subject group
Figure 3.2: Mean reaction time (seconds) per
attentional switch on the visual elevator task -
Experimen One (20 patients vs. 20 controls)
subject group
Figure 3.3: Mean scaled score on the visual
elevator task - Experiment One (20 patients
vs. 20 controls)
However, while the scaled scores for the timing scores on the visual elevator task were
normally distributed (i.e. S-W m = 0.98, p = 0.557), it was noted that for accuracy on both the
elevator counting with distraction and the visual elevator tasks the distribution of scaled
scores deviated significantly from a normal distribution (i.e. S-W («> = 0.92, p = 0.007 and S-W
(40) = 0.90, p = 0.002). Therefore, in order to determine the reliability of the findings outlined
above, the accuracy data (i.e. scaled) from each of these was analysed using a suitable non-
parametric test, i.e. Mann-Whitney U-test.
These analyses also revealed a significant difference between patients and controls with
regards to the number of correct items on both the elevator counting with distraction (i.e. U
= 126.00, p = 0.46) and visual elevator (i.e. U = 112.50, p = 0.017) tasks.
It can, therefore, be concluded that patients performed significantly worse than controls on
both the elevator counting with distraction and visual elevator tasks, i.e. in both tasks the
mean number of correct items was significantly lower for patients than controls.
Furthermore, patients were also significantly slower than controls to perform correct items
in the visual elevator task. This was evident in both the mean time per attentional switch in
this task and the scaled scores for each group.
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These observations are indicative of impaired selective attention and cognitive flexibility in
individuals with major depression. Furthermore, they support the notion of a dysfunction
of auditory verbal working memory and psychomotor slowing in the patient group.
3.3 n-backtask
As previously noted, the effects of interest in terms of performance of the n-back task were
the main effect of participant group (i.e. patients vs. controls) and level of task difficulty (i.e.
0-, 1-, 2-, and 3-back). In order to assess the effect of each of these factors two 2x4 mixed
ANOVA's were conducted, i.e. one analysis concerned with accuracy (i.e. percentage
correct) and one concerned with reaction time (ms) on the n-back task.
3.3.1 Accuracy
As a result of the order of presentation of stimulus items, participants responded to a greater
number of 0-back trials than any other n-back level. Therefore, rather than comparing
participants raw scores, scores at each level of n-back were converted to percentage scores.
The percentage correct for each participant and each level of n-back was then used for the
data analysis.
Analysis of the percentage correct at each level of n-back revealed a significant main effect of
level of n-back (i.e. F <1.71,65.13) = 41.68, p < 0.001) and a significant main effect of participant
group (i.e. F <i,38) = 5.93, p = 0.02). However, there was no significant interaction between
these two factors (i.e. F (1.71,65.13) = 1.96, p = 0.156).
Post-hoc paired sample t-tests were conducted to determine between which levels of n-back
there were significant differences in performance (i.e. percentage correct) across the
participant groups. After Bonferroni correction for multiple comparisons (i.e. revised critical
value of p = 0.0167) it was determined that there was a significant difference between
performance at 0- and 1-back (i.e. t (39) = 2.25, p = 0.015), 1- and 2-back (i.e. t <39) = 8.08, p <





Figure 3.4: Mean percentage correct at each level of n-back in experiment one: 20 controls
vs. 20 patients
In addition to the significant main effects outlined above, the data analysis also revealed a
number of significant within-subjects contrasts. With regards to the level of difficulty of n-
back significant reverse Helmert (or difference) contrasts were noted between 1- and 0-back
(i.e. F (i,38) = 5.54, p = 0.024), between 2- and 1-back (i.e. F <i,38> = 65.26, p < 0.001), and between
3- and 2-back (i.e. F <i,38) = 53.90, p < 0.001). The linear contrast for this factor was also
significant, (i.e. F a,38) = 56.78, p < 0.001).
Furthermore, there was also a significant difference observed in the within-subjects reverse
Helmert contrasts for the interaction between the level of n-back and participant group
between the 1- and 0-back levels of the task (i.e. F <i,38) = 4.56, p =0.039). For this interaction
effect all other contrasts failed to reach significance.
Therefore, based on the preliminary data analysis we can presume that both patients and
controls experienced a linear increase in difficulty in performing the n-back task with each
incremental increase in task difficulty, as reflected in the decrease in participant accuracy
with the increase in N. It is also evident that patients perform consistently worse than
controls across the task (i.e. see Figure 3.4), and that this difference is indeed significant.
However, it would appear that this difference in accuracy on the n-back task between the
participant groups is consistent in nature, i.e. patients do not appear to get
disproportionately worse than controls as the level of the task difficulty increases.
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3.3.2 Reaction time
The second 4x2 mixed ANOVA comparing the reaction time differences across the levels of
task difficulty and between the subject groups also revealed a significant main effect of level
of n-back (i.e. F <1.934,73.484) = 15.34, p < 0.001) and a significant main effect of participant group
(i.e. F (i,38) = 25.16, p < 0.001). Furthermore, there was an observed significant interaction
between these two factors (i.e. F (1.934,73.484) = 4.18, p < 0.02).
The significant within-subjects contrasts observed in this analysis included significant
quadratic and cubic contrasts for both level of n-back (i.e. F a,38) = 6.81, p = 0.013 and F (1,3s) =
5.19, p = 0.028) and for the interaction between level of n-back and participant group (i.e. F
(1,38) = 4.40, p = 0.043 and F <i,38> = 10.53, p = 0.002). The linear contrast for level of n-back was
also significant, (i.e. F (i,38) = 19.82, p < 0.001).
N-back
Figure 3.5: Mean reaction time (ms) at each level of n-back: Patients vs. controls
Post-hoc paired samples t-tests, using Bonferroni correction for multiple comparisons,
revealed a significant difference in the mean reaction time across groups between 0- and 1-
back levels of task difficulty (i.e. t (39) = 4.40, p < 0.001). However, there was no significant
difference observed between 1- and 2-back task levels (i.e. t (39) = 1.06, p = 0.296), nor between
2- and 3-back levels (i.e. t (39) = 1.64, p = 0.109).
Moreover, post-hoc independent samples t-tests, again using the Bonferroni correction,
revealed a significant difference between patients and controls at all levels of the n-back task
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(i.e. O-back t ps) = -2.93, p = 0.003,1-back t (27.96O) = -5.42, p < 0.001, 2-back t (38) = -4.49, p < 0.001,
3-back t (27.H7) = -3.99, p < 0.001).
Based on this preliminary analysis of the data we may presume that patients are
significantly slower than controls to respond to stimulus items at all levels of the task. As
with the differences observed in accuracy, it would appear that this deficit is consistent in
it's nature, in so much as the disparity in the reaction times of patients and controls does not
appear to either increase nor decrease across the levels of the task.
Furthermore, it may be presumed that while the reaction times of both patients and controls
decreases (i.e. they get faster) between the baseline level of the task (i.e. 0-back) and the
subsequent task levels, there is no relative speeding up or slowing down between the 1-, 2-,
and 3-back levels.
These findings support the idea of impairment in working memory function in the
depressed patients, accompanied by significant psychomotor slowing in this group.
3.3.3 Controlling for demographic differences between participant groups
While attempts were made to match the depressed patients with controls of the same age,
gender, and IQ, the resultant samples did differ significantly in their mean NART estimated
IQs. More specifically, it was noted that the mean IQ of controls was greater than that of
patients (i.e. t (37.477) = 2.46, p = 0.019), despite a similar range of scores in each group (i.e.
range for controls = 97 - 127, range for patients = 96 - 129). This was of some concern given
previous observations of the relationship between specific measures of performance, such as
tests of psychomotor function (e.g. inspection time) and measures of individual difference
such as IQ (e.g. Deary & Stough, 1996; Deary, McCrimmon & Bradshaw, 1997). Therefore, in
order to attempt to control for the effect of any difference in IQ between the patients and
controls on the results noted above two mixed analyses of co-variance were carried out, i.e.
one for accuracy and one for reaction time data. The same factors were entered into these
analyses as were entered in the previous ANOVA calculations (i.e. level of difficulty of n-




As opposed to the previous analysis of accuracy on the n-back task, there was no observed
significant main effect of level of n-back when IQ was entered as a co-variate (i.e. F (3,111) =
1.97, p = 0.123). However, there was still a significant main effect of participant group (i.e. F
(i,37) = 6.856, p = 0.013).
In addition, there were two significant interactions noted in this analysis. The first of these
was the interaction between level of n-back and IQ (i.e. F (3,111) = 3.30, p = 0.023). The
interaction between level of n-back and participant group was also significant (i.e. F (3,111) =
2.70, p = 0.049).
In order to determine at which levels of n-back participant IQ has a significant impact upon
performance post-hoc correlations were carried out. It was found that NART estimated IQ
was correlated significantly with performance at the 0-back level of the task (i.e. r = 0.33, p =
0.039). However, there was no significant correlation between IQ and performance at any
other of the task levels. It should be noted, however, that if we were to correct for multiple
comparisons this correlation would become non-significant.
Mean Percentage Correct - 0-back
Figure 3.6: Scatterplot of participant's NART estimated IQ against the percentage of items
correct at the 0-back level of the n-back task.
With regards to the within-subjects contrasts, a significant linear contrast was observed with
regards to the interaction between participant IQ and level of n-back (i.e. F (1,37) = 4.12, p =
0.05). All other within-subjects contrasts were non-significant.
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Post-hoc independent samples t-tests revealed a significant difference between patients and
controls on 0-back (i.e. t <38) = 2.39, p = 0.022), 1-back (i.e. t po.787) = 2.69, p = 0.007), and 2-back
(i.e. t <33.47) = 2.43, p = 0.01) task levels, but not at the 3-back level (i.e. t (38) = 1.41, p = 0.084).
However, after adjusting the critical value of p in order to control for multiple comparisons,
it was concluded that the only significant differences between patients and controls had
occurred at the 1- and 2-back levels of the n-back task.
It can, therefore, be concluded that while performance, in terms of accuracy, does decline
with increasing level of difficulty of n-back, this decline is not statistically significant when
we control for participant IQ. Furthermore, it may be inferred that the effect of IQ on
performance of the taskmay only be significant at the baseline level of the task.
Finally, we can conclude that not only do patients perform worse than controls on the n-back
task; but that when IQ is controlled for there is an apparent increase in the effect of
diagnosis. Moreover, it would appear that the differences observed between the
experimental groups is underpinned by a significant difference in performance at the 1- and
2-back levels only.
3.3.3.2 Reaction Time
As with the accuracy analysis, when IQ was entered as a co-variate in the analysis, there was
no significant main effect of n-back on participant reaction time (i.e. Fp.ni) = 1.85, p = 0.142).
There was also no significant interaction between level of n-back and participant IQ (i.e. F
(3,ni) = 1.23, p = 0.303). However, there was both a significant main effect of participant
group (i.e. F (1,37) = 21.90, p < 0.001) and a significant interaction between participant group
and level of n-back (i.e. F (3,111) = 4.94, p = 0.003).
In addition, while there were no significant within-subjects contrasts with regards to level of
n-back or it's interaction with participant IQ, there were both linear and cubic contrasts for
the interaction between level of n-back and participant group (i.e. F (1,37) = 4.54, p = 0.040 and
F (1,37) = 9.41, p = 0.004, respectively).
In order to determine the nature of the interaction between participant group and level of n-
back, post-hoc one-way within subjects ANCOVAs were carried out. Each of these analyses
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estimated whether there was a significant difference between depressed patients and healthy
controls at each level of n-back, after controlling for participant IQ. The results of these
analyses were indicative of significant main effect of participant group at all levels of n-back
(i.e. 0-back: Fa,37)= 5.79, p = 0.021; 1-back: Fa,37)= 24.59, p < 0.001; 2-back: Fa,37)= 18.29, p < 0.001;
and 3-back: Fa,37)= 15.91, p <0.001). Thus, indicating that the interaction effect was due to
differences in the magnitude of the discrepancy in performance of patients and controls and
each level of the task, after controlling for IQ.
Therefore, we can conclude that not only does participant IQ have a significant effect on the
effect of level of n-back with regards to accuracy but also significantly impacts any effect
relating to mean reaction time. However, it would appear that any differences in the
performance of patients and controls were not necessarily affected by the disparity in mean
IQ between the groups. This is evident in both the consistency of the main effect of
participant group and interaction between participant group and level of n-back across the
two separate analyses.
3.4 Effect of clinical variables upon cognitive performance
As previously noted, some studies have highlighted the impact of clinical dimensions on
participant outcome on measures of cognitive performance. For example, factors of interest
highlighted in other studies have included aspects of illness such as severity of depression,
and duration of illness, although there is considerable disparity regarding the importance of
such factors on task performance. Therefore, further exploratory analyses (i.e. Pearson's
product moment correlations) were carried out to examine the relationship between the
clinical measures obtained in this study and the measures of cognitive performance (i.e. TEA
subtests and n-back measures) in the patient sample.
Significant correlations were only observed between the length of time since initial diagnosis
and mean percentage correct at the 2- and 3-back levels of the n-back task (i.e. r = -0.51, p =
0.021 and r = -0.52, p = 0.020, respectively) and between BDI score and mean percentage
correct at the 3-back level only (i.e. r = -0.56, p = 0.011). Therefore, it appears that duration of
illness and self-assessed severity of depression may have a possible effect upon performance
but only at the more difficult levels of the task.
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Chapter 4: Methodology - Experiment Two
4.1 Design
As with experiment one, a case control study with a single between subjects factor of
participant group (i.e. depressed patients vs. healthy controls) and the within subjects factor
of level of difficulty of n-back (i.e. 0-, 1-, 2-, and 3-back) was used to test the experimental
hypotheses. In terms of behavioural performance, the dependent variables were mean
percentage correct and mean reaction time, at each level of n-back, with both simple group
and task difficulty effects and group x task difficulty interactions being of interest.
Participants' performance on the n-back task was assessed while undergoing a functional
MRI scan, i.e. using BOLD-sensitive, echo planar imaging (EPI), with a parametric, block
design. Therefore, the additional dependent variables in the present study were increases
and decreases in regional brain activity with increasing task difficulty (i.e. in both patients
and controls), and relative increases and decreases in functional activation between patients
and controls associated with the linear increase in the level of difficulty of the n-back task.
4.2 Participants
4.2.1 Recruitment
The recruitment of participants for this study was covered by the same ethical and
management approval as was obtained for the first study. This was due to the fact that a
single submission was made to the appropriate ethics committees detailing both
investigations, with the first study being noted as a pilot investigation and the second study
as the main experiment.
4.2.1.1 Patient recruitment
A number of patients who participated in the first study also chose to participate in the
functional MRI investigation. In order to recruit the additional participants required for the
study the same prospective approach to patient recruitment that was used in the pilot study
was employed (see Chapter 2 for full details).
In brief, staff at the Royal Edinburgh Hospital that were involved in care of patients were
provided with the two information sheets (i.e. 'Information for Medical Staff and 'Patient
Information Sheet': see Appendix 2). They were asked to confer the participant information
sheet upon any individuals in their care who they felt would be suitable to take part in the
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study and who would be able to take part. Staff were also asked to provide details of those
patients who were interested in participation to the researchers. Moreover, they were asked
to provide details of other salient information about the patient, e.g. if there was any known
history of drug or alcohol abuse.
This approach to patient recruitment was supplemented by regular visits and telephone calls
to the hospital wards and day hospitals to check on recent admissions and status of patients
who were likely to suitable for participation.
Once suitable individuals had been identified they were contacted directly by the
researchers. The full outline of the aims and methods of the study were then explained to
the individual in question, and they were given the opportunity to ask any questions they
had regarding the investigation. Patients were given a minimum of 24 hours to consider
participation, during which they were advised to discuss participation with their friends and
family, as well as those responsible for their psychiatric care. If after careful consideration
the patient was willing to participate in the study arrangements were made for pre-testing (if
necessary) and scanning sessions, and their consultant was notified of the patient's intention
to participate in the study.
4.2.1.2 Control recruitment
As with the patient participants, some of the control participants in experiment two had also
participated in the pilot study. The remaining control participants were recruited
opportunistically. Potential controls were approached based on either an expressed interest
in participation in the study or through recommendation from colleagues, and were selected
based on their ability to fulfil the criteria used to match controls to patients (see Chapter 2:
Methodology: Experiment One). Individuals who were willing to consider participation as
a control participant were given a copy of the information sheet for participants, and asked
to take a minimum of 24 hours to consider participation. It was also recommended that they
discuss participation in the study with their friends and family.
While the control sample included staff of the University of Edinburgh, Division of
Psychiatry and the Royal Edinburgh Hospital, it was ensured that all individuals were
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aware that participation was entirely voluntary and that no control participant was involved
in a dependent relationship with any of the researchers.
4.2.2 Participant details
Participants were ten individuals with a diagnosis of major depressive disorder and ten
matched normal, healthy controls. Patients and controls were matched as closely as possible
for age, gender, and IQ (see Table 4.1). Where possible they were also matched as closely as
possible for occupation. Within the patient sample there was one left-handed and nine
right-handed participants. All of the control participants were right-handed.
Patients were either in- or out-patients (i.e. 3 and 7 respectively) of the Royal Edinburgh and
associated hospitals. They were selected on the basis of a diagnosis of major depressive
disorder (as confirmed by a member of staff involved in their psychiatric care) and a
minimum score of 15 on both the BDI and HRSD at the time of testing.
Participant group Mean age (years) (mean(s.d.)) Mean IQ (meanis.d.)) Male: Female
Patients 31.9 (7.42) 107.2 (7.53) 2:8
Controls 30.6 (8.18) 112.1 (8.40) 3:7
Table 4.1: Summary of participant demographic details: Experiment Two
All participants were required to meet the same exclusion criteria as experiment one (see
Chapter 2). However, in addition, given that participants were required to undergo
magnetic resonance imaging, it was ensured that individuals met the following additional
exclusion criteria: No history of head surgery; no metal fragments in any part of the body
(e.g. shrapnel), either past or present; no previous injury incurred while working with metal
which required medical attention; and no metal implants e.g. joint replacement, Harrington
rods etc.
It was also noted whether participants wore dentures, a dental plate, a brace, contact lenses,
a hearing aid, an intrauterine contraceptive device (IUCD) or sterilisation clips.
Within the depressed participant group nine patients were taking anti-depressant
medication at the time of participation (see Table 4.2). One patient was taking a combination
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of medications at the time of participation, i.e. tryptophan, trazodone, and diazepam. The
single patient participant who was not medicated had been medication free for a period of 2
months prior to participation. This patient had previously been prescribed a course of
venlafaxine.





Tryptophan Amino acid 1*
Venlafaxine SSRI & NARI 5
Table 4.2: Antidepressant medication prescriptions of patient participants - Experiment two.
(* = Same participant)
Eight patients and five controls that participated in the current experiment had previously
taken part in the pilot study. As a result of this these individuals had already completed one
full trial of the n-back task prior to scanning. For this reason all novel participants were
given an opportunity to complete a practice session on the n-back task prior to scanning. It
was felt that this was particularly advantageous with the patient sample as it ensured that
patients were capable of undertaking the task. Accordingly, any patients likely to
experience a catastrophic reaction to testing could be deselected prior to scanning.
4.2.3 Excluded/withdrawn participants
Three patients were recruited via the procedure outlined above but failed to score a
minimum of 15 on the HRSD, and thus were excluded from any further testing. A further
eight patients were approached by their consultant and agreed to participate in the study,
but failed to respond to numerous attempts to contact them and arrange appointments for
testing. In addition one patient experienced a catastrophic reaction to testing during the
practice session, and was therefore excluded.
Furthermore, two volunteers who were initially selected to participate as matched controls
were also excluded from the study. After recruitment it was discovered that one of these
controls had suffered a number of mild head injuries in childhood, and had experienced a
brief episode of depression during adolescence. The second of these two controls, while
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having not been diagnosed with major depressive disorder, had previously been prescribed
anti-depressant medication. Therefore, in order to preserve the integrity of the control
sample it was deemed appropriate to not include either of these individuals.
4.3 Materials (see Appendix 2)
4.3.1 Pre-test materials
The same participant information sheet and consent form as were used in the first study
were employed in the current investigation. Three additional pre-test measures were also
employed in this study. The first of these was a medical questionnaire similar to the one
employed in experiment one. However, in the version for this study, participants were also
asked to indicate whether they were left or right handed.
The second measure completed by participants was a pre-scan questionnaire designed to
ascertain whether, or not, there were any grounds for exclusion from MRI scanning (as per
the additional exclusion criteria outlined above). For example, participants were asked to
whether they had any metal objects or fragments in any part of their body.
The final pre-test measure was a patient information sheet. This form was constructed for
use by a member of the staff involved in patient care for the provision of patient information
relevant to participation in this study.
4.3.2 Affective indices
The affective assessments used in this study were the Beck Depression Inventory Beck et al.,
1961, the Stress Arousal Checklist Mackay et al., 1978, the Alderley Park State Questionnaire
Walker, 1990, and the Hamilton Rating Scale for Primary Depressive Illness Hamilton, 1967.
An account of the nature of these assessments and a brief description of their administration
can be seen in Chapter 2.
4.3.3 Cognitive assessments
National Adult Reading Test Nelson & Willison, 1991
The NART was employed in order to obtain an estimate of WAIS-R Full Scale IQ - i.e.
current IQ in the controls and premorbid IQ in the patient sample.
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The Test of Everyday Attention Robertson et al., 1994
The same subtests of the TEA that were used in the pilot study were used in the current
investigation, i.e. the Elevator Counting with Distraction and Visual Elevator subtests.
The n-back task
The n-back task that we created was specifically designed in order to make it appropriate
not only for neuropsychological testing but for use in functional imaging investigations.
Therefore, we were able to utilise the same version of the n-back task as was employed in the
first experiment in this study. The structure of the task was identical to the original version;
however, the program for the paradigm was altered in order to make the task compliant
with the software used to present stimuli in the scanner (i.e. Integrated Functional Imaging
System (IFIS; Psychology Software Tools). This alteration simply involved editing the
original E-prime programme file by including a number of IFIS extensions that allow the
task to be synchronised with the scanner. The aim of this type of editing of the task is to
ensure that the presentation of the behavioural paradigm will be appropriately co-ordinated
with the acquisition of the functional imaging data.
Additional editing of the task focussed on the length of the paradigm. Given the relatively
large number of repetitions of the levels of the n-back task employed (i.e. 10 blocks of each of
1-, 2-, and 3-back, and 30 blocks of 0-back) the original running time of the task was
approximately 30 minutes. Therefore, it was decided that it would be advantageous to
separate the original task into two distinct experimental blocks, each consisting of five trials
of 1-, 2, and 3-back with each of these blocks being separated by a block of 0-back.
The final alteration that was made to the n-back task was the revision of the length of each
individual block of n-back. In the original paradigm there were equal numbers of items in
each n-back trial. Given that a block of 0-back preceded each block of 1-, 2-, and 3-back there
was a considerably greater proportion of 0-back trials than any other single type of n-back
trial. As we were more interested in the pattern of activation associated with the increased
load on the central executive, rather than that associated with the baseline processes, it was
decided that we should alter the number of 1-, 2-, and 3-back trials in order to increase the
proportion of data acquired relating to these experimental manipulations. Therefore, 1-, 2-,
and 3-back trials were extended to include the presentation of 14 stimulus items within each
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block. Accordingly, the blocks of 0-back were reduced to the presentation of 9 stimulus
items.
4.3.4 Scanner specifications and scanning protocol
All participants were scanned in a 1.5 T GE Signa MRI scanner, which was located at the
SHEFC Brain Imaging Research Centre, at the Western General Hospital, Edinburgh.
BOLD sensitive echo planar fMRI images were acquired with a TR of 2.5 seconds, and a TE
of 40 milliseconds. The flip angle was 90°, with a field of view of 24 cm. The in plane
resolution was 64 x 64, with a plane orientation that was near axial (i.e. aligned in parallel
with the anterior commisure-posterior commisure (AC-PC) line). All functional scans were
5mm in thickness with no slice gap, thus a total of 30 slices were obtained. Data was
acquired for two functional sessions, with each functional acquisition being 18 minutes 55
seconds in length (see details below). T2 and T1 weighted structural images were also
obtained for each participant. The scanning parameters for these acquisitions were as
follows:
Tl weighted structural image
acquisition
T2 weighted structural image
acquisition
TE (milliseconds) Min full 102
TR (milliseconds) - 6300
TI (milliseconds) 600 -
Flip angle 15 -
Field of View 22 24
Matrix 256 x192 256 x 256
Slice thickness (mm) / No. of
slices
1.7/128 5/20
Slice Gap (mm) 0 1.5
Time (mins) 7min 15 sec 1 min 41 sec




As in the original study, participants were provided with the information sheet a minimum
of 24 hours prior to participation, and were given the opportunity to pose any queries that
they had about the nature of the study to the researchers. They were also advised to consult
medical staff (where applicable) and their friends and family regarding participation.
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Participants were asked to sign three copies of the consent form, one copy for their own
records, one for the researchers, and, in the case of patients who participated, one copy to be
appended to their medical records. Furthermore, all participants were asked to complete
two pre-test questionnaires, i.e. the medical questionnaire and a pre-scan questionnaire, as
previously outlined.
4.4.2 Affective assessment
All affective indices were completed on the day of participation, prior to the commencement
of scanning. All participants completed the BDI Beck et al., 1961, the SAC Mackay et al.,
1978, and the APSAQ Walker, 1990 prior to commencing scanning. Patients were
additionally required to complete the HRSD Hamilton, 1967.
In addition, for each patient who participated, an individual involved in patients' psychiatric
care was asked to complete a patient information sheet. As in experiment one, this form was
used to corroborate information the patient had provided regarding their medical
background and to acquire any additional information which may have been of interest to
the researchers, e.g. current medication (including dosage), length of depressive illness etc.
4.4.3 Cognitive assessment
Prior to scanning, all participants completed the two TEA subtests Robertson et al., 1994.
Participants who had not previously participated in the first experiment also completed the
NART Nelson & Willison, 1991 and the original version of the n-back task (see Chapter 2 for
details). This latter assessment was done in order to match participants who only
participated in the second study with those who had participated in both studies in terms of
level of practice on the n-back task.
4.4.4 Functional magnetic resonance imaging
4.4.4.1 Paradigm presentation
In functional MRI there are two typical strategies used for the presentation of behavioural
paradigms, i.e. block-design and event-related. Block-design presentation involves
determining the changes in cerebral activation during performance over the extended period
of a block of a particular task. Event-related presentation, on the other hand, is concerned
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with measuring the level of activation across the cortex (or in regions of interest) at a discrete
time point that corresponds to the presentation of a specific stimulus or a specific response.
While event-related presentation can result in reduced motion artefacts and practice effects,
block-design does have the advantage of being a relatively simple and robust approach to
activation studies, and can give researchers a better signal to noise ratio. Therefore, the
current study decided to take an initial block-design approach to the presentation of the n-
back task. However, the design of our original paradigm also allowed for the potential
analysis of event-related responses at a later date if necessary.
The n-back task was presented visually to participants in the scanner using a LCD display
mounted on the head coil (IFIS: Psychology Software Tools, Pittsburgh, PA). Once the
participant's comfort in the scanner had been assured it was determined whether or not they
could adequately read information presented on this display. Prior to the practice phase
participants viewed a number of instructions screens, which outlined the nature of the task
in general and the nature of each of the various levels of n-back. They were instructed to
respond using the pushbutton units (IFIS: Psychology Software Tools, Pittsburgh, PA). Each
unit is ergonomically-shaped, with a pushbutton beneath the thumb and each fingertip.
Each participant was provided with a right-hand pushbutton unit and was advised that, in
terms of responding, the fingers of the right hand should be considered as relating to
positions 1-5 moving from left to right, from the thumb (i.e. position 1).
For the purposes of scanning there were three n-back phases, i.e. an initial practice phase,
followed by two experimental phases. Although all participants had completed an entire
run of the n-back task it was felt that a practice within the scanner would be advantageous
as it would give each individual the opportunity to get used to both the type of display and
the response units. In this practice phase participants were given the opportunity to attempt
a block each of 1-, 2-, and 3-back, with each block being separated by a block of 0-back. In
the experimental trials participants completed five blocks each of 1-, 2-, and 3-back, again
with a block of 0-back occurring between each (i.e. resulting in a total of 15 blocks of 0-back).
As a result of the changes made to the experimental paradigm there was a notable change to
the total run time of the n-back task. Each stimulus item was presented with an ISI of 3
seconds. Given that there was 9 items in each 0-back block and 14 items in all other n-back
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blocks, the length of each 0-back block was 27 seconds, with all other n-back blocks having a
total length of 52 seconds Furthermore, between each n-back block a prompt screen,
indicating which task (i.e. 0-, 1-, 2-, or 3-back) the participant was to perform appeared for 3
seconds. The resultant length of the practice phase was, therefore, 6 minutes and 15 seconds,
with each of the two experimental phases having a run time of 18 minutes and 55 seconds
(see Figure 4.1).
Practice Phase















Figure 4.1: Running order for presentation of n-back blocks in each phase of the n-back task
during functional imaging - Experiment two. Note: S = shadow, 1=1-back, 2=2-back, and
3=3-back.
A functional pre-scan and the T2 weighted structural scan were acquired during
performance of the practice phase. Participants then attempted the first experimental phase,
which was followed by the T1 weighted structural scan. Following this scan the second
functional pre-scan was conducted. On completion of this scan participants attempted the
second experimental phase.
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As previously noted, participants performance on each of the n-back trials was recorded in
terms of accuracy (i.e. correct or incorrect) and reaction time (in milliseconds).
4.4.5 Data Analysis
Full details of all analyses (behavioural and functional) can be seen in the following chapter
(i.e. Chapter 5: Results: Experiment Two).
4.4.5.1 Behavioural Data
The behavioural data were analysed using SPSS for Windows (Release 11; SPSS Inc.). The
main analyses were two 4x2x2 mixed ANOVA's, considering the effect of level of n-back
task difficulty (i.e. 0-, 1-, 2-, or 3-back), participant group (i.e. patients vs. control), and
imaging session (i.e. experimental phase 1 vs. experimental phase 2), on both accuracy (i.e.
mean percentage correct) and reaction time. In addition, independent samples t-tests were




All functional data were processed and analysed using SPM99
(http://www.fil.ion.ucl.ac.uk/spm), running in MATLAB (Mathworks, Natick, MA, USA).
■ Data preprocessing
Prior to preprocessing, participants BOLD EPI images were reconstructed to ANALYSE
format (Mayo Foundation, Rochester, MN, USA). For each participant, EPI volumes were
then realigned to the first volume in the series using rigid body transformation. Following
realignment the movement parameters for each participant were examined in order to
determine the degree ofmovement of participants in the scanner, during functional imaging.
The functional imaging data were then normalised. Given the noted occurrence of lesions in
the temporal cortex in two of the depressed patients (see section 5.6 for details), prior to
normalisation each participant's EPI images were co-registered to their own T1 structural
image. The functional images were normalised using a linear affine transformation
followed by non-linear deformations, and were resampled using sine interpolation to cubic
voxels of size 8mm3 (i.e. 2x2x2 mm).
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The normalised images were then smoothed spatially, in order to minimize residual inter-
participant differences, using a 3D Gaussian filter (i.e. 6x6x6 mm3 FWHM (full width half
maximum)).
■ Data analysis
Fixed effects analyses were initially calculated to determine linear increases and decreases in
activation in individual voxels with increasing task difficulty, using a block design, for
patients and controls. In addition, fixed effects analyses were then conducted in order to
compare patients and controls in terms of relative differences in increased and decreased
activation associated with increasing task difficulty.
Second level (i.e. 'random effects') analyses were then conducted in order to account for the
influence of individual variability on the observed pattern of activation. These analyses
were based upon the outcomes of the fixed effects contrasts for each individual participant.
As with the fixed effects, random effects were calculated for the voxels of increased and
decreased activation in controls and patients, associated with the linear increase in difficulty
of n-back, and for the relative differences in activation between patients and controls.
As a result of some of the behavioural observations (see Chapter 5) it was decided that we
should consider the pattern of activation associated with correct responses only in patients
and controls. Therefore, a series of event-related analyses were conducted. Instances where
both patients and controls performed accurately were isolated and analysed for changes in
activation at each level of task difficulty and associated with the linear increase in n-back
difficulty. In addition the data was also analysed for relative differences in activation
associated with correct responses only between the patients and controls. Moreover,
comparisons were made between instances where patients performed the task correctly and
when they performed the task incorrectly, at each level of n-back. Again, both fixed and
random effects models were calculated.
Structural data
The T1 weighted structural images from each participant were examined for any evidence of
structural deficit.
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Chapter 5: Results - Experiment Two
Analysis of T1 weighted structural images revealed structural anomalies in three
participants in the patient sample (see imaging results below for details). Detailed analysis
of these apparent structural deficits revealed that in two of the three patients the anomalies
in regions of cortex that were not involved in, or significantly close to, the average pattern of
activation seen in the patient group during performance of the n-back task. Therefore, these
individuals were included in the functional imaging analysis. The structural deficit in the
third patient was determined to be in a region that was proximate to areas of functional
interest. Accordingly, this patient was excluded from the analysis of functional imaging
data.
In addition, a functional artefact was observed in the temporal lobes of one control
participant (see imaging results below for details). Although there was no structural deficit
associated with this dysfunction (as determined by examination of the T1 weighted
structural image for this participant), there was a significant artefact on the EPI images
obtained for the individual concerned. Consequently, this participant was also excluded
from the analysis of functional images.
Therefore, the sample size for patients and controls was reduced to 9 for both groups in the
functional imaging analysis. However, given that all participants met the criteria for
participation, it was assumed that the behavioural data collected from all individuals during
functional data acquisition was still valid with respect to behavioural and
neuropsychological observations. Therefore, two behavioural analyses were conducted, i.e.
an initial analysis including all participants involved in scanning and a secondary analysis
involving only those participants whose data was included in the analysis of functional
imaging.
5.1 Behavioural Results: All Participants
5.1.1 Affective indices
Independent samples t-tests revealed significant differences between the patients and
controls on the BDI (i.e. t <9.07; = 6.43, p < 0.0005), on the stress and arousal dimensions of the
SAC (i.e. t (9.77) = 4.02, p = 0.0015 and t (is) = 4.51, p < 0.0005, respectively), and on the APSAQ








HRSD 21.10 (5.55) 15-32 N/A N/A N/A
BDI 28.00 (13.44) 10-51 0.60 (0.89) 0-2 27.40
SAC-
Stress
9.70 (6.12) 1-17 1.10 (1.37) 0-4 8.60
SAC-
Arousal
8.60 (3.59) 3-12 2.50 (2.32) 0-5 6.10
APSAQ 34.30 (12.99) 20-58 17.90 (4.07) 12-27 16.40
Table 5.1: Mean scores on each of the affective assessments in experiment two: Patients vs.
controls
However, as with the previous study, the distribution of scores on each of the affective
measures deviated significantly from a normal distribution (i.e. BDI S-W (20) = 0.82, p = 0.002;
SAC-stress S-W <2o> = 0.76, p < 0.001; SAC-arousal S-W (20) = 0.90, p = 0.042; and APSAQ S-W
(20) = 0.85, p = 0.006). Therefore, the scores on each assessment were further compared using
a series ofMann-Whitney U tests.
The non-parametric analyses also revealed a significant difference between the experimental
groups on the BDI (i.e. U = 0.00, p < 0.001), on the stress and arousal indices of the SAC (i.e.
U = 9.50, p = 0.001 and U = 10.00, p = 0.002), and on the APSAQ (i.e. U = 4.00, p < 0.001).
Therefore, it can be concluded that not only did the patients exhibit a significant level of
depression in comparison to the controls, but they also experienced significantly higher
levels of state stress, arousal, and anxiety at the time of testing.
5.1.2 Test of Everyday Attention
5.1.2.1 Elevator Counting with distraction
Independent samples t-test analysis of the elevator counting with distraction data revealed
no significant difference between the experimental groups in the average number of correct
responses. This was true for both the raw scores (i.e. t (is) = 0.00, p = 1.00) and the scaled
scores (i.e. t <i8> = -0.45, p = 0.329).
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5.1.2.2 Visual Elevator
Independent samples t-tests were also used to compare patient and control performance on
the visual elevator task (i.e. accuracy and reaction time).
5.1.2.2.1 Accuracy
While there was a significant difference between patients and controls on the raw accuracy
scores (i.e. t <is) = -1.95, p = 0.034) the scaled scores of the two experimental groups on the
accuracy measure of the visual elevator task were not significantly different (i.e. t m = -1.47,
p = 0.079).
Experimental Group
Figure 5.1: Comparison of mean scaled scores for accuracy on the elevator counting with
distraction and visual elevator subtests of the TE - Experiment two (10 patients vs. 10
controls).
5.1.2.2.2 Timing
The t-test analyses also revealed a significant difference between patients and controls with
respect to the average time taken per attentional switch on the visual elevator subtest. The
experimental groups differed in both the mean raw scores (i.e. t (9.68) = 2.24, p = 0.025) and the
mean scaled scores (i.e. t (n.83> = -2.408, p = 0.017) on this measure.
Therefore, it can be concluded that there was no evidence of a dysfunction of selective
attention, cognitive flexibility, or auditory-verbal working memory in the patient group (as
compared with healthy controls) in this study. However, the significant differences between
patients and controls on the timing measure of the visual elevator task is indicative of
psychomotor slowing associated with the experience of major depression.
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Figure 5.2: Mean time (seconds) per attentional
swtich on each correct item of he VE task -
Experiment two (10 pattients vs. 10 conrols)
subject group
Figure 5.3: Mean scaled score on the visual
elevator task - Experiment two (10 patients vs.
10 controls)
5.1.3 n-back task
The performance of participants on the task, as undertaken during functional imaging, was
analysed using two 2x2x4 mixed ANOVAs, i.e. one for accuracy and one for reaction time.
The main factors of interest were participant group (i.e. patients vs. controls) and level of
difficulty of n-back. Although the effect of scanning session (i.e. session 1 vs. session 2) was
not considered as an important factor in the formation of the experimental hypotheses for
this study, it was included as a factor in the analyses in order to determine whether there
was any significant effect on performance on the n-back task associated with the use of two
different behavioural sessions during scanning.
5.1.3.1 Accuracy
As in the previous experiment, accuracy was measured in terms of the percentage of correct
responses at each level of n-back. The first ANOVA analysis revealed a significant main
effect of level of n-back (i.e. F (i.8i,54) = 17.15, p < 0.001) and a significant main effect of group
(i.e. F (i,i8) = 4.727, p = 0.043). However, there was no significant main effect of scanning
session (i.e. F <i,i8) = 0.37, p = 0.552) and no significant interactions between any of the factors
(i.e. n-back*Group: F <1.81,54) = 0.757, p = 0.465; Session*Group: F <i,i8) = 2.96, p = 0.552; n-
back*Session: F (1.56,54) = 1.855, p = 0.181; n-back*Session*Group: F (1.56,54) = 0.237, p = 0.735).
A priori reverse Helmert contrasts revealed a significant difference in average percentage
correct between 2- and 1-back conditions (i.e. F<i,is) = 15.169, p = 0.001) and between 3- and 2-
back conditions (i.e. F <i,is) = 22.733, p < 0.001 ). In addition, the linear contrast for level of n-
back was also significant (i.e. F (i,i8) = 24.135, p < 0.001). However, the contrast between 1-










Figure 5.4: Mean percentage correct at each level of n-back - Experiment two (10 patients
vs. 10 controls).
Post-hoc paired samples t-tests comparing the mean performance at each level of n-back
revealed significant differences between 0- and 1-back (i.e. t <i9) = 1.92, p = 0.035), between 1-
and 2-back (i.e. t <i9) = 3.88, p < 0.001) and between 2- and 3-back (i.e. t <i9) = 3.76, p < 0.001).
These findings were still statistically significant after correction for multiple comparisons
(i.e. Bonferroni).
Therefore, as predicted, both patients and controls exhibited a linear increase in difficulty
associated with the linear increase in the level of n-back. Moreover, patients experienced
greater difficulty across all levels of the task than control participants. As in experiment one,
the impairment seen in patients was consistent in nature.
5.1.3.2 Reaction time
The results of the second mixed ANOVA analysis revealed a significant main effect of n-
back (i.e. F (1.54,54) = 19.04, p < 0.001), a significant main effect of scanning session (i.e. F (us) =
8.21, p = 0.01), and a significant interaction between level of n-back and scanning session (i.e.
F (3,54) = 4.27, p = 0.009) on the mean reaction time of participants. There was, however, no
significant main effect of participant group (i.e. F <i,i8) = 1.86, p = 0.190), no significant
interaction between scanning session and participant group (i.e. F (i,i8) = 2.51, p = 0.131), and
no significant three-way interaction between level of n-back, scanning session, and




Figure 5.5: Mean reaction time (ms) at each level of n-back - Experiment two (10 patients
vs. 10 controls).
Figure 5.6: Mean reaction time (ms) for scanning sessions 1 and 2 - Experiment two (10
patients vs. 10 controls).
NBACK
Figure 5.7: Mean reaction time (ms) at each level of n-back - Experiment two (Session 1 vs.
session 2: all participants).
A priori reverse Helmert contrasts for level of difficulty of n-back revealed a significant
difference in average reaction time between 1- and 0-back (i.e. F <us) = 14.80, p = 0.001),
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between 2- and 1-back (i.e. F (us) = 23.70, p < 0.001), and between 3- and 2-back (i.e. F (us) =
20.01, p <0.001).
Post-hoc paired sample t-tests, with Bonferroni correction for multiple comparisons,
revealed a significant difference in mean reaction time at the 0-back level between sessions 1
and 2 (i.e. t <i9) = 6.603, p < 0.001). However, no significant differences were observed
between scanning sessions for 1-, 2-, and 3-back levels (i.e. t (i9> = 0.409, p = 0.687, t <i9> = 1.398,
p = 0.178, t (i9) = -0.150, p = 0.882, respectively).
Further post-hoc analysis (i.e. paired samples t-tests, with Bonferroni correction)
demonstrated significant differences in the mean reaction times at 0- and 1-back (i.e. t(i9> =
3.737, p = 0.001), between 1- and 2-back (i.e. t <i9) = 3.303, p = 0. 002), but not between 2- and 3-
back (i.e. t <i9> = 2.004, p = 0.06).
Thus, it may be asserted that, for all participants, RT was significantly inversely related to
the increase in 'N' between the 0- and 2-back levels of the n-back task. However,
participants did not experience any significant change in the time taken to respond to
stimulus items with the change in task level to 3-back.
In addition, whereas participants average reaction times to 0-back items was significantly
slower in the first scanning session, reaction times at the other levels of n-back were not
significantly different between sessions.
It should also be noted that, in contrast to the results of experiment one, there was no
significant difference in the reaction times of patients and controls during performance of
the n-back task. This finding is indicative of relatively preserved psychomotor function in
the group of depressed patients who participated in this study.
5.1.4 Relationship between clinical dimensions and cognitive performance: All
participants
In order to determine whether there was any significant relationship between the affective
states of the patients involved in this study and the measures of cognition employed a series
of bivariate correlations were calculated (i.e. Pearson's product moment correlation co-
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efficient). The results of these analyses revealed no statistically significant association
between BDI, HRSD, SAC, and APSAQ scores for the depressed patients and their scores on
both the subtests of the TEA and both accuracy and reaction time measures on the n-back
task (i.e. picrit.) < 0.05).
5.2 Behavioural Results: Scanning analysis participants only
5.2.1 Participant details
Data obtained from 9 patients and 9 control participants was included in the final analysis of
functional images (see Table 5.2 below).
Participant
group













Table 5.2: Demographic details of those participants included in the analysis of functional
imaging data in Experiment Two.
Independent samples t-tests revealed no significant difference between these subgroups of
patients and controls with respect to mean age or IQ (i.e. t (i6> = 0.18, p = 0.863 and t (i6> = -1.5,
p = 0.269, respectively). Moreover, there was no significant difference in the distribution of
male and female participants between the groups (i.e. x2 a) = 0.599, p > 0.05).
5.2.2 Affective Indices
The outcome of independent samples t-tests, used to compare the participant subgroups on
the affective measures, were indicative of significant differences between patients and
controls on the BDI (i.e. t (8.06) = 5.91, p <0.001), both the stress and arousal dimensions of the
SAC (i.e. t (8.66) = 3.56, p = 0.003, t (i6) = 4.09, p < 0.001, respectively), and on the APSAQ (i.e. t
(9.54) = 3.44, p < 0.004).
All of these measures, with the exception of SAC-arousal, deviated significantly from a
normal distribution (i.e. BDI: S-W (is) = 0.81, p = 0.002; SAC-stress: S-W (is) = 0.74, p < 0.001;
and APSAQ: S-W (is) = 0.84, p = 0.006). However, Mann-Whitney U analyses confirmed the
significant group differences on the affective indices (i.e. BDI: U = 0.00, p < 0.001; SAC-stress:








HRSD 20.56 (5.59) 15-32 N/A N/A N/A
BDI 28.56 (14.13) 10-51 0.67 (0.87) 0-2 27.89
SAC-
Stress
9.44 (6.97) 1-17 1.00 (1.41) 0-4 8.44
SAC-
Arousal
8.22 (3.60) 3-12 2.33 (2.40) 0-5 5.89
APSAQ 34.44 (13.78) 20-58 17.89 (4.31) 12-27 16.56
Table 5.3: Mean scores on each of the affective assessments in experiment two for those
participants included in the analysis of functional brain images.
Therefore, the same profile of affective state at the time of assessment in the subgroups of
participants included in the functional imaging analysis mimicked the pattern seen in the
entire participant sample. Thus, suggesting the subgroup of participants who were included
in imaging analysis were representative of the group as a whole.
5.2.3 Test of Everyday Attention
5.2.3.1 Elevator counting with distraction
Independent samples t-tests revealed no significant difference in the mean number of correct
items on the elevator counting with distraction task between patients and controls. Again,
this was accurate for both raw and scaled scores on this task (i.e. t <i6) = 0.08, p = 0.468 and t (i6>
=-0.23, p = 0.411).
5.2.3.2 Visual Elevator
5.2.3.2.1 Accuracy
Within these sub-groups, patients did not perform significantly worse than controls in terms
of number of correct responses (scaled) on the visual elevator subtest. This was evident in
the results of independent samples t-tests of the raw (i.e. t <i6> = -1.55, p = 0.07) and scaled (i.e.
t (i6) = -1.05, p = 0.15) scores on this measure.
5.2.3.2.2 Timing
Patients were significantly slower than controls in the average time taken to make an
attentional switch. This disparity in psychomotor function was reflected in the differences
between the mean reaction time per attentional switch (i.e. t (s.6i> = 1.89, p = 0.046) and in the




A 4 x 2 x 2 mixed ANOVA of the average accuracy, i.e. percentage of correct responses,
revealed a significant main effect of level of difficulty of n-back (i.e. F <1.73,48) = 15.87, p <
0.0001), but there was no significant main effect of scanning session (i.e. F <U6) = 0.15, p =
0.708) or participant group (i.e. F (U6> = 2.93, p = 0.106). Furthermore, no significant
interactions between any of the factors was observed, i.e. n-back*Group: F (1.731,48) = 0.54, p =
0.566; Session*Group: F (i,i6> = 2.17, p = 0.160; n-back*Session: F (1.550,48) = 1.34, p = 0.272; n-
back*Session*Group: F (1.550,48) = 0.76, p = 0.448).
A priori, reverse Helmert contrasts revealed a significant difference in performance between
2- and 1-back levels (i.e. F (1,16) = 10.99, p = 0.004), and between 3- and 2-back levels (i.e. F <i,i6)
= 22.79, p < 0.001), but not between 0- and 1-back levels (i.e. F a,i6) = 2.14, p = 0.163) of the n-
back task.
Post-hoc paired samples t-tests were conducted to further explore the main effect of level of
difficulty of n-back. After appropriate adjustment for multiple comparisons, significant
differences were noted between the 1- and 2-back levels of the task (i.e. t (17) = 3.36, p = 0.004)
and between 2- and 3-back levels (i.e. t <i7> = 4.27, p < 0.001). However, there was no apparent
significant difference in the mean accuracy between the 0- and 1-back task levels (i.e. t (17) =
0.06, p> 0.05).
5.2.4.2 Reaction time
A 4 x 2 x 2 mixed ANOVA of mean reaction time (ms) revealed a significant main effect of
level of difficulty of n-back (i.e. F (1.42, 48) = 15.56, p < 0.001), a significant main effect of
scanning session (i.e. F (1,16) = 5.35, p = 0.034), and a significant interaction between level of
difficulty of n-back and scanning session (i.e. F (3,48) = 5.19, p = 0.003). There was, however,
no significant main effect of participant group (i.e. F (i,i6> = 0.94, p = 0.346), no significant
interaction between level of n-back and participant group (i.e. F (1.42,48) = 0.10, p = 0.843), no
significant interaction between scanning session and participant group (i.e. F (1,16) = 1.63, p =
0.220), and no significant three-way interaction (i.e. F (3,48) = 1.89, p = 0.144).
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Planned comparisons for mean reaction time at each level of n-back revealed a significant
difference between 1- and 0-back (i.e. F (U6> = 13.68, p = 0.02), between 2- and 1-back (i.e. F
(i,i6) = 19.35, p < 0.001), and between 3- and 2-back (i.e. F <i,i6) = 14.41, p = 0.002).
Post-hoc paired samples t-tests, with Bonferroni correction for multiple comparisons (i.e.
p<crit) = 0.0125), revealed a significant difference inmean reaction time between sessions 1 and
2 at the 0-back level of task difficulty (i.e. t <i7> = 6.51, p <0.001). However, there was no
significant difference between scanning sessions at 1-back (i.e. t (i7> = 0.06, p = 0.955), 2-back
(i.e. t (i7) = 0.64, p = 0.528), or 3-back (i.e. t (i7> = -0.20, p = 0.848) levels of tasks difficulty.
5.2.5 Relationship between clinical dimensions and cognitive performance: Scanning
participants only
In those patients who were included in the scanning analyses, no significant associations
were found between the measures of affective state (i.e. BDI, HRSD, SAC, and APSAQ) and
any of the measures of cognitive performance (i.e. both TEA subtests and both accuracy and
reaction time measures on the n-back task).
5.3 Summary of Behavioural Findings
5.3.1 Affective Indices
Prior to commencement of testing it was assured that all patients were exhibiting a
significant severity of depressive symptomology, and that all controls had no history of
psychiatric illness or current symptoms of major depression. This distinction between the
experimental groups was supported by the observed significant difference in the mean BDI
scores of patients and controls. Patients also exhibited significantly greater levels of state
stress and arousal (as assessed by the Stress Arousal Checklist) and state anxiety (as assessed
by the APSAQ) prior to participation.
5.3.2 Test of Everyday Attention
Overall, the outcomes on the TEA subtests suggest an absence of impairment in selective
attention, cognitive flexibility, nor auditory verbal working memory in the patient group, as
compared with healthy controls. However, despite similar levels of performance accuracy
between the experimental groups, patients were slower to respond to stimuli in the visual
elevator task. This was evident in the analysis of reaction times in both analyses of




A significant main effect of level of difficulty of n-back was observed in both of the
behavioural analyses, with planned comparisons revealing a significant difference between
each consecutive level of task difficulty. Therefore, it would appear that all participants
experienced an increase in task difficulty with each incremental increase in cognitive load on
the n-back task.
Moreover, analysis of the data for all participants revealed a significant main effect of
participant group, with patient scores being significantly lower than those of control
participants. While this significant finding was not replicated in the analysis of data from
those participants included in scan analyses, the pattern of findings was similar. Therefore,
the failure to obtain a significant finding in this latter analysis may be the result of reduced
statistical power due to the small sample numbers.
Both behavioural analyses confirmed the lack of a significant difference in performance
across functional MRI scanning session. Thus, suggesting no effect of scanning session on
the observed level of participant accuracy on the n-back task.
5.3.3.2 Reaction time
Overall, the results relating to participant reaction time on the n-back task are indicative of a
significant decrease in participant reaction time with increasing task difficulty, i.e. as N
increased participants exhibited a relative speeding up of their response times.
Examination of the descriptive data would seem to indicate that patient's reaction times
were on average slower than those of controls (i.e. across all levels of n-back and across
sessions). However, both behavioural analyses were suggestive of no effect of participant
group on mean reaction time. This lack of a significant difference between patients and
controls is indicative of relatively preserved psychomotor function in the depressed patients
who participated in this study.
While there was an apparent reduction in reaction time with each increase in the level of
task difficulty between sessions 1 and 2, there appeared to be little difference in the reaction
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time scores for 1-, 2-, and 3-back conditions across the two imaging sessions. The only
significant effect of scanning session was the apparent difference in the average reaction
time at 0-back between sessions 1 and 2.
5.3.4 Relationship between clinical dimensions and cognitive performance
The findings of both sets of correlation analyses failed to find a significant association
between severity of depression (i.e. both BDI and HRSD), state stress, and state anxiety in
the depressed patients and their level of performance on the cognitive measures. Not only
was there no significant association between affective scores and accuracy on the cognitive
tasks but there was also no apparent relationship between affective state of depressed
individuals and measures of psychomotor function in this study.
5.4 Comparison of the effect size for experimental group differences in performance on
the n-back task: Experiment One vs. Experiment Two.
It is possible that the relatively smaller number of participants in experiment two had a
significant impact upon the relative level of statistical power in this study. A reduced power
level is of concern given the relative differences in the observations of previous
investigations of WM function in MDD, which may reflect the magnitude of this type of
effect. Thus, it was deemed appropriated to compare the relative effect size of participant
group effects on performance on the n-back task between the first two studies. These
comparisons were conducted for both accuracy and reaction time in each study (i.e. using
Cohen's d estimates of effect size; see Figures 5.8 and 5.9 below).
Comparison of the relative effect size differences in accuracy on the n-back task between
patients and controls in the two studies revealed a greater effect of participant group across
all levels of N in the second experiment. However, these differences appear to be rather
minimal in magnitude, implying that the findings of the two studies with regards to the
effect of participants group on n-back accuracy are comparable.
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N-back
Figure 5.8: Comparison of effect size (i.e. Cohen's d) for the main effect of participant group
on accuracy - Experiment one vs. experiment two
Figure 5.9; Comparison of effect size (i.e. Cohen's d) for the main effect of participant group
on reaction time - Experiment one vs. experiment two.
In contrast to the effect of participant group on accuracy, the effect size with respect to the
effect of experimental group on participant reaction time appears to be greater in the first
experiment. Indeed, this may reflect the statistically significant effect of participant group
on this measure that was noted in the first study, but not the second.
Overall, the pattern of results observed, in terms of effect size, is similar in the two studies.
This may be indicative of reduced statistical power in the second study as a result of the
smaller participant numbers. Alternatively, the differences between experimental conditions
may be the result of a confounding effect of performance of the task during scanning in the
latter experiment. Nonetheless, the similarities between studies are indicative of a consistent
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profile of performance on the n-back task, between patients and controls, irrespective of
experimental condition (i.e. experiment one vs. experiment two).
5.5 Structural imaging results
5.5.1 Patients
Examination of the structural images (i.e. T1-weighted MRI) revealed structural
abnormalities in three of the patients. In two of these patients there were lesions in the
temporal lobes, presumed to be small cerebral haemangioma - possibly the result of a minor
head injury. Analysis of the patterns of functional activation associated with these two
patients were determined not to differ significantly from that seen in the other depressed
patients involved in the study. Moreover, the lesion sites in these individuals were deemed
to be far enough removed from the regions of task associated activation. Therefore, both of
these participants were included in the functional imaging analysis.
The third patient was noted to have a significant white matter lesion. When the pattern of
activation during task performance was examined for this individual it was concluded that
the lesion site was too close to regions of significant activation. More specifically, the lesion
site was particularly close to posterior cortical regions that showed an apparent decrease in
activation associated with the linear increase in task difficulty. Therefore, in order to
minimise any distortion in the results of the functional imaging analysis this patient was
excluded from the data analysis.
5.5.2 Controls
Analysis of the T1 images of the control participants revealed no significant abnormalities in
cortical structure of any of the normal individuals who participated in this study.
5.6 Functional Imaging Results: Block design
Despite normal structural data in all of the control participants, during functional scanning
of one participant there was a significant artefact in the functional images. It was suggested
that the artefact might have been the result of a non-clinically significant abnormality in
metabolic functions. As a result of the location (i.e. left temporal lobe) and extent of this
artefact, this patient was also excluded from the analysis.
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Consequently, this functional artefact and the noted significant structural abnormality in the
patients meant that suitable imaging data was obtained from 9 depressed patients and 9
normal controls. Imaging data from these participants was examined for significant effects
of the between groups factor of participant group and the within subjects factor of task
difficulty upon cortical activation.
As previously outlined, all of the data were preprocessed and analysed using SPM99
(www.fil.ion.ucl.ac.uk/spml. For each individual participant BOLD EPI images were co-
registered to their own T1 MRI image. Following co-registration the images were normalised
and smoothed (i.e. see pp 132-133 for full details of the data preprocessing).
Fixed effects contrasts were then calculated for individual participants. Similar contrasts
were also calculated for the relevant within- and between-groups factors. This first level
analysis involved calculating the voxels in which activation was either increased or
decreased in association with the parametric increase in the level of difficulty of the n-back
task.
The fixed effects contrasts for each participant were then used to calculate within and
between group random effects for factors of interest. Independent samples t-test were used
to calculate within group contrasts, whereas between group contrasts were calculated using
a one-way ANOVA.
In addition to these core analyses, contrasts were also calculated for the relative increases
and decreases in activation between each level of the task (i.e. 0- vs. 1-back, 0- vs. 2-back, Ci¬
vs. 3-back, 1- vs. 2-back, 1- vs. 3-back, and 2- vs. 3-back). As with the previous analyses,
these contrasts were calculated for both within and between groups.
Regions of significant activation were defined as those clusters of activation where the
corrected probability level of the cluster was less than or equal to 0.05. In this study
significant clusters were noted for all contrasts in the second level analysis.
While the original output from SPM99 gave the locations of voxels and clusters of significant
activation in MNI co-ordinates, for the purposes of reporting these co-ordinates were
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converted to a standard Talairach space (i.e. using non-linear transformation). The
neuroanatomical descriptors of the anatomical locations of clusters of significantly altered
activation were then determined using the Talairach Daemon database (Lancaster et al.,
1997; Lancaster et al., 2000). This programme enables the user to input three-dimensional
voxel co-ordinates (i.e. x, y, z) and based on this information generates an output file which
describes the location of the voxels of interest with reference to the hemisphere, lobe, cortical
description (i.e. cortical or subcortical) and Brodmann area (e.g. left hemisphere, frontal lobe,
medial frontal gyrus, BA 8).
The outcomes of the analyses relating to the main factors of interest (i.e. the effect of
participant group and the linear increase in difficulty of the n-back task) are outlined in the
following sub-sections (full details of all clusters of significant activation relating to each of
the experimental manipulations are available in Appendix 3A).
5.6.1 Control activation associated with performance of the n-back task; Block design
(Note: The extent of clusters of significant activation is noted for both the number of voxels
comprised by the cluster (i.e. Ke) and the volume of the cluster (i.e. mm3) based on an
individual voxel volume of 8 mm3 (i.e. 2x2x2 mm))
The pattern of activation seen in control participants during performance of the n-back task
is depicted in Figures 5.10 - 5.12. In association with the parametric increase in difficulty of
n-back, significant increases (i.e. p (corrected) < 0.05) in activation were noted in control
participants in the right inferior parietal lobule (BA40; cluster size (Ke)/vo1. = 1428/11424
mm3, p < 0.001), the left superior parietal lobule (BA40; Ke/vo1. = 639/5112 mm3, p < 0.001),
the right medial frontal gyrus (BA8; Ke/vo1. = 116/928 mm3, p = 0.004) and the middle frontal
gyrus, bilaterally (BA6, 9, 10 and 46; Ke/vo1. = 244/1952 mm3, p < 0.001; Ke/vo1. = 458/3664
mm3, p < 0.001; Ke/vo1. = 407/3256 mm3, p = 0.001; Ke/vo1. = 144/1152 mm3, p = 0.028; Ke =
79/632 mm3, p = 0.004).
With the same changes in the experimental parameters significant decreases in activation
were noted in a number of regions of cortex. In the left hemisphere significant clusters were
observed in the cingulate gyrus (BA31; Ke/vo1. = 2945/23560 mm3, p < 0.001), the medial
frontal gyrus (BA11/8; Ke/vo1. = 4461/35688 mm3, p < 0.001), the fusiform gyrus (BA37;
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Ke/vo1.=158/1264 mm3, p < 0.001 and Ke/vo1. = 104/832 mm3, p = 0.007), the cuneus (BA19;
Ke/vo1. = 172/1376 mm3, p < 0.001) and the insula (BA43/52; Ke/vo1. = 224/1792 mm3, p <
0.001). Regions of significantly decreased activation in the right hemisphere in controls
included the precentral gyrus (BA13; Ke/vo1. = 1211/9688 mm3, p < 0.001), the
parahippocampal gyrus (BA28/37; Ke/vo1. = 157/1256 mm3, p < 0.001), the middle frontal
gyrus (BA11; Ke/vo1. = 80/640 mm3, p = 0.026), the middle occipital gyrus (BA18; Ke/vo1. =
83/664 mm3, p = 0.022), the lingual gyrus (BA18; Ke/vo1. = 94/752 mm3, p = 0.012), and the
oilmen (Ke/vo1. = 242/1936 mm3, p < 0.001). Moreover, decreased activation was seen
bilaterally in the middle temporal (BA21 & 22; Ke/vo1. = 145/1160 mm3, p = 0.001 and Ke/vo1.
= 87/696 mm3, p = 0.018) and superior temporal (BA22; Ke/vo1. = 167/1336 mm3, p < 0.001 and
Ke/vo1. = 94/752 mm3, p = 0.012) gyri.
5.6.2 Patient activation associated with performance of the n-back task: Block design
The following images (i.e. Figure 5.13 - 5.15) illustrate the regions of significant increase and
decrease in activation associated with the increase in task difficulty of the n-back task in the
depressed patients. With an increase in a significant increase was observed in patients in the
left hemisphere in the cerebellum (i.e. pyramis and declive; Ke/vo1. = 229/1832 mm3, p <
0.001), and a trend towards significance was noted in the left lingual gyrus (BA18; Ke/vo1. =
60/480 mm3, p = 0. 055). In the right hemisphere significant increases were noted in the
inferior frontal gyrus (BA46 & 47; Ke/vo1. = 300/2400 mm3, p < 0.001 & Ke/vo1. = 165/1320
mm3, p < 0.001), the inferior parietal lobule (BA40; Ke/vo1. = 2817/22536 mm3, p < 0.001), and
the middle frontal gyrus (BA10; Ke = 412/3296 mm3, p < 0.001 & Ke/vo1. = 99/792 mm3, p =
0.004). A significant bilateral increase was also seen in the superior frontal gyrus (BA6;
Ke/vo1. = 868/6944 mm3, p < 0.001 & Ke = 576/4608, p < 0.001).
Significant decreases associated with increasing task difficulty were seen in the depressed
patients in the left hemisphere in the medial frontal gyrus (BA10; Ke/vo1. = 1071/8568 mm3, p
< 0.001), the superior temporal gyrus (BA22 & 41; Ke/vo1. = 134/1072 mm3, p = 0.001 & Ke/vo1.
= 145/1160 mm3, p < 0.001), and the posterior cingulate (BA31; Ke/vo1. = 1270/10160 mm3, p <
0.001). Significant decreases were also observed in depressed patients in the following
regions in the right hemisphere: transverse temporal gyrus (BA41; Ke/vo1. = 617/4936 mm3, p
< 0.001); precentral gyrus (BA4; Ke/vo1. = 104/832 mm3, p = 0.003); cingulate gyrus (BA24;
Ke/vo1. = 157/1256 mm3, p < 0.001); and the middle temporal gyrus (BA38; Ke/vo1. = 108/864
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mm3, p = 0.002). A decrease in activation was also noted bilaterally in the cerebellum (i.e.
uvula and pyramis; Ke/vo1. = 83/664 mm3, p = 0.012, and the culmen; Ke/vo1. = 83/664 mm3, p
= 0.012 & Ke = 66/528 mm3, p = 0.036) in patients.
Figure 5.10: Statistical parametric map of the voxels of increased activation in the control
participant group (i.e. N = 9) with the linear increase in difficulty of the n-back task -
Experiment two: Random effects.
Figure 5.11: Statistical parametric map of the voxels of decreased activation in the control
participant group (i.e. N = 9) with the linear increase in difficulty in the n-back task -
Experiment two: Random effects.
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Figure 5.12: Increased (red colour scale) and decreased (blue colour scale) activation in
controls with associated with the linear increase in difficulty of the n-back task - Experiment
two (random effects, p corrected ^ 0.05). The significant activations are superimposed 2D
slices of a normalised, mean EPI image (i.e. image based on data obtained from 12 normal,
healthy participants).
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Figure 5.13: Statistical parametric map of the voxels of increased activation in depressed
patients (i.e. N = 9) associated with the linear increase in task difficulty of the n-back task -
Experiment two: Random effects.
Figure 5.14: Statistical parametric map of the voxels of decreased activation in depressed
patients (i.e. N = 9) associated with the linear increase in task difficulty of the n-back task -
Experiment two: Random effects.
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Patients: Block design
Figure 5.15: Increased (red colour scale) and decreased (blue colour scale) activation in
patients associated with the linear increase in difficulty of the n-back task - Experiment two
(random effects, p corrected s 0.05). The areas of significant activation are superimposed on a
normalised, mean EPI image (as before).
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5.6.3 Comparison of areas of significant activation between patients and controls: Block
design
Figure 5.16 & 5.17 depict the contrasts results of those cortical regions activation that differed
in their degree of activation between patients and controls, associated with the increased
difficulty of the n-back task. While there are a number of voxels that show group
differences, significant differences were only evident in the medial orbital prefrontal cortex
(MOPFC)/subgenual (rostral) anterior cingulate (rAC) (BA 12; Ke/vo1. = 128/1024 mm3, p =
0.025). This region was shown to be relatively more active in patients than controls with
increasing difficulty of n-back
Figure 5.16: Statistical parametric map of the voxels of relatively increased activation in the
depressed patients (i.e. N = 9) compared to the control participants (i.e. N = 9) associated











Figure 5.17: Statistical parametric map of the voxels of relatively decreased activation in the
depressed patients (i.e. N = 9) compared to the controls participants (i.e. N = 9) associated
with the linear increase in task difficulty of the n-back task - Experiment two: Random
effects.
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5.6.4 Correlation between regions of activation and severity of depression in MDD patients
In order to determine whether there was any significant contribution of the severity of
depression to the pattern of activation seen in patients, a correlation analysis considering the
relationship between signal intensity and HRSD score was conducted for depressed patients
only. In order to achieve this the contrasts for increased and decreased activation with
increasing difficulty of n-back were correlated with patients' HRSD score. The results of this
random effects analysis can be seen in Figures 5.18 and 5.19. No statistically significant
correlations were noted between clusters of significant increased or decreased activation and
severity of depression. Indeed, even below threshold there were relatively few regions that











Figure 5.18: Statistical parametric map of the voxels of increased activation in the depressed
patients (i.e. N = 9) that were correlated with the severity of depression as measured by the
HRSD - Experiment two.
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Figure 5.19: Statistical parametric map of the voxels of decreased activation in the
depressed patients (i.e. N = 9) that were correlated with the severity of depression as
measured by the HRSD - Experiment two.
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5.7 Functional imaging results: Event related design
It was suggested that there might be a potential confounding effect of level of performance
on the observed differences between patients and controls in the previous set of functional
analyses. Therefore, it was deemed appropriate to consider the event-related activity
associated with accurate task performance. More specifically, the areas of activation
associated with correct responses only at each level of the n-back task were examined. As
with the block-design analyses, the factors of interest in these analyses were the level of
difficulty of the n-back task and the relative differences in activation between patients and
controls.
The first step in this analysis was to plot all of the behavioural responses for each
participant, across all levels of task difficulty. This was done in order to determine the
general pattern of behavioural responses for both participant groups at each level of n-back.
Of particular interest was whether, or not, there was a sufficient number of correct responses
for each participant at each task level such as would justify their inclusion in the event
related analysis. Once this had been assured, the behavioural data for each participant was
then examined in order to determine the nature of each type of response, based on the
following categories: i.e. correct actual response; correct no response; incorrect actual
response; and incorrect no response. For the event related analysis the response type of
interest was 'correct actual response'. Although it would have been interesting to examine
the difference between correct and incorrect actual responses, both within and between
participant groups, the number of incorrect actual responses at all levels of task difficulty
was not sufficient enough to result in a large enough number of corresponding functional
images, such as would have been required for meaningful analysis of the EPI data.
Following identification of correct actual responses the timing of each correct response for
each participant was identified, i.e. the time at which the stimulus item occurred relative to
the beginning of the n-back paradigm. The timing of all correct actual responses for each
participant was then saved to a text file, which was later used as an input file in the
functional imaging analysis to identify the relevant images for each correct response for
individual participants at each level of difficulty of n-back according to onset time.
After the determination of the fixed effects contrasts were calculated for individual
participants in order to determine the voxels of significant activation associated with correct
158
items only at each level of n-back and those associated with the linear increase in task
difficulty. As with the block design analysis for this study, our main interest was in voxels
of significant activity that exhibited either a parametric increase or decrease in accordance
with the parametric increase in the level of n-back. However, in this instance only those
modulations of activation that were associated with correct actual responses were of interest,
both within and between experimental groups.
In the calculation of the event related fixed effects analysis the haemodynamic response time
was accounted for using the default Haemodynamic Response Function in SPM99. This
particular function of SPM99 can be used to ensure that the haemodynamic response time is
taken into account when determining the relevant functional images of interest. Failure to
take note of this potential confounder may result in discrepancy between the actual event of
interest and the measured 'event', thus impacting upon the reliability of the analysis of the
functional imaging data.
An additional potential confounding effect in the event related analysis was the discrepancy
between the TR (i.e. 2.5 seconds) and the ISI that was used in the n-back paradigm (i.e. 3
seconds). However, it is a feature of SPM99 that these two parameters need not match
exactly. Indeed, SPM99 can take account of this potential discrepancy in the analysis of
functional imaging data. This is achieved by computing the predictors of brain activity on a
very fine resolution in time and than resampling them at a lower resolution to have one
single value per volume.
As with the previous neuroimaging analysis, the first level, fixed effects contrasts for
individual participants were utilised in the second level, random effects analysis. Random
effects contrasts were calculated for within and between participant groups. Of interest
were regions that exhibited an increase or decrease in activation associated with the increase
in task difficulty, for correct actual responses only. In identifying clusters of significant
change in activation the critical value of the corrected probability level was 0.05. Regions of
significant cortical activation were determined by converting MNI co-ordinates to standard
Talairach space. The Talairach co-ordinates were then used to identify the relevant cortical
regions of interest, i.e. using the Talairach Daemon Database. Although various
comparisons were made between the activation associated with correct responses at each of
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the various levels of n-back, in the following sub-sections only those data relating to the
overall linear increase in task difficulty are reported (Note: details of all significant findings
can be viewed in Appendix 3B).
5.7.1 Control activation associated with performance of the n-back task: Event related
The pattern of activation associated with correct responses only in control participants is
depicted in the following figures (i.e. Figure 5.18 - 5.20). Increased activation was noted in
the left hemisphere in the inferior frontal gyrus (BA46; Ke/vo1. = 164/1312 mm3, p < 0.001)
and in the following regions in the right hemisphere: inferior parietal lobule (BA40; Ke/vo1. =
3346/26768 mm3, p < 0.001 & Ke/vo1. = 68/544 mm3, p = 0.028); superior temporal gyrus (BA6;
Ke/vo1. = 73/584 mm3, p = 0.018); and the thalamus (Ke/vo1. = 132/1056 mm3, p < 0 .001).
Increased activation was also seen bilaterally in the middle frontal gyrus (BA10/8; 6; 10; & 9;
Ke/vo1. = 212/1696 mm3, p < 0.001; Ke/vo1. = 2011/16088, p < 0.001; Ke/vo1. = 77/616 mm3, p =
0.014; and Ke/vo1. = 65/520 mm3, p = 0.033), the insula (BA43/52; Ke/vo1. = 339/2712 mm3, p <
0.001 & Ke/vo1. = 144/1152 mm3, p < 0.001), and the cerebellum (i.e. declive, culmen, and
tuber; Ke/vo1. = 250/2000 mm3, p < 0.001; Ke/vo1. = 268/2144 mm3, p < 0.001;.and Ke/vo1. =
103/824 mm3, p = 0.002).
Decreased activation associated with correct responses only was noted in controls as the
level of difficulty of n-back increased in a number of clusters. In the left hemisphere regions
of significantly decreased activation associated with accurate performance of the task
included both posterior and anterior cingulate cortex (BA23 & 24/25; Ke/vo1. = 1624/12992
mm3, p < 0.001 & Ke/vo1. = 149/1192 mm3, p < 0.001) and in the angular gyrus (BA39; Ke/vo1. =
181/1448 mm3, p < 0.001). Bilaterally decreased activation was noted in the following areas:
insula (BA43/52; Ke/vo1. = 1032/8256 mm3, p < 0.001 & Ke/vo1. = 63/504, p = 0.039; medial and
superior frontal gyri (BA9/6; Ke/vo1. = 2695/21560 mm3, p < 0.001); parahippocampal and
fusiform gyri (BA20 & 37; Ke/vo1. = 221/1768 mm3, p < 0.001; Ke/vo1. = 122/976 mm3; p < 0.001;
& Ke/vo1. = 108/864 mm3; p = 0.002); paracentral lobule (BA5; Ke/vo1. = 380/3040 mm3, p <
0.001); middle temporal gyrus (BA21; Ke/vo1. = 202/1616 mm3, p < 0.001; Ke/vo1. = 86/688
mm3, p = 0.007; & Ke/vo1. = 161/1288 mm3, p < 0.001); and superior temporal gyrus (BA40 &
41; Ke/vo1. = 132/1056 mm3, p < 0.001 & Ke/vo1. = 59/472 mm3, p = 0.052).
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Figure 5.20: Statistical parametric map of the voxels of significantly increased activation in
the control participants (i.e. N = 9) associated with the linear increase in difficulty of the n-
back task - Experiment two: Correct responses only (random effects).
Figure 5.21: Statistical parametric map of the voxels of significantly decreased activation in
the control participants (i.e. N = 9) associated with the linear increase in difficulty of the n-
back task - Experiment two: Correct responses only (random effects).
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Controls: Event related
Figure 5.22: Increased (red colour scale) and decreased (blue colour scale) activation in
controls with increasing task difficulty - Experiment two: Correct responses only (random
effects). (Random effects, p corrected ^ 0.05). Mean increase and decrease areas of activation
are superimposed upon normalised, mean EPI image (as before).
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5.7.2 Patient activation associated with performance of the n-back task: Event related
The pattern of activation observed in patients during accurate performance of the task was
similar to that seen in controls (see Figures 5.21 - 5.23). Increased activation was seen in the
left hemisphere in a cluster covering the precuneus and postcentral gyrus (BA7; Ke/vo1. =
192/1536 mm3, p < 0.001) and in the cerebellum (i.e. declive and tuber; Ke/vo1. = 228/1824
mm3, p < 0.001). In the right hemisphere significant increases in activation associated with
correct responses with increasing difficulty were seen in the insula (BA43/52; Ke/vo1. =
124/992 mm3, p < 0.001), the precentral and middle frontal gyri (BA9 & 6; Ke/vo1. = 366/2928
mm3, p < 0.001 & Ke/vo1. = 255/2040 mm3, p < 0.001), in the medial frontal gyrus (BA6/8;
Ke/vo1. = 293/2344 mm3, p < 0.001), and in a region comprising the precuneus and the middle
temporal gyrus (i.e. BA 19; Ke/vo1. = 436/3488 mm3, p < 0.001). In addition, increased
activation was seen bilaterally in the inferior parietal lobule (BA40; Ke/vo1. =861/6888 mm3, p
< 0.001 and Ke = 239/1912 mm3, p < 0.001).
As with the increased activation, the pattern of decreased activation seen in patients during
correct responses was similar to that seen in controls. In the left hemisphere a significant
accuracy associated decrease was noted in the superior frontal gyrus (BA8; Ke/vo1. =
451/3608 mm3, p < 0.001) and in clusters involving the precuneus, the medial frontal gyrus
and the paracentral lobule (BA7/6/5; Ke/vo1. = 2514/20122 mm3, p < 0.001), and the inferior
frontal and subcallosal gyri (i.e. BA25/44; Ke/vo1. = 63/504 mm3, p = 0.036). Significant
decreases in the right hemisphere were seen in the precentral gyrus (BA6; Ke/vo1. = 70/560
mm3, p = 0.021), in the cuneus and precuneus (BA19; Ke/vo1. = 159/1272 mm3, p < 0.001), in
the medial frontal gyrus (BA10; Ke/vo1. = 1336/10688 mm3, p < 0.001), and in a cluster
comprising the insula and the precentral gyrus (BA43/52; Ke/vo1. = 322/2576 mm3, p < 0.001).
Moreover, significant decreases were observed bilaterally in a number of clusters involving
the middle temporal gyrus (BA39 & 21; Ke/vo1. = 99/792 mm3, p = 0.033; Ke/vo1. = 196/1568
mm3, p < 0.001; Ke/vo1. = 145/1160 mm3, p < 0.001; & Ke/vo1. = 59/472 mm3, p = 0.049), the
lingual gyrus (BA19; Ke/vo1. = 83/664 mm3, p = 0.008 & Ke/vo1. = 66/528 mm3, p = 0.029), and
the cerebellum (i.e. uvula and culmen; Ke/vo1. = 74/592 mm3, p = 0.016 & Ke/vo1. = 201/1608
mm3, p < 0.001).
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Figure 5.23: Statistical parametric map of voxels of increased activation in depressed
patients (i.e. N = 9) associated with the linear increase in difficulty of the n-back task -
Experiment two: Correct responses only (random effects).
Figure 5.24: Statistical parametric map of the voxels of decreased activation in depressed
patients (i.e. N = 9) associated with the linear increase in difficulty of the n-back task -
Experiment two: Correct responses only (random effects).
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Figure 5.25: Increased (red colour scale) and decreased (blue colour scale) in patients with
increasing task difficulty - Experiment two: Correct responses only (random effects; p corrected
^ 0.05). Mean increased and decreased activations are superimposed on normalised, mean
EPI image (as before).
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5.7.3 Comparison of areas of significant activation between patients and controls during
performance of the n-back task: Correct responses only
The contrasts that were calculated to compare the cortical activation of patients and controls
on correct responses only revealed no significant differences between groups (see Figure
5.24). As with the other contrasts, this comparison was concerned with those activations
associated with the linear increase in task difficulty. However, additional comparisons of
the relative activations of the two groups at the various levels of the task also revealed no
statistically significant differences between the groups when comparing correct responses
only.
Figure 5.26: Statistical parametric map of the areas of relative increase in depressed
patients (i.e. N = 9) compared to control participants (i.e. N = 9) associated with the linear




Chapter 6: Methodology - Experiment Three
6.1 Design
Experiment three used a counter-balanced cohort design to test the experimental hypotheses
(see Chapter 1: pp 90). As with the previous studies that made up this project, the primary
within-subjects factor in this investigation was the level of difficulty of the n-back task (i.e. 0-
, 1-, 2-, and 3-back). However, in the case of the current experiment, there was also the
additional within-subjects factor of medication status (i.e. medication-free vs. post-
medication).
With respect to behavioural performance, the dependent variables of interest were accuracy
(i.e. percentage of correct responses) and reaction time (in milliseconds) at each level
difficulty of the n-back. The analyses of the behavioural results of participants were
designed to determine the main effect of level of difficulty of n-back and medication status
on measures of performance of the n-back task. Moreover, these analyses also took account
of the potential interaction between level of difficulty and medication status on participant
performance.
As in second study in this series, performance on the n-back task was assessed while
participants underwent BOLD EPI functional neuroimaging. However, in this study
participants underwent two complete scanning trials, i.e. one scan while medication-free and
a second scan following the subacute administration of anti-depressant medication. During
each of these scanning trial participants underwent two separate scanning sessions (i.e.
session 1 vs. session 2). The functional imaging data acquired during both of these scanning
sessions were analysed in order to ascertain the level of cerebral activation associated with
the increasing difficulty of the n-back task, and for relative increases and decreases in
activation associated with the change in medication status. The comparison of functional
activation between conditions was based on the differences in pattern of increased and
decreased activation associated with the linear increase in difficulty of n-back in participants
while medication-free and post-medication. The contrasts relevant for each comparison
were calculated for both first and second scanning session independently, and for the overall




The recruitment and testing of participants in this study were covered by the ethical
approval of the Lothian NHS board, Psychiatry and Psychology Research Ethics Committee,
and by management approval from the board of the Lothian Primary Care NHS Trust.
In a method similar to the previous studies, participants for experiment three were
opportunistically sampled, using a combination of prospective sampling and word of
mouth. Individuals were approached who fulfilled the criteria for inclusion and had
expressed an interest in participation. The criteria for inclusion were the same as the criteria
used to screen control participants in experiment two (see Chapter 4). In addition, it was
also ensured that participants would not be taking any other medication at the proposed
time of participation, which might have interacted negatively with the medication they were
required to take in the current experiment. These criteria resulted in an experimental sample
of participants that were free of any physical or psychological condition such as would have
a potential effect on both the behavioural and functional neuroimaging data, and thus
exclude them from participation in this type of study.
Individuals who volunteered to participate in the study were given an information pack,
which detailed the requirements for participation and the nature of the study (see section
6.3.1). Participants were given a minimum of 48 hours to read this information and to
decide whether they were both suitable for participation and would be willing to take part.
In a similar approach to experiments one and two, it was verbally reiterated to volunteers
that participation was on an entirely voluntary basis, that if they should decide to participate
they were free to withdraw at any time and without giving a reason, and that they should
feel free to discuss participation with any relevant parties, including friends, relative, and
the experimental investigators. While the sample of individuals approached to take part did
include persons known to the researchers no participant was involved in a dependent
relationship with either of the investigators.
Prior to giving consent to participate, volunteers were informed that for taking part in the
study they would receive a cash payment of £50.00. As a result of the number and length of
testing sessions participants were required to complete for this investigation, this payment
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was given as a means to cover expenses incurred as a result of participation. Participants
were further advised that they would receive a proportion of the expenses payment for each
phase of the study that they completed, i.e. £10.00 for the pre-test session and £20.00 for each
functional imaging session. It was thought that be allocating the payment in this manner,
rather than giving a single payment for completing all stages, would prevent participants
from feeling under an obligation to complete the study in order to obtain the payment
Given that this experiment involved giving anti-depressant medication to a non-clinical
population, a stipulation of ethical approval was the provision of information regarding
participation to each participant's general practitioner. The reasons for this were twofold.
Primarily, this measure was included so as to alert GPs to the participation of their patients,
in order that they could notify the investigators of any medical reason for individuals not to
take part in the study. The second reason for this approach was the desire to ensure that
details of participation were appended to an individual's medical records. Therefore, if
during the course of the study or in the future there was any medical relevant outcome
relating to the consumption of the medication used in the investigation then the participant's
doctor would have prior knowledge of the situation.
Once all the necessary information had been obtained from each individual participant a
letter was sent to his or her GP (see Appendix 2). A copy of both the participant
information sheet and the consent form were attached to this letter. The letter informed the
GP that their patient had consented to take part in the study and briefly outlined what
would be expected of the participant. While GP's were not asked to provide the researchers
with any clinical information about the participant they were requested to let the
experimenters know if they had any concerns about their patient participating in the study.
6.2.2 Participant details
From those individuals who volunteered for participation, a sample of ten healthy, right-
handed participants were chosen for participation, based on their ability to meet the relevant
criteria for inclusion (i.e. 3 male and 7 female participants). Prior to participation these
individuals were allocated to one of two experimental cohorts, i.e. Group A or Group B. The







Mean (s.d) IQ: Mean (s.d)
Years ofeducation: Mean
(s.d)
Group A (5) 1/4 25.6 (2.7) 106.2 (8.0) 15.2 (1.9)
Group B (5) 2/3 23.6 (4.3) 105.8 (8.7) 15.0 (2.7)
Total (10) 3/7 24.6 (3.6) 106.0 (7.9) 15.1 (2.2)
Table 6.1: Demographic details of participants - Experiment three.
6.3 Materials (see Appendix 2)
6.3.1 Recruitment materials
The information pack given to individuals who expressed an interest in participation
contained a copy of each of the following forms:
(a) Exclusion Criteria List
In order to ensure that participants were aware of the criteria for participation they were
given a list of all experimental exclusion criteria (as previously outlined). This list detailed
the physical and psychological criteria that participants were required to meet in order to be
suitable for participation in experiment three.
(b) Information Sheet for Participants
The information sheet prepared for this experiment detailed the aims of the study, the
methods of investigation, and the requirements of participation. The information sheet also
explained what would be expected of individuals who did participate in the project and the
possible effects that participation may have on them
(c) Medication Information Sheet
Although the information sheet for participants did highlight the potential side effects of
taking the anti-depressant medication, participants were also provided with a separate
information sheet containing information relating specifically to the recognized side effects
of escitalopram.
The medication information sheet gave details about the medication that would be used in
the study, i.e. escitalopram, and listed the most commonly experienced side effects
associated with its prescription. The information regarding the previously documented side
effects was adapted from information obtained from the website of company involved in the
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manufacture of escitalopram oxalate in the United States (i.e. www.lexapro.com; accessed
25/10/2002). The information given here not only detailed potential side effects, the
comparative incidence of these side effects in individuals taking escitalopram and those
taking placebo medications were also noted.
(d) Statement on Compensation Arrangement
In order to ensure that participants were completely aware of the compensation policy
associated with the sort of investigation, a separate form was included which outlined the
conditions of compensation for participants involved in research at the University of
Edinburgh. This form was included as part of the requirements of the relevant ethics
committees.
(e) Consent Form
Each information pack also included two copies of the consent form for this study, i.e. one
for the participant to keep and one to be returned to the investigators. This consent form
asked participants to confirm that they had read the information provided and that they
were willing to participate in the project based on this information. It confirmed to
individuals that participation in the study was voluntary, and that they were free to
withdraw at any stage, without giving a reason, and without their legal or medical rights
being affected. In addition, the consent form also asked participants to acquiesce to the
provision of details of their participation to their GP prior to taking part, and to
acknowledge that if necessary their GP would be alerted to the acquisition of clinically
salient information during the course of the investigation.
A practical requirement of the recruitment procedure was the acquisition of personal
information from participants. Therefore, a copy of each of the following forms was also
included in the information pack. Participants were asked to complete each form and return
it, with their consent form, to the investigators.
(f) GP Information Sheet
On this form, participants had to complete name and contact details for their current GP.
(g) Personal Details Form
This form asked individuals to give their name and current contact details.
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Each individual was also asked to provide details of their availability, outlining the dates
and times which they were available for testing. In conjunction with the details of time and
availability limitations of scanning sessions, the availability information for each participant
was used to allocate participants to experimental cohorts.
The final pre-test measure was a medical history questionnaire (see Appendix 2). Given
that it was essential for participants to meet the same inclusion criteria as control
participants in the second investigation of this series, the same version of the medical history
questionnaire that was developed for experiment two was also used in this study.
6.3.2 Behavioural measures
The following sections of this chapter detail those affective and cognitive measures that were
employed in experiment three. More in-depth details of the nature and administration of
measures that were used in this study, which were also employed in experiments one and
two, can be viewed in Chapter 2.
6.3.2.1 Affective assessments
In order to ensure that the results of all of the investigations, which comprised this project,
were consistent and comparable in their data acquisition, the same affective assessments that
were employed in the previous studies were also used in this study.
Thus, the presence/absence of significant current depressive symptomology in participants
at the time as test was assessed using the Beck Depression Inventory (Beck et al., 1961) was
used. While, the Stress Arousal Checklist (Mackay et al., 1978) was used to measure state
stress and arousal, and the Alderley Park State Anxiety Questionnaire (Walker, 1990) was
employed as a measure of state anxiety.
6.3.2.2 Cognitive assessments
National Adult Reading Test (Nelson & Willison, 1991)
The NART was employed in order to estimate full scale WAIS-R IQ in eight of the
participants in the group. However, the remaining two participants both identified
themselves as being dyslexic. Despite the fact that both participants asserted that the level of
impairment they experienced was relatively small, it was assumed that the NARTmight not
provide the most accurate measure of IQ for these individuals. Given that participants were
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already being asked to commit to relatively long testing session it was decided that
conducting a full WAIS-R testing session would be out of the question. Therefore, a
previously used short-form of this IQ test was used instead. The details of this form are as
follows:
Four-Test Short Form WAIS-R
The short-form of the WAIS-R used in this investigation was developed by Reynolds,
Willson & Clark, (1983) as an alternative to the full WAIS-R testing session. Although there
are many different types of short-form WAIS-R assessments that have been conducted, each
using a different selection of subtests, this particular variation provides an estimate of full
scale IQ based on performance on four of the WAIS-R subtests, i.e. 'Information', 'Picture
Completion', Arithmetic', and 'Block Design'.
This form of abbreviated WAIS-R was chosen for this investigation as it has previously been
shown to have a reasonable level of validity. For example, IQ estimates based on Reynolds et
al.'s (1983) short form of the WAIS-R were shown to not differ significantly from the actual
full scale IQ in a population of adults with mild to severe traumatic brain injury (Guilmette
et al., 1999). Thus, it was assumed that this form would not only allow for a significant
reduction in testing time, but would also enable an accurate estimate of full scale IQ in those
participants who had been identified as dyslexic.
Test of Everyday Attention (Robertson et al., 1994)
The same subtests of the TEA that were used in the previous two experiments were also
used in experiment three, i.e. visual elevator and elevator counting with distraction. These
tests were included as measures of selective attention, cognitive flexibility and auditory
verbal working memory.
n-back task
The same version of the n-back paradigm that was developed for the scanning sessions in
experiment two was also used in the experimental sessions of the current study. However, a
new practice version of the task was created, which was designed to take account of the
increased time involved in completion of the stages of this experiment, compared to the
testing sessions of experiments one and two.
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Although we already had the version of the task that was used in experiment one it was felt
that this particular form was rather lengthy for the purposes of this study. There were two
reasons for this. Primarily, participants were already being asked to give up a significant
amount of their personal time and we were keen not to unnecessarily increase this amount
of time. Secondly, given that participants would have to complete the task inside the
scanner on two separate occasions it was decided it would be best to minimise exposure to
the task in order to prevent both significant practice effects and potential boredom with the
task. Therefore, a practice version of the n-back task was designed with the specific purpose
of reducing the time taken to complete participant pre-testing.
Essentially, this was achieved by halving the number of trials of each level of n-back seen in
the original version of the task, i.e. subjects were presented with five blocks each of 1-, 2-,
and 3-back conditions interspersed with blocks of 0-back. As with the version of the task
used in the pilot study each block of n-back only began when participants pressed the
'space' bar. Therefore, the practice run of the task was self-paced, with a minimum run time
of approximately 15 minutes.
Rey Auditory Verbal Learning Test (RAVLT; Rey, 1964; Majdan, Sziklas & JonesGotman,
1996)
In addition to the other cognitive assessments, a novel measure of cognitive function was
included in this study, i.e. the RAVLT (Full details of the administration, scoring, and norms
of the RAVLT can be found in Spreen, 1998). The RAVLT was employed in this study in
order to assess the potential impact of the administration of escitalopram on factors
pertaining to memory and learning. Indeed, this particular measure of has been designed to
assess immediate memory span, novel learning, susceptibility to interference, and
recognition memory (Spreen, 1998).
The variation of the RAVLT that was used was developed by Madjan and colleagues (i.e.
Majdan et al., 1996), and consisted of two lists of 15 nouns each (i.e. List A and List B). The
researcher read aloud the nouns on the first list (i.e. List A), pacing the speed at which they
read in order to ensure a 1 second interval between each noun. After the last noun had been
read participants were given a free-recall test, i.e. they were asked to recall as many items as
they can from the list. The same procedure was then repeated until participants have
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completed five consecutive trials. Once the fifth trial has been completed participants are
read an 'interference' list (i.e. List B), and were asked to recall as many items as they could
from this list. Immediately following the free-recall of List B participants were given a free-
recall test of the items on List A. After an interval of 20 minutes participants were presented
with a list of 50 nouns, containing all items from Lists A and B, and a number of distractor
items. Participants were then asked to highlight those items that they recognised from List A
only.
There are a variety of measures that can be obtained from the RAVLT, e.g. raw score,
number of errors, type of errors etc. However, in this instance participants were allocated a
score based on the total number of items correctly recalled/recognised at each stage of the
assessment. While the number and types of errors that participants make are also noted
they were not used in any of the data analyses in this study.
In order to ensure that there was no confounding effect of practice or long-term memory on
participant's results in their second testing session, two different forms of this measure were
used in the current investigation (i.e. Form 1 and Form 2; see Appendix 2).
Anti-depressant medication
There were two criteria for the choice of antidepressant medication that was used in
experiment three. Primarily, it was felt that the type of medication used should be an
accurate reflection of the types of medication that were being taken by patients in
experiment two, in order to make the findings of the two studies more comparable.
Secondly, ethical considerations dictated that the choice of medication should be one that
would be less likely to induce negative side effects. Therefore, the medication that was
chosen for experiment three was a selective serotonin reuptake inhibitor, escitalopram (also
known as 'Cipralex' (UK) or 'Lexapro' (USA)). Escitalopram is the pure S-enantiomer
(single isomer) of the racemic bicyclic phthalane derivative citalopram (see Figure 6.1).
Escitalopram is a more modern medication than its parent compound, and as such can be
administered in lower effective doses and has reduced side effects. These qualities have







Figure 6.1: Chemical structure of escitalopram
Escitalopram is normally administered a film coated, round tablets containing escitalopram
oxalate in strengths equivalent to 10 mg and 20 mg escitalopram base. Participants in this
study were prescribed lOmg tablets. Although this dose is greater than the minimal effective
dosage of 5 mg, it was felt that as a subacute administration method used in this study, this
slightly higher dose would be more representative of the dose levels seen in patients. The
tablets given to participants also contained the following inactive ingredients: talc,
croscarmellose sodium, microcrystalline cellulose/colloidal silicon dioxide, and magnesium
stearate.
Scanner specifications
All participants were scanned in a 1.5 T GE Signa MRI scanner, which was located at the
SHEFC Brain Imaging Research Centre, at the Western General Hospital, Edinburgh.
BOLD sensitive echo planar fMRI images were acquired with a TR of 2.5 seconds, and a TE
of 40 milliseconds. The flip angle was 90°, with a field of view of 24 cm. In addition, the in
plane resolution was 64 x 64, with a plane orientation that was near axial. All functional
scans were 5mm in thickness with no slice gap, thus a total of 30 slices were obtained. Data
was acquired over two functional sessions, with each functional acquisition being 18
minutes 55 seconds in length.
T2 and T1 weighted structural images were also obtained for each participant. The scanning
parameters used for these structural acquisitions were identical to those employed in the




As noted, individuals who expressed an interest in participation were given an information
pack a minimum of 48 hours prior to participation. If participants were able to confirm that
they met all of the criteria for inclusion in the study and had read both of the information
sheets, they were asked to complete the three consent forms, the GP information sheet, the
availability form, and the personal details form. They were advised to retain one copy of the
consent form and the information sheets for their own records and to return all other
completed forms to the researchers.
Following completion of each of these pre-test measures participants were allocated to one
of the two experimental groups (i.e. five each to Group A and Group B). Although it would
have been ideal to randomly allocate participants to their sub-groups the relatively small
number of participants and the difficulties associated with scheduling, for both parties,
meant that participants were largely allocated to groups based upon the personal availability
and the availability of the scanner for testing.
Given the potentially sensitive nature of the data that was collected from participants, prior
to commencing the affective and neuropsychological assessments individuals were
reassured that all information about them that was acquired during the course of the study
was entirely confidential and that all data would be coded in such a way as to make their
individual contributions to the data set undecipherable to any persons other than the key
investigators.
6.4.2 Procedure: Group A
6.4.2.1 Phase 1: Pre-scanning assessment
Initially individuals in Group A were invited along for a preliminary assessment phase. For
participants in this group this initial assessment occurred on the same day as the first
scanning session, prior to commencement of scanning (i.e. Day 1). The assessments that
participants completed during this session were as follows:
Pre-test measures
They were asked to complete the medical history and pre-scan questionnaires, in order to
confirm their suitability for participation.
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Affective assessments
Following completion of the pre-test measures, participants undertook the necessary
affective assessments, i.e. the BDI, the SAC, and the APSAQ. Although all participants were
asked to confirm that they had no history of psychiatric illness the BDI was used to indicate
whether, or not, there was any significant current level of depressive symptomology. Based
on the standard rating procedures, a score of 9 or more on this assessment at this stage was
deemed to be indicative of a mild level of depression, and therefore a reason to
automatically exclude an individual from participation. The other affective measures were
simply used to give an indication of state stress, arousal, and anxiety.
These measures were completed at this initial stage in order to provide a baseline measure of
current affective state, which could then be compared to the affective state of participants in
the post-medication condition.
Cognitive assessments
Each individuals WAIS-R full scale IQ was estimated using one of the two methods outlined
above. Completion of the IQ assessment was followed by the two TEA subtests, and the
initial stages of the RAVLT.
The practice version of the n-back task then served as a distracter task between the initial
recall and later recognition phases of the RAVLT. After a period of at least 20 minutes
participants were then asked to complete the RAVLT.
Prescription of medication
Following completion of the various cognitive measures participants met with a medical
practitioner in order to obtain their course of medication. Participants were provided with 7,
10 mg escitalopram oxalate tablets. They were advised to consume one tablet per day for the
next seven days, i.e. commencing the course of medication on the day following the initial
assessment and primary scan phases.
It confirmed with participants that they understood the nature of the medication they
would be taking and that they knew of no reason why they should not take the medication.
Furthermore, they were provided with 24-hour contact details, which they were advised
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they should use to contact the researchers if at any point during the study they felt unwell or
had any concerns.
6.4.2.2 Phase 2: Medication free scan
As already noted above, the first scanning session for individuals in Group A occurred on
the same day as the pre-scanning assessment. Therefore, all the necessary pre-scanning
affective and cognitive assessments had already been completed prior to scanning.
The scanning protocol in this experiment was identical to the protocol in experiment two
(see Chapter 4 for details). In brief, participants completed two BOLD EPI functional MRI
sessions, each lasting 18 minutes 55 seconds. During each session they completed a number
of blocks of each of the various levels of the n-back task. In addition to the attainment of the
functional imaging data, T1 and T2 weighted structural images were also acquired for each
participant.
6.4.2.3 Phase 3: Post-medication scan
On the day that participants took the final dose of escitalopram (i.e. Day 8), and not longer
than 6 hours after they had taken the last tablet, they attended for their second scanning
session.
Prior to scanning participants again completed each of the affective and cognitive
assessments that they had undertook in their first experimental phase (with the exception of
the NART/WAIS-R). Participants first of all completed the initial free recall (both repeated
and interference tests) phase of the RAVLT, i.e. using the second, previously unseen version
of the task. In order to provide individuals with some sort of distracter task, this initial
phase was followed by each of the affective assessments and the two TEA subtests. After an
interval of at least 20 minutes, and completion of the other measures participants were
presented with the recognition phase of the RAVLT.
Additional information obtained from participants at this point included details of the time
at which they had taken the final dose of escitalopram, any side effects they had experienced
while taking the medication, including the frequency and duration of these side effects, and
how severe they felt these side effects to be.
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Blood sampling
On the day of the second scan, and prior to scanning, participants provided a blood sample
(lOmL), which was collected by venipuncture (ante-cubital vein) into lithium heparin. The
date and time of sampling were recorded. Plasma was separated by centrifugation and the
plasma was stored in clearly labelled tubes at -20°C. Plasma was later analysed for total S-
citalopram and total N-desmethylcitalopram (norcitalopram) using high-performance liquid
chromatography. This procedure was carried out by Dr Edgar Spencer and his team at
Guy's and St. Thomas' Hospital, London, UK.
After they had provided the necessary blood sample, participants underwent the second
scanning session. The protocol for this session was exactly the same as for the first session,
with the exception that there was no practice phase inside the scanner.
6.4.3 Procedure: Group B
While the procedure of each of the individual phases, i.e. initial assessment phase,
medication-free phase, and post-medication phase, was identical for participants in Group B,
the phase order was altered.
On day 1, participants attended for the initial assessment phase, after which they were given
their prescription of escitalopram, i.e. lOmg/day for 7 consecutive days. On day 8 (i.e. the
final day on which they took the medication) they attended for their 'post-medication' scan.
A further 7 days later (i.e. day 15) they attended for their 'medication-free' scan.
6.4.4 Data analysis
Full details of the analyses conducted on both the behavioural and functional data can be
seen in Chapter 7. However, in brief, the main analyses were as follows:
6.4.4.1 Behavioural Data
The behavioural data were analysed using SPSS for Windows (Release 11; SPSS Inc.). The
main analyses were two 4x2x2 within group ANOVA's, which considered the effect of
level of difficulty of the n-back task (i.e. 0-, 1-, 2-, or 3-back), medication status (i.e.
medication-free vs. post-medication), and imaging session (i.e. scanning session 1 vs.
scanning session 2), on both accuracy (i.e. mean percentage correct) and reaction time.
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Independent samples t-tests were conducted to compare the performance of participants
between experimental phases (i.e. medication-free vs. post-medication), using the data
acquired for each of the additional cognitive and affective assessments administered to
participants at each stage.
6.4.4.2 Functional Imaging Data
All functional data were processed and analysed using SPM99
(http://www.fil.ion.ucl.ac.uk/spm/). With respect to the preprocessing of functional imaging
data, the same realignment, normalisation and smoothing parameters as were employed in
experiment two were used here (see pp 132-133 for details). The only notable difference in
the preprocessing of imaging data in experiment three was that participants' EPI images
were not co-registered to their T1 structural images. Instead, they were normalised to the
SPM99 EPI template image, omitting a separate co-registration step in preprocessing.
Fixed effects analyses were initially calculated for individual participants in order to
determine linear increases and decreases in cortical activation in individual voxels
associated with the linear increase in the level of difficulty on the n-back task. Fixed effects
contrasts were also constructed for the each of the experimental conditions, i.e. medication-
free and post-medication. Moreover, fixed effects analyses were conducted in order
compare these experimental conditions in terms of relative differences in increases and
decreases in activation associated with increasing task difficulty.
The fixed effects contrasts for each participant were also used to determine the regions of
significant cortical activation in a random effects model of the functional activation
associated with both of the within subjects factors of interest, i.e. level of task difficulty and
experimental condition.
6.4.5.3 Examination of structural images
Although, the structural imaging data was not used for volume calculations, the T1
structural images of all participants were examined for any evidence of significant structural
abnormalities.
181
Chapter 7: Results - Experiment Three
7.1 Results of blood sample analysis
Each participant was required to provide a blood sample prior to their post-medication scan,
and after they had taken their final dose. It was ensured that the time of consumption of the
last dose of medication was no longer than six hours before scanning (i.e. mean = 230
minutes, s.d. = 78.59 minutes, minimum = 115 minutes, maximum = 340 minutes).
Blood plasma separated from each sample obtained was analysed for concentration of total
S-citalopram and total N-desmethylcitalopram (norcitalopram), using high-performance
liquid chromatography. The results of this analysis are detailed in Table 7.1 below. All



















Table 7.1: Concentration of citalopram and desmethylcitalopram detected in blood serum
samples from participants in experiment three. (Note: nd = not detected, concentration
below limit of accurate measurement of 10 pg/L).
7.2 Behavioural Results
7.2.1 Affective Assessments
Paired samples t-tests on each of the affective measures revealed that medication had no
effect on mean BDI score (i.e. t <9> = -1.60, p = 0.145), mean stress score (i.e. t (9) = 1.08, p =
0.155), nor mean arousal score (i.e. t (9) = -0.36, p = 0.365). However, there was a significant
difference between medication-free and post-medication scores on the APSAQ (i.e. t <9> = -
2.17, p = 0.029).
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Table 7.2: Mean scores and distribution of scores on each of the affective measures in
experiment three: Medication free vs. post-medication
In order to determine whether these results were the result of the medication or whether
there was a confounding effect of scanning session (i.e. first vs. second scan irrespective of
medication status), further paired t-tests were carried out.
The results of this additional set of analyses were also indicative of no effect of scanning
order on measures of depression (i.e. BDI: t (9) = 1.60, p = 0.145), stress (i.e. t (9> = 0.51, p =
0.619), or arousal (i.e. t (9) = -0.12, p = 0.909) scores. In addition, there was no observed
significant difference between the average scores for participants on the APSAQ between the
first and second test sessions, irrespective of medication status (i.e. t (9) = 0.78, p = 0.456).
Therefore, it can be concluded that subacute administration of escitalopram had no
significant effect on the presence of depressive symptoms in participants. Similarly,
escitalopram appeared to have little or no effect on the level of state stress or arousal that
participants experienced on each of the testing occasions. However, the converse was found
to be true for levels of state anxiety. Indeed, the consumption of escitalopram for 7 days
resulted in an increase in state anxiety in participants, as indicated by the relative increase in
APSAQ scores between the medication free and post-medication testing sessions. The
failure to find a significant difference in the average APSAQ scores between first and second
scanning trials, without regarding medication status, indicates that the increase in anxiety in
attributable to the administration ofmedication, rather than an effect of repeat testing.
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7.2.2 Test of Everyday Attention
Additional paired samples t-tests were carried out in order to compare the relative
performance of participants in the medication-free and post-medication experimental
conditions on each of the measures of TEA subtests used in this study.
7.2.2.1 Elevator counting with distraction
The administration of escitalopram had no effect on the performance of participants on the
elevator counting with distraction task. This was true for both the raw and scaled accuracy
scores on this measure (i.e. t (9) = -0.56, p = 0.591 and t p> = -0.74, p = 0.479, respectively).
7.2.2.2 Visual elevator
7.2.2.2.1 Accuracy
As with the elevator counting with distraction task, there were no significant differences in
participant performance in medication-free and post-medication conditions on the accuracy
measure on the visual elevator subtest. Again, this was observed in the analysis of both raw




Med Free Post Med
Medication Status
Figure 7.1: Comparison of mean scaled scores for the elevator counting with distraction and
visual elevator tasks - Experiment three: Medication free vs. post-medication condition.
7.2.2.2.2 Timing
Similarly, the experimental manipulation of medication status did not have a significant
effect on the timing score on the visual elevator task. A series of t-test analyses revealed no
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significant difference between conditions in the mean time (in seconds) per attentional
switch (i.e. t <9> = -0.963, p = 0.361), nor in the mean scaled score for reaction time (i.e. t <9> =










Figure 7.2: Mean reaction time (seconds) per
attentional switch on the visual elevator task -
Experiment three: Medicaion-free vs.






Figure 7.3: Mean scaled score on the visual
elevator task - Experiment three: Medication-free
vs. pos-medication condiions (i.e. N = 10)
To determine that there was no confounding effect of the order of testing session on the
outcomes of the previous statistical analyses, first and second session scores for each of the
TEA subtests were compared for differences in mean score, irrespective ofmedication status.
The results of these paired samples t-tests were indicative of no significant difference
between first and second scanning sessions on the accuracy measures on both the elevator
counting with distraction and visual elevator tasks, i.e. for raw and scaled scores.
While there was evidence of a significant difference between the first and second test
sessions for the raw timing score on the visual elevator task (i.e. t (9> = 4.147, p = 0.002), the
comparison of scaled timing scores was non-significant.
Therefore, it may be concluded that the administration of escitalopram to normal healthy
volunteers had no significant effect upon the cognitive performance of participants on
measures of selective attention, cognitive flexibility, and auditory verbal working memory.
Although there was an indication that there may have been an order effect of testing session
on the psychomotor function of participants, based on observed differences in raw timing
scores, analysis of the scaled scores revealed no difference. Thus, suggesting that the
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psychomotor performance of participants was consistent between experimental conditions,
and between first and second test sessions, irrespective of medication status.
7.2.3 Rey Auditory Verbal Learning Test
The first analyses carried out on the RAVLT data were designed to ascertain whether there
was a significant difference in the mean number of items recalled on each learning trial
between medication-free and post-medication conditions. The results of these analyses (i.e.
paired samples t-tests) were indicative of analogous performance of participants between
the experimental conditions on each of the learning trials of the RAVLT. In addition, there
was no significant effect of medication status on the mean number of items recalled on the
other measures on this task, i.e. interference, delayed recall, and recognition trials.
The number of items recalled is not the only measure of performance that can be derived
from data obtained during performance of the RAVLT. An additional measure that is
available to investigators is the effect of interference - i.e. the effect of the interference trial
list on recall in the subsequent recall condition. The degree of interference experienced by
participants is a further indicator of the level of difficulty experienced by participants during
performance of the task. Therefore, further analyses were conducted in order to determine
whether escitalopram had any significant impact on this interference effect.
The difference between scores on trial 5 and the delayed recall trial were calculated for each
participant, for medication-free and post-medication test sessions. A paired samples t-test
was then conducted to determine whether there was any significant difference between
experimental conditions. However, the results of this analysis were indicative of no
significant difference in interference in the different experimental conditions (i.e. t (9) = 0.10, p
= 0.924).
As with the other measures, a series of paired samples t-tests were carried out to determine
whether there was any significant effect of test session on participants' scores on the RAVLT,
irrespective of medication status. While there were no significant differences observed
between first and second session test scores for the five learning trials on the RAVLT, there
was a significant difference in the number of correctly recalled items between the first and
second sessions on the delayed recall and recognition trails (i.e. t (9) = 3.431, p = 0.008 and t <9>
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= 2.433, p = 0.038, respectively). In both instances the number of items correctly recalled was
greater in the first test session. However, if we correct for multiple comparisons, using a
Bonferroni correction, then this latter significant finding should be deemed non-significant.
Thus, indicating that the only significant effect of test session is on the mean number of
items correctly recalled in the delay recall trial of the RAVLT.
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Interference trial Delayed trial Recognition
RAVLT Condition
Figure 7.4: Mean number of items correctly recalled at each stage of the RAVLT task -
Experiment three: Medication free vs. post-medication test conditions (i.e. N = 10).
Therefore, while it would appear that the course of escitalopram taken by the participants
had no effect on either verbal learning or on interference, it does seem that there was an
effect of session on the delayed recall of verbal material. However, rather than exhibiting a
positive practice effect with repeated testing, participants performance on the levels of the
task that tested retention of items was impaired by repeated exposure to this test.
7.2.4 n-back task
In order to establish the effect of medication status on performance on the n-back task (i.e.
both accuracy and reaction time) two 2x2x4 (i.e. medication status, scan session, and level
of n-back) within-subject ANOVAs were carried out.
7.2.4.1 Accuracy
Although there was further evidence in this experiment of the significant main effect of the
level of difficulty of the n-back task (i.e. F <1.475,13.274) = 8.260, p = 0.008), the initial ANOVA
analysis revealed no significant main effect of medication status on performance accuracy on
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the n-back task (i.e. F <i,9> = 0.02, p = 0.808). Moreover, there was no significant main effect of
scanning session (i.e. F (1,9) = 0.69, p = 0.428), and no significant interactions between any of
the factors of interest.
With regards to within-subjects contrasts, there was a significant linear contrast associated
with the level of difficulty of n-back (i.e. F <i,9) = 12.32, p = 0.007). Furthermore, the reverse
Helmert contrasts between 1- and 0-back, 2- and 1-back, and 3- and 2-back levels of task
difficulty were all statistically significant (i.e. F <i,9> = 5.25, p = 0.048, F <i,9) = 11.02, p = 0.009, F
(i,9) = 8.44, p = 0.017). All other within-subjects contrasts failed to reach statistical
significance.
Post-hoc paired sample t-tests revealed a significant difference between mean performance
between 0- and 1-back levels of the task (i.e. t (9> = 2.29, p = 0.024) and between the 2- and 3-
back task levels (i.e. t <9> = 2.46, p = 0.018), but no significant difference between the
performance outcomes of participants on the 1- and 2-back task levels (i.e. t (9) = 1.50, p =
0.0845). However, if we correct for multiple comparisons using the Bonferroni method of
correction, then all post-hoc findings associated with accuracy outcomes between the levels
of n-back fail to reach significance.
7.2.4.2 Reaction time
The second within subjects ANOVA for performance on the n-back task (i.e. reaction time)
was also indicative of no significant main effect of medication status (i.e. F (i,9> = 0.09, p =
0.766). On the other hand, there was a significant main effect of the level of n-back (i.e. F(i.726,
15.538) = 48.67, p <0.001) and a significant main effect of scanning session (i.e. F (i,9) = 9.47, p =
0.013). Moreover, the interaction between these two factors was also significant (i.e. F <3,27) =
6.83, p = 0.001).
Significant linear contrasts were noted for session (i.e. F (1,9) = 9.47, p = 0.013), level of n-back
(i.e. F (i,9) = 73.61, p <0.001), and for the interaction between these factors (i.e. F (1,9) = 16.29, p =
0.003). There was also a significant quadratic contrast for the level of n-back (i.e. F (1,9) =
19.35, p = 0.002) and significant reverse Helmert contrasts between 1- and 0-back (i.e. F (1,9) =
32.89, p < 0.001), between 2- and 1-back (i.e. F 0,9) = 52.98, p < 0.001) and between 3- and 2-
back (i.e. F (1,9) = 77.50, p < 0.001).
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N-back
Figure 7.5: Mean percentage correct at each level of n-back - Experiment three: Medication
free vs. post medication conditions (i.e. N = 10)
N-back
Figure 7.6: Mean reaction time (ms) at each level of n-back - Experiment three: Scanning
session 1 vs. session 2.
In order to determine the nature of these significant effects, the mean reaction time for
session 1 and session 2 across both scans was calculated, and a series of paired samples t-
tests were carried out.
A significant difference between the mean reaction times for 0-back between session 1 and
session 2 was noted (i.e. t <9> = 4.74, p = 0.001). It was found that participants' reaction times
for 0-back stimulus items in session 2 were quicker than in session 1. Nonetheless, there was
no significant difference noted between sessions 1 and 2 for the other levels of n-back.
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Paired samples t-tests were also conducted to compare the mean reaction time for each level
of n-back, irrespective of medication status and scanning session. Significant differences
were observed in mean reaction time between 0- and 1-back (i.e. t p> = 5.74, p < 0.001),
between 1- and 2-back (i.e. t (9) = 3.20, p = 0.011), and between 2- and 3-back (i.e. t (9> = 5.80, p <
0.001). These results were still statistically significant after correction for multiple
comparisons (i.e. Bonferroni).
In order to determine whether there was any effect of test session, irrespective of medication
status, two 2x4 within-subject ANOVAs were carried out, in which the factors of interest
were scanning session (session 1 vs. session 2) and level of n-back. As with the main
ANOVA analyses, one analysis considered the effect upon percentage correct, while the
other looked at reaction time.
These analyses revealed a significantmain effect level of n-back on both accuracy (i.e. F (3,27) =
11.62, p < 0.001) and reaction time (i.e. F <1.779,16.012) = 53.86, p < 0.001). However, there was no
significant main effect of test session, and no interaction between these two factors.
With regards to the main factor of interest in this study (i.e. medication status), it can be
concluded that the consumption of escitalopram had no significant effect on either the
accuracy or reaction times of participants on the n-back task. Therefore, implying that the
subacute administration of SSRI medication had no impact upon the integrity of working
memory function in a sample of normal healthy adults.
However, the level of difficulty of the n-back task had a significant effect on both accuracy
and reaction time, irrespective of medication status or scanning session. More specifically,
participant's accuracy declined between the baseline level of the task (i.e. 0-back) and the
first of the working memory levels of the task, and between 2- and 3-back levels. This
decline in mean percentage correct was accompanied by a relative decrease in reaction time.
Thus, implying an inverse relationship between perceived difficulty and psychomotor
performance, i.e. as the task got more difficult participants reactions to stimulus items were
faster.
190
7.2.5 Correlations with cognitive performance
7.2.5.1 Medication-free condition
Although there was no evidence of affective abnormality in the participants in either
experimental phase, with the exception of state anxiety, analyses were conducted in order to
determine whether there was any relationship between the affective state of participants in
the medication-free condition and performance on the various cognitive tasks.
The results of a series of bivariate correlations revealed that the only significant associations
between affect and cognitive performance in this study were a significant positive
correlation between score on the APSAQ and percentage correct on the 3-back level of the n-
back task (i.e. r = 0.73, p = 0.016), and between BDI score and number of items correctly
identified on the 'delayed recall' and 'recognition' levels of the RAVLT (i.e. r = 0.67, p = 0.034
and r = 0.67, p = 0.036, respectively). All other correlations failed to reach significance.
7.2.5.2 Post-medication condition
A similar series of correlations were conducted to compare the same measures in the post-
medication condition. Moreover, the concentration of citalopram as measured from the
blood plasma of participants was also included in these analyses.
Significant positive correlations were noted between post-medication BDI and number of
items correctly recalled on the second, third, fourth, and interference recall conditions of the
RAVLT (i.e. r = 0.80, p = 0.006; r = 0.75, p = 0.013; r = 0.72, p = 0.020; and r = 0.76, p = 0.011,
respectively), and between APSAQ score and the number of items correctly recalled on the
third and fourth recall conditions of the RAVLT (i.e. r = 0.77, p = 0.009 and r = 0.73, p < 0.016).
All other correlations between affective measures and cognitive performance in the post-
medication condition failed to reach statistical significance.
7.3 Structural imaging results
Examination of the structural scans (i.e. T1 weighted EPI) revealed no significant
abnormalities in any of the participants in this study. Therefore, all participants were
included in the analyses of the BOLD EPI functional imaging data.
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7.4 Functional imaging results
As with the previous study, all data were analysed using SPM99. Following spatial
transformation of the images fixed effects contrasts were calculated for each participant.
Contrasts were calculated for the changes in the level of activation across the cortex
associated with the linear increase in difficulty of the n-back task, i.e. block-design. Both
increase and decrease contrasts were calculated.
Random effects contrasts were calculated using the individual fixed effects contrasts. More
specifically, contrasts were calculated for the mean increases and decreases in activation
with the parametric increase in the level of difficulty of n-back for both within and between
conditions (i.e. independent sample t-test and ANOVA, respectively).
Significant clusters of activation were defined as those with a corrected probability level of
less than or equal to 0.05. Following identification of the significant clusters of activation the
co-ordinates of the local maxima of activation were converted from MNI to Talairach
stereotactic space, i.e. using the same non-linear transformation as in the previous
experiment. The neuroanatomical descriptions of the locations of the significant clusters
were determined using the Talairach Daemon Database.
The following sections summarise the outcomes of the imaging analysis pertaining to those
regions showing alterations in the level of activation with the increase in difficulty of n-back
in the medication-free and post-medication conditions, and the relevant differences between
conditions. However, full details of the results of the functional imaging data in this study
can be viewed in Appendices 3C and 3D.
7.4.1 Pattern of activation observed during performance of the n-back task: Medication-
free
With the linear increase in difficulty in the n-back task significant increases were noted in a
number of regions of cortex (see Figure 7.7). A significant cluster of increased activation was
observed in the left hemisphere in a region comprising both superior and inferior parietal
lobes (BA7/40; Ke/vo1. = 3064/24512 mm3, p < 0.001). In addition, a significant increase was
seen in bilateral activation in the middle and superior frontal gyri (BA6, 46 & 8; Ke/vo1. =
728/5824 mm3, p < 0.001; Ke/vo1. = 583/4662 mm3, p < 0.001; Ke/vo1. = 622/4976 mm3, p < 0.001;
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and Ke/vo1. = 118/944 mm3, p = 0.013) and in the right cerebellum (i.e. pyramis; Ke /vol.=
189/1512 mm3, p = 0.001).
Significant decreases were noted in medication-free participants in the left hemisphere in the
middle and inferior frontal gyri (BA11; Ke/vo1. = 92/736 mm3, p = 0.04), the superior frontal
gyrus (BA8; Ke/vo1. = 478/3824 mm3, p < 0.001 and Ke/vo1. = 102/816 mm3, p = 0.026), the
angular and middle temporal gyri (BA39/21; Ke/vo1. = 206/1648 mm3, p < 0.001), and in an
additional cluster of activation comprising the claustrum and the superior temporal gyrus
(BA 22/21; Ke/vo1. = 498/3984 mm3, p < 0.001). Significant decreases were also seen in the
right pre- and postcentral gyri (BA4; Ke/vo1. = 142/1136 mm3, p = 0.005), cerebellum (i.e.
oilmen; Ke/vo1. = 122/976 mm3, p = 0.011), and in the parahippocampal and superior
temporal gyri (BA35/38; Ke/vo1. = 1057/8456 mm3, p < 0.001). In addition, in the medication-
free condition there were a number of significant decreases in a number of inter-hemispheric
clusters. The local maxima of these clusters were as follows: lingual gyrus (BA18; Ke/vo1. =
2835/22680 mm3, p < 0.001), middle occipital gyrus (BA18; Ke/vo1. = 859/6872 mm3, p <
0.001), and the medial frontal gyrus (BA6; Ke/vo1. = 910/7280 mm3, p < 0.001).
7.4.2 Pattern of activation observed during performance of the n-back task: Post-
medication
Following the subacute administration of escitalopram, significant increases in activation
were noted the left hemisphere increased in the insula (BA43/52; Ke/vo1. = 256/2048 mm3, p <
0.001) and in a cluster involving the inferior and superior parietal lobules and the precuneus
(BA7; Ke/vo1. = 3767/30136 mm3, p < 0.001). Significant increases were also seen in the right
hemisphere in the insula and inferior and middle frontal gyri (BA43/52/47,9, & 6; Ke/vo1. =
205/1640 mm3, p < 0.001; Ke/vo1. = 62/496 mm3, p = 0.054; and Ke/vo1. = 556/4448 mm3, p <
0.001), and in two interhemisphic clusters - i.e. both comprising the superior and middle
frontal gyri (BA 10 & 6; Ke/vo1. = 333/2664 mm3, p < 0.001 and Ke/vo1. = 844/6752 mm3, p <
0.001).
Conversely, significant decreases in activation with increasing level of difficulty of n-back
were found in the left hemisphere in the middle temporal and angular gyri (BA39; Ke/vo1. =
242/1936 mm3, p < 0.001), the lingual gyrus (BA18; Ke/vo1. = 64/512 mm3, p = 0.048), and the
hippocampus (Ke/vo1. = 172/1376 mm3, p < 0.001). A significant decrease was also observed
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in the right hemisphere in cingulate gyrus (BA24; Ke/vo1. = 102/816 mm3, p = 0.004). As with
the clusters of increased activation, decreased activation was noted in interhemispheric
clusters, i.e. in the superior frontal gyrus (BA8; Ke/vo1. = 1779/14232 mm3, p < 0.001), the
cuneus (BA18/19; Ke/vo1. = 233/1864 mm3, p < 0.001), and the cingulate gyrus (BA24/31;
Ke/vo1. = 2016/16128 mm3, p < 0.001).
Figure 7.7: Statistical parametric map of voxels of increase activation associated with the
linear increase in difficulty of the n-back task in the medication-free condition - Experiment
three: Random effects.
Figure 7.8: Statistical parametric map of voxels of decreased activation associated with the
linear increase in difficulty of the n-back task in the medication-free condition - Experiment
three: Random effects.
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T value T value
Medication free: block design
Figure 7.9: Increased (red colour scale) and decreased (blue colour scale) activation
associated with the linear increase in difficulty of the n-back task in the medication-free
condition - Experiment three: Random effects. The patterns of activation have been
superimposed on a normalised, mean EPI image (details as before).
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Figure 7.10: Statistical parametric map of voxels of increased activation associated with the
linear increase in difficulty of the n-back task during the post-medication condition -
Experiment three: Random effects.
Figure 7.11: Statistical parametric map of voxels of decrease activation associated with the




T value T value
Post medication: block design
Figure 7.12: Increased (red colour scale) and decreased (blue colour scale) associated with
the linear increase in difficulty of the n-back task during the post-medication condition -
Experiment three: Random effects. The patterns of activation have been superimposed on a
normalised, mean EPI image (details as before).
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7.4.3 Comparison of the observed pattern of activation between medication free and post-
medication conditions
The random effects contrasts for the comparison of relative activation between the
medication-free and post-medication conditions revealed no clusters of statistically
significant different activation (see Figures 7.15 and 7.16). Yet, despite the lack of significant
random effects, the fixed contrasts revealed clusters of activation that were significantly
different between the two experimental conditions (see Appendix 3A for full details). Given
that participants acted as their own controls it is likely that the fixed effected differences
between conditions may reflect genuine medication related effects on cortical activation, but
which are effected by the reduced statistical power resulting from the use of a relatively
small sample, and by the increased conservativeness of the random effects analysis.
In the fixed effects contrasts, a significant increase was seen in gray matter in the left
hemisphere in a cluster which involved anterior cingulate and middle frontal gyrus (BA24;
Ke/vo1. = 280/2240 mm3, p = 0.008) - i.e. the level of activation in this region was relatively
more increased in participants in the medication-free condition compared to the post-
medication condition.
Conversely, a statistically significant relative decrease in the medication-free condition was
observed in the left middle occipital gyrus (BA19; Ke/vo1. = 195/1560 mm3, p = 0.040), the
right superior temporal gyrus (BA42; Ke/vo1. = 442/3536 mm3, p < 0.001), and the right
cerebellum (Ke/vo1. = 212/1696 mm3, p = 0.029).
Figure 7.13: Statistical parametric map of the voxels of relatively increased activation in the
medication-free compared the post-medication condition, i.e. associated with the linear
increase in difficulty of the n-back task - Experiment three: Fixed effects.
o
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Figure 7.14: Statistical parametric map of the voxels of relatively decreased activation in the
medication-free compared to the post-medication condition, i.e. associated with the linear
increase in difficulty of the n-back task - Experiment three: Fixed effects.
Figure 7.15: Statistical parametric map of voxels of relative increase in the medication-free
condition compared to the post-medication condition, i.e. associated with the linear increase








Figure 7.16: Statistical parametric map of voxels of relative decrease in the medication-free
condition compared to the post-medication condition, i.e. associated with the linear increase
in difficulty of the n-back task - Experiment three: Random effects.
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Additional analyses were conducted to aid the interpretation of the data outlined about. In
order to determine whether any effect observed between the two experimental conditions
was genuinely due to the effect of medication a random effects contrast was calculated
whereby participants first scan was compared with their second scan irrespective of
medication status. Furthermore, we sought to establish whether the failure to observe any
significant effects in the random effects comparison was the result of outliers in the data. In
order to achieve this an image was created for each participant that was equal to the
difference in activation between the medication-free and post-medication images for the
changes in activation associated with the parametric increase in difficulty of n-back. These
images were then utilised to calculate a one-sample t-test for the mean difference in levels of
activation between the two conditions, rather than comparing the means of the two
conditions, which would be readily distorted by outliers in the data set. Both of these
analyses revealed no statistically significant clusters of activation.
Therefore, the outcomes of the analyses of functional imaging data are indicative of a reliable
activation in areas cortex previously identified as being sensitive to manipulations in
working memory task, including a number of frontal and parietal regions. However, there
does not appear to be any significant effect of the subacute administration of escitalopram on
metabolic activity, as measured using BOLD fMRI, during performance of the parametric
working memory task. Nonetheless, the results of the fixed effects comparisons of
participants in the medication-free and post-medication conditions does indicate a potential
medication mediated effect on activation in the anterior cingulate, as well as more posterior
cortical regions.
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Chapter 8: Summary, discussion, and conclusions
8.1 Summary of experimental findings
The first section of this chapter will review and summarise the key observations from the
series of investigations that comprised this project. Given the volume of data resulting from
these studies, the outcomes of each separate study will initially be considered independently
of the others.
8.1.1 Experiment one
The main aim of the first experiment was to determine whether individuals with a diagnosis
of major depression would experience a deficit in working memory function, in comparison
to a sample of matched healthy controls. In addition, this study was also concerned with the
performance of depressed patients and normal controls on other measures of executive
function, including assessments of cognitive flexibility and selective attention.
Experimental limitations
Although both the HRSD and the BDI assessments were indicative of a significant level of
current depression in the patient sample in this study, it is important to recognise the
limitations imposed by not employing a structured diagnostic interview in order to establish
the psychiatric profile of patients. The reliance on the diagnosis of individual physicians
may have confounded the outcomes due to the possibility of individual differences in
diagnosis, and even the possibility of misdiagnosis. The use of a diagnostic interview may
have been useful in ensuring the reliability of the assertion that patients were indeed
suffering from MDD and may have aided in establishing the psychiatric homogeneity of the
patient sample.
In comparison to a number of previous investigations the patients who participated in this
study were relatively young, and on average appeared to be suffering from chronic
depression (i.e. the average length of current depressive episode = 13.9 months). Given the
potential limitations imposed by each of these factors, it is important to bear both of these
factors in mind when interpreting the outcomes of this investigation. Previous
investigations are indicative of a qualitative difference in the cognitive profile of different
age-based cohorts of depressed patients (e.g. Elliott, 1998). Similarly, there is the possibility
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of significant differences in the cognitive presentation of depressed patients based on the
duration and severity of illness (see section 1.1 for a review).
The lengthy duration of depressive episode and the relatively young age of participants may
be indicative of a comparatively young age of onset of first episode of depression in the
patients who took part in this study, which may also have had a significant impact on the
pattern of neuropsychological function noted in this group. The relevant background
literature does support the notion of a significant relationship between the age of onset and
performance on measures of executive function (i.e. Grant et al., 2001), thus making this of
particular concern in the interpretation of the findings of this study.
While both of these factors do not necessarily impact upon the reliability of the observations
made in this investigation, it is imperative to note that the relatively young age of the patient
sample and the chronic nature of their presentation may make the findings of this study
specific to this sub-group of depressed patients.
Affective profile
Depressed patients who were selected to participate in the experiment one were individuals
with a diagnosis of MDD. The results of the psychometric measures of depression used in
this study, i.e. the BDI and the HRSD, were indicative of a significant level of depression in
patients who participated in the experiment (i.e. mean score 33.25 and 23.90, respectively).
Moreover, the experience of major depression in patients was associated with a significant
increase in the subjective level of state stress, arousal, and anxiety (i.e. as determined by the
SAC and APSAQ affective indices).
The normal psychiatric state of the healthy volunteers was determined with the use of the
same affective assessments, with the exception of the HRSD. Levels of state stress, arousal,
and anxiety were also significantly smaller in the controls compared to the depressed
patients, and all controls scored within the 'normal' range of the BDI. Indeed, controls'
scores were almost exclusively in the normal range on all affective measures.
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Cognitive profile
The differences in the affective profile of the patients and controls were associated with a
range of discrepancies in performance on the measures of executive function that were
employed in experiment one.
Depressed patients were found to be significantly impaired in the accuracy measures of the
elevator counting and visual elevator subtests of the TEA. Thus, indicating a significant
depression associated dysfunction of selective attention, attentional switching, and cognitive
flexibility. Moreover, the average time taken to make attentional switches on the visual
elevator task was significantly increased in depressed patients, which was indicative of a
degree of psychomotor slowing associated with the experience ofmajor depression.
The primary measure of executive function in experiment one was the parametric working
memory task that participants were required to undertake, i.e. the n-back task. The
parametric increase in the number of items to be recalled on the n-back task resulted in the
predicted increase in the perceived difficulty of the task in both patients and controls.
Indeed, both post-hoc analyses and a priori contrasts revealed a significant decrease in
performance with each incremental increase in task difficulty in both experimental groups.
The effect of the level of difficulty of n-back was evident not only in the significant main
effect of n-back on the mean percentage of items correctly recalled at each level of task
difficulty, but also in the significant linear contrast for the effect of the parametric
manipulation of cognitive load on accuracy.
With regards to the relative performance of depressed patients and healthy controls on the
n-back task, there was an apparent depression associated deficit in accuracy on the n-back
task. This was evident in the lower levels of the number of correct responses in patients at
all levels of the task. The lack of a significant interaction between participant group and
percentage of correct items at each level of n-back was suggestive of a dysfunction in
working memory in depressed patients that was consistent in nature, i.e. the discrepancy in
the accuracy of patients and controls did not alter disproportionately as the difficulty of the
n-back task was increased.
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The disparity in the performance of depressed patients and controls was also evident in
participants' reaction times on the n-back task. There was a significant effect of affective
status on mean reaction time at each level of n-back, which was evident in the longer
reaction times of depressed patients, compared to controls, at all levels. In addition, there
was also a significant interaction between participant group and level of n-back, suggesting
a disproportionate effect of task difficulty on reaction time in the two experimental groups.
However, post-hoc analysis indicated that this interaction effect was the result of a relative
speeding up of responses in all participants between 0- and 1-back conditions of the task.
The post-hoc analysis of participants' reaction time data also aided in the interpretation of
the main effect of n-back that was observed in experiment one. The analysis failed to find a
statistically significant difference in the mean reaction times of all participants between the
subsequent levels of the task (i.e. 1- vs. 2-back, and 2- vs. 3-back). This observation suggests
that the noted main effect of n-back was the consequence of the discrepancy in reaction time
between the first two levels of the task, rather than an effect of the increase in cognitive load
across all tasks levels.
An important discrepancy that was identified in the profile of depressed patients and
controls was a significant difference in the mean NART estimated IQ scores of the two
participant groups. To determine the potential effect of this difference upon the previously
observed outcomes, the analyses for the n-back data were recalculated including estimated
IQ as a covariate.
The inclusion of IQ in the ANCOVA analysis did not effect the previously observed
depression associated deficit in terms of accuracy on the task, but did result in a failure to
observe a significant main effect of the level of difficulty of n-back. Post-hoc analysis of the
data revealed that there was only a significant association between mean accuracy on the 0-
back levels of the task and participant IQ, thus, suggesting that at baseline levels of the task
factors that are related to IQ may play a more significant role in participant performance
than aspects of executive function. All other correlations between the performance at the
additional levels ofN and IQ were not significant.
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Further post-hoc analysis of the relative performance of participants at each level of the n-
back task (i.e. one-way ANCOVAs, with IQ as a covariate) revealed that there was a
significant difference between the mean accuracy of depressed patients and controls at the 1-
and 2-back levels of n-back, and a trend towards a significant difference at the 3-back task
level. This observation indicates that the previously noted discrepancy in the performance
of patients and controls at the 0-back level of the task was confounded by factors related to
participant IQ, such as psychomotor ability.
Controlling for IQ in the analysis of reaction times on the n-back task produced a similar
pattern of results. The inclusion of IQ as a covariate in the analyses resulted in a failure to
find a significant main effect of n-back in both participant groups. However, if we consider
the findings of the previous analysis of average reaction time on the n-back task, this is
apparently only a reversal of the effect of n-back on reaction time on 0-back trials. There was
also a significant effect of depression on reaction time, despite controlling for IQ in this
analysis, in conjunction with a significant interaction between participant group and level of
difficulty of n-back. Post-hoc ANCOVAs revealed that the experience of depression had a
significant effect on reaction time, resulting in differences between patients and controls on
all levels of the n-back task, even after controlling for the discrepancies in the mean IQ of the
two groups.
The results of these analyses suggest that participant IQ is an important mediating factor in
performance of the n-back task, but only with respect to the performance accuracy of
participants at the 0-back level of task difficulty. The observation of an effect at this level of
the n-back task with the inclusion of IQ as a covariate of performance may be attributed to
the previously documented association between elementary factors of cognitive function -
such as psychomotor ability - and intelligence (e.g. Deary & Stough, 1996; Deary et al., 1997).
This implies that performance on the n-back task is at least partially related to the
psychomotor ability of the participant, which is in turn related to estimates of participant IQ.
Despite the confounding effect of IQ on performance, the mean differences between patients
and controls were not substantially affected by the inclusion of IQ as a covariate in the latter
data analysis, which indicates that the differences seen in patients and controls cannot be
explained by differences in psychomotor ability alone. If this were the case, then the
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ANCOVA analyses would have been anticipated to fail in finding a significant main effect of
participant group on measures of performance accuracy.
The final factor of consideration in the analyses of the cognitive performance of participants
in experiment one was the relationship between clinical variables and performance of
depressed patients on the executive measures that were used. Severity of depression (i.e.
BDI) was significantly negatively correlated with the performance of participants at the 3-
back level of the working memory task, thus, indicating that the relationship between
severity of depression and cognitive performance may only be of importance on more
difficult cognitive tasks.
The only other clinical variable that was found to have an association with cognitive
performance was the time between initial diagnosis and time of assessment. Significant
negative correlations were noted between this factor and the mean percentage of correct
items at the 2- and 3-back levels of the task in depressed patients. Given that the patients
who participated in this study were significantly depressed at the time of assessment, this
finding is indicative of a relationship between chronic depressive illness and performance on
working memory tasks. However, as with severity of depression, this effect seems to apply
only to the more difficult levels of the task.
Therefore, the results of experiment one were indicative of an impairment of working
memory function in adults with major depression. While the degree of depression
associated impairment may have been partially related to a dysfunction of psychomotor
ability, motor impairment was not sufficient to explain the discrepancy in the performance
of depressed patients and healthy volunteers. However, the effect of the manipulation of
cognitive load in the working memory paradigm that was used in this study was apparently
mediated to some degree by participant intelligence. Moreover, the linear increase in
cognitive load did not disproportionately affect the ability of depressed patients to perform
the n-back task, which suggests that the effect of cognitive load may not have been the
primary factor in the noted deficit in working memory of patients
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8.1.2 Experiment two
The experimental methodology employed in experiment two was designed to ascertain if the
performance of a test of working memory would be associated with a disparity in the
regions of cortical activation exhibited by depressed patients and healthy volunteers.
Although two sets of statistical analyses were conducted - one for all participants involved
in the study, and one for those participants who were included in the analysis of functional
neuroimaging results - the following summary is concerned with the general pattern of
results for depressed patients and controls in the first of these analyses.
The power of this study to detect genuine differences between the depressed patients and
healthy controls on behavioural measures was potentially reduced as a result of two main
factors. On one hand, there was the likelihood that differences in performance on measures
of executive function may be difficult to detect, or borderline for distinguishing between
depressed and non-depressed individuals. In addition, the relatively small number of
participants in experiment two (i.e. only ten for both experimental groups) further reduced
the power of the study to detect genuine behavioural differences between patients and
controls. Therefore, the determination of an accurate profile of cognitive function associated
with major depression, which appropriately accounted for the performance of depressed
patients in this study, is more easily obtained by the examination of the entire data set,
rather than of sub-sets of data. For this reason, it is preferential to consider the results of the
preliminary analysis of this data set. However, the comparison of the profile of cognitive
function in the experimental groups which were observed not only between the two
analyses in this investigation, but also between experiment one and experiment two
outcomes, may aid the determination of those factors of cognition which are altered in
depressed patients, and which may be sensitive to reduced levels of statistical power.
In the second experiment similar limiting factors relating to the patients' profile were noted
as were observed in the previous study. Again, the failure to use a structured diagnostic
interview, the relatively young age of participants, and the chronic duration of their
depressive episodes may have impacted upon the cognitive profile of patients who





As with the previous study, depressed patients in experiment two exhibited a significant
level of depression - on both the BDI and the HRSD - in conjunction with relatively high
levels of state stress and anxiety. Controls, on the other hand, were confirmed to be free of
depressive symptoms, and tended to score within a more normal range for measures of
stress and anxiety. This pattern of cognitive function was established in both the
preliminary data analyses and the analyses of data from those participants who were
included in the functional imaging analysis only.
■ Cognitive profile
In contrast to experiment one, depressed patients were unimpaired on both the visual
elevator and elevator counting with distraction subtests, with respect to accuracy. However,
patients' reaction times on the visual elevator were significantly slower than controls. The
pattern of findings was the same in the second set of analyses. Thus, suggesting that the
integrity of the mechanisms of cognitive flexibility, selective attention, and attentional
switching were all preserved in the sample of depressed patients who participated in
experiment two, while psychomotor function was relatively impaired.
Although the analysis of the outcomes on the TEA subtests were indicative of a sparing of
central executive function, and a dysfunction of psychomotor ability, the pattern of findings
relating to performance on the n-back task suggested the opposite profile of impairment.
Indeed, the accuracy of depressed patients was significantly reduced on the n-back task
compared to controls. Yet, patients were not significantly slower than normal controls in
their response times at any level of the task.
The other factors of interest in the analysis of n-back performance in this experiment were
the level of difficulty of n-back and the scanning session. The level of difficulty of n-back
was found to have a significant effect on the both accuracy and reaction time measures of n-
back performance, across experimental groups. Post-hoc analyses revealed a relative decline
in accuracy associated with each incremental increase of cognitive load. In addition,
increased reaction times in participants were found to be associated with the parametric
increase in cognitive load up to and including the 2-back conditions of the task.
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While the use of two separate scanning sessions appeared to have no effect on the accuracy
of participants on the n-back task, there was a significant interaction between the level of n-
back and scanning session on reaction time measures. However, post-hoc analyses revealed
that scanning session was a contributory factor only on the reaction time of participants on
0-back levels of the task. Given that the effect of scanning session is particular to the
baseline level of the task, rather than applicable to all levels of the tasks, suggests that there
is something specific about performance at the 0-back level that is amenable to some factor
related to the scanning session. For example, it is possible that the effect of scanning session
at this level of the task was the result of an increased level of stress or arousal, resulting from
the rather long scanning sessions that were used in the functional imaging paradigm in this
investigation.
The profile of participant performance on the n-back task was similar in the sub-group of
participants who were included in the functional imaging analysis. However, the second
analysis failed to find a significant main effect of participant group on accuracy on the n-
back task. However, there was considerable similarity in the cognitive profile of the
participants who were included in the analysis of functional imaging data and participants
in experiment one. Moreover, the pattern of cognitive function in both analyses of
experiment two were also similar. Thus, it is likely that the failure to find a significant effect
in the behavioural analysis of participants who were included in the functional imaging
analysis is related to the reduced statistical power associated with the diminished number of
participants in the second experiment, rather than a lack of a genuine difference in the
performance of patients and controls. However, it is important to note that the smaller
number of participants in the second experiment was due to the practical considerations of
conducting an fMRI investigation.
A series of correlations revealed no significant associations between clinical dimensions in
the depressed group and performance on any of the measures of executive function. This
may have been due to a lack of relationship between affective state and cognitive function.
Alternatively, it may have been the result of homogeneity in the affective profile in the
depressed group, or in a similarity in the performance of patients on each of the cognitive
measures, irrespective of variability in affective factors.
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■ Profile of cognitive function in depression: Experiment one vs. experiment two
Effect size comparisons of the relative performance of depressed patients and healthy
controls on the n-back task revealed a greater effect of depression on accuracy on the n-back
task in the second study. The similarity of the profile of cognitive function in both studies
supports the notion of a genuine difference between the ability of depressed patients and
healthy controls to successfully undertake tasks reliant on human working memory.
Moreover, this observation is indicative of reduced statistical power in the second data
analysis in experiment two.
In contrast, the comparison of the effect sizes in experiments one and two revealed a greater
effect of experimental group on the observed reaction times of participants during
performance of the n-back task in the first investigation. This difference was statistically
significant in the first study, but not in the second, probably due to smaller group sizes in
the latter. Despite the difference in the magnitude of effect sizes pertaining to reaction time
differences between patient and controls at each level of n-back, the pattern of findings was
similar in experiments one and two.
Unlike measures of accuracy, deficits in psychomotor ability in depressed individuals tend
to be consistent across studies, even on those studies, and have been noted in those
experiments that have used quite elementary psychomotor assessments or have tested
comparatively few patients. Therefore, the failure to find a significant difference between
patients and controls on this measure on the n-back task may reflect more than just reduced
statistical power, as a result of relatively small group numbers. This raises the question of
which factors specific to this investigation may have led to a relative speeding up of the
response times of depressed patients?
All experimental factors were kept constant between experiments one and two, with the
exception of the introduction of the performance of the working memory task during
functional neuroimaging in the latter study. Thus, it would appear to be some factor
associated with the performance of the n-back task whilst being scanned led to the observed
similarity in the reaction times of depressed patients and healthy controls. One possible
explanation of this finding is that increased levels of stress and arousal in either participant
group impacted upon psychomotor function during scanning. Although the pre-test
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measures where not indicative of such an alteration, the environment of the scanner may
have induced an increased level of state stress and arousal. Such an effect could have
resulted in an impairment of psychomotor performance of controls, or may have led to an
arousal related reduction in the reaction times of patients. Either of these effects would
bring about the reduction in the disparity in psychomotor function of patients and controls.
However, in order to qualify this it would be necessary to have some measure of stress and
arousal which could be conducted while participants are inside the scanner, e.g. measuring
heart rate, or other physiological indicators of stress and arousal.
Functional neuroimaging results
The main analyses of the functional neuroimaging data were concerned with the regions of
altered cortical activation - i.e. increased and decreased - that were associated with the
parametric increase in difficulty of the n-back task in both patients and controls. The
analyses were also designed to ascertain regions of cortical activation, during task
performance, which were differentially activated in patients and controls. In order to
account for the potential confounding effect of differences in the behavioural performance of
the experimental groups, those regions that exhibited load-dependent activation associated
with correct responses only on the n-back task were determined for depressed patients and
healthy controls, and compared for relative differences.
The original block-design analysis of the functional imaging data revealed clusters of
significantly increased activation associated with the increase in cognitive load in the control
group in both hemispheres in parietal and frontal cortex - including inferior and superior
parietal regions and both middle and medial frontal gyri. However, the pattern of decreased
activation was much more diffuse in controls, comprising regions in both hemispheres and
across the cortex - including parietal (i.e. posterior cingulate cortex), frontal (i.e. medial and
middle frontal gyri), temporal (i.e. superior and middle temporal, parahippocampal,
precentral, and fusiform gyri, and insula), and occipital regions (i.e. middle occipital and
lingual gyri, and the cuneus). The relative specificity of regions of increased activation, in
comparison to the diffuse pattern of decreased activation, in response to the increased
difficulty of the n-back task may be indicative of a selective activation of cortical regions
associated with the response to cognitive load in controls, and a corresponding decrease in
cortical areas not necessary for the response to such experimental manipulations.
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The regions of increased activation in patients associated with the increase in the level of n-
back also included regions of the frontal and parietal cortex, such as the inferior, middle and
superior frontal gyri, and the inferior parietal lobule, but also included clusters of significant
activation in both the cerebellum and the lingual gyrus. The analysis of functional imaging
data also revealed significant decreases in activation in patients in a number of cortical
regions. As with controls, decreased activation associated with increased task difficulty
occurred in parietal (i.e. posterior cingulate cortex), frontal (i.e. medial frontal gyrus), and
temporal (i.e. transverse, superior and middle temporal gyri) regions. Moreover, clusters of
decreased activation in depressed patients were noted bilaterally in the cerebellum. Thus,
the pattern of activation in depressed patients was also suggestive of a relatively specific
pattern of altered cortical activation in response to task demands.
Although the analysis of the experimental groups independently was indicative of
differences in the level of activation in a number of regions between patients and controls,
the statistical analysis of the alteration in cerebral activation in the experimental groups
revealed relatively few differences between patients and controls. Indeed, comparison of the
regions of both increased and decreased activation associated with the increased difficulty of
the n-back task in depressed patients and healthy controls revealed a statistically significant
difference in the magnitude of cortical activation between the groups in one region only, i.e.
the MOPFC/rAC. More specifically, it was observed that the level of activation in this region
was relatively higher in the depressed patients than in controls. However, it should be
noted that both groups of participants exhibited a decrease in activation in this regions that
was associated with the linear increase in the difficulty of n-back, but that the magnitude of
the decrease in depressed patients was smaller than that seen in controls. It has already
been noted, that the behavioural differences between patients and controls in this study may
have been the result in a differential response to task difficulty, thus, it is possible that
MOPFC activation was associated with a motivational aspect of task performance, rather
than changes in cognitive load per se.
One of the main reasons for employing an fMRI paradigm in this study was to determine
regions of abnormal cortical activation that were associated with behavioural dysfunctions
in individuals with major depression. Therefore, the assumption could be made that the
differences in the level of activation of the MOPFC may have been a critical factor in the
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observed disparity in the accuracy of patients and controls performance on the n-back task.
To determine whether this was indeed the case, the second series of analyses of the
functional imaging data concentrated on the activity associated with accurate performance
only in both experimental groups.
The pattern of activation seen in the secondary event-related analysis of functional imaging
data was very similar to that which was noted in the initial block-design analysis. The
event-related analysis of correct responses only in control participants associated with the
linear increase in difficulty of the n-back task revealed significant increases in activation in
the inferior and middle frontal gyri, the inferior parietal lobule, the superior temporal gyrus,
the thalamus, the insula, and the cerebellum. Decreased activation in control participants
was also noted in a number of regions across the cortex - including frontal (i.e. medial and
superior frontal gyri, and anterior cingulate), parietal (i.e. posterior cingulate, and
paracentral lobule), and temporal (i.e. superior and middle temporal, parahippocampal, and
fusiform gyri, and the insula) regions.
In depressed patients, increased activation associated with the increased level of difficulty in
correct responses only, was noted in the following regions: inferior parietal lobule; the
middle and medial frontal gyri; the precuneus, pre- and postcentral gyri; the middle
temporal gyrus; the insula; and the cerebellum. The increased activation in these regions co-
occurred with a relative decrease in activation, associated with correct responses only and
with increasing task difficulty, in diffuse cortical regions. Regions of significantly decreased
activation were noted in the frontal (i.e. inferior, medial and superior frontal, subcallosal,
and precentral gyri), parietal (i.e. paracentral lobule), occipital (i.e. cuneus, precuneus, and
lingual gyrus), and temporal (i.e. insula and middle temporal gyrus) cortices, as well as the
cerebellum.
As with the previous block-design analysis of the functional neuroimaging data, in the
event-related analysis of correct responses there was considerable overlap between
depressed patients and healthy controls for regions of increased and decreased activation
associated with the linear increase in task difficulty. However, in contrast to the previous
block-design findings, the results of the comparison of the pattern of activation between
patients and controls in the event-related analysis revealed no statistically significant
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clusters of either relatively increased or decreased activation between experimental groups.
This indicates that the network of cortical regions which respond to changes in cognitive
load is the same in both depressed patients and healthy controls, in those instances when
participants are responding accurately.
All factors relating to the data analysis in the block-design and event-related analyses were
identical, with the exception of the inclusion of data pertaining to cortical activation
associated with incorrect responses in the block-design analysis. Therefore, it is possible that
any differences in the cortical activation of patients and controls, which were highlighted in
the block-design analysis, can be attributed to the relative weakness in the performance of
patients on the n-back task. Thus, the failure of depressed patients to appropriately decrease
activation in the MOPFC in response to increased task demands may be critically related to
an aspect of task difficulty in measures of working memory that is specifically associated
with major depression.
An important finding in both the block-design and event-related analyses of the functional
imaging data in experiment two was the observation that specific neuroanatomical regions,
such as the medial prefrontal cortex, comprised areas of both increased and decreased
activation. This co-localisation of clusters of increased and decreased activation in single
regions of cortex in response to the increase in cognitive load was noted both in depressed
patients and normal controls. A number of the anatomical regions that were noted to
exhibit clusters of both increased and decreased activation were regions that have previously
been noted to be critical for working memory in normal healthy adults. For example,
regions in frontal cortex which constitute the DLPFC, such as the medial and superior
frontal gyri, and parietal regions, such as the inferior parietal lobule, demonstrated both
increased and decreased responses in cortical activation in response to the increase in task
difficulty.
The final factor of interest in the analysis of functional neuroimaging data in experiment two
was the association between the severity of depression patients - as determined using the
HRSD - and regions of altered cortical activation during performance of the n-back task.
The results of a correlation analysis between level of activation in areas of increased and
decreased activity associated with the linear increase in the difficulty of the n-back task and
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severity of depression revealed no significant associations between these two variables. This
may represent a reasonable level of homogeneity in the affective measures of the depressed
patients who participated in this study, which is evident in the relatively small standard
deviation of patient scores on the HRSD (i.e. s.d. = 5.55). Alternatively, it may imply that the
differences in the activation response to task difficulty noted between depressed patients
and healthy controls are consistent and not amenable to variations in depressive severity.
However, in order to determine this it would be essential to ascertain whether variations in
cortical activation can be observed in a depressed sample that exhibit greater variability in
the severity of depression. Alternatively, this could be achieved by determining whether
there are relative differences in cortical activation patterns associated with executive
function in samples ofmildly, moderately, and severely depressed patients.
8.1.3 Experiment three
Antidepressant medication was identified as a potential confounding factor in the
behavioural performance and cerebral metabolism of depressed patients in experiment two.
Therefore, experiment three was designed to determine the potential contribution of
antidepressant medication to both of these outcome measures. This was achieved by
measuring the effect of the subacute administration of escitalopram (i.e. lOmg/day for 7
days) on the performance of normal healthy volunteers on measures of executive function
and learning. In addition, participants in experiment three were also assessed for alterations
in cerebral activation associated with the performance of the n-back task, in both medication-
free and post-medication conditions.
Behavioural results
■ Affective profile
Prior to participation, it was assured that all volunteers in experiment three scored within
the normal range on the BDI. Participants were also required to undertake the BDI, along
with the SAC and the APSAQ, at both experimental phases - i.e. while medication-free and
post-medication. Although the administration of the course of escitalopram did result in an
increase in participants' state anxiety, there was no significant effect of AD medication on
level of depression, or state stress and arousal.
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■ Cognitive profile
The comparison of participants' scores on the elevator counting with distraction and visual
elevator subtests of the TEA in the medication-free and post-medication experimental
conditions revealed no significant effect of escitalopram on either of these measures. Thus,
indicating that the subacute administration of an SSRI medication had no effect on the ability
of participants to perform measures of selective attention, cognitive flexibility, and
attentional switching. Moreover, these observations are suggestive of a sparing of
psychomotor function in healthy adults who are given AD medications in a subacute
administration paradigm.
Participants also completed a measure of verbal learning and memory - the RAVLT. The
administration of antidepressant medication was found to have no effect on two
performance dimensions of this task - i.e. mean number of items correctly recalled and the
interference effect. This suggests that the consumption of escitalopram had no impact upon
participants' ability to perform measures reliant on the integrity of short- and long-term
memory.
As with the second experiment, the performance of participants in the n-back task was
assessed during the acquisition of an fMRI scan. Analysis of the data obtained during
scanning revealed a significant main effect of the level of n-back on both the mean number of
correct responses and average reaction. Moreover, linear contrasts for the effect of n-back
and reverse Helmert contrasts between each of the levels of the task were significant on both
of these outcome measures. This indicates that the parametric increase in the level of
cognitive load was evident in a linear decrease in both the mean accuracy and the mean
reaction of participants, in both experimental conditions. However, the participants'
medication status had no significant effect on either measure of performance. This is
suggestive of a failure of subacute administration of SSRI medication in healthy adults to
effectWM function.
An additional factor of interest in the analysis of n-back data was the effect of scanning
session (i.e. session 1 vs. session 2) within each experimental condition. There was no
significant difference between the mean accuracy of responses in the first and second
scanning sessions. Moreover, although there was an apparently significant main effect of
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scanning session and a significant interaction effect involving scanning session and level of
n-back on participant reaction time, post-hoc analysis revealed that scanning session only
had an impact on reaction time at the 0-back level of the task. This finding is similar to the
results of experiment two, which further suggests a possible effect on performance of factors
which are likely to change as a result of multiple scanning sessions, such as stress and
arousal.
Therefore, it would appear that the subacute administration of antidepressant medication to
normal healthy volunteers had no effect on the accuracy of the measure of working memory
used in this study, i.e. the n-back task. Moreover, antidepressant medication had no impact
on participants' reaction time at each level of n-back. Both of these findings are consistent
with the normal performance of participants on the TEA, which was indicative of a sparing
of executive function and psychomotor ability in the experimental sample. The findings are
also in accordance with the observations of other investigations of the effect of SSRI
medications on cognitive function in normal healthy adults (e.g. Hindmarch, 1988;
Hindmarch & Kerr, 1994; Hindmarch, 1995; Fairweather et al., 1997; Nathan, Stough &
Siteram, 2000).
■ Comparison of behavioural findings: Experiment two vs. experiment three- medicated,
healthy volunteers vs. depressed patients
The analysis of behavioural findings in the second study was indicative of two types of
impairment of cognitive function associated with major depression. The first of these was
slowing of psychomotor function, which was evident in the increased reaction time of
depressed patients on the visual elevator task. The second observed deficit was a decrease
in mean accuracy of patients on the n-back task. The failure to observe a similarity in the
behavioural performance of the depressed patients in the second study and the healthy
volunteers in the post-medication phase suggests that the impairments that were noted in
experiment two are more likely due to MDD, rather than an effect of AD medication in
depressed patients.
However, it is essential to note that the effect of AD medication in normal healthy volunteers
is not necessarily the same as the impact of similar medications in clinically depressed
patients. Indeed, there may be an interaction effect between AD medication and features of
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MDD, which brings about impairments specific to the administration of AD medication to
clinically depressed individuals. Therefore, prior to drawing conclusions relating to the
effect of antidepressants on cognitive function in patients with major depression, based on
observations of the effect of such medications in normal controls, it is important that such
potential interactions are taken into account.
Of particular interest in the comparison of behavioural findings was the observation of a
relative speeding up of reaction time associated with the linear increase in the level of n on
the n-back task in both experiments two and three. While there was a main effect of n on
reaction time in the first investigation, post-hoc analysis revealed that there was only a
relative improvement in psychomotor function with the incremental increase between the Gl¬
and 1-back levels of the task. However, in the case of the latter investigations post-hoc
analysis found that each subsequent parametric modulation of task difficulty resulted in a
significant decrease in participants' reaction time, thus suggesting that psychomotor ability
and task difficulty may be in someway linked. Moreover, the results of experiments two
and three indicate that this effect may be generalised to different and varied populations,
given that the effect was noted not only in depressed patients and healthy controls but also
in a sample of medicated, healthy controls.
Given the sparsity of relevant background literature relating to this type of phenomenon it is
difficult to postulate potential mechanisms for the relationship between these two factors.
One potential explanation is that the correlation between the level of n-back and reaction
time may be modulated by increased state stress and/or arousal, such as would be expected
to be induced as a result of the increased task difficulty. For example, as the level of n
increases the number of items participants are required to retain in the central executive
increases, in order to clear the executive for new items in higher task levels participants may
experience a greater pressure or immediacy in their need to respond, hence resulting in a
notable decrease in their response times. While this is one potential explanation for the
observed effect, it is impossible to draw conclusions in the absence of objective data to
corroborate the notion of increased stress and arousal during task performance, e.g. such as
heart rate or skin conductance measures. It is also important to note that while one could
argue that the effect of n-back on stress, and hence reaction time, may be the result of time
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rather than difficulty, the counterbalancing of the order of presentation of n-back levels in
the two scanning sessions would infer that difficulty is the critical factor here.
Functional neuroimaging results
Given the findings of previous studies of the effect of antidepressants on cognition in normal
healthy volunteers, the observation of no significant effect of escitalopram on measures of
cognitive function was not unexpected. However, the predicted effects of this class of
medications on cerebral metabolism are less clear. Therefore, analyses of functional imaging
data was designed to determine whether the subacute administration of escitalopram
resulted in significant alterations in the pattern of functional activation during performance
of the n-back task.
Alterations in regions of cortical activation associated with the linear increase in difficulty
were determined for participants during medication-free and post-medication experimental
conditions. In addition, the patterns of significant activation associated with each condition
were compared in order to determine relative differences in activation associated with the
administration of antidepressant medication. Given that there was no observed difference in
the behavioural measures of n-back performance between medication-free and post-
medication conditions, patterns of cortical activation were determined for the original block
design only (i.e. rather than repeating the previous event related analysis).
In the medication-free condition the increase in the level of difficulty of the n-back task
resulted in increased activation in the superior and inferior parietal lobes, in the middle and
superior frontal gyri, and the cerebellum. However, as in the previous study, the pattern of
decreased activation associated with the same parameter changes was evident in a more
diffuse range of cortical areas, including a range of frontal and temporal regions, such as the
inferior, middle, and superior frontal gyri, the pre- and postcentral gyri, the middle and
superior temporal gyri, the angular gyrus, the claustrum, and the parahippocampal gyrus.
Moreover, decreased activation was also noted in the right cerebellum.
The increase in task difficulty in the post-medication condition was also associated with
increased activation in the frontal and parietal cortices. Regions of significantly increased
activation included both inferior and superior parietal lobes and the inferior, middle, and
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superior frontal gyri. Increased activation was also noted in the insula and the precuneus.
Decreased activation, on the other hand, was noted in fewer regions in the post-medication
condition, yet still involved a relatively diverse network of frontal (i.e. superior frontal and
cingulate gyrus) and temporal (i.e. middle temporal and angular gyri) regions. In addition,
decreased activation was also noted in occipital regions in the post-medication scanning
condition - including the cuneus and the lingual gyrus.
Although there appears to be a difference in the number of regions involved in the
performance of the task in two experimental conditions, the random effects analysis revealed
no regions of statistically significantly different activation between the two experimental
conditions. Thus, it may be the case that the same regions were activated in both conditions,
but that in one or other of the conditions the effect may have been below the threshold for
detection. Alternatively, the random effects analysis may have been too conservative to
detect genuine differences in the cerebral activation of participants in the medication-free
and post-medication condition. Indeed, for the purpose of the random effects analysis the
data were treated as if they were between-subjects, rather than repeat measures. Thus, the
actually estimated variance in the random effects analysis was likely to have been greater
than expected for the current within subjects design.
In order to determine whether this latter assertion was correct, fixed effects contrasts were
constructed, with the following factors of interest: level of difficulty of n-back and the
relative effect of medication status. The results of this analysis revealed medication related
increases in activation in a single cluster, which comprised the middle frontal gyrus and the
anterior cingulate (BA24), and a relative decrease in activation in clusters in the middle
occipital and superior temporal gyri, and the cerebellum.
Overall, the analysis of the functional imaging data acquired in experiment three was
indicative of a similar pattern of changes in cortical activation associated with the increase in
difficulty of the n-back task in both the medication-free and post-medication conditions of
the investigation. However, there is tentative evidence of alterations in the cerebral
metabolism of a few regions as a result of the administration of antidepressant medication to
the ten healthy volunteers who participated in this study. However, these latter findings are
based on observations from a fixed effects analysis, and would need to be replicated in a
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suitable random effects analysis before any they can be generalised to healthy volunteers on
escitalopram per se.
■ Comparison of functional neuroimaging findings: Experiment two vs. experiment three -
Medicated, healthy volunteers vs. depressed patients
The regions of increased and decreased activation associated with the increase in the level of
difficulty of the n-back task were relatively consistent between experiments two and three.
Indeed, the increased activation of both parietal and prefrontal regions was noted
consistently in the analysis of the functional imaging data in both experiments. Moreover, a
diffuse pattern of decreased activation was also noted in the analyses of all experimental
groups, across both studies.
A major finding of the functional imaging data in experiment two was the relative increase
in activation in the MOPFC/rAC in depressed patients, compared to controls. The initial
random effects analysis of the functional activation of participants in experiment three
revealed no regions of significantly different activation related to medication status. This
implies that the abnormality in MOPFC in depressed patients was the result of factors
specific to MDD, rather than antidepressant medication. While, a secondary fixed effects
analysis of the functional imaging data in experiment three was indicative of medication
effects on the magnitude of AC activity (see Appendix 3C), this cluster was more dorsally
located than the significant cluster of interest in the second study. The spatial dissociation
between these two clusters in experiments two and three is indicative of the fact that the
noted MOPFC/rAC dysfunction in depressed patients is the result of some factor of
depressive illness, rather than an outcome due to the impact of antidepressant medication in
our patient sample. Nonetheless, it is important to note that the differential effect on
cerebral metabolism may simply be due to the sampling of different experimental
populations, and that at this stage it is difficult to rule out medication effects in our
depressed sample.
As with the behavioural results, of primary concern is the extent to which the effects of
antidepressant medications in healthy volunteers can be generalised to clinical populations.
Indeed, previous studies of the metabolic effects of AD medications have found cortical
differences in metabolism in treatment-responsive patients, but not in healthy volunteers
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(e.g. Kalin et al., 1997; Bonne et al., 1999; Mayberg et al., 2000; Kennedy et al., 2001; Drevets
et al., 2002). This implies that the effects of antidepressants on regional cerebral metabolism
may depend on the interaction between medication and factors relating to symptom
reversal, rather than just medication alone.
In this instance it is also important to note that the observed differences in AC activation in
experiment three are inferred from the results of the fixed effects analysis of the functional
neuroimaging data. Fixed effects analyses are normally associated with the impression of
increased statistical power, as a result of their failure to take account of the individual
variability of participants. However, the use of a repeated measures paradigm in experiment
three actually removed at least one source of variation in the analysis, which should make
the results of the fixed effects analysis more reliable and thus more credible. Therefore, it
may be asserted that the differences observed between participants while medication-free
and after medication in the fixed effects analysis may reflect genuine difference related to the
administration of escitalopram. Consequently, the relative increase in activation in the AC
in the post-medication condition in the fixed effects analysis in experiment three may be
associated with the similar effects seen in depressed patients in other experiments
The accuracy of this assertion can partially be determined by the examination of the
evidence relevant to the relative differences in the action of antidepressant medication
between healthy volunteers and depressed patients. In addition, the clarification of the
nature of the dysfunction noted in experiment three can be ascertained by exploring the
evidence relating to the role of the anterior cingulate in cognitive function and the integrity
of AC function in MDD.
The issues arising from the analysis of both the behavioural and functional imaging data
from this series of investigations, and how they contribute to our understanding of the
aetiology of cognitive dysfunction in major depressive disorder will be explored in the
following sections of this chapter.
8.2 Discussion
Having considered the outcomes of each of the studies separately, the following subsections
attempt to integrate the results of the studies that constituted this projectwith the findings of
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previous investigations that are pertinent to the understanding of cognitive performance and
cortical function in patients with major depressive disorder.
8.2.1 Working memory function in major depression
Despite the proposition that the observed deficits in cognitive function in depressed patients
may be attributed to a deficit in the central executive component of human working memory
(i.e. Channon et al., 1993), investigations of working memory in MDD have been inconsistent
in their observations. One potential explanation for the discrepancy in the experimental
outcomes of different studies is a lack of appropriate sensitivity in the measures of working
memory that have been employed. Therefore, the use of a more suitable measure of
working memory, which allows for manipulation of the contributory processes of WM,
should enable the construction of a more accurate account of this form of executive function
in depressed patients. This assertion was a central component of the current series of
investigations.
It has already been noted that a primary aim of both experiments one and two was the
estimation of the integrity of working memory function in major depression. More
specifically, both of these investigations aimed to determine whether the use of a more
sensitive measure of WM, which could be varied in order to increase the level of difficulty
by manipulating the magnitude of cognitive load (i.e. the n-back task), would produce more
distinct and reliable differences between depressed patients and healthy controls.
The analyses of the results in both studies were indicative of a notable impairment in
working memory function in adults with MDD. The impairment of WM was observed in
measures of accuracy in both experiments one and two. However, the manipulation of the
level of cognitive load in the working memory task did not have a differential effect on the
performance of patients. Indeed, it appeared that the deficit seen in patients on the n-back
task was consistent in nature, thus, suggesting that the magnitude of cognitive load was not
necessarily the primary cause of WM deficit in depressed patients, and that the deficit may
be the result of another factor that contributed to performance.
It has been suggested that the profile of cognitive dysfunction in major depression can
largely be attributed to the degree of psychomotor impairment experienced by depressed
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patients. Therefore, it is possible that the executive dysfunction that was noted in depressed
patients in experiments one and two may be attributable to the noted deficit in psychomotor
ability. However, although depressed patients were noted to be significantly slowed on the
n-back task compared to controls in the first experiment, in experiment two there was no
observed effect of depression on reaction time measures in the n-back task, yet depressed
patients were still relatively impaired on this task. Indeed, the effect size for the difference
in accuracy between patients and controls was found to larger in the second study.
Consequently, while psychomotor function is likely to be a contributory factor in cognitive
performance in depressed patients, abnormal psychomotor ability is not sufficient to explain
the differences in performance of the patients and controls on the n-back task in the
experiments in this study.
Alternatively, it could be argued that motivation had played a critical role in the
performance of depressed patients on the n-back task. Indeed, a consistent deficit in
motivation may result in a consistent impairment in cognitive performance. Whether
depressed patients experienced reduced motivation in this study can be partially determined
by consideration of aspects of the data used to calculate the event-related contrasts. In order
to conduct the event-related analysis of the functional imaging data acquired in the second
study it was necessary to construct models of the individual responses for each participant.
This was achieved by using the response data for each participant, and within each data set
identifying four classes of response, i.e.: (1) correct actual response; (2) correct no response;
(3) incorrect actual response; and (4) incorrect no response. If motivation were a primary
factor in the relative detriment in the performance of patients, it would be reasonable to
suppose that the differences in the mean number of correct items at each level of difficulty of
n-back could be attributed to a failure of depressed patients to respond to individual
stimulus items. This type of difference would be evident in an increased number of
'incorrect no response' items across the levels of n-back. However, when the pattern of
results was examined for both patients and controls, it was noted that patients had a greater
tendency to respond incorrectly, than to not respond at all. Thus, indicating that motivation
to perform the n-back task was not necessarily reduced in depressed patients in these
studies.
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Other potential factors that may have contributed to the performance of depressed patients
were also determined to have had a minimal effect on the group differences. For example,
the differences in the mean estimated IQ of patients and controls was noted to contribute to
the performance of both experimental groups at the 0-back level of the task, but had little
impact on the observed group differences. In addition, other factors that have been noted to
contribute to the cognitive performance of depressed patients in other studies, such as
severity of depression and other clinical factors were found to have little effect on the extent
of the performance of depressed patients on the n-back task in these studies. Therefore, it
would appear that the differences between the performance of depressed patients and
healthy controls on the n-back task can be reasonably attributed to a factor of working
memory performance, rather than some other contributory factor, such as motor
impairment, motivation, or IQ.
Although there was not a differential effect of the level of cognitive load on the degree of
deficit exhibited by depressed patients on the working memory task, the dysfunction of
patients on the n-back task may still be attributable to an abnormality in executive processes
in major depression. However, as opposed to an impairment related to the level of cognitive
load of a given measure of executive function, the dysfunction of working memory may be
due to a consistent level of difficulty experienced by depressed patients on such measures.
The notion of a general and consistent level of perceived difficulty on measures of executive
function is supported by the observed differences in the performance of patients and
controls on the TEA subtests in experiment one. In addition, although the differences
between patients and controls on the TEA subtests were not statistically significant in
experiment two, the mean scores of patients on the visual elevator task were relatively less
than those of controls (i.e. both raw and scaled scores).
The findings of this study do not entirely rule out the likelihood of an effect of cognitive load
in depressed patients, but instead suggest that the magnitude of load may have to be
increased beyond the levels explored here in order to detect a differential profile of
perceived difficulty in depressed patients and healthy controls. Support for this notion
comes from the observed levels of performance of both depressed patients and healthy
controls at the 3-back level of the variation of the n-back task used in this study. Indeed,
although depressed patients were relatively impaired compared to controls at all levels of
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the task, at the maximal levels of task difficulty both groups continued to perform at a
greater than chance level. However, if the difficulty of the task was increased, in order to
induce levels of performance that were near ceiling levels in the depressed group, then the
magnitude of the difference in the performance accuracy of depressed patients and healthy
controls may begin to differentially increase.
Consequently, the behavioural findings of this study are indicative of an impairment of
executive function in patients with MDD, which is not attributable to other factors of
depressive illness, such as psychomotor dysfunction or motivation. However, the
manipulations of the working memory task used in this study were not extensive enough to
allow us to determine whether this deficit is attributable to a dysfunction of central executive
function or whether it can be accredited to more general task difficulty related impairment.
8.2.2 Regional abnormalities in brain metabolism in major depression
One potential way to address the issue of the aetiology of the types of executive deficits
noted in the behavioural findings of these experiments is to examine the metabolic correlates
of the performance of the n-back task, and to compare regions of significant difference
between depressed patients and healthy controls on putative regions of activation
supporting workingmemory function.
The comparison of the regions which exhibited significant alterations in their degree of
activation in response to the linear increase in difficulty of the n-back task, revealed
relatively few differences between depressed patients and controls. However, a significant
difference in the magnitude of decreased response in response to an increase in cognitive
load was noted in the MOPFC/rAC between patients and controls. Although, both groups
experienced this decrease, the extent of decreased activity was significantly less in depressed
patients. Therefore, in the data analysis this difference was noted as a relative increase in
patients.
In order to determine the role of this apparent dysfunction in the observed behavioural
dysfunctions that were noted in the performance of the n-back task in depressed patients, it
is important to consider the potential role of this region in cognition and affect in normal
healthy adults, whether MOPFC dysfunction has been noted other functional neuroimaging
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studies of major depression, and the relationship of functional abnormalities of MOPFC in
depression to the cognitive profile of depressed patients.
8.2.2.1 Medial orbitofrontal prefrontal cortex function and major depression
The activation of the medial orbital frontal region of prefrontal cortex has been implicated in
a number of cortical functions in both normal healthy adults and clinical samples.
Moreover, it has been postulated to play a role in both cognitive and affective processing.
For example, studies of guessing (i.e. vs. knowing) in normal healthy adults have found a
significant increase in the activation of orbitofrontal prefrontal cortex (i.e. BA11/25; Elliott,
Rees & Dolan, 1999). Similarly, significant activation of this region has also been noted in
investigations of response inhibition. Horn and colleagues found that in a sample of normal
male participants noted significant responses in the right medial orbitofrontal cortex during
performance of a 'Go/No-go' task (i.e. Horn et al., 2003).
Of particular relevance to the study of functional abnormalities associated with major
depression is the role of MOPFC in the previously discussed abnormal response to negative
feedback that has been noted in depressed patients (see section 1.1.3.2, pp32-33 for full
details). In their investigation of the response of depressed patients to feedback, Elliott and
colleagues found a highly specific focal functional abnormality in patients with unipolar
depression in the MOPFC in response to feedback, compared to conditions of no feedback
(Elliott et al., 1998). These investigators found that in comparison to healthy controls,
activation in this region was significantly attenuated in depressed patients, in both
hemispheres, in those conditions were feedback was given.
It is possible that the abnormal response of MOPFC in situations of feedback in depressed
adults may be to some degree mediated by the role of this region in modulating stress and
anxiety responses. In an investigation of the neuroanatomy of anxiety, it was noted that the
presence of anxiety (i.e. in adults with a diagnosis of one of three anxiety disorders) was
associated with activation of the right posterior medial orbital frontal cortex, in comparison
to healthy control participants (i.e. Rauch et al., 1997).
This notion of the role of MOPFC in the modulation of affective responses is further
supported by evidence regarding the role of the rostral and ventral sections of the AC in
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affect. Indeed there is evidence to suggest that lesions of this region can result in variety of
dysfunctions of affect, including apathy and emotional instability (see Bush, Luu & Posner,
2000 for a review). Moreover, the induction of sad mood in normal healthy adults has been
shown to activate this region of cortex and rAC has been shown to be activated in adults
with major depression (in Bush et al., 2000).
In addition to a function in affective and cognitive processing in normal and clinical
populations, there is evidence to suggest that MOPFC may play a significant role in the
response of unipolar depressed patients to anti-depressant medication. A series of studies
by Helen Mayberg and colleagues have highlighted the role of rostral (subgenual) anterior
cingulate in the treatment response profile of MDD patients (e.g. Mayberg et al., 1997;
Mayberg et al., 2000). In an early study Mayberg noted that hypometabolism in rAC
characterised treatment non-responders compared to healthy controls. Responders, on the
other hand, were noted to be hypermetabolic in the same region. Moreover, in this study
this was the only region which uniquely differentiated between responders and non-
responders (Mayberg et al., 1997). These findings were supported by similar observations
in a later study by the same author. In an examination of regional metabolic effects of
fluoxetine in MDD non-responders were again characterised by a failure to note changes in
the subgenual AC (Mayberg et al., 2000). Again, these observations are likely to be linked to
the affective function of MOPFC/rAC. More specifically, it could be suggested that the
hypoactivation of this region in treatment responsive patients may simply reflect the
persistence of the affective symptoms ofMDD.
In a recent review of imaging studies of major depression, Mayberg suggested that as
opposed to the classic lesion-deficit approach to imaging of depression that we should
consider observed metabolic patterns in MDD as "a combination of 'functional lesion' and
an on-going process of attempted self-correction or adaptation" (Mayberg, 2003: p 196).
Within this proposed framework hypermetabolism may be viewed as a compensatory
activation of regions of cortex (i.e. frontal areas) in response to the chronic activation of
limbic-subcortical structures, with the aim of overriding the persistent effect to such activity
on affect. Conversely, Mayberg suggests that hypometabolism is the result of a failure to
initiate or maintain this compensatory response in frontal cortical regions, thus resulting in
228
the persistence of negative affect, psychomotor dysfunction, and impaired executive
function.
Having considered the potential, and varied, roles of MOPFC/rAC the important question is
how this reflects upon the observed increase in activity in this region in depressed patients,
compared to controls, in our second experiment. The results of the analysis of the functional
imaging data from experiment two suggest that not only did depressed patients exhibit a
relative increase in this area with the parametric increase in the level of n-back, but that this
hyperactivation was associated with those instances where patients were performing the
task incorrectly.
The primary assumption may be that the due to an increased level of state stress and arousal
in depressed individuals (i.e. as measured prior to scanning) may have increased the level of
activation of the noted MOPFC/rAC. However, it is important to determine how such an
increased level of stress may have impacted upon the performance of depressed
participants, such as would bring about the noted impairment of this group across levels of
the n-back task. One potential account of this effect comes from a review of the reciprocal
suppression of blood flow in affective vs. cognitive task by Drevets and Raichle (i.e.Drevets
& Raichle, 1998). In their review, these authors suggest that cognitive: affective distinction
that has been noted between dorsal and rostral aspects of AC, respectively (see below for
further details) is often reflected in a pattern of reciprocal suppression during one type of
task or the other. Based on this assumption, it could be asserted that the increased activation
that was noted in the second study in MOPFC/rAC in depressed individuals may have had
the effect of suppressing activation in the dorsal AC, which is a region previously noted to
be involved in aspects of task difficulty in the performance of tests ofWM.
The increased activation MOPFC in MDD patients in experiment two can be partially
explained by the evidence from the work of Mayberg and colleagues considered above.
However, while the hypermetabolism of MOPFC in depressed individuals would suggest
that our patients were treatment responders and that the increased activity of this cluster is
indicative of an attempt to compensate for the over activation of limbic-structures, it has
already been noted that the average duration of current depressed episode in our depressed
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sample was relatively long, thus suggesting that at least some of our participants would
have been potentially classed as non-responders.
With respect to the role of MOPFC activation in the cognitive profile of our participants
there are two key factors: MOPFC activation under conditions of guessing and MOPFC
activation in situations of feedback.
As discussed above, situations of guessing may incur increased activation in the MOPFC in
normal healthy controls, primarily in the RH. It is possible that in trials where depressed
patients were unsure of the correct answer they would be more likely to guess the correct
response. Indeed, this notion is supported by the fact the patients were more likely to make
an incorrect response, rather than to not respond at all. Therefore, the increased activation of
MOPFC/rAC in depressed patients, relative to controls, may have reflected those instances
in which they were unsure of the correct response and were more likely to respond
incorrectly. While this assertion fits well with the behavioural and functional observations,
it should be noted that in experiment two the relevant cluster was on the LH, as opposed to
the RH, as in Horn's study, which may have implications for the reliability of this
interpretation of the data.
The variation of the n-back task that was used in this series of investigations did not include
any form of explicit feedback for participants during task performance. This was done in
order to minimise the effects of feedback on performance of the depressed participants.
Based on previous findings, the inclusion of feedback in this paradigm may have been
predicted to result in an attenuation of activation in the MOPFC in depressed individuals.
Conversely, it could be suggested that the absence of feedback would result in a failure of
depressed participants to reduce the level of activation in MOPFC/rAC. Although, this does
not fully explain the relative increase in activation seen in depressed patients, it is likely to
be a contributory factor in the observed profile of cerebral activation in experiment two.
Given the complexity of the function of MOPFC/rAC it is difficult to ascertain an
unequivocal account of the differences in activation that were noted between the depressed
patients and the healthy controls who participated in experiment two. However, it is likely
that the contributory role of this cortical region to both cognitive and affective processing,
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i.e. due to it's own functional diversity and it's reciprocal connections to regions of cortex
also involved in both types of function, at least partially accounts for the role of MOPFC in
the observed deficit in performance of depressed patients on measures of executive function.
8.2.3 The impact of escitalopram on measures of cognition and cerebral metabolism in
healthy volunteers
The lack of a significant effect of the administration of escitalopram on any of the measures
of cognitive function in experiment three was in agreement with the observations of
previous investigations of the effects of SSRI medication in normal healthy volunteers. Prior
studies of the effects of both the acute and subacute administration of AD medication to
normal healthy adults have tended to note that SSRI medications have little or no effect on
the profile cognitive function (see Chapter 1: section 1.3).
Although it could be asserted that this pattern of results may be specific to healthy
volunteers, reviews of both single and multiple dose administrations of ADs indicate that
the cognitive profile in medicated healthy volunteers appears to mimic the observations of
cognitive function associated with the chronic administration of antidepressants in clinically
depressed individuals (see Amado-Boccara et al., 1995 for a review). This implies that the
cognitive dysfunctions in depressed individuals can be attributed to the presence of
depressive symptoms, rather than the administration of antidepressant medication.
Moreover, these findings indicate that any deficits in cognition that are associated with
antidepressants should also be apparent in healthy volunteers who are given the same kinds
of medication. Therefore, it would appear that the deficits noted in executive function in
depressed patients in the first and second experiments are not the result of antidepressant
medication, but are related to the experience ofMDD.
The available evidence is suggestive of a lack of a significant association between SSRI
medications and cortical metabolism in healthy volunteers. This notion was further
supported by the failure to note a behavioural difference in working memory performance
associated with medication status, and the results of the initial random effects analysis of
functional imaging data. Support for the notion of spared cerebral function in medicated
healthy volunteers come from previous findings of the specificity of changes in cortical
metabolism resulting from antidepressant medication. Indeed, the available data suggests
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that SSRI medications induce changes in cerebral perfusion in treatment responsive adults
with MDD only.
However, the secondary fixed effects analysis of functional imaging data in experiment three
indicated that medication status was associated with increased activation in the same region
as was noted to be dysfunctional in the depressed patients, i.e. the anterior cingulate (BA24).
Despite the reduced power of this finding, it is suggestive of an effect of antidepressant
medication on metabolism in the healthy volunteers who participated in experiment three.
Moreover, although one may question the reliability of this observation this region is one
that has been consistently implicated in cognitive function in normal, healthy adults, and
which is known to exhibit functional abnormalities in patients with MDD. Therefore, it is
important to consider the potential role of such a dysfunction in previously noted cognitive
deficits in depressed adults.
Anterior cingulate function has an integral role in both cognitive and affective processing in
normal health adults, with its contribution to both classes of function being largely described
as 'executive'. In support of the diverse nature of AC function, lesions of this area have been
noted to result in a variety of symptoms, including dysfunction of attention, apathy, deficits
in autonomic function, akinetic mutism, and emotional instability (Bush et al., 2000). Across
both cognitive and affective domains, it has been suggested that the anterior cingulate is
involved in initiation, motivation, and goal-directed behaviours (Devinsky, Morrell & Vogt,
1995).
With respect to the contributions of the AC to both cognitive and affective processing, it has
been suggested that the cytoarchitecture of the AC can be subdivided into regions that are
specialised for the cognitive and affective processes it is involved in (i.e. dorsal and rostral-
ventral, respectively; see Bush et al., 2000 for a review). The regions of anterior cingulate
which are involved in the mediation of cognitive function have been noted to have a number
of reciprocal connections to other regions of cortex, including dorsolateral PFC (BA 46/9),
parietal cortex (BA 7) and both premotor and supplementary motor areas (Devinsky et al.,
1995). It has been suggested that the dorsal anterior cingulate cortex contributes to executive
processing via these reciprocal connections using a range of functions, including response
selection, competition monitoring, complex motor control, error detection, and, crucially,
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working memory (e.g. Devinsky et alv 1995; Bush et al., 1999; Carter, Botvinick & Cohen,
1999).
With respect to working memory performance, the previous review of putative regions of
activation in working memory tasks was indicative of the role of anterior cingulate in
working memory function (see Chapter 1, section 1.2). A number of investigations have
noted significant changes in the level of activation in the anterior cingulate during the
performance of working memory tasks (e.g. Schumacher et al., 1996; Braver et al., 1997;
Callicott et al., 1999; Jansma et al., 2000). Jansma and colleagues found a large regions of
load sensitive activation in the anterior cingulate (i.e. Jansma et al., 2000). However, it has
been suggested that the alteration of anterior cingulate activity is a crucial response to the
level of task difficulty, rather than a load-dependent response (e.g. Barch et al., 1997).
The pattern of AC function in resting state and functional activation studies of MDD has not
been consistent. While some studies have found alterations of AC function in depressed
patients, including both increases (e.g. Videbech et al., 2002) and decreases (e.g. Bench et al.,
1992; Bench et al., 1993; Elliott et al., 1997; Kumari et al., 2003), other investigations have
failed to find any evidence of a dysfunction of AC associated with MDD (e.g. Saxena et al.,
2001; Videbech et al., 2003). However, these differences may reflect inter-study variation in
factors pertinent to the observation of metabolic differences between healthy controls and
depressed patients. Indeed, in a review of cingulate gyrus function, Ebert & Ebmeier, (1996)
found evidence of altered anterior cingulate perfusion in a range of functional imaging
studies of the relationship between depressive symptoms and cerebral metabolism.
Although one study found evidence of a reduced cerebral blood flow in rostral AC (i.e.
Kumari et al., 2003), given the functional distinction of the anatomical substructures of the
AC this abnormality in cingulate function may instead reflect affective, rather than cognitive,
processes. However, studies of cognitive dysfunction in MDD have noted significant
correlations between AC activity and memory function in depressed patients (e.g. Dolan et
al., 1994). Therefore, the evidence from functional neuroimaging studies of major depression
appears to support the notion of a dysfunction of anterior cingulate associated with both
affective and cognitive aspects of depressive symptomology.
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The observations of the role of anterior cingulate activation in both normal participants and
depressed patients supports the notion that the observed dysfunction in the anterior
cingulate in the patients in experiment two was a contributory factor to the observed deficit
on the behavioural measures of the n-back task in this experimental group. The dorsal
location of the cluster of significantly increased AC activation in the depressed patients (i.e.
BA 24) suggests that the abnormal activity of the AC was associated with the pattern of
executive dysfunction seen in depressed patients, rather than being related to the affective
abnormalities noted in the patients. Given the varied role of the dorsal anterior cingulate, it
is difficult to ascertain which aspect(s) of working memory function are likely to be impaired
by this type of abnormality.
While there is considerable evidence to suggest that the anterior cingulate is involved in
executive processes, determining the specific role of AC in measures of WM is a relatively
difficult process. However, there is evidence to suggest that the function of this cortical
region may be restricted to aspects of task difficulty associated with the performance of
parametric measures of working memory, rather than cognitive load.
8.3 Further research recommendations
Further investigation of the performance of individuals with MDD on the n-back measure of
working memory, during functional neuroimaging, is recommended for a number of
reasons. Firstly, it is suggested that the extension of the maximal levels of difficulty of the n-
back task would allow for the estimation of whether depressed patients experience of
differential decrease in performance as the level of cognitive-load approaches ceiling levels
of performance, compared to controls. This type of manipulation should allow for the
further clarification of whether depression associated deficits in working memory are simply
the result of the effect of factors such as a generalised task difficulty, state stress, or
sensitivity to performance feedback, or whether memory load does indeed play a significant
role in depressed patients' ability to undertake such measures.
Moreover, this type of manipulation of the n-back task might alter the metabolic effects
noted in the second experiment. Indeed, it is possible that increasing task difficulty may
enable a clearer definition in the role of the MOPFC in modulating the performance of
depressed patients on this type of measure, by allowing a more detailed exploration of the
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corresponding behavioural data. Similarly, a differential decrease in performance as a result
of increased load on the central executive may be reflected in functional abnormalities in
putative regions of central executive function, such as the dorsolateral prefrontal cortex.
As previously noted, the depressed samples that participated in the first and second
experiments were a relatively specialised group of patients. They were comparatively
young cohort, with respect to other studies of this type, and they tended to exhibit
symptoms of chronic depressive illness. Therefore, the repetition of this paradigm in larger
and more varied groups of depressed participants is recommended. It is likely that this
would help to address the issue of whether the lack of significant differences on specific
aspects of behavioural performance are the result of the relatively small and specialised
experimental groups who participated in functional neuroimaging in this study. In
addition, such replication of the experimental paradigm would also allow for the
determination of whether, or not, the observations in these studies are specific to young,
chronically ill depressed patients, or whether the type of deficit that were noted (i.e. both
behavioural and functional) are characteristic of a wider population of depressed
individuals.
A significant limitation, which was noted post-hoc, was the failure to include physiological
measures of stress and arousal during scanning. Although this would have been useful in
general in extrapolating the relationship between various variables of interest, it would have
been of particular use in exploring the association between psychomotor function and task
difficulty. Therefore, in future studies of this sort it may be practical to include some sort of
measure of physiological arousal, such as breathing or heart rate or skin conductance,
during functional imaging.
The final recommendation for further research is the repetition of the paradigm used in
experiment three. There are relatively few studies of the effects of AD medication on
cerebral metabolism in healthy volunteers, and the results from this study are not entirely
unequivocal. Therefore, further investigation of this issue is warranted in order to ascertain
an accurate profile of cerebral metabolism associated with medicated status. This will not
only aid in the clarification of such effects in healthy volunteers but will also assist in
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determining which aspects of functional abnormality in MDD can be attributed to
depressive illness and which are the result of a patient's medication status.
8.4 Conclusions
In conclusion, the results of the series of investigations that comprised this study were
indicative of a dysfunction of executive processes in adults with major depressive disorder,
relative to matched healthy controls. This dysfunction included measures of selective
attention, cognitive flexibility, and attentional switching, in addition to a main deficit in
working memory function (i.e. as measured using the n-back task).
The degree of disparity in the performance of depressed patients and healthy controls could
not be attributed to group differences in IQ, nor was it the result of impaired psychomotor
function or reduced motivation in depressed individuals. The origin of the working
memory deficit noted in depressed patients appeared to be the result of a dysfunction of an
aspect of the performance of measures of working memory pertaining to task difficulty,
rather than manipulations of the magnitude of load on the central executive component of
the working memory system.
This latter assertion was partially supported by the observation of abnormal activity in thee
MOPFC/rAC in depressed patients, associated with the linear increase in the level of
difficulty in the n-back task, i.e. patients were found to experience a relative increase in the
level of functional activation in this region. In addition, consideration of the event related
responses in cortical activation suggest that the increased activation in this region was
related to both affective and cognitive responses to task difficulty in those instances in which
patients performed the task incorrectly (i.e. stress/arousal and guessing, respectively).
In the final experiment altered activity in the anterior cingulate was observed in a fixed
effects analysis of functional imaging data from a group of healthy volunteers who had been
given a short-course of an SSRI medication. While this observation did not have a direct
impact upon the observations of this study it does have implications for the interpretation of
the observation of AC dysfunction in previous neuroimaging studies of MDD. For example
it could be suggested that the altered activity in the AC of depressed patients could
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potentially be attributed to the medication status of individuals with MDD, rather than
being symptomatic of depressive illness.
In comparison to previous investigations of working memory function in MDD, this study
has been successful in demonstrating a dysfunction of human working memory in
depressed adults. The results of the functional neuroimaging data are indicative of a
dysfunction in the medial orbital prefrontal cortex/rostral (subgenual) anterior cingulate,
which is likely to have contributed to the observed behavioural differences in depressed
patients and healthy controls on the measures of executive function that were used in this
study, via mediation of both affective and cognitive function.
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Depressed(40)i. .2 endogenous&20neur tic) vs.Controls(20)
1.ReyAuditoryVerbalL arningT st (RAVLT;Rey,1964Lezak,83) 2.Digitsymbolubstituti nteandblock design(DSST)WAI -R;We chler,1981 3.Digitspanforwards(DGF)andi spanbackwards(DGB)WMS-R; Weschler,1987) 4.TrailmakingA&B(ArmyIndividual TestBattery,1944) 5.F-ASverbalflu ncy(Borkowski,etal., 1967) 6.NationalAdultReadingT s(NART; Nelson&CTConnell,1978)
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1.DGF&B(WMS-R) 2.ReactiontimeA(i.e.simple)&reactio timeB( .e.choice)Hubb rt,1987) 3.TrailsA&B 4.Strooptask(Golden,1978) 5.FASverbalflu ncy(Borkowski,tal., 1967) 6.WisconsinCardSorti gTest- Abbreviated(WCST-64;Heaton,1981) 7.Similarities(WAIS-R) 8.ReyAVLT 9.Visualreproduction(WMS-R) 10.DSST(WAIS-R) 11.NART(Nelson,982)
Attention(1) Immediater c ll(1) Psychomotorspeed(2&5) Informationprocessing speed(2) Set-shiftingab lity(2,36& 9) Visuomotorspeed(3&9) Selectiveattention(4&9) Abilitytoconceptual se(7) Immediateemory(rec ll) (8) Short-termmemory(recall &recognition)(8)
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Neuropsychologicaltest scoresinverselycorrelated withdepressionseverity (i.e.HRSD)and psychomotordisturbance. Noeffectofmedication statusoncognitivefun tion. Alsolittleeffectof psychosisandgeonlevel ofimpairment.
Bartolicetl.(1999)
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Brand,Jolles&Gispen- deWied(1992)
Depressed(24)i. .SM- m-Rclassification:13 dysthymic,7major depressed,2atypical& bipolar)vs.Controls(26)
Word-learningtask(adaptedfr m RAVLT;(Lezak,1983Mayes6)-,3&
5trialvari tions
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'Unimpaired'de ressed (UD)10vs.'Impaired'* (19)vs.ControlsC)(20) (unimpaired/impaired distinctioneterminedby assessmentonthe CAMCOGindexofth CAMDEX(Rothetal. 1988)) * -10'borderlineimpaired' (BD),9'impaired'I )
1.CAMCOG 2.Mini-MentalStateExam nation( MSE; Folsteinetal.,1975) 3.WAIS-R(Weschler,1986)-vocabulary, similarities,co prehension,arithmet c, anddigit-span 4.SchonellGradedWorReadingT st (Schonell,1942;NelsonandMcKenna, 1975) 5.WeschlerLogi alM mory(LM)and Word-PairAssociateLearningT s(PALT; Weschler,1945) 6.RAVLT(Taylor,1959) 7.Brown-Peterson( P)testrow ,1958; Peterson&t rson,1959) 8.Verbalflu ncy-'free','cat gory'and 'letter' 9.TokenTest(Spre&Bento ,1969) 10.WeiglTest(Wei ,941)
Languagefu ction Memory-recalland recognition Attention Behaviouralregulation
UD Impairedonr ngefmeasures. Thosemostsen itivetdepr s on includedrecallmemory(esp ciall afterdelay),sp ctsofrecognition memory,short-termemory(w re rehearsalisprevented),v rbal fluency,a dlanguage comprehension. UDvs.BI Majorityofcognitivetestsrevealed gradientoffunctioi.e.UD>BD>ID
Absenceofa yignificant relationshipbetwee cognitivefunctiona dy indexofdepressionlating toseverity,ymptomology, ortreatment.
Channon&Green(1999)
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1.Phonologicalsim l rityeffe t (WildingandMohin ra,1980) 2.Wordlengtheffect(adaptedfrom Baddeleyetal.,1984) 3.DGF(Weschler,1981) 4.Forwardblocksequence(Wes hl r, 1981) 5.DGB(Weschler,1981) 6.Backwardblocksequence(Wes hler, 1981) 7.PacedAuditorySerialdditionT s (PASAT;followingGothametal., 1988) 8.Trail-makingtest(Reit n,1958) 9.Lettercancellationt st(Dill ., 1974)
Workingmemory (1.-3.Phonologicall p, 4.Visuospatialsketchpad 5.-9.Centralexecutive)
Someevidencefimpairment testsofcentralx cu ivefunction, withrela ivesp ringofthe phonologicallo pa dvisuospat al sketchpad.
Nosignificantcorrelatio s betweenself-report measures(i. .BDIand LeytonObsessi nal Inventory(Snowdon,1980), andtheSt teTraitAnx ty Inventory(Spielbergeral., 1970),pasthistoryof depression,a thistoryof dysthymia,orco en HRSD,tomedicationstatus (i.e.medicatedvs unmedicated)withscores onthebackwarddigitsp n andPASAT.
Cohenetal.(1982)
Depressed(11)i. .3 euthymic,3moderate,and 3severe:2bipolar patients)vs.Controls(5)
1.Motortask-forceexert d(inkg)in squeezingadynamom ter,ndur tion ofhalf-maximalresponse 2.Memorytask-recollectionoftrigrams
Changesimotornd memoryresponse associatedwithm odshift
Nodifferencebetw end pressed andcontrolsinleft-oright hand peakforce. Durationofhalf-max malresponse significantlylessindepressedgroup. Severelydepressedpati ntsshow arapiddeclineinmemory performancewithtimeofr call comparedtothersubgroups.
Deficitsinmotorand cognitiveperformanc seemedtobproportionate toseverityfdepression (i.e.HRSD&BDI)
Cohenetal.(1999)
Schizophrenics(26 inpatient&27outpatient) vs.Depressed(25). Controls(31)
1.AXversionofthecontextproc ssingtest (AX-CPT);Servan Schrieber,Cohen,& Steingard,1997) 2.Strooptask(MacLe d,1991) 3.Lexicaldisambiguationt sk 4.Digitspan 5.Wordspanrecall
Context-processing(1) Selectiveattention(2) Inhibition(2) Languageprocessing(3) Short-termmemory(4&5)













1.Freeecalltask 2.Word-stemcompletionta k Bothtasksusingaffectivelyvalen ed words
Explicitmemory(1) Implicitmemory(2)
Intheexplicitmemorytaskcontrols recalledmorwordsthandep ss patients.Moreover,depressed patientsweremolik lytrecall negativelyvalencedwordsthan positivelyvalencedw rds.The oppositepatternwasobservedinth controls. Noeffectfgrouprwo dvalen e inthemplicitmemoryask.
N//A
Elderkin-Thompsontal. (2003)
Minordepressed(28)v . Majordepressed(26)v . healthyelderl(38)
1.ModifiedCarSo tTest(MCST;Nelson, 1976) 2.TrailmakingA&B(Lezak,1995) 3.Blockdesign(Wes hler,1981) 4.CaliforniaVerbalL ar ingT st( VLT; Delis,ta .,1987) 5.BostonNamingTest( NT;Kapla ,tl, 1983) 6.ContinuousVisualMemoryT st (CVMT;Trahan&Larrabee,1988) 7.Semanticflue y(Lai e,1988) 8.DGF&B(Weschler,1987) 9.MMSE
Verballearningndrec ll(4 &7) Maintenanceofs t(1) Executivefun tion(2B),3, &5) Nonverbalrecognition memory(6) Workingmemory(8)
Controlsperformedbet erthan majordepressedpatientsote tsf verbalr calandmaintenanceofs t. Majorlsoperformedworsthan minordepressedindividualso thesem asures.Controlperform d betterthanminordepressed individualsontestsfxec tive functioning.Workingmemorywas borderlinef rseparatingcont ols andmajordepressed
Partialcor elations controllingfoagend educationindicatedth performancedeclinedwith increases verityof depression(i. .HRSD).
Elliot&Greene(1992)
Depressed(10)v . Controls(10)
1.Cuedrecall 2.Freerecall 3.Word-stemcompletion 4.Homophonespelling
Explicitmemory(1&2) Implicitmemory(3&4)













1.NART 2.CANTABtestbattery-( )P tternand spatialrecognition,(b)Simultaneousa d delayedmatch-to-sample(SMTS& DMTS),(cspatialands workingmemory,( )TOL,fNew (g)attentionalset-shiftingtaski. .ID/ED paradigm-ID:intra-dimensional,ED: extra-dimensional). 3.F-A-Sverbalflu ncy(Benton,1968)
Recognitionmemory(2(a)) Visuospatialmemory(2(a), 2(b),c ) Spatialworkingmemory (2(d)) Set-shifting(2(e)) Planning(2(0&2(g))
Patientsweresignificantlyimpaired onF*A*S,patternands ial recognition(ac uracyandr action time),SMTSD(accuracyand reactiontime)*,spa alan,sp tial workingmemory(i. .eerr s andlessuseofstrat gy)TOL& newTOL(i. .globaldeficiti performanceaccuracyndsloweo two-andhree-moveproblems,but fasteronour-andive-move problems) Nosignificantgroupsdifferencesin movementti sonTOLand attentionalset-sh fti g. * -covaryingforMTSlatency removedthesignificantgr upeffe t onDMTSlatency
Significante fecoffailure onsubsequence performanceinatients- i.e.motivationaldefic t. Significantcorrel tion betweenclinicalrati g scores(i.e.HRSD, Montgomery-Asberg DepressionRat gScale (MADRS)ontgomery& Asberg1979),&Clinical InterviewforDepression (CID)Paykel,1985)nd neuropsychologicaldeficits -especiallymnemonic deficits.
Fossatietal.(1999)
Depressed(20)v . Schizophrenic(14)vs. Controls(20)
1.P-R-Vverbalflu ncy(Benton,1968; Cardebat,etal.,1990) 2.DGF&B(WAIS-R)( eschler,1981) 3.Cognitiveestimat(Shall ce&Ev ns, 1978) 4.WCST(modifiedversion,Nelson,1976) 5.DelisT st(cardso tingte )(adapted fromDelistal.,1992) 6.Grober&Buschk 'smemorytask('f andcueselectivereminding'adapte fromGrober,etal.,1988)(i.ever al learningt sk)
Spontaneouscog itive flexibility(1&5) Reactivecognitivflexib lity (a)Setshifting4 (b)Setmaintenance1&4) Initiation(1&5) Selection(1&3) Workingmemory(1,2,3,4,& 5) Episodicmemory(6)
Depressedpatientsexhibit executivebunotmn monici. .task 6)deficits. Deficitsinseveral'higher-level' functionsombi edtproduc executiveimpairmentsnde ressed patients-includingomplex integrationforconceptormati , spontaneouscognitiveflexibility, andinitiationbility











Depressed(29)v . Schizophrenic(57)vs. Bipolardepressed(16)
1.WAIS-Rshortform(Silverstein,985) 2.WideRangAchievementT st- Revised(WRAT-R)readingt t(Jastak& Wilkinson,1984))(i.e.ameasureof premorbidintellectualfuncti n) 3.WMS-FormII (a)Visualreproduction (b)Pairedassociatele ning (c)Logicalmemory 4.WCST(Axelrod,eta .,1992) 5.TheCategoryest(LaLonde,1985) 6.Lineorientation(Ben o ,al.,1978) 7.Facialre ognition(Bento ,l.,1978)
Visuomotorspeed(3(a)) Selectiveattention(3(a),4 Recall(3( ),b),andc ) Set-shifting(4) Conceptformation(5) Cognitiveflexibility(5) Problemsolving(5)
Schizophrenicpatientsmo impairedth naffectiveatientso testsofpsychomotorspeed, attention,memoryndproblem solving.
Indepressedpatients, symptomeverity(i. .Brief PsychiatricRatingScale (BPRS;Overall&Gorh m, 1962)accountedform r than28%ofvariancein cognitiveperformance.
Golinkoff&Sweeney (1989)




Ineffortfultasksdepressedpatient hadtendencyorecallan recognisefewerordthacontrols. Resultssuggestthapoor r performanceofdepr ssedatients reflectbasimemoryimpairments ratherthangeneralinabilityo allocatecognitiveefforttm re demandingtasks.












1.Halstead-ReitanTr lM k gst(P r A) 2.Digitspantes 3.CPT(Cornblatt,etal.,1989) 4.TheHopkinsVerbalL ar ingst (Brandt,1991) 5.Visualreproduction(WMS-R;Weschler, 1987) 6.Halstead-Reitanc tegoriest s 7.COWAT(F-A-S) 8.WCST(Heaton,1981) 9.TrailMak ngest(P rB) 10.CANTAB 11.TheStockingsfCambr d eask (basedonTOL;Sh llice1982) 12.Spatialworkingmemorytask 13.ID/EDAttentionalSet-shiftingta k 14.Spatialrecognitionmemorytask 15.SMTS&D 16.Patternrecognitionm moryt sk 17.Pairedassociatedle ning 18.Spatialspantest
Psychomotorspeed(1) Verbalattention(2) Sustainedatte tion(3) Verbalmemory(4) Immediateanddelayed visualmemory(5) Executivefun tion(6-10) Conceptformation(6&8) Verbalfluency(7) Maintenance(8) Set-shifting(8,13) Cognitiveflexibility(9) Planning(11) Workingmemory(12) Visuospatialmemory(14- 18)
Nosignificantdifferen esbetween depressedpatientsandhe lthy subjectsona ymeasurefatte tion, psychomotorfuncti ningor mnemoniceasures. Depressedatientswerim re ontheWCSTnsev ralparameters, includingnumberofcategori s completed,perseverativer pons s perseverativee ror,andfailur sto maintainse . Nodeficitswerese ninothertestf executivefunctioning.
No significantcorrelation betweensev rityof depression(i. .BDI& HRSD)andmeasuresof executivefunctioning memory,attentionor psychomotorerformance. Modestrelationships betweenclinicianrat d severityofdepressionand performanceonso etests fromtheCANTAB. Differencesinperformance onDMTS,ID/ED&WCST arepersistenceof depressivesymptoms Significantage- orrected correlationsf ragef onsetffirstepi ode, psychomotorspeed,and executivefunctioning-i. . lateronsetassociatedwith greaterdeclinin performance.
Grossmanetal.(1993)
Depressed(44)v . Controls(44)
KaufmanAdolesce tandA ult IntelligenceT st(KAIT;Kaufman& Kaufman,1993)'
Tertiarymemor Planningbility Secondarymemo- delayednimmediate recall













1.MMSE 2.DGF&B 3.Rivermeadbehaviouralmemoryt st (RBMT) 4.Oralverbalflu ncytask (a)Letterpromptm (b)Semanticc tegory(animal) 5.Sillysentencest st(Collli s&Qui ian, 1969) 6.Wordstemc mpletion 7.DSST
Short-termmemory(2) Episodicmemory(3&6) Semanticemory(4&5) Implicitmemory(6) Psychomotorspeed(7)
Patientswereunimpair doshort- termme ory,recognition,s ma tic memoryandimplicitemory. However,comparedtc ntrols patientsshowedignificantdef cits inpsychomotorspedanfrerecall (i.e.bothimmediateanddelayed)- i.e.suggestiveofparedenco ing andimpairedsearchretrieval processes. Noevidencefahedonibi sin recallofpositiveandn g tively valenceditems.
Nocorrelationbetween severityofdepressionand levelofmemory impairment. Presenceofp ychotic symptomsdidnoteffectth cognitiveprofilobserved inpatients.
Kessing(1998)
Euthymicdepressed(118) vs.Euthymicbipolar(28) vs.Controls(58)
1.CAMCOG 2.TheMattisDementiaR t ngSc l (MDRS;Mattis,1976) 3.TheGottfries-Brane-Steen(G ) DementiaRatingScale(Gottfr s,l., 1988) 4.MMSE 5.GlobalDeteriorationScale(GDS; Gottfries,etal.,1982)
Language(1&2) Attention(1&2) Abstractthinking(1&2) Verbalandnon-verbal short-andlong-term memory(1&2) Calculation(1&2) Perception(1&2) Praxis(1&2)
Patientswitho lyneepisoded d notdifferfromcontrolsna y measure.Pati ntswithorth n oneepisodewersig ificantly impairedonallmeasuresv . controls.
BDIscorecorrelat d significantlywithMMSE, GBS,andD . No.fepisodessignificantly associatedwithCAMCOG andMDRSmeasures.
Landro,Stiles Sletvord,(2001)
Depressed(22)v . Controls(30)
1.Fingertapping( .e.wot sksfromh AutomatedPsychologicalTest( PT; Levander&Elithorn,1987) 2.Choicereactiontim(fr mAPT) 3.TrailmakingA&B 4.DSST 5.PASAT-&B(i.e.4 02s c, respectively) 6.DGF 7.RandtMemoryT s(Randt,Brown,& Osbourne,1980) 8.KimuraRec ringecognitionFigures Test(Kimura,1963) 9.COWAT 10.WAIS-RBlockDesign 11.WAIS-Rsimilarities
Motorfunc i n(1) Selectiveattention(2) Mentalflexibility(3i.e. differencebetweenA&B) Visuomotortracking(4) Workingmemory(5) Short-termmemory(6) Long-termmemory-verbal andnon-verbal(7&8) Verbalfluency(9) Visuospatialfunction(10)
Significantdifferencesbetween groupsinselectiveatt n on, workingmemory,verballong-term memory,andverbalflu ncy-i. . patientsworse. Selectived ficitinepr ssed patientsoselectiveatt n ionnd workingmemory. Short-termmemoryleastimpair d















Patientsh dimpairedrecollec ion memorybutnoimpairmenth bit memorycomparedt ntrols.
Impairmentwasnot predictedbyindicesof currentmood(i.e.HRSD& SCID)butwaspredic edy self-assessmentofmood (i.e.BDI-II)andpast numberofdepressions. Noevidencefff to medicationonp rformance
Merriamtal.(1999)
Depressed(79)i. . unmedicatedformin.28 days)vs.Schizophrenic (47)vs.Controls61
WCST
Set-shifting
Depressedatientsmadeor errors(i.e.bothperseverative&non- perseverative),tooklong rreach thefirstcategory,ompletedew r categoriesoverall,h dfew r conceptual-levelrespons sand lowerearning-to-learnsc resthan controls.




Memory Intellectualpro esses Psychomotoractivity Auditoryattention Sustainedatte tion Visualmemory Verbalencoding Verbalmemory
Nosignificantdifferencesbetwee patientsandco trol-except singlemeasureofatt ntion.
Nosignificantc rrelatio s betweensymptomology(i. . measuredu ingHRSD)and cognitiveperformance
Moffootetal.,(1994)
Melancholicdepressed (20)i.e.patientswithde r diurnalvariation)s. Controls(20)
1.DGF&GB(followingRandtBrown, 1983) 2.DSST 3.RAVLT 4.CANTAB- (a).RT (b).SMTS&D 5.Dynamometerh ndsque zet sk
Attention Concentration Psychomotorspeed(2& 4(a)) Workingmemory(1) Verballearningnd memory(3) Visuospatialmemory(4(b)) Motorperformance(5)













Depressed(25)v . Schizophrenic(25)vs. Obsessive-Compulsive (25)vs.Controls70
1.WCST(Loong,990) 2.StroopTask(Moritz,s&Jun ,1998) 3.TrailMak ngA&B(Reita ,1992) 4.DGF&BG 5.(Creative)v rbalflu ncySchoppe, 1975)
Set-shifting(1) Selectiveattention(2) Inhibition(2) Concentration(3) Psychomotorspeed(3) Short-termmemory(4) Workingmemory(4) Verbalfluency(5)
Depressedpatientswereim r
onallmeasurescompar dt controls.
Coreclinicalratingswere notsignificantlycorrelated withtaskperformance(i.e. HRSD). DatafromtheOCDpati nts indicatednosignificant effectofanti-depressantsn performance.
Murphyetal.(1999)
Manicdepressed(18)v . Depressed(28)v . Controls-A*(18)& Controls-B*(22)
* -groupA:manic matched,groupB: depressedmatch
1.NART(Nelson,982) 2.MMSE(Folstein,etal.,1975) 3.Patternandspatialrecogn tionm mory 4.SMTS&D 5.TOL 6.Affectiveshiftingtask-i. .Go/No-go
Spatialrecognitionmemory (3) Visuospatialmemory(4) Planning(5) Workingmemory(5) Inhibitorycontrol(6)
(Note:Re:Behaviouraldfo depressedpatients-onlya af r task6presented) Depressedatientswerim ren theirabilityoshiftefocus attention,ndexhibitedbi sfor negativestimuli.
Nosignificantcorrelatio s betweenmeasuresof severity(i. .HRSD, MADRS,&CID)and performancemeasures.
Murphyetal.(2001)
Manicdepressed(18)v . Depressed(22)v . Controls(26)
1.NART(Nelson,982) 2.MMSE(Folstein,etal.,1975) 3.Decisionmakingta(Rogers,tl., 1999a)
Decisionmaking
Depressedatientswerim red
onthistask,c mparedont ols, i.e.slowerdelib rationtimes, failurestoaccumulatesmany points,andsub ptimalbett ng strategies.
Severityofdepression(i. . HRSD)wasnotsignificantly correlatedwiththqu lity ofdecisi n-making.
Murphyetal.(2003)
Depressed(27)v . Controls(23)
1.ProbabilityReversaltask(Swain on,t al.,2000) 2.Spatialworkingmemory(CANTAB) (Robbins,etal.,1994,8)-i.feed ack andno-feedbackvariations
Visualdiscrimination(1) Workingmemory(2)
Depressedatientswerim ren theirab lityomaintainresponses t whenrec ivingn gativefeedback. Theirab litytocqu rendrevers thenec ssaryvisualdiscrimination wasimpaired. Onthespatialworkingmemory task,depre sedpatientsmad significantlymorebetween-search errorsthancontrols,butwe estill abletousenegativefeedback facilitateperformanc .












22predominantly vegetativesymptoms,14 predominantly psychologicals mptoms) vs.Controls(40)
* -alldepressed participantswere>45 years.
1.WAIS-R(Weschler,981) 2.WMS-R(Weschler,1987) (a)Logicalmemory (b)Visualreproductions 3.Rey-OsterriethComplexFigu(R CF; Lezak,1995) 4.WarringtonRecognitiMem ryT st (RMT;Warrington,1984) 5.BNT(Kaplan,et.,1987) 6.COWAT(Lezak,1995) 7.Stroop(Goodglass&Kapl n,1979) 8.AuditoryConsonantTrigramsest (ACT;Stuss,etal.1982) 9.WCST(Heatontal.,1993)
Short-termrecall(2( )) Set-shifting(2(b)&9) Visuomotorspeed(2(b)) Selectiveattention(2(b)&7) Visuospatialmemory(3) Recognition(4) Executivefun tion(5) Verbalfluency(6) Inhibition(7) Verbalmemory(8)












Medicationfre * depressed(44)v .Controls (44) (* medicationfr eora least6weekspriorto testing)
1.DSST(Weschler,981) 2.RAVLT( ey,1964) 3.Pairedassociatesle rning(CANTAB) 4.PatternRecognitio(CANTAB) 5.Spatialrecogn tion(CANTAB) 6.Simulatneous/delayedmatchingt sample(CANTAB) 7.FAS(Benton&Hasher,1976) 8/Excludeletter'fluencyst(ELFT) (Bryanetal.1997) 9.Vigilcontinuousperformancetest (Cegalis&Bowlin,1991) 10.Spatialworkingmemory(CANTAB) 11.TOL(CANTAB)
Neurocognitivefunction (1.Psychomotor performance,2.V rb l learningdmemory,3.- 6.Visuospatiallearn ngd memory,7.-11.Sustained attentiondex cutive function)
Evidenceofsignificant neurocognitiveimpai menty ung adult,outpatients,withuni olar depression.Im airme tcross rangeofcognitivedoma ns- includingattention/execut ve function,andvisuospatialle rn ng andmemory.Deficitsl t exclusivelyonmeas resfaccuracy.




1.'Executive'tasks (a)Sp tialspan;bi lworking memory;(c)TOL;dID/ED 2.Visualmemorytasks (a)DMTS;bSp tialrecognition; Patternrecognition
Short-termmemory capacity(1(a)) Workingmemory(1(b), 1(c)) Planning(1(c)) Attentionalse -shifting (1(d)) Visuospatialmemory(2(a)- (c))
Patientswerenotimpaired(vs. controls)omeasuresfSTM capacity,spatialWM,pl nning ability,cognit vespeed,DMTSr recognitionmemory. Patientsd dshowimpairmento subsequentmov mentlatencieson TOL,andontte tionalse -shifting.
Medication(i.e.tak ng medicationvs.no medication)hanoeffe t












1.DanishAdultReadingT(DART) (Nelson&McConnell,1978) 2.WAIS-vocabulary,inform tion,DGF& DGB,(Weschler,1955) 3.Subtractingserialvens(Smith,1967) 4.Stroop(St op,1935) 5.WAIS-R-DS T(Weschler,1981) 6.TrailmakingA&B(Reitan,1955) 7.Verbalfluency(Borkowski,B nto,& Spreen,1967) 8.Tokenest(Spellacy&Spr en,1969) 9.Brown-PetersonTest(Peters ,1966) 10.WMS-R-visualreprod ction (Weschler,1987) 11.Test/Logicalmemorytest(Weschler, 1945) 12.LuriaVerb larningT st (Christensen,1975) 13.WCST(Heaton,981)
Verbalint lligence(1&2 (notDGF&B)) Attention(2DGF&DGB), 3,&4) Visuomotorspeed(5&6) Language(7&8) Memory(2DGF&DGB),9, 10,11&2) Executivefun tion(13)
Patientsperformeds gnificantly worsethancontrolsmeasurf verbalintelligence(notDART), attention,verbalfluency,sho t-term memory(i. .onBrown-P tersontest -althoughdifferencewaso ly significantatlon estdel yint rv ls, immediater c llontest/logical memorytest,andhvisual reproductiontest). Regardingexecutivefunction,the onlydiffere cebetweenpatientsand controlstalmostreachsignificance wasfailuretomaintainset(i. . patientsscored,onaverage,great r onthismeasure). Resultscouldnotbeexplained simplyinter sofgroupdifferences inpsychomotorspeed(i. .patien s weresignificantlylow rthan controlsoverarangefmeasu es). Indeed,thonlysignificant differencethatappear dob alteredbyco-varyingfo psychomotorspeedwas performanceonve balflu y wordsbeginningithS.











Depressed(12,i. .6 unipolarand6're ctive') vs.Bipolar(16) Controls(41) (Note:allparticipants wereimprisonedatth timeofassessment,h majorityawaitingtri l)
1.WAIS-R(short-form) 2.Verbalfluency (a)freessociationbcat goryF&S 3.Visualretention: (a)simpleverbalbmixedfunction 'faces' 4.Visualrecognition: (a)alphabetbembedd dlett rcbrok n letter(d)brok nfigure 5.SchonellGradedW rReadingT st
Verbalfluency Visualmemory




1.Simpleinformationprocessing 2.Sustainedefforta dinformation processing
Automaticprocessing(1) Effortfulprocessing(2)
Depressedindividualswere significantlyimpairedoth effortfultaskcomparedc nt ols butnotonthea tomaticask.
Suggestedthatpoor rfree recalloftheentire depressedgroupislik lyto beamedicationeffect.
Shahetal.(1999)







tonegativefeedback. Moreover,resp nst negativefeedbackw snot effectedbydiurnal variation.
Sweeney,Kmiec,& Kupfer(2000
Depressed(58)v .Bi olar (35)vs.Controls51
1.TOL 2.SpatialWM 3.ID/ED 4.Spatialrecognition 5.SMTS&D 6.Patternrecognition 7.Paired-associatelearning 8.Spatialspan 9.Bigcircle/littleircle 10.Fivestagereactiontim
Planning(1) Workingmemory(2) Attentionalset-shifting(3) Visuospatialmemory(4,5
6,&7) Short-termmemory(8) Psychomotorspeed(9&10)
Nogroupdifferencesntasks9&10
-i.e.cognitivediffere cesuet differencesinproc singrath rthan differencesnmotorspeed. Significantdef citsidepressed restrictedtoepisodicmem ry.











Euthymicpatients(26)i.e. Manic(9)vs.Depre sed (10)vs.Bothmanicand depressed(7))v .Controls (notspecified) Note:pati nt classificationsbasedonth typeofepisodehatlead theirhospitalisation
1.Synonym,reasoning,andblock-test (SRB)battery(Dureman,S lde,& Batteriet,1971) 2.Schulze10-wordtest(Claeson,t., 1971) 3.Memoryfordesignst st(Graham& Kendall,1960) 4.Halstead-ReitanNeuropsychology Battery(Bolls,1981)- )trail-makingest, (b)rhythmtest,cfingerapping
Verbalunderstanding(1- synonymstest) Visual-constructiveskill(1- blockdesigntest) Verbalmemory(2) Non-verbalm mory(3) Visuospatialscanningand flexibility(4(a)) Non-verbalauditory perception,attentiond sustainedconcentration (4(b)) Motorspeed(4(c))
Overallp rformanceofeuthymic patientswaslo rthcontrol . Thisdifferencewasind pendentof theypeofepisodeatl d hospitalisation. Theonlysignificantdiffere ce betweentht r epati tsub¬ groupswasontherail-makingB test-i. .significantdeclineT scoresofpatientadmittedfb th manicanddepressedepi odes comparedth sad ittnlyf episodesofdepres ion.Patients admittedformaniao lywer significantlyimpairedoynonym andtrail-makingBcomparedwith depressedonly.
Numberofhospitalisation episodeswassignificantly correlatedwithreasoning, generalintellig nce,a d trail-makingA&Bi.e. thosepatientswithhigh r levelofimpairmenth d greaternumberof hospitalisations. Onlytrail-makingAwas significantly(po itively) correlatedwithlengthof illness. Allothercorrelationsfor effectsofage,g nd r lengthofill ess,and numberofhospitalisations oncognitivefun tiowere non-significant.
Thomas,Goudeman& Rousseaux(1999)
Depressed(10)v . Controls(10) (Note:Patientsw re assessedbothduring periodofilln ssand recovery)
1.Singletask-simplebimodalRT 2.Singletask-choicbimodalRT 3.Dualtask-simplebimodalRT 4.Dualtask-choicebimodaRT
Effortfulprocessing Automaticprocessing























Nosignificantcorrelation betweeninspectiontim andlevelofd pression(i. . asmeasuredu ingtheZ n DepressionScale(Zung, 1965)). Significantneg tive correlationbetw eth lengthofdepressionfr m firstdepressiveepisod( . . p<0.05),andtre towardsnegative correlationbetw en inspectiontimeand durationofcurre tepis de (i.e.p=0 06)
WatkinsndBrow (2002)
Depressed(14)v . Controls(14)














3studies: 1&2.Depressed(10)v . Controls(10) 3.Affectivedisorder(10; i.e.Depressed(4),Bi olar (TypeI)1),&Bipolar (TypeII)5 )vs.Controls (10)
1.Levelsofprocessinglearningt sk 2.Categorisationandrec llfwords
Encoding
Impairmentinrecallofnformation wasmostevidentinpatientsthose processingconditionsthatrequired theuseofmoreelabo ateproc ssing strategies. Ifdepressedpatientsarprovid withorganisationa dstructurethen learning-memorydeficitsareot apparent.
N/A
Wolfeetal.(1987)
Depressed(20)v .Bi olar (12)vs.Huntington's0 vs.Controls(20)
1.RAVLT 2.FAS
Verbalrec land recognition(1) Verbalfluency(2)
Depressedatientswereimp re withrespecttobotcalland recognition,comparedt ntrols. However,depressedpatientsr notimpairedontestsfverbal fluency.
N/A
XX
Appendix1B:Summaryofreviewsneuropsychologicala dcognit vef ct nidepression Note:Detailsarepres ntedfs lectionr vi war i s(i. .meta-analytical,sy tematicrs l ctiveinure)whichh vsumm risedthv dofd f sp cim i cognitioninndividualswithaunipolardepress veill s.Thebs lectionin ludesrev wst th xami eda tlyco paringp t e tsw thMDDn o participantsbutlsow tho herpsy hi tricg oups.Moreover,mfthrevi wspre dincludde ailfst i si v lvingco pl mentarymethodolog es( .g.n ur aging evidence).How v r,thdatapresentedh rao lyt osr lativec g ivefunctionfindividualshm jorde ssi n. Authors)(dateMethodCognitivefunction(s)finterestConclusion(s)
Factor(s)ofinterest
Austin,Mitchell& Goodwin(2001)
Selective computerisedrevi w -cognitivedefic tsin depressionandthe r braincorrelates
1.Episodicmemoryandle rning 2.Executivefun tion
Evidenceofanumb rdysfunctionb th visualanderbexplicitmemorywith relativesparingofimplicitmemory. Despitearlyconflictsirepo ts,evidencef executivedysfun tionacrossstudies,which maybespecifictoet-shiftingtasks.





Significantimpairmeofb thre llnd recognitionindepressedpatients.Alth ugh, theauthorsnoteatonlyssociationi determinedbytheinv stigation,rath rth cause,usaldirectionorunderlying mechanism. Resultsindicatedth tmpairmentsof memoryw recharacteristicofso e,butno all,psychiatricdisorders.Thut possibilitythatimpairmentsrssociated withgeneralisedaspectsofpsychopathology, ratherthansyndromepecificfacto s.








Meta-analysis-i.e. examinationof performanceof depressedand Alzheimer-type dementia(DAT) patientsostandard andexperimental clinicaltestsof cognitivefun tion.
1.Intelligence 2.Verbalfunction 3.Perception-(a)visualandb auditory 4.Memory-(a)registration,bv rb l long-term,(c)non-v rball -t ,d mixed,and(e)remote. 5.Conceptualability 6.Executivefun tion 7.Motorperformance 8.Constructionalability 9.Orientation 10.Attentionandtr cki g 11.Mentalstatus
Significante fects z sfordepressedpati ts, comparedt ntrols,otes sfint lligence verbalfunction,auditorypercepti n,mem (i.e.exceptmix demory),conceptual ability,executivefunctioning,motor performance,constructionalabil ty,ttent andtr cking,me talstatus.
Patientcharacteristics:Old rdepressedati ntsshow d greaterimpai mentsthayoungde ress dti ts. Datasuggestthatgivenimil rlevelsofd pression, olderdepress dpatientswouls i lrformorth youngerpatie ts. Inpatientstatuswaconsistentlyrelatedteffeciz . Endogenousdepressedindividualw rnotm r impairedth nnon-endogenousdepress v s. ECTuse,andsev ritywerl ossociatedithrity ofimpairment. Taskcharacteristics:Rel ivetoc ntrols,depressed patientsperformedprop rtionatelyworsontestf speedandvigilance. Depressedindividualsrecallmoreont stwi h depressedcont nt,rath rthann utralole a t. Comparedtoc nt ols,depresspatientsidnob t r onmemorytaskswh rehstimulircatego i ed,v . thosewereynot.Tsamastruofvisual vs.verbaltasks,andofr calecognitiontasks Moreover,th rwasnevidencesupport propositionthatedefici sse ninepressioarm re severeinthon-dominanthemi phere. However,performancesubtestsnthWAISwerem susceptibletoheffectsfdepre sionthanv rbae ts.
Crews&Ha rison(1995)
Reviewofstudies examiningthe neuropsychologyof depression-anit' relationtocogni ve theoryandtherapof depression
1.Executivefun tion 2.Psychomotorfunction 3.Abstractionability 4.Visuospatialprocessing 5.Constructionalability 6.Mnemonicfunction
Depressedatientsappeartobim r do testsofexecu ivefunction(i luding sustainedattention,mo ivaand concentration),psychomotorfuncti n, abstract,visuospatialprocessing constructionalabil ty,dmnemonic function(i.e.bo hshort-andlong-t rmvisual andverbalm mory).









ofneuropsychological profileinde ression, theinteraction betweencognitivea d clinicalfeatures,a d theneuroimaging evidencer latingto neuropsychologyand neuropathology.
1.Mnemonicfuncti 2.Executivefunction 3.Effortfulvs.automaticpr cessing 4.Moodcongruentbiasesinformatio processing
Patientsshowdef citsinbothm mory(i. . bothvisualanderbal,short-long- erm) andexecutivefunction-altho ghdeficitsi thelatt rmaybeoreprominentin depression. Whiletherisevidenceofmpairmentn effortfulbutn ta t ma icprocessingi depression,th reisal ocontradictory evidence-th refor ,ne doclarifywh ther cognitiveeffortinausefulconcept explainingthepatt rnofn uropsychological impairmentobservedndepres ion. Thereisevidencetosuggestat performanceofdepr ssedpatientsi facilitatedbythusofunpleasantstimuli (i.e.vspleasantorneut lstimuli).Thi appearstoholdruf rb thexplicitn implicit(e.g.riming)studies
Motivation:Lackfmotivationaybenecli ic lfa or thatpl ysacausalroleinneuropsychologicaldeficits associatedwithdepre s on-buouldnexplaithe relativesparingofcert inognifun tionsei sometudies.Th ,isuggestedt atmayb morespecificis ueofresp nsetp rformancfeedback thatisekeys ue(i. .abnormalresponseneg tive feedbackindepressedindividu ls). Severityofdepression:Inconsistenciesithep ting therelationshipbetwe ns v rityofd pr ssiand cognitiveperformance. Statevs.tr itfactorsindep ession:Bal ncofevidence suggeststhaereianot bleimprovementc nitiv performanceonrecov ryfrdepr ssi .However, thereisevidenceosuggestt atbothraiandt t factorscontributetheogn tivpr f ldepressed individuals. Hospitalisation:Inpatientserformworseth outpatientsnmeasurene ro sychologicalfunc ion. Medication:R entevide cese mstouggesth twhile traditionalicyclicmedi at oncadisruptc rt n aspectsofcognition,moreod rnanti-de ressanth v alessnoticeableeff ct(i.e.ibo hpa entsndcon rol ). Age:Depressionismorer liablyelatedtcognitive impairmentneld rlydepress dtientsthatho underthagof40-howev ,isisnotece sarily straightinteractionffect.Therevidencetosuggest thatwhiledepressionintho eund r40smorr liably associatedwithexecutivdysfun t on,tho eover50 showimpairmentthatextendsom moryfunc i ,and thoseover70showadditionalimp irme tf cognitiveslowing.
Hartlage,etl.(1993)
Reviewofstudies concernedwith relativeperformanc ofindividualswith depressiononte tsf effortfuland automaticprocessing.
1.Automaticprocessing 2.Effortfulprocessing.
Depressioninterfereswithffortful processing. Depressiononlyminimallyinte fereswith automaticprocessing.








Reviewoflit rature examiningattentionin depression.
1.Globalattentionalimp irme t Specificcognitiveprocess s,i. .: 2.Informationprocessing 3.Automaticvs.effortfulpr cessing 4.Attentionalresources 5.Selectiveattention
Consensusofmo tstudieithatdepr s d individualsexhibitdecreasecogn tiv efficiencyont stsfatten on-i. .b th impairedperformanceandspe .Th s decreaseinefficiencyoccursatb th lynd latestagesofinformationprocess ng. Depressedpatientswillexh bitnon-specific impairmentofselectivett ntiontasks requiringspeed.Memorytudiesof depressionshowthatim airmentrelated toheoverallprocessingrequir mentan toaprecisem morystag ,nduggest impoverishmentfb tinputandu put informationprocessing.H w ver,th patternofdeficitisnon-specific.e.similar patternse ninoth rpsychiatricgroups.
N/A
Roediger&McDermott (1992)
Reviewoffourst dies examiningimplicit memoryindepression
Implicitmemory





1.Speech 2.Motorresp nsetime (alsocon ideredgrossm t rac ivity andbo ymovement)
Speech:chpausetimeandt speechinitiationargr aterndepress d thancontrols.W ereas,fundamental frequencychangerate,undame tal frequencyvariability,andrateofrticulation arelldecreas dinpr ssion. Motorresp nsetime:Deci ionand motorresponseti earbothincrease depression,aisthec ntralrocessing componentfde isitime.Si lreactio timeisncreas dpsychotic,butnoon- psychotic,depression.









1.Motorfunc i nandea lyinform tio processing 2.Memory 3.Executivefun tion 4.Responsetnegativfe db ck
Studiessugge tpsychomotorlowingin MDD,aswellimp irmentnthearly stagesofinf rmationproc sing(i.e.as measuredu inginsp ctioti e).Evid nc alsosuggestiveofmemorydysf ncti ni verbal,spatiandemotion ltasks.P ti nts withMDDhavealsoshowndeficitsont sk ofplanning,decision-makinga dresponse inhibition.Furthermore,depr ssed individualsexhibitanbnormalresponset negativefeedback.
N/A
Veiel(1997)
Met-analysisofl appropriatestudies publishedbetween 1975and97 examiningthe neuropsychologyof depression.
1.Attentiona dconcentratio 2.Verbalflu ncy 3.Scanningandvisuo-motortr cking 4.Visuospatialfunctions 5.Verballearning(acquisitionnd retention/retrieval) 6.Non-verballearning(acquisitiod retention/retrieval) 7.Mentalflexibi itya dcontro 8.Compositeindicatorsfbraindam ge 9.ChoiceRT









Meta-analysisof studiesbetween1980- 1997examining neuropsychological functionidepression (i.e.22studies meetingresearch criteria)
1.Episodicmemory 2.Declaritivememory 3.Responseinitiationandpersistenc 4.Attention 5.Semanticmemory 6.Primaryme o 7.Workingmemory 8.Motorspeed 9.Visual-perceptualconceptualisa ion
Allthosestudiesatwerexamin d comparedMDDpatientsw thn rmal controls.Testfepisodicmemory, declarativememory,responsiniti tiand persistenceandttentionllshow dbove medianeffectsiz s.Min m lef tiw re noteditestsfsemanticmemory,pri ary memory,workingtorsp edand visual-perceptualconceptualisation.Th ri evidencethatdepressionhaselect veeff cts ontheencodingproc ssesi pisodic memory.Mor over,th risevidencf impairmentnde ressionofeffort ulr attention-demandingtasks.Howev r,no oftheeff ctsiz snot dwerelargn ugh allowforthecompletediscriminationf patientsfromcontrols.
N/A
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Depressedgroupshoulr duceduptakeinthmajorityof corticalandsub-corticalregions,mostpr nouncedi temporalandinferiorfront l,pa ietreas.
Strongpositiveassociationbetwee uptakeandscoresonthNew astle scale,especiallyinthcingulatareas andfrontalcortex. NegativeassociationbetweenHRSD scoresandnte iortr cuptak .
Bench,tal.,(1992)1
Depressed(33:10with severecognitiv impairment)vs.Controls (23)
PETwith,5Oxygen
InthedepressedgroupCBFwasdec ail ftA andleftDLPFC.Therewaslsostrongtendencyto a d decreasedbloodfl winightDLPFCanthl ftan ular gyrus,andincreasentheleftpost riorcingulateyr .I thecognitivelyimpairedgroupewerealsosign ficant decreasesinCBFthl ftmedialfrontagyrusand increaseCBFthecereb llarv rmis.
Nosignificantdifferencesbetwee medicatedandunmedicatepati n si thoseregionspreviouslyidentif eda significant.
Bench,tal.,(1993)1
Depressed(40)v .Controls (23)
PETwith,5Oxygen-i.e.e ami ing correlationbetw enrCBFandth e factorswithloadingr:(1)anxiety,2 psychomotorretardationand depression,and(3)cognit ve performance.
Despitenormalglob lblo dfl w,depressedpatients showedreducCBFintheleftA ,DLFPC,and leftangulargyrus,comparedt nt ols.Strongtre d towardssig.Increaseiheleftpost rioringulatr x (BA23,30).Datasuggestthatymptomaticpecifi itym y beattributedtoregionalfunc iondefici siMDD.Fa t r 1showedaignificantpositivecorrelatiowithrCBFin posteriorcingulatec rtexandthinferiorpariet llobul bilaterally.F ctor2cor elatedneg tivelywithrCBFith leftDLPFCandngulargyr s.Factor3correlated positivelywithrCBFinthelefmedialprefrontalcort x.










PETwith15Oxygen-i.e.longitud nal studyofrCBFinpatientswhile depressedanduringclinicalremi ion




PETwith18FDG-i.e.changesnrCBF beforeandftertr tm nt
AssociationsinrCBFweredeterminedth4HRSDfactors





Nosignificantdifferen esbetweepatientdcontrolsin rCBF.However,therasasignificantlater lisat on bloodfl wine dogenous(i.e.vson-endogenous)pati nts -i.e.bloodfl wwassignificantlylo ernthLH.T sametrendwasobservedinendogenous.
Age,sexandHRSDscorewen t relatedtorCBF(i. .lef ,right,tot lr outerrim)
Dolan,etal.,(1992)
Cognitivelyimpaired depressed(10:1bi olar) vs.unimpaired(10:1 bipolar)
PETwith15Oxygen
Resultsindicatedaprofi eofrCBFbnormal tiesithe cognitivelyimpairedgroupthaconsistedfdecreas sin theleftanteriormedialprefrontalco t xndincreas s thecereb llarv mis.Th schangesardditionalto seenindepressioalone. .compar dt ntrols(N=23), patientsshoweddecreaserCBFinl ftandrighDLPFC(BA 46),leftACgyrus(BA32andtheri hinsula.
Noevidentsignificanteffe tf medicationstatus,illn ssdurat on,or yearsofeduc tionnrCBF.
Dolan,etal.,(1993)
Depressed(40)v . Schizophrenic(30)
PETwithI5Oxygen-i.e.r lationship betweenpsychomotorretardatiand rCBF









Depressed(29)v .Controls (16) (seeBench,tal.,1994for fulldetailsofparticipants andmetho ology)
PETwith15Oxygen-i.e.correlatio betweenrestingstaterCBFand principalcomponentsident fiedfro neuropsychologicaldata,r ultingi twofactors,ithloadingso(1) memoryand(2)atte tion.









Depressed(21:12familial puredepressiveisorder (FPDD),9depression spectrumdisorder)vs. Bipolar(15:7bipolar- depressed,8bipolar- manic)vs.Controls(12)
PETwith18FDG-i.e.examining glucosemetabolisminthea ygdala
Leftamygdalametabolismwincr sebo htheFPDD andbipolar-depressedgroups,com aret nt ol .
Leftamygdalametabolismw s positivelycorrela edwithstressed plasmaCortisollevelintheunipo ar depressedpatients.
Hickieetal.,(1999)
Depressed(25:unipolar andbipolar,rationot specified)
SPECTwithTc-HMPAO-i.e. correlationbetweenres i gstateCBF andpsychomotorperformance
ChangesirCBFt eleftneo-striatumwerinv rsely correlatedwithRT-i.e.pati n stgrea estsychomotor retardationshowedleastrCBFinc aseduringperformance ofchoicereactiontime.










inthelefthemisph recomparedntrols.As ila trendwasobservedfthrighthemisph re,butfail d reachsignificance.









PETwith15Oxygen-i.e.correlation betweenrestingCBFandnumberof principalcomponentsextractedfr m scoresonaneuropsychologicalb tt ry






Depressedgroupshowad cr aseinl balcorticalblo flowcomparedtcontrols.M reover,depr sspatients exhibitedabnormalityitopographicdistri utionfbl od flow-i.e.duetr ductionns le tivefr ntal,cen ral, superiortemporal,andntparietalreg ns.Thtte mayreflectdysfunctionithparallelist ibu edco tica networkinvolvingfrontalandtemporoparietallym associationare s.
Theext ntoftopographicabnormality wasassociatedithbothgnd severityofdepression(i. .HRSD),but notwithmed cationsta usor depressivesubtype.
Saxena,etal.,(2001)
Depressed(27)v .OCD (27)vs.OCD+MD1 vs.Controls(17)
PETwith18FDG
Lefthippocampalmetabolismwsignif cantlylo ern MDDalonendOC+patientsthinor controls.Moreover,thalamicmet bolismwasignif cantly elevatedinOCDandMDlon .I ddi ion,patientsw th OCD+MDhadsignificantlylowermetabol sminth thalamus,caudatendhippoc p sth nOCDone. Otherselectedr gionsofin r st,wh chown significantmaieffectofpartic pg oup,included (bilaterally)thcaud te,DLPFCdorsalndve trAC, OFC,putamen,andVLPF .











DecreasedrCBFinthsubgenualportionfl ftA cortex(BA25),andinsular,later ltempor lpa ieta cortices,andincreasedCBFdierightrebellumleft occipitalcortexinpsychoticdepress dom aredt controls.Comparedtn -psychoticdepresspa ients, thosewithpsychoticfeaturesshow ddecreasCBFinA andinferiorfrontalcortex,cr as drCBFthight cerebellum.Aft ro-varyingforHRSDscorethindingf reducedCBFinthsubgenualApsychoticvs.on- psychoticdepressedatien sremai esign ficant.





Duringdepressedepi o e,nipolardpat ents showedarelativeinc sCBFtheleftfrontalort x comparedtb thntrolsa dipol rpatients.These differencestendedosapp aroremission.R mitt d, depressedpatientsal oexhibitehig rperfu i nindex (PI)intherightemporalregionancontrols.











Aftercontrollingfoeff ctsfage,gender,y ar education,anddegreeoflat ralispati ntsexh bit d significantincreasebloodfl wtheighthipp campus andtheleftcereb llumomparedntro s.Thwa alsotrendowar sincre sedfl wheleftat ral occipito-temporalgyrusinpati ntscomparedt nt ols.
Therewasasignificantincr set e proportionfbloodfl wintheari al andtemporallobesinfe alecompa d




Patientsexhibitedincreasebloodfl wth hippocampus,cerebell mACgyrus,andthbasala glia comparedtcontrols.
Strongnegativecorrelationbetw eth extentofpsychomotorretardationand bloodfl winthedorsolat ralan supraorbitalprefrontcortices. Severityofdepression(i.e.HRSD)was correlatedwithbloodfl winth hippocampus.
Wu,etal.(1992)
Depressed(15)v .Controls (15)
PETwith18FDG-i.e.effectofsl ep deprivationonbraimet bolismin depression
Aftersl epdeprivation4essedpatientshow reducedHRSDscor s-i. .'responders'.P i rt le p deprivationessedespondersexhibit ds gnificantly highermetabolicrateinthcingulateor xt nn- responders,thisnormalisedafterdepriva ion.
N/A
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Depressed(10)v . Schizophrenic(10)vs. Controls(20)
133Xenoninhalati-. . during3conditio s:(1)resting state,(2)implensorimotor task,(3)cognitivet sk
Set-formation,set- maintenance,a dse - shifting:WCST















Planning:TOL (vs.'guessing7ta k)-under 3feedbackconditions:(1) positive(2)negative,and3 neutral




Executivecontrol,i. . responseinhibiti : auditoryGo/No-got sk
Functional:Bothgr upssh wedtheamevoltagp rni'Go'ask,but 'No-go'taskdepre sivepatientsshowedr ductionfhearlyfront -t mporal positivityintheN2imewindow,hichasassociateditre pon enhibit on controls.Suggestsadysfunc ionalctivationfthne w rksubservingexecu ve controlduringanearlystagefrticalpr cessing. Behavioural:D pressedatienterformedwelcon rolsit'Go' d tions, butwereimpairedonth'No-go'condition(i. .responsen ibit n)
Kimbrell,etal., (2002)
Depressed(38:range fromeuthy ic- severelydepr ss d(i. . HRSD>22))vs. Controls(37)
PETwith,8FDG-i.e. measuringregionalc rebr glucosemetab lism(rCMRglu)
Sustainedattention: auditorycontinuous performancet st















Cognitivee erationf affect-i.e.usingaf ectively positiveandnegati picture-captionairs















Workingmemory- Sternbergworkinmemo y task





Functional::Bothpatientsandon rolsactivatedlefAC,DLPFC,medi PFC,andrightcerebellumduringp rformanceofthask.How ver,h er nosignificantdifferen esthepatt rofactivatiobetw npatientsdcontrols. Behavioural:Depressedatientswersignificantlyimpa r dotverbalflu y taskcomparedntrols
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BOLDfMRI-block design (2)whole-brain imaging
(1)VWM:visual,N-back0--» 3-back) (2)samep radigm,buthorter blockduration&fewertrials ofeachlevel





































Workingmemorytas sresultedingrea rpref ontalactiv ionthan n-WMtask.No -WM




(1)SWM:visual,DMTS.2 factorsofintere t,. .2Dvs 3Dobjects&no.fo jtbe remembered(1vs.3). (2)Samevisualt ks(1), plusauditorypresentationof stimuli.









BOLDfMRI-block design(u i g structuredeq ation modelling)
VWM:visual,N-back(0-&2 back)














Appendix 2A: Recruitment materials
1. Information sheet for medical staff: Experiments One & Two
2. Patient recruitment advertisement: Experiments One & Two
3. Control recruitment advertisement: Experiments One & Two
4. Information sheet for participants: Experiments One & Two
5. Consent from: Experiments One & Two
6. Information pack: Experiment Three
a. Exclusion criteria list
b. Information sheet for participants
c. Medication information sheet
d. Statement on compensation arrangements
e. Consent form
f. GP information sheet
g. Personal details form









Tel: 0131 537 6802 Fax: 0131 537 6106
Email: e.j.rose@sms.ed.ac.uk
Research project: Working Memory in Depression
Information sheet formedical staff
We are currently trying to recruit patients with major depression to take part in a study
looking at working memory deficits in depression and their underlying causes (the details of
which have already been presented to and reviewed by the Lothian Psychiatry/Clinical
Psychology Research Ethics Committee).
There are two phases to this study. In the pilot phase patients are asked to attention the
Royal Edinburgh to complete a number of behavioural, affective, and neuropsychological
tests, in order to assess the severity of depression and the level of cognitive impairment. In
the second experimental phase, we are asking patients to attend the Western General
Department of Clinical Neurosciences Unit, where they will be asked to complete a working
memory tasks while have a functional MRI can. Participation in either phase is expected to
take approximately 1 hours. We have already begun conducting the pilot study and it is
expected that the first experimental trials will run sometime between now and early next
year.
We are presently looking for a further 15 patients to participate in the pilot phase , and an
additional 10 patients to take part in the experimental trials. We are hoping to recruit patient
already receiving in- or out-patient care for depression, or those who have only recently been
referred to outpatient services. It is expected that patients who wish to participant will fulfil
the following inclusion criteria:
1. Aged between 18 and 50 years old
2. No history of head injury
3. No previous neural surgery
4. No history of diabetes, liver disease, heart attacks, strokes, or other major physical
illness
5. Not colour blind
6. Not currently pregnant
7. No recent alcohol or drug abuse
8. No ECT in the last six months
9. No change in medication within the last week (including changes in dose)
10. No history of psychotic symptoms
It is essential that we meet with patients prior to them taking part in order to discuss the
study and what would be expected of them. All patients who wish to participate in this study
will be provided with an information sheet a minimum of 48 hours prior to participation. They
will be advised to discuss participation with both their families and their physician. They will
also be advised that they are free to withdraw at any stage.
Any questions regarding participation, from both staff and patients, can be directed to either
Prof. Klaus Ebmeier or myself at the above address









Tel: 0131 537 6802 Fax: 0131 537 6106
Email: e.j.rose@sms.ed.ac.uk
Working Memory in Depression: an fMRI study
Patient Recruitment
Prof. Klaus Ebmeier and myself area currently conducting a study looking at cognitive and
functional brain deficits in major depression
We are looking for individuals with a diagnosis of major depression to take part in this study,
who meet the following criteria:
11. Aged between 18 and 50 years old
12. No history of head injury
13. No previous neural surgery
14. No history of major physical illness
15. No recent alcohol or drug abuse
16. No ECT in the last six months
17. No change in medication within the last week (including changes in dose)
18. No history of psychotic symptoms
This study is being conducted in two phases. The first involves completion of a couple of
assessments of mood, two short tests of attention, and a computerised working memory
task. The second phase involves completion of the memory task, while undergoing a
functional MRI scan. Participation in either phase is expected to last between 1 - 1 % hours.
All patients who wish to participate will be provided with an information sheet a minimum of
48 hours prior to taking part, and given the opportunity to ask any questions they may have
regarding participation.
If you are aware of any patients who may be suitable to participate, or have any questions
regarding the study, please contact either Prof. Ebmeier or myself. You can telephone me














Tel: 0131 537 6802 Fax: 0131 537 6106
Email: e.j.rose@sms.ed.ac.uk
Working Memory in Depression: an fMRI study
Volunteers Needed
Prof. Klaus Ebmeier and myself area currently conducting a study looking at cognitive and
functional brain deficits in major depression and are currently in need of healthy volunteers
to participate as controls in this study.
The study is being conducted in two phase. The first involves completion of a couple of
questionnaires relating to mood, two short tests of attention, and a computerised working
memory task. The second phase involves completion of the working memory task while
undergoing a functional MRI scan.
19. Aged between 18 and 50 years old
20. No history of head injury
21. No previous neural surgery
22. No history of major physical illness
23. No history of mental health problems
If you, or anyone you know, meets the above criteria and would be interested in participating
the study please let me know. Similarly if you have any questions regarding the study
please feel free to contact me. I can be contact on the above number, or on the internal














Tel & Fax: +44-131-537-6505
You are being invited to take part in a research study. Before you decide it is
important for you to understand why the research is being done and what it will
involve. Please take time to read the following information carefully and discuss it
with friends, relatives, and your GP if you wish. Ask us if there is anything that is not
clear of if you would like more information. Take time to decide whether or not you
wish to take part.
Consumers for Ethics in Research (CERES) publish a leaflet entitled 'Medical
Research and You'. This leaflet gives more information about medical research and
looks at some questions you may want to aask. A copy may be obtained from
CERES, PO Box 1365, London, N16 OBW.
Thank you for regarding this.
What is the purpose of this study?
People who are depressed often report that they have memory and attention difficulties in
everyday situations, particularly if it is necessary to keep track of some sorts of information
and ignore others. For example, holding in mind directions about a route whilst ignoring a
radio program. Only a small amount of research has been directed at understanding these
sorts of problems in depression.
Why have I been chosen?
You will either be one of 20 patients who have been in contact with the hospital or outpatient
clinic and have been diagnosed as suffering from a major depressive episode, or one of 20
healthy volunteers studied in the control group.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be
given this information sheet to keep and be asked to sign a consent form. If you decide to
take part you are still free to withdraw at any time and without giving a reason. This will not
affect the standard of care you receive as a patient.
What will happen to me if I take part?
If you would like to be included in this study, you will be invited to the University Department
of Psychiatry at the Royal Edinburgh Hospital fro about an hour. In addition to having a go at
the memory task you will be asked to answer questions about your medical history and fill
out some short questionnaires about how you are feeling at the moment. In this study, we
would like to find out under what circumstances people with depression find it difficult to keep
track of information. To do this we will ask you to have a go at a computerised memory task
in which you be asked to keep in mind particular place on a computer screen and respond by
button pressing. We will adjust the difficulty of the task by varying how long you need to
keep this information in mind. The point of this study is to define the range of difficulty coped
with by depressed and not depressed people.








Tel & Fax: +44-131-537-6505
What are the possible side effects, risks or disadvantages of taking part and what
happens if something goes wrong?
We do not anticipate that any harm could come to you as a result of participating, but if there
is a problem, the Lothian Primary Care Trust is responsible for negligent harm, while the
University of Edinburgh is insured against accidental injury.
What are the possible benefits of taking part?
Although we do not expect that any benefits will come to participants, it is hoped that your
participation will be of benefit to those suffering from depression in the future.
Will my taking part in the study be kept confidential?
All information that is collected about you during the course of the research will be kept
strictly confidential. Any information about you which leaves the hospital will have your name
and address removed so that you cannot be recognised from it.
What will happen to the results of the research study?
The results will be published in a form that makes it impossible to identify individuals.
Who is organising or funding the research?
This research is organised by the Department of Psychiatry, University of Edinburgh, funded
by the Scottish Higher Education Funding Council, and your doctor will not be paid for
including you in the study.
Who has reviewed this study?
This study has been reviewed by the Lothian Psychiatry/Clinical Psychology Research
Ethics Subcommittee.
Contact for further information:
K P Ebmeier, Professor of Psychiatry and Consultant Psychiatrist, Royal Edinburgh Hospital,
Tel: 0131-5376526
Independent advisor:
Dr D Cunningham Owens, Reader in Psychiatry, Department of Psychiatry, Kennedy Tower,
Royal Edinburgh Hospital (Tel: 0131-5376000)
Thank you for taking part in this study. You will be given a copy of this Information









Tel & Fax: +44-131-537-6505
Consent form
Research Project: Working Memory in Depression
Researcher: Prof. Klaus Ebmeier
Participant identification number:
Please read each of the following statements and initial the corresponding box:
Initial box
I confirm that I have read and understood the information sheet for the above study
and had the opportunity to ask questions.
I understand that my participation is voluntary and that I am free to withdraw at any
time without giving a reason, without my future medical care or legal rights being
affected.
I understand that responsible persons from the University of Edinburgh and the
University of Strathclyde may examine sections of my medical notes.
I agree to take part in the above study.
L L
Name of patient Date Signature
L Z
Name of researcher Date Signature
3 copies to be made: 1 for patient; 1 for researcher; and 1 for hospital notes
XLIX
Division of Psychiatry







Escitalopram and working memory
In order to take part in this study you must meet the following criteria:
1. Aged 18 - 50 years
2. No history of psychiatric illness
3. No history of serious physical illness - e.g. heart attack, stroke, diabetes, liver
disease etc.
4. No previous serious head injury
5. Not colour blind
6. Not currently pregnant
7. No history of drug or alcohol addiction or serious abuse












Research Project: Escitalopram and working memory
Researchers: Prof K. Ebmeier and Emma Jane Rose
You are being invited to participate in the above research project. Before you decide
whether or not to take part it is important for to understand why the research is being done
and what it will involve. Please take the time to read the following information carefully, and
discuss it with other if you wish. Ask us if there is anything that is not clear or if you would
like more information. Take time to decide whether or not you wish to take part.
What is the purpose of the study?
When people are depressed they are often prescribed an anti-depressant medication. These
medications work on levels of two different neurotransmitters in the brain, i.e. serotonin and
noradrenalin, which are implicated in mood and attention. In healthy volunteers anti¬
depressant medications appear to affect attention and concentration. The purpose of this
study is to look at the effects that a selective serotonin reuptake inhibitor (SSRI), i.e.
escitalopram, has on the ability of healthy volunteers to perform certain short-term memory
and attention tasks.
Why have I been chosen?
You are one of a number of healthy individuals who have been approached to take part in
the study.
Do I have to take part?
Participation in the study is entirely voluntary. If you decide to take part in the study you are
still free to withdraw at any time, without giving a reason.
What will happen to me if I take part?
If you decide to take part in the study you will be invited to the University Department of
Psychiatry for an initial interview, where you will be asked some questions regarding your
medical history and fill out some questionnaires about your current mood. You will then be
allocated to one of two groups. Individuals in group one will be asked to complete a
computerised memory task, while undergoing a functional MRI scan. This type of scan
allows us to see which parts of the brain become active while you complete the task. These
individuals will then be asked to take 10mg of escitalopram/day for the next 7 days. After
this you will be invited back to complete the same memory task again in the scanner.
Individuals in group 2 will initially be prescribed 10mg escitalopram/day for 7 days; they will
then undergo a scan while completing the task. Individuals in this group will then be invited
to return for a second scan 7 days after they cease taking the medication. In addition after
taking the medication for 7 days a sample of you blood will be taken in order that we can
check the levels of the anti-depressant.
LI
You will also be asked to provide a blood sample on the day that you commence the
antidepressant treatment, and on the final day of the course of medication.
What are the possible side effects, risks or disadvantages of taking part, and what
happens if something goes wrong?
You may suffer some side effects while you are taking these drugs. We expect these to be
mild. In some individuals escitalopram can cause nausea, headache, dizziness, insomnia,
agitation, nervousness, constipation, diarrhoea, palpitation, dry mouth, sleepiness,
weakness, increased sweating or tremor. Some individuals also find that their concentration
is altered. Given this possibility we do not recommend that you take part if you are about to
undergo any important examinations. We expect that any side effects you may experience
will be mild and we do not expect that any harm could come to you as a result of taking part.
However, if there is a problem Lothian Primary Care Trust is responsible for negligent harm,
while the University of Edinburgh is insured against accidental injury. There will be an
available contact on the research team 24 hours a day 7 days a week if there are any
questions or problems. Your general practitioner will also be informed about your
participation and will be able to contact the research team if the study code needs to be
broken.
What are the possible benefits of taking part?
While we do not anticipate any direct benefits to the participants of this study, it is hoped that
your participation will be of benefit to those individuals suffering from depression.
Will my taking part in this study be kept confidential?
All information that is collected about you during the course of the research will be kept
strictly confidential. Any information about you which is collected will have your name and
address removed so that you cannot be recognised from it.
What will happen to the results of the research study?
The results of the study will be published in a form that makes it impossible to identify
individuals who took part in the project. After the study is completed your information will be
kept by the Department of Psychiatry and may be used again in the future for other research
projects.
Who is organising or funding the research?
This research is organised by the Department of Psychiatry, University of Edinburgh, and is
funded by the Scottish Higher Education Funding Council, and the Medical Research
Council.
Contact for further information:
Prof K. Ebmeier, Professor of Psychiatry and Consultant Psychiatrist, Royal Edinburgh
Hospital, Tel: 0131 537 6505
or
Ms Emma Jane Rose, MRC PhD Student, Department of Psychiatry, Royal Edinburgh
Hospital, Tel: 0131 537 6802
independent advisor:
Prof D Blackwood, Professor of Psychiatry, University of Edinburgh, Kennedy Tower, Royal
Edinburgh Hospital, Tel: 0131 537 6000
Thank you for taking the time to read this. If you decide to take part in this study you
will be given a copy of this information sheet and a signed consent form to keep.
LII
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Research project: Escitalopram and working memory
Escitalopram is an antidepressant medication, which belongs to a class of drugs known as
selective serotonin reuptake inhibitors (SSRI's). As with all medications, escitalopram has a
number of reported potential side effects.
The following table indicates the percentage of patients with depression who experienced
the most common side effects associated with use of escitalopram, and how these figures
compared with individuals who where prescribed a placebo (i.e. a 'dummy' medication)
TABLE 1 - TREATMENT-EMERGENT ADVERSE EVENTS*
INCIDENCE IN PLACEBO-CONTROLLED CLINICALTRIALS
Body System/Adverse Event Percentage of Patients Reporting
Escitalopram (n=715) Placebo (n=592)
Dry Mouth 6% 5%
Nausea 15% 7%
Fatigue 5% 2%
Increased Sweating 5% 2%
Somnolence 6% 2%
insomina 9% 4%
Ejaculation disorder 9% <1%
(from www.lexapro.com. accessed 25/10/2002)
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Statement on compensation arrangements
The University of Edinburgh holds a no-fault insurance clinical trials protection policy which
provides compensation to a research subject in respect of accidental injury arising out of a
clinical trial undertaken in the name of the university.
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Research Project: Escitalopram and working memory
Researchers: Prof. Klaus Ebmeier and Emma Jane Rose
Participant identification number:
I confirm that I have read and understood the information sheet for the above study
and had the opportunity to ask questions.
I understand that my participation is voluntary and that I am free to withdraw at any
time without giving any reason, without my future medical care or legal rights being
affected.
I agree for notice to be sent to my General Practitioner about my participation in this
study,
I agree to the provision of clinically significant information to my General Practitioner
about my participation in this study.
I understand that this is a non-therapeutic research project from which I cannot
expect to derive benefit.













Name of researcher Date Signature
3 copies to be made: 1 for participant; 1 for researcher; 1 for GP
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Escitalopram and working memory
Please complete the following details and return it to me in the enclosed envelope, along















Tel: 0131 537 6000
Dear Dr
RESEARCH PROJECT: The effect of escitalopram ori working memory in healthy
volunteers: A functional MRI Study
Your patient has agreed to take part in the above research project.
He/she will be asked to take 10 mg of escitalopram/day for 7 days. In addition he/she will be
asked to complete a working memory task while undergoing a functional MRI scan.
Participants will be scanned both on and off medication.
Your patient has already been screened for any history of psychiatric or serious medical
illness. However, if you feel that there is any reason why he/she should not participate in the
study please do not hesitate to contact us. Similarly, if at any point during the study you feel
that he/she should be withdrawn from participation please let us know.
With this letter I have enclosed a copy of the information sheet for this project and a copy of
your patients consent form.
If you have any queries please feel free to contact me.
Kind regards,
Emma Jane Rose
Clinical Supervisor: Professor Klaus Ebmeier.
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Appendix 2B: Pre-test materials
1. Medical history questionnaire: Patients
2. Medical history questionnaire: Controls




Please complete the following questionnaire by either filling in the boxes, or, where required,
by ticking the appropriate box. Please be careful to answer all questions, and to answer
each question truthfully. All information obtained will be treated confidentially.
Name:
Date of Birth:
Sex: Female EH Male j 1
Occupation:





Any other major physical illness






2. Have you ever suffered a head injury (even mild)?
Yes No
3. Have you ever had any form of neural surgery?
Yes □ No Q
4. Are you colour blind?
Yes EH No EH
5. Are you currently pregnant?
Yes □ NO □
6. How many units of alcohol have you consumed in the last week?
(Note: 1 unit = 125ml glass of wine, 25ml measure of normal strength spirit, or 1/2 pint of
normal strength lager, beer or cider)
Does this indicate an average/normal week for you (i.e. your average consumption per week
over the last three months)?
Yes EH No EH
If no, how many units would you consume in an average/normal week?
LX
7. Are you currently taking any prescription medication?
Yes Q No EZ1 Medication/Dose
If yes, are you taking this medication in accordance with your doctor's orders?
Yes No Q
If no, describe
8. How long has it been since you were first diagnosed as suffering from depression?
9. Have you ever received ECT as part of your treatment for depression
Yes □ No□ Time since last ECT treatment:
10. Are you left or right handed?
Medical History: Controls
Please complete the following questionnaire by either filling in the boxes, or, where required,
by ticking the appropriate box. Please be careful to answer all questions, and to answer
each question truthfully. All information obtained will be treated confidentially.
Name:
Date of Birth:
Sex: Female Q Male □
Occupation:
1. Have you ever suffered from any of the following conditions (please tick)?:
Diabetes j
Liver disease [J
Heart attack j j
Stroke ED
Any other major physical illness □
(If yes, which illness
2. Have you ever suffered a head injury (even mild)?
Yes QJ No Q
3. Have you ever had any form of neural surgery?
Yes □ No □
4. Are you colour blind?
Yes □ No □
5. Are you currently pregnant?
Yes No Q
6. How many units of alcohol have you consumed in the last week?
(Note: 1 unit = 125ml glass of wine, 25ml measure of normal strength spirit, or 14 pint of
normal strength lager, beer or cider)
Does this indicate an average/normal week for you (i.e. your average consumption per week
over the last three months)?
Yes Q No j_j
If no, how many units would you consume in an average/normal week?
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7. Are you currently taking any prescription medication?
Yes Q No Q
If yes, are you taking this medication in accordance with your doctor's orders?
Yes Q No j^J
If no, describe
8. Have you ever been diagnosed as suffering from any psychiatric illness?
Yes Q No Q
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Patient Information Sheet
Patient Identification Number:
Name of person providing information:
Date:
1. How long has it been since the patient was first diagnosed as suffering from major
depression?
2. Has the patient ever been diagnosed as suffering from any psychotic symptoms?
Yes □ Non
3. Has the patient ever been diagnosed are suffering from drug and/or alcohol abuse?
Yes I I No I I
4. Is the patient currently prescribed any medication?
Yes □ No□ Medication/Dose: .
5. Has the patient ever received ECT as a treatment for their depression?
Yes □ Noll]
LXIV





1. Do you suffer from any heart disease or rhythm disorder? □ □
2. Have you had recent surgery of any type (within the last six □ □
months)?
3. Have you had any operations to your head (e.g. vascular □ □
clips, a cochlear implant, or a shunt)?
4. Have you ever had any metal fragments (e.g. shrapnel) in □ □
any part of your body?
5. Have you ever had any metal fragments in your eyes? □ □
6. Do you now, or have you ever worked with metal and had an □ □
injury which required medical attention?
7. Could you be pregnant? □ □
8. Have you had any metal implants (e.g. joint replacement, □ □
Harrington rods etc.)?
9. Do you wear dentures, a dental plate, a brace, contact □ □
lenses, or a hearing aid?
10. Do you suffer from diabetes or epilepsy? □ □
11. Do you have an IUCD or sterilisation clips? □ □
12. Do you have any metallic implants or foreign metallic objects □ □
in your body other than those mentioned above?
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Appendix 2C: Affective assessments
1. Beck Depression Inventory
2. Stress Arousal Checklist
3. Alderley Park State Anxiety Questionnaire
Beck Depression Inventory
ID DATE TIME (AM/PM)
1. 0 I do not feel sad
1 I feel sad
2 I am sad all the time and I can't snap out of it
3 I am so sad or unhappy that I can't stand it
2 0 I am not particularly discouraged about the future
1 I feel discouraged about the future
2 I feel I have nothing to look forward to
3 I feel that the future is hopeless and that things cannot improve
3 0 I do not feel like a failure
1 I feel I have failed more than the average person
2 As I look back on my life all I can see is a lot of failures
3 I feel I am a complete failure as a person
4 0 I get as much satisfaction out of things as I used to
1 I don't enjoy things the way I used to
2 I don't get real satisfaction out of anything anymore
3 I am dissatisfied or bored with everything
5 0 I don't feel particularly guilty
1 I feel guilty a good part of the time
2 I feel guilty most of the time
3 I feel guilty all of the time
6 0 I don't feel I am being punished
1 I feel I may be punished
2 I expect to be punished
3 I feel I am being punished
7 0 I don't feel disappointed in myself
1 I am disappointed in myself
2 I am disgusted with myself
3 I hate myself
8 0 I don't feel I am any worse than anybody else
1 I am critical of myself for my weakness' or mistakes
2 I blame myself all the time for my faults
3 I blame myself for everything bad that happens
9 0 I don't have any thoughts of killing myself
1 I have thoughts of killing myself but would not carry them out
2 I would like to kill myself
3 I would kill myself if I had the chance
10 0 I don't cry anymore than usual
1 I cry more now than I used to
2 I cry all the time now














































am no more irritated now than I ever am
get annoyed or irritated more easily than I used to
feel irritated all the time now
don't get irritated at all by the things that used to irritate me
have not lost interest in other people
am less interested in other people than I used to be
have lost most of my interest in other people
have lost all of my interest in other people
make decisions as well as I ever could
put off making decisions more than I used to
have greater difficulty in making decisions than I used to
can't make decisions at all anymore
don't feel I look any worse than I used to
am worried that I look old or unattractive
feel that there are permanent changes in my appearance that make me look
unattractive
believe that I look ugly
can work about as well as before
t takes extra effort to get started at doing something
have to push myself very hard to do anything
can't do any work at all
can sleep as well as usual
don't sleep as well as usual
wake up 1 - 2 hours earlier than usual and find it hard to get back to sleep
wake up several hours earlier than I used to and cannot get back to sleep
don't get more tired than usual
get tired more easily than I used to
get tired from doing almost anything
am too tired to do anything
My appetite is no worse than usual
My appetite is not as good as it used to be
My appetite is much worse now
I have no appetite at all anymore
I haven't lost much weight, if any, lately
I have lost more than 5 pounds
I have lost more than 10 pounds
I have lost more than 15 pounds
I am purposely trying to lose weight by eating less Yes No
I am no more worried about my health than usual
I am worried about physical problems such as aches and pains, or upset stomach
or constipation
I am very worried about physical problems and it is hard to think of much else
I am so worried about my physical problems that I cannot think of anything else
I have not noticed any change in my interest in sex
I am less interested in sex than I used to be
I am much less interested in sex now





MACKAY, COX, LAZZERINI, AND BURROWS (1978)
REVISED BY COX AND MACKAY (1985)
MANUAL BY GOTTS AND COX (1987)
INSTRUCTIONS
The adjectives below describe different feelings and moods. Please use this list to describe
your feelings at this moment in time.
If the adjective definitely describes yours feelings circle the:
©+?"
If the adjective more or less describes your feelings circle the:
++©?"
If you do not understand the adjective, or you cannot decide
whether it describes how you feel circle the:
♦♦♦0-
If the adjective does not describe how you feel circle the:
"*?Q
Your first reactions will be the most reliable, therefore do not spend you too

















++ + ? Tired ++ + ?
++ + ? Idle ++ + ?
++ + ? Up tight ++ + ?
++ + ? Alert ++ + ?
++ + 9 Lively ++ + ?
++ + ? Cheerful ++ + ?
++ + ? Contented ++ + ?
++ + ? Jittery ++ + ?
++ + ? Sluggish ++ + ?
++ + ? Pleasant ++ + ?
++ + ? Sleepy ++ + ?
++ + ? Comfortable ++ + ?
++ + ? Calm ++ + ?
++ + ? Stimulated ++ + 9
++ + ? Activated ++ + ?
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The Alderley Park State Anxiety Questionnaire (APSAQ)
Name:
Below are 12 statements
Please indicate to what extent each statement applies to you NOW.
For example, if at this moment you feel you can cope 'moderately' well please tick the
column marked 'MODERATELY'
It is important to answer ALL 12 questions
Please tick one box only for each statement
Not at all Slightly Moderately Considerably Extremely
1. I feel I can cope
2. I am worried
3. I feel calm
4. I feel afraid
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
5. I want to escape □ □ □ □ □
from here
6. My body feels □ □ □ □ □
relaxed
7. My heart is beating □ □ □ □ □
faster
8. I can breathe freely □ □ □ □ □
9. I have butterfliesin
□ □ □ □ □
my stomach
10. I feel sweaty □ □ □ □ □
11. I can think clearly □ □ □ □ □
12. My mind is racing □ □ □ □ □
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Appendix 2D: Cognitive assessments
1. National Adult Reading Test
2. Rey Auditory Verbal Learning Test
a. Form 1
b. Recognition List: Form 1
c. Form 2
d. Recognition List: Form 2




















































Total = recall order
R = Repeated recall
RC = s corrects themselves
RQ = s unsure of item
E = error
EC = error (confabulation)















































































Total = recall order
R = Repeated recall
RC = s corrects themselves
RQ = s unsure of item
E = error
EC = error (confabulation)























































Keytoresultsables: LH:lefthemisphere RH:righthemisphere LH/RHinterhemispheric BA:rodmannarea Ke:clustersiz(i. .numbofvox ls,whereeachl=
8mm3)





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Medialorb talprefrontal cortex/subgenual(rostral) anteriorci gulate
128
0.025
*=notsignificantbutre dowar stat sticali nificance.
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